Sentence,class,file
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/5b/vhrm-11-203.PMC4378876.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 203–209Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  203ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S4013 4Lowering triglycerides to modify cardiovascular  risk: will icosapent deliver?,Non-OADS,/arxiv_data1/oa_pdf/9f/5b/vhrm-11-203.PMC4378876.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/9f/5b/vhrm-11-203.PMC4378876.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/5b/vhrm-11-203.PMC4378876.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/dc/tcrm-11-481.PMC4378877.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 481–487Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  481Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6749 1Umeclidinium bromide/vilanterol combination  in the treatment of chronic obstructive pulmonary  disease: a review Dionisios Spyratos Lazaros Sichletidis Pulmonary Department,   “G Papanikolaou” Hospital,   Aristotle University of Thessaloniki,   exohi, Thessaloniki, GreeceAbstract:  Chronic obstructive pulmonary disease (COPD) is a common disease among  the elderly that could be prevented by smoking cessation.",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/tcrm-11-481.PMC4378877.pdf
"The latter contribute to  COPD severity, as they are related to more rapid decline in lung function8 and worse  prognosis.9 In addition, the systemic manifestations of the disease and comorbidities  have been proven to act as prognostic factors.10,11 Although COPD is a chronic, incurable disease, its treatment can be divided into  three different components: prevention (smoking cessation, avoidance of occupational  and environmental exposure, vaccinations), pharmacotherapy (bronchodilators, inhaled Correspondence: Lazaros Sichletidis Pulmonary Department, “G  Papanikolaou” Hospital, Aristotle  University of Thessaloniki, Karolou  Dil 3, Thessaloniki 54623, Greece Tel +30 231 026 0858 Fax +30 231 026 0858 email sichlet@med.auth.g r Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Spyratos and Sichletidis Running head recto: Umeclidinium bromide/vilanterol in COPD DOI: http://dx.doi.org/10.2147/TCRM.S67491",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/tcrm-11-481.PMC4378877.pdf
"Available from: http://www.goldcopd.org/ uploads/users/files/GOLD_Report_2015.pd f. Accessed Jan 17, 2015.",OADS,/arxiv_data1/oa_pdf/1f/dc/tcrm-11-481.PMC4378877.pdf
"Available from: http://www.fda.gov/ newsevents/newsroom/pressannouncements/ucm379057.ht m. Accessed  Jan 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/tcrm-11-481.PMC4378877.pdf
Available from: http://www.ema.europa.eu/ ema/index.jsp?curl =pages/medicines/human/medicines/002751/ human_me d_001754.jsp&mid =WC0b01ac058001d12 4.,Non-OADS,/arxiv_data1/oa_pdf/1f/dc/tcrm-11-481.PMC4378877.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/tcrm-11-481.PMC4378877.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/dc/tcrm-11-481.PMC4378877.pdf
"Median Score Rank Ordered Final Expert Panel Ratings of Importance of Tailoring Aspects of Care to the Needs of Women Veterans * Panel Scores MedianMean (SD) First contact (19 aspects) Outreach policies and practices VA Web site (http://www.va.gov) 5 4.67 (0.50)Information letters (ie, descriptions of VA health care options and services)5 4.33 (1.00) Outreach and education efforts in the community (eg, Vet Centers, social service agencies, stateVeteran commissions)5 4.33 (0.87) Marketing campaigns to increase Veteran enrollment4 4.44 (0.53) First telephone contact 4 4.22 (0.97) Debrieﬁng phase (ie, information session immediately before military discharge)4 4.00 (1.00) Registration procedures for enrolling in and accessing care Entrance to the VA (including front desk) 4 3.89 (0.93)Registration ofﬁce 4 3.78 (0.83)General information when entering the VA health care system4 3.78 (0.83) My Health eVet content (patient web portal) 3.5 3.00 (1.31) Transportation to the VA 3 2.78 (1.09) First appointment experience Privacy issues 5 4.56 (0.73)Physical safety on campus, in buildings 5 4.44 (0.73) Making the ﬁrst appointment 5 4.33 (1.12) Availability of female provider 5 4.33 (1.00)Availability of female nurse 4 4.33 (0.50)First contact 4 3.89 (1.05)Availability of other female personnel 4 3.78 (0.97)Waiting room 3 3.22 (0.83) Ambulatory care settings: primary care (49 aspects) Assessment, screening, and preventive care Obtaining mammogram 5 3.78 (1.72)Obtaining Pap smear 5 3.78 (1.72)Military sexual trauma (MST) screening 4 4.33 (0.71) Approach to screening for sexually transmitted infections4 4.11 (0.78) Obesity management/weight loss programs 4 4.11 (0.33) General mental health assessment 4 4.00 (1.12)Medical history assessment (social history) 4 3.78 (1.09)Smoking cessation programs 4 3.67 (0.50)Medical history assessment (family history) 3 3.56 (1.01) Cardiovascular risk screening 3 3.44 (0.53) Immunizations 2 2.33 (1.22) Structure, stafﬁng, and care arrangements Appropriately equipped examination tables routinely available5 4.89 (0.33) Reliance on designated women’s health providers in primary care/PACT clinics5 4.22 (1.09) VA-paid fee basis (per visit fee) or contract arrangements with providers in thecommunity5 4.22 (1.39) Enhancing teamlet to women Veteran communication4 4.00 (1.07) Integration of selected high-use specialists by women Veterans directly in women’s clinics or Women’s Health PACT teams4 3.78 (0.83) Integration or referral to non-MD professionals4 3.56 (1.01) Enhancing within teamlet communication 4 3.33 (1.41) Care management processes for women Veterans4 3.11 (1.45) (Continued )TABLE 1.",Non-OADS,/arxiv_data1/oa_pdf/ba/a9/mlr-53-s156.PMC4379113.pdf
Available at http://www.va.gov/vetdata/docs/Quickfacts/Homepage_slideshow_06_30_14.PDF.,Non-OADS,/arxiv_data1/oa_pdf/ba/a9/mlr-53-s156.PMC4379113.pdf
"RESULTS Table 1 shows descriptive statistics by cancer site (and distribution of by sex and age in Supplementary Table 1,Supplemental Digital Content 1, http://links.lww.com/MLR/ A879).",Non-OADS,/arxiv_data1/oa_pdf/98/36/mlr-53-302.PMC4379114.pdf
"(The gamma regression equa- tions used to generate the cancer-specific excess costs are shown in Supplementary Table 2, Supplemental DigitalContent 2, http://links.lww.com/MLR/A880 accompanied by instructions for readers to generate cost by phase for any sex by age combination.)",Non-OADS,/arxiv_data1/oa_pdf/98/36/mlr-53-302.PMC4379114.pdf
"Costsvaried only about 3- to 4-fold in the last month of life if dyingfrom cancer (Supplementary Figure 1, Supplemental Digital Content 3, http://links.lww.com/MLR/A881).",Non-OADS,/arxiv_data1/oa_pdf/98/36/mlr-53-302.PMC4379114.pdf
"To facilitate use of the costs reported in this paper, we have provided instructions and examples of how to estimate the cost associated with differenttypes of cancer based on the gamma regression equations in the Supplementary material (Supplemental Digital Content 2, http://links.lww.com/MLR/A880).",Non-OADS,/arxiv_data1/oa_pdf/98/36/mlr-53-302.PMC4379114.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.1 Clinical and Molecular Hepatology 2015;21:1-6 Review Corresponding author :  Anna S. Lok Division of Gastroenterology and Hepatology, University of Michigan,  3912 Taubman Center, SPC 5362, 1500 East Medical Center Drive, Ann  Arbor, MI, USA Tel: +1-734-936-7511, Fax: +1-734-936-7392 Email: aslok@umich.eduAbbreviations:   AASLD, American Association for the Study of Liver Diseases;   ALT, alanine aminotransferase; APASL, Asian Pacific Association for the  Study of the Liver, EASL, European Association for the Study of the  Liver; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen;  HBV, hepatitis B virus; HCC, hepatocellular carcinoma; IFN, interferon;  PEG-IFN, pegylated interferon.",Non-OADS,/arxiv_data1/oa_pdf/3f/9e/cmh-21-1.PMC4379190.pdf
"(Clin Mol Hepatol 2015;21:1-6) Keywords:  Hepatitis B virus; Chronic hepatitis B; Management; Personalized medicine Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/9e/cmh-21-1.PMC4379190.pdf
"2 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.1Clin Mol Hepatol Volume _21  Number _1  March 2015proteins or on restoration of host immune response to HBV, viral  relapse occurs in most patients when treatment is stopped.",Non-OADS,/arxiv_data1/oa_pdf/3f/9e/cmh-21-1.PMC4379190.pdf
Personalized treatment of hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.1were predominantly infected with HBV genotypes B and C and  who did not receive antiviral treatment.,Non-OADS,/arxiv_data1/oa_pdf/3f/9e/cmh-21-1.PMC4379190.pdf
4 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.1Clin Mol Hepatol Volume _21  Number _1  March 2015tients require many years or lifelong treatment.,Non-OADS,/arxiv_data1/oa_pdf/3f/9e/cmh-21-1.PMC4379190.pdf
"Personalized treatment of hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.1mend that in HBeAg-negative patients, nucleos(t)ide analogues  should be continued until HBsAg loss but the APASL guidelines  stated that treatment may be withdrawn after completing at least  two years treatment with undetectable HBV DNA documented on  three occasions six months apart.",Non-OADS,/arxiv_data1/oa_pdf/3f/9e/cmh-21-1.PMC4379190.pdf
6 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.1Clin Mol Hepatol Volume _21  Number _1  March 2015benefit can be derived while minimizing costs and adverse reac - tions (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/3f/9e/cmh-21-1.PMC4379190.pdf
http://www.apregistry.com/forms/interim_report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3f/9e/cmh-21-1.PMC4379190.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.104 Clinical and Molecular Hepatology 2015;21:104 Erratum Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.In the published version of this article, there was an error in the legend of Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/08/a3/cmh-21-104.PMC4379191.pdf
"Clin Mol Hepatol 2014;20(4):355-360. http://dx.doi.org/10.3350/cmh .2014.20.4.355 Yoo-Kyung Cho, Young Nam Kim, and Byung-Cheol Song.",Non-OADS,/arxiv_data1/oa_pdf/08/a3/cmh-21-104.PMC4379191.pdf
Clin Mol Hepatol 2014;20(4):368-375.  http://dx.doi.org/10.3350/cmh.2014.20.4.368,Non-OADS,/arxiv_data1/oa_pdf/08/a3/cmh-21-104.PMC4379191.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.14 Clinical and Molecular Hepatology 2015;21:14-21 Review Corresponding author :  Wankyo Chung Healthcare Management, School of Business, Hallym University,   1 Hallymdae-hak-gil, Chuncheon 200-704, Korea Tel: +82-33-248-1848, Fax: +82-33-228-1804 E-mail: wankyo@hallym.ac.kr Abbreviations:   DALYs, disability adjusted life years; KHPS, Korean health panel survey;  NHI, national health insurance  Received :  Nov. 15, 2014 /  Accepted :  Jan. 9, 2015INTRODUCTION  Liver disease has become one of the most important public  health concerns with increasing life expectancy in Korea.1 It is as - sociated with a significant increase in mortality and risk of many  morbidities.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
"(Clin Mol Hepatol 2015;21:14-21) Keywords:  Cost of illness; Liver disease Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
"Cost of liver disease http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.14This high mortality of liver disease among the economically ac - tive population means the economic burden of liver disease can  be immense for individuals, families, and society.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
"16 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.14Clin Mol Hepatol Volume _21  Number _1  March 2015tivity costs, matter —maximizing efficient resource allocation  within society.4 When all the relevant resources are identified and measured,  appropriate unit costs should be used in valuing them.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
"Cost of liver disease http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.14classifications of disease); the limitations are that costs of comor - bidities are included and costs for services and poor patients, not  covered by the NHI, are excluded.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
"18 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.14Clin Mol Hepatol Volume _21  Number _1  March 2015(0.8%).13-15  The data for Korea from the same source shows that liver cancer  caused 11,962 deaths and cirrhosis of the liver caused 6,169  deaths in 2012.",OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
"Cost of liver disease http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.14ry, not liver disease.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
20 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.14Clin Mol Hepatol Volume _21  Number _1  March 2015estimated using data from the Survey on the benefit coverage rate  of NHI by the NHI Service.,OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
"Ko - rean Statistical Information Service, http://kostat.go.kr/portal/korea/ index.action.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
"Cost of liver disease http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.14ley, New York, 1987.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
"Curtis L. Unit costs of health and social care 2009, Personal Social  Services Research Unit, University of Kent, http://www.pssru.ac.uk/ archive/, 2009.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
"National Evidence-based Healthcare Collaborating  Agency, http://neca.re.kr/eng/, 2013.",Non-OADS,/arxiv_data1/oa_pdf/17/b6/cmh-21-14.PMC4379192.pdf
pISSN 2287-2728        eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.22 Clinical and Molecular Hepatology 2015;21:22-23 Editorial Liver fibrosis is a wound-healing process that happens in almost  patients with ongoing chronic liver injury.,Non-OADS,/arxiv_data1/oa_pdf/09/b8/cmh-21-22.PMC4379193.pdf
"12, 2015  Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/b8/cmh-21-22.PMC4379193.pdf
"http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.22study, they excluded patients with an ALT level >80 IU/mL to pre - vent ALT values affecting results and found that a higher initial liv - er stiffness value was associated with liver stiffness improvement  in patients with CHB with antiviral therapy and in patients with  stable disease state for about 2 years.",Non-OADS,/arxiv_data1/oa_pdf/09/b8/cmh-21-22.PMC4379193.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.24 Clinical and Molecular Hepatology 2015;21:24-31 Original Article Corresponding author :  Byung Seok Kim Department of Internal Medicine, Catholic University of Daegu School of  Medicine, 33 DooRyoo Gongwon-ro 17 Gil, Namgu, Daegu 705-718, Korea Tel: +82-53-650-4043, Fax: +82-53-656-3281 E-mail: kbs9225@cu.ac.krAbbreviations:   ADV, adefovir; ALT, alanine aminotransferase; CHB, chronic hepatitis  B; CVR, complete virologic response; ETV, entecavir; HBeAg, hepatitis  B e antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma;  NAs, nucleos(t)ide analogues; PVR, partial virologic response; RFMP ,  restriction fragment mass polymorphism; TDF, tenofovir; VR, virologic  response Received :  Oct. 24, 2014 /  Revised :  Feb. 24, 2015 /  Accepted :  Feb. 25, 2015INTRODUCTION  Ultimately, the treatment for chronic hepatitis B (CHB) aims to  suppress hepatitis B virus (HBV) replication, relieve inflammation,  prevent fibrosis and hepatocellular carcinoma (HCC), and increase the survival rate.1,2 However, chronic HBV infection is not com - pletely eradicated due to persistence of covalently closed circular  DNA (cccDNA) of nucleus in the infected hepatocytes, and this can  result in HBV reactivation.3-5 So it is important to decrease and  maintain serum HBV DNA level to the undetectable level as the ac -Efficacy of prolonged entecavir monotherapy in   treatment-naïve chronic hepatitis B patients exhibiting  a partial virologic response to entecavir  Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, and Byung Seok Kim Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea Background/Aims:  The optimal management of patients exhibiting a partial virologic response (PVR) to entecavir (ETV)  has not been determined .",Non-OADS,/arxiv_data1/oa_pdf/f2/b9/cmh-21-24.PMC4379194.pdf
"(Clin Mol Hepatol 2015;21:24-31) Keywords:  Chronic hepatitis B; Entecavir; Partial virologic response Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/b9/cmh-21-24.PMC4379194.pdf
"Entecavir for partial virologic response http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.24tual purpose of treatment for CHB.6-8 The current guidelines advise  to check suboptimal responders by monitoring a virologic response  at each timepoint in the use of nucleos(t)ide analogues (NAs), to  provide an opportunity to modify a treatment so as to improve the  antiviral efficacy.9,10 Partial virologic response (PVR) is defined as more than 2 log10  IU/mL decrease in HBV DNA but in detectable level by real-time  PCR at week 242,10 in the Korean Association for the Study of the  Liver (KASL) and the American Association for the Study of Liver  Disease (AASLD) guidelines or when a HBV DNA decreases more  than 1 log10 IU/mL but is detectable to the patients treated for at  least 6 months with satisfactory compliance in the European As - sociation for the Study of Liver (EASL) guidelines1.",Non-OADS,/arxiv_data1/oa_pdf/f2/b9/cmh-21-24.PMC4379194.pdf
"26 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.24Clin Mol Hepatol Volume _21  Number _1  March 2015Korea) technology to identify the drug resistance mutation in the  HBV polymerase gene.18,19  Statistical analysis HBV DNA levels were logarithmically transformed for analysis.",OADS,/arxiv_data1/oa_pdf/f2/b9/cmh-21-24.PMC4379194.pdf
Entecavir for partial virologic response http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.24(14.3%) had PVR at week 48.,Non-OADS,/arxiv_data1/oa_pdf/f2/b9/cmh-21-24.PMC4379194.pdf
"28 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.24Clin Mol Hepatol Volume _21  Number _1  March 2015Factors associated with delayed virologic response In comparison with characteristics in the patients with complete  virologic responders and delayed virologic responders, there was  no significant difference among age, gender, cirrhosis, and HCC  (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/f2/b9/cmh-21-24.PMC4379194.pdf
Entecavir for partial virologic response http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.24the long-term treatment response.,Non-OADS,/arxiv_data1/oa_pdf/f2/b9/cmh-21-24.PMC4379194.pdf
"30 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.24Clin Mol Hepatol Volume _21  Number _1  March 2015While only treatment-naïve patients were followed up in our  study, the patients who experienced oral antiviral agents were in - cluded in some studies.",Non-OADS,/arxiv_data1/oa_pdf/f2/b9/cmh-21-24.PMC4379194.pdf
Entecavir for partial virologic response http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.2418.,Non-OADS,/arxiv_data1/oa_pdf/f2/b9/cmh-21-24.PMC4379194.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.32 Clinical and Molecular Hepatology 2015;21:32-40 Original Article Corresponding author :  Oh Sang Kwon Division of Gastroenterology, Department of Internal Medicine, Gachon  University Gil Medical Center, Gachon Medical School Gil Medical Center,  21, Namdong-daero 774beon-gil, Namdong-gu, Incheon 405-760, Korea Tel: +82- 32-460-3778, Fax: +82-32-460-3408 E-mail: kos@gilhospital.comAbbreviations:   ALT, alanine aminotransferase; CHB, chronic hepatitis B; CHC, chronic  hepatitis C; CI, confidence interval; ETV, entecavir; HBV, hepatitis B virus;   HBeAg, hepatitis B envelope antigen; HCV, hepatitis C virus;   INF, interferon;  kPa, kilopascals; LAM, lamivudine; LS, liver stiffness;   OR, odds ratio; SVR, sustained virologic response; TE, transient  elastography Received :  Jun.",Non-OADS,/arxiv_data1/oa_pdf/20/fd/cmh-21-32.PMC4379195.pdf
"(Clin Mol Hepatol 2015;21:32-40) Keywords:  Chronic hepatitis B; Hepatic fibrosis; Liver stiffness; Transient elastography Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/fd/cmh-21-32.PMC4379195.pdf
Liver stiffness and chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.32agement is started timely.,Non-OADS,/arxiv_data1/oa_pdf/20/fd/cmh-21-32.PMC4379195.pdf
34 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.32Clin Mol Hepatol Volume _21  Number _1  March 2015hepatitis B surface antigen for more than 6 months.,Non-OADS,/arxiv_data1/oa_pdf/20/fd/cmh-21-32.PMC4379195.pdf
Liver stiffness and chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.32sistance and then antiviral agents were changed during the study  period.,Non-OADS,/arxiv_data1/oa_pdf/20/fd/cmh-21-32.PMC4379195.pdf
36 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.32Clin Mol Hepatol Volume _21  Number _1  March 2015found in the clinical characteristics and laboratory data between  LS-improved and LS-deteriorated group (Table 2).,OADS,/arxiv_data1/oa_pdf/20/fd/cmh-21-32.PMC4379195.pdf
"Liver stiffness and chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.32Patients’ characteristics and LS value according to  whether LS is improved or deteriorated in antiviral  therapy (-) group In the antiviral therapy (-) group, 29 patients achieved an LS im - provement and in 26 patients LS deteriorated.",Non-OADS,/arxiv_data1/oa_pdf/20/fd/cmh-21-32.PMC4379195.pdf
"38 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.32Clin Mol Hepatol Volume _21  Number _1  March 2015tion.32-36 In previous reports, LS was found to be affected by serum  levels of total bilirubin, ALT, gamma-glutamyl transpeptidase,  platelet count, albumin, international normalized ratio, and old  age.1,10,11,37 Among these, serum ALT level was found to most im - portantly affect LS, more specifically, LS value and ALT levels were  found to be positively related.32,38 Therefore, LS values should be  cautiously interpreted when serum ALT is elevated.",Non-OADS,/arxiv_data1/oa_pdf/20/fd/cmh-21-32.PMC4379195.pdf
Liver stiffness and chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.32sive assessment of changes in liver fibrosis via liver stiffness measure - ment in patients with chronic hepatitis B: impact of antiviral treatment  on fibrosis regression.,Non-OADS,/arxiv_data1/oa_pdf/20/fd/cmh-21-32.PMC4379195.pdf
40 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.32Clin Mol Hepatol Volume _21  Number _1  March 201531.,Non-OADS,/arxiv_data1/oa_pdf/20/fd/cmh-21-32.PMC4379195.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.41 Clinical and Molecular Hepatology 2015;21:41-48 Original Article Corresponding author :  Kyung-Ah Kim Department of Internal Medicine, Ilsan Paik Hospital, Inje University  College of Medicine, 170 Juhwaro, Ilsanseogu, Goyang 411-706, Korea.",Non-OADS,/arxiv_data1/oa_pdf/86/59/cmh-21-41.PMC4379196.pdf
"(Clin Mol Hepatol 2015;21:41-48) Keywords:  Chronic Hepatitis B; Tenofovir; Nucleos(t)ide analogue-experienced; Lamivudine-resistant Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/59/cmh-21-41.PMC4379196.pdf
"42 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.41Clin Mol Hepatol Volume _21  Number _1  March 2015and host factors can affect this course, the serum HBV DNA level  is one of the most important factors affecting prognosis.2,3 The  long-term suppression of HBV replication is therefore an important  goal in the effective treatment of chronic HBV infection.4,5 Tenofovir disoproxil fumarate (TDF) is an oral prodrug of tenofo - vir, an acyclic nucleoside phosphonate analogue of adenosine  5’-monophosphate, with an excellent safety profile and potent an - ti-HBV efficacy in adults.6,7 Up to 6 years of treatment with TDF,  long term suppression of HBV can lead to regression of fibrosis  and cirrhosis without emergence of resistance to TDF in nucleos(t) ide analogue (NA)-naïve patients.8,9 Apart from the demonstrated  efficacy in naïve chronic hepatitis B patients, it has been recently  reported to be effective in patients who previously failed lamivu - dine (LAM) and/or adefovir (ADV).10-12 However, most of these  studies were conducted in region where genotype A or D is domi - nant, whereas most Korean patients are infected with genotype C  HBV.13 TDF was approved for the treatment of CHB in December  2012 in Korea.",Non-OADS,/arxiv_data1/oa_pdf/86/59/cmh-21-41.PMC4379196.pdf
"Liver stiffness and chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.41RESULTS Baseline characteristics of patients From November 2012 to July 2014, a total of 212 patients were  treated with TDF monotherapy.",Non-OADS,/arxiv_data1/oa_pdf/86/59/cmh-21-41.PMC4379196.pdf
44 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.41Clin Mol Hepatol Volume _21  Number _1  March 2015Virological and biochemical responses to TDF  monotherapy Mean reduction of serum HBV DNA was 3.03 log IU/mL at week  24 and 3.33 log IU/mL at week 48 respectively.,Non-OADS,/arxiv_data1/oa_pdf/86/59/cmh-21-41.PMC4379196.pdf
Liver stiffness and chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.41100 80 60 40 20 0 Figure 2 .,Non-OADS,/arxiv_data1/oa_pdf/86/59/cmh-21-41.PMC4379196.pdf
46 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.41Clin Mol Hepatol Volume _21  Number _1  March 2015tients but no genotypic resistance was identified.,Non-OADS,/arxiv_data1/oa_pdf/86/59/cmh-21-41.PMC4379196.pdf
"Liver stiffness and chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.41studies included relatively small numbers of patients, and more - over there have been few studies on head-to-head comparison of  the efficacy of TDF monotherapy between NA-naïve and NA-ex - perienced patients in Korea and to address whether the extent of  viral suppression is actually not different depending on the prior  exposure to NA or antiviral resistance.",Non-OADS,/arxiv_data1/oa_pdf/86/59/cmh-21-41.PMC4379196.pdf
48 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.41Clin Mol Hepatol Volume _21  Number _1  March 2015is effective alone or with emtricitabine in adefovir-treated patients with  chronic-hepatitis B virus infection.,Non-OADS,/arxiv_data1/oa_pdf/86/59/cmh-21-41.PMC4379196.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.49 Clinical and Molecular Hepatology 2015;21:49-59 Original Article Corresponding author :  Su Cheol Park Department of Internal Medicine, Korea Cancer Center Hospital, Korea  Institute of Radiological and Medical Sciences, 75 Nowon-gil, Nowon-gu,  Seoul 139-706, Korea  Tel: +82-2-970-1229, Fax: +82-2-970-2410 Email: hepapark@kcch.re.krAbbreviations:   EGFR, epidermal growth factor receptor; HCC, hepatocellular  carcinoma; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide; TKIs, tyrosine kinase inhibitors Received :  Nov. 5, 2014 /  Revised :  Jan. 30, 2015 /  Accepted :  Feb. 5, 2015INTRODUCTION  Liver cancer is the sixth most common neoplasm in the world,  and its poor prognosis makes it the third leading cause of cancer- related mortality.1 Because of early angioinvasion and metastasis, only a small proportion of patients with hepatocellular carcinoma  (HCC) receives surgical resection or liver transplantation as a cura - tive treatment.2 Except for sorafenib, a multikinase inhibitor, there  are no effective systemic treatments of HCC.",Non-OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
"(Clin Mol Hepatol 2015;21:49-59) Keywords:  Silibinin; Gefitinib; Sorafenib; Hepatocellular carcinoma Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
50 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.49Clin Mol Hepatol Volume _21  Number _1  March 2015vival was 10.7 months3 and 6.5 months4 in a sorafenib-treated  group.,OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
Combined treatment with silibinin and targeted drugs http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.49Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
52 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.49Clin Mol Hepatol Volume _21  Number _1  March 2015Western blot Cell lysates were prepared in non-denaturing lysis buffer (20  mmol/L Tris-HCl; pH 7.4; 150 mmol/L NaCl; 1 mmol/L EDTA; 1  mmol/L EGTA; 1 mmol/L ß-glycerophosphate; 1 mmol/L sodium  vanadate; 1 μ g/mL leupeptin; 1 mmol/L PMSF).,Non-OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
Combined treatment with silibinin and targeted drugs http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.49Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
54 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.49Clin Mol Hepatol Volume _21  Number _1  March 2015Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
Combined treatment with silibinin and targeted drugs http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.49Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
56 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.49Clin Mol Hepatol Volume _21  Number _1  March 2015cells.,OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
Combined treatment with silibinin and targeted drugs http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.49treatment of gefitinib or silibinin.,Non-OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
58 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.49Clin Mol Hepatol Volume _21  Number _1  March 2015formation by silibinin in androgen-dependent human prostate carci - noma LNCaP cells: Role in prostate cancer prevention.,Non-OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
Combined treatment with silibinin and targeted drugs http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.49receptors as combined markers of prognosis in hepatocellular carci - noma.,Non-OADS,/arxiv_data1/oa_pdf/39/62/cmh-21-49.PMC4379197.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.60 Clinical and Molecular Hepatology 2015;21:60-70 Original Article Corresponding author :  Kang Mo Kim Department of Internal Medicine, Asan Liver Center, Asan Medical Center,  University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu,  Seoul 138-736, Korea Tel: +82-2-3010-3190, Fax: +82-2-485-5782 E-mail: kimkm70@amc.seoul.kr Eun Sil Yu Department of Pathology, Asan Medical Center, University of Ulsan College  of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-4552, Fax: +82-2-485-8121 E-mail: esyu@amc.seoul.krAbbreviations:   HCC, hepatocellular carcinoma; FGFR, fibroblast growth factor receptor;  FGF, fibroblast growth factor; YSR, year survival rate;  AJCC, American  Joint Committee on Cancer aThese two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
"(Clin Mol Hepatol  2015;21:60-70) Keywords:  Hepatocellular carcinoma; Fibroblast growth factor; Receptor; Immunohistochemistry; Survival Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
"FGFR2 expression predicts survival in HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.60INTRODUCTION  Hepatocellular carcinoma (HCC) is the third most common cause  of cancer-related death worldwide and its incidence is increas - ing.1,2 In patients in the early stages HCC, hepatic resection is the  treatment of choice, but even after curative resection, recurrence  is common, and is the main cause of death.1,3 However, there are  no adequate adjuvant therapies for HCC patients who have under - gone curative hepatic resection except interferon.4 Moreover, most  HCC patients are diagnosed at advanced stages, and the progno - sis for advanced HCC is currently very poor.5,6 The only effective  systemic agent is sorafenib, which has shown modest effects in  prolonging survival.7 The progression of HCC from preneoplastic  lesions to advanced HCC occurs stepwise.",Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
62 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.60Clin Mol Hepatol Volume _21  Number _1  March 2015in human HCC and its association with the clinical outcomes of  this disease remains still unclear.,Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
"FGFR2 expression predicts survival in HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.60To validate our FGFR isotype expression analysis and its clinical  implications, we selected an additional 73 HCC patients (56 males  [76.7%]; median age, 55 years [range: 28–79 years], Supplemen - tal Table 2) obtained from an independent cohort which included  HCC patients who had received a curative resection as their pri - mary therapy between 2007 and 2009.",Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
64 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.60Clin Mol Hepatol Volume _21  Number _1  March 2015positively stained cells.,Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
"FGFR2 expression predicts survival in HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.60Statistical analysis Differences in continuous variables between two groups were  evaluated using the Student t-test, and differences in categorical  variables were evaluated with the X2 test or Fisher’s exact test.",OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
"66 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.60Clin Mol Hepatol Volume _21  Number _1  March 2015HCC tissues (18.7 and 3.8%, respectively).",Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
"FGFR2 expression predicts survival in HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.60Cox regression model on the same set of patients identified Child- Pugh class B ( P<0.01), AJCC T3 stage ( P=0.02), and positive  FGFR2 expression of HCC ( P=0.02) as independent predictors of a  poor prognosis in terms of postsurgical survival of HCC patients.",Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
68 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.60Clin Mol Hepatol Volume _21  Number _1  March 2015ics of FGFR2 and effects of altered FGFR2 expression on down - stream signaling in HCC.,OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
FGFR2 expression predicts survival in HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.60an independent prognostic marker of postsurgical survival in HCC  patients.,Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
SUPPLEMENTARY MATERIALS Supplementary data related to this article is available online   http://e-cmh.org/suppl/chm-21-1-60-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
"70 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.60Clin Mol Hepatol Volume _21  Number _1  March 2015receptor, hepatocyte growth factor/c-met and acidic fibroblast growth  factor/fibroblast growth factor receptors during hepatocarcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/60/e8/cmh-21-60.PMC4379198.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.7 Clinical and Molecular Hepatology 2015;21:7-13 Review Corresponding author :  Dongho Choi Department of Surgery, Hanyang University College of Medicine,   222 Wangsimni-ro, Seongdong-gu, Seoul 133-791, Korea Tel.",Non-OADS,/arxiv_data1/oa_pdf/ca/01/cmh-21-7.PMC4379199.pdf
"(Clin Mol Hepatol 2015;21:7-13) Keywords:  Liver regeneration; Hepatectomy; Liver transplantation Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/01/cmh-21-7.PMC4379199.pdf
"8 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.7Clin Mol Hepatol Volume _21  Number _1  March 2015MECHANISM OF LIVER REGENERATION  After liver resection, the residual liver responds by undergoing  hyperplasia (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ca/01/cmh-21-7.PMC4379199.pdf
"Clinical implications of advances in liver regeneration http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.7factor α (TNF- α) and interleukin-6 (IL-6) are released from Kupffer  cells, and these contribute to the initiation of the cell cycle (G0 to  G1) by binding to their receptors.8,9 Several factors for instance he - patocyte growth factor (HGF), epidermal growth factor (EGF), and  transforming growth factor  α (TGF- α) are thought to initiate the  G1 to S transition.10 These factors stimulate DNA replication and  mitosis by binding to their corresponding receptors.11 TGF- β1 is a  noted inhibitor of hepatocyte proliferation.12 In the normal liver,  growth factors and TGF- β have agonistic effects.",Non-OADS,/arxiv_data1/oa_pdf/ca/01/cmh-21-7.PMC4379199.pdf
"10 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.7Clin Mol Hepatol Volume _21  Number _1  March 2015ening complications of hepatectomy, and takes place in up to 10%  of cases.21 A number of different criteria are used for PHLF.",Non-OADS,/arxiv_data1/oa_pdf/ca/01/cmh-21-7.PMC4379199.pdf
"Clinical implications of advances in liver regeneration http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.7seeable future, to a remarkable change of therapeutic strategy in  the area of cell-based therapies for life-threatening liver diseases.",Non-OADS,/arxiv_data1/oa_pdf/ca/01/cmh-21-7.PMC4379199.pdf
12 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.7Clin Mol Hepatol Volume _21  Number _1  March 2015  4.,Non-OADS,/arxiv_data1/oa_pdf/ca/01/cmh-21-7.PMC4379199.pdf
Clinical implications of advances in liver regeneration http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.7tation using the left lobe.,Non-OADS,/arxiv_data1/oa_pdf/ca/01/cmh-21-7.PMC4379199.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.71 Clinical and Molecular Hepatology 2015;21:71-79 Original Article Corresponding author :  Woo Kyoung Jeong Department of Radiology and Center for Imaging Science, Samsung  Medical Center, Sungkyunkwan University, School of Medicine, 81 Irwon- ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-1923, Fax: +82-2-3410-0049 E-mail: jeongwk@gmail.comAbbreviations:   AMV, Ablative margin volume; ALT, Alanine aminotransferase;  AST, Aspartate aminotransferase; CT, Computed tomography;  HCC, Hepatocellular carcinoma; RFA, Radiofrequency ablation; US,  Ultrasound; WBC, White blood cell Received :  Feb. 9, 2015 /  Revised :  Feb. 25, 2015 /  Accepted :  Feb. 25, 2015INTRODUCTION  Hepatocellular carcinoma (HCC) is the most common primary  hepatic malignancy, accounting for 85-90% of all primary liver  cancers, and its incidence is increasing worldwide.1 Radiofrequen -cy ablation (RFA) is a local ablative treatment option that has the  potential to be a curative therapy for very early and early BCLC  stages of HCC.2 RFA is considered a promising option because of  its simplicity and effectiveness.3-5 One of the main advantages of  RFA is the relatively low incidence of treatment-related morbidity Alteration of laboratory findings after radiofrequency  ablation of hepatocellular carcinoma: relationship to  severity of the underlying liver disease and the   ablation volume Sang-Wook Shin1, Woo Kyoung Jeong1,2, Sanghyeok Lim1, Yongsoo Kim1, and Jinoo Kim1,3 1Department of Radiology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri; 2Department of Radiology  and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul; 3Department of  Radiology, Ajou University Hospital, Ajou University College of Medicine, Suwon, Korea Background/Aims:  To investigate sequential changes in laboratory markers after radiofrequency ablation (RFA) of  hepatocellular carcinoma (HCC) and the relationship of these changes to the severity of the underlying liver disease.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/cmh-21-71.PMC4379200.pdf
"(Clin Mol Hepatol 2015;21:71-79) Keywords:  Alanine aminotransferase; Child-Pugh class; Hepatocellular carcinoma; Leukocytosis; Radiofrequency  ablation Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/cmh-21-71.PMC4379200.pdf
"72 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.71Clin Mol Hepatol Volume _21  Number _1  March 2015and mortality compared to surgery and transarterial chemoembo - lization (TACE).6-8 Although hepatic resection remains the main - stay of HCC treatment, hepatic resection is not recommended in  patients with portal hypertension and hyperbilirubinemia; howev - er, transplantation or local ablative treatments, including RFA and  percutaneous ethanol injection, can be used in these patients ac - cording to the most recent EASL guideline.2 In the setting of ade - quate technical and clinical experience, RFA is considered effec - tive for the treatment of small-sized HCCs, with overall survival  approaching that of surgical resection.9-11  However, thermal injury to non-tumor liver tissue is inevitable  after RFA, and acute deterioration of functioning hepatocytes can  occur.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/cmh-21-71.PMC4379200.pdf
Laboratory Changes after RFA of HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.71mixed with 50 mL of 5% dextrose in water.,Non-OADS,/arxiv_data1/oa_pdf/22/f6/cmh-21-71.PMC4379200.pdf
"74 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.71Clin Mol Hepatol Volume _21  Number _1  March 2015Tumor ablation volume Volumes of index tumors and ablation zones were calculated on  the pre-procedural and immediate post-procedural CT scans, re -spectively.",OADS,/arxiv_data1/oa_pdf/22/f6/cmh-21-71.PMC4379200.pdf
"Laboratory Changes after RFA of HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.71atitis C infection were included in the CPA group, the difference in  underlying liver diseases between groups was not statistically sig - nificant.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/cmh-21-71.PMC4379200.pdf
"76 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.71Clin Mol Hepatol Volume _21  Number _1  March 2015diseases, as assessed by Child-Pugh classification.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/cmh-21-71.PMC4379200.pdf
"Laboratory Changes after RFA of HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.71times that of ALT in hepatocytes.19 Peak AST activity typically pre - cedes ALT in the setting of hepatic injury and declines rapidly be - cause the half-life of AST is shorter than that of ALT.21  In our study, the serum ALT level increased slowly and the serum level of the enzyme in CPB patients was significantly lower than  that in CPA patients.",Non-OADS,/arxiv_data1/oa_pdf/22/f6/cmh-21-71.PMC4379200.pdf
78 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.71Clin Mol Hepatol Volume _21  Number _1  March 2015an oven effect.,OADS,/arxiv_data1/oa_pdf/22/f6/cmh-21-71.PMC4379200.pdf
Laboratory Changes after RFA of HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.71  7.,Non-OADS,/arxiv_data1/oa_pdf/22/f6/cmh-21-71.PMC4379200.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.80 Clinical and Molecular Hepatology 2015;21:80-84 Case Report Corresponding author :  Han Chu Lee Department of Internal Medicine, Asan Medical Center, University of  Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138- 736, Korea Tel: +82-2-3010-3915, Fax: +82-2-3010-8043 E-mail: hch@amc.seoul.krAbbreviations:   CT, computed tomography; WBC, white blood cell; Ig, immunoglobulin;  SUV, standardized uptake value; HPF, high-power field; H&E, hematoxylin  and eosin Received :  Apr.",Non-OADS,/arxiv_data1/oa_pdf/61/61/cmh-21-80.PMC4379201.pdf
"(Clin Mol Hepatol 2015;21:80-84) Keywords:  Actinomycosis; Multiple liver abscess; Differential diagnosis Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/61/cmh-21-80.PMC4379201.pdf
A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.80showed no abnormal findings.,Non-OADS,/arxiv_data1/oa_pdf/61/61/cmh-21-80.PMC4379201.pdf
"82 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.80Clin Mol Hepatol Volume _21  Number _1  March 2015showed the organizing abscesses, which was the same for the  previous one (Fig.",Non-OADS,/arxiv_data1/oa_pdf/61/61/cmh-21-80.PMC4379201.pdf
A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.80was administered and then changed to oral amoxicillin for 11  weeks.,Non-OADS,/arxiv_data1/oa_pdf/61/61/cmh-21-80.PMC4379201.pdf
84 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.80Clin Mol Hepatol Volume _21  Number _1  March 2015results.,OADS,/arxiv_data1/oa_pdf/61/61/cmh-21-80.PMC4379201.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.85 Clinical and Molecular Hepatology 2015;21:85-88 Case Report Corresponding author :  Dae Won Jun Department of Internal Medicine, Hanyang University College of  Medicine, 222 Wangsimni-ro, Seongdong-gu, Seoul 133-791, Korea  Tel: 82-2-2290-8338, Fax: 82-2-2298-9183 E-mail: noshin@hanyang.ac.kr Abbreviations:   AST, aspartate transaminase; ALT, alanine transaminase; AFP , α-fetoprotein;  eGFR, estimated glomerular filtration rate; HCC, hepatocellular carcinoma;  RFTA, radiofrequency thermal ablation; TACE, transcatheter arterial  chemoembolization Received :  May 13, 2013 /  Revised :  Jul.",Non-OADS,/arxiv_data1/oa_pdf/01/3d/cmh-21-85.PMC4379202.pdf
"(Clin Mol Hepatol 2015;21:85-88) Keywords:  Tumor lysis syndrome; Hepatocellular carcinoma; Steroid Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/3d/cmh-21-85.PMC4379202.pdf
86 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.85Clin Mol Hepatol Volume _21  Number _1  March 2015CASE REPORT A 90-year-old male who presented with symptoms of general  weakness and poor oral intake visited the emergency department  of our hospital.,Non-OADS,/arxiv_data1/oa_pdf/01/3d/cmh-21-85.PMC4379202.pdf
"Low dose steroid induced tumor lysis syndrome  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.85DISCUSSION Although, tumor lysis syndrome is most commonly observed in  chemosensitive malignancy, such as acute lymphocytic leukemia  and Burkitt’s lymphoma, it is rare in solid tumors.5,7 However re - cently it has been reported in various solid tumors, including lung  and breast carcinomas.5,8,9 The most important risk factor for tu - mor lysis syndrome is tumor burden, which can easily result in au - tonecrosis and the release of intracellular substances.",Non-OADS,/arxiv_data1/oa_pdf/01/3d/cmh-21-85.PMC4379202.pdf
88 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.85Clin Mol Hepatol Volume _21  Number _1  March 2015can also cause the syndrome in patients with HCC.,Non-OADS,/arxiv_data1/oa_pdf/01/3d/cmh-21-85.PMC4379202.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.89 Clinical and Molecular Hepatology 2015;21:89-94 Liver Pathology Corresponding author :  Young Nyun Park Department of Pathology, Yonsei University College of Medicine, 50-1  Yonsei-ro, Seodaemun-gu, Seoul, Korea Tel.",Non-OADS,/arxiv_data1/oa_pdf/62/be/cmh-21-89.PMC4379203.pdf
"In addition, positivity for antinuclear antibody (ANA;  1:640, speckled pattern), anti-DNA (454.5 AU/mL; reference  range: <92.6 AU/mL), anti-cardiolipin IgG (21.5 GPL U/mL; refer -Budd-Chiari syndrome with multiple large regenerative  nodules Haeryoung Kim1, Ji Hae Nahm2, and Young Nyun Park2 1Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam;   2Department of Pathology, Yonsei University College of Medicine, Seoul, Korea Keywords:  Budd-Chiari syndrome; Large regenerative nodule; Pathology; Liver Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/be/cmh-21-89.PMC4379203.pdf
"90 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.89Clin Mol Hepatol Volume _21  Number _1  March 2015ence range: <10 GPL U/mL), anti-RNP (43.5 AU/mL; reference  range: <20 AU/mL), anti-SS-A/Ro (148.9 AU/mL; reference range:  <20 AU/mL) and anti-SS-B/La (86.2 AU/mL; reference range: <20  AU/mL), and decreased protein S (38%; reference range:  62~154%) were noted.",Non-OADS,/arxiv_data1/oa_pdf/62/be/cmh-21-89.PMC4379203.pdf
Budd-Chiari syndrome with multiple large regenerative nodules http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.89Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/62/be/cmh-21-89.PMC4379203.pdf
92 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.89Clin Mol Hepatol Volume _21  Number _1  March 2015 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/62/be/cmh-21-89.PMC4379203.pdf
Budd-Chiari syndrome with multiple large regenerative nodules http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.89patic veins frequently demonstrated variable degrees of fibrous in - timal thickening (Fig.,Non-OADS,/arxiv_data1/oa_pdf/62/be/cmh-21-89.PMC4379203.pdf
"94 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.89Clin Mol Hepatol Volume _21  Number _1  March 2015gion, and the expansion of β-catenin-activated centrizonal region  in FNH has been presumed to result in the “map-like” overexpres - sion of glutamine synthetase.",Non-OADS,/arxiv_data1/oa_pdf/62/be/cmh-21-89.PMC4379203.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.1.95 Clinical and Molecular Hepatology 2015;21:95-103 Liver Imaging Corresponding author :  So Yeon Kim Department of Radiology and Research Institute of Radiology, Asan  Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro  43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-5980, Fax: +82-2-476-4719 E-mail: sykimrad@amc.seoul.krAbbreviations:   AASLD, american association for study of liver diseases; ADC, apparent- diffusion coefficient; APASL, asian pacific association for the study  of the liver; CT, computed tomography; DWI, diffusion-weighted  imaging; EASL, european Association for the study of the Liver; HCC,  hepatocellular carcinoma; LI-RADS, liver imaging-reporting and  data system; MRI, magnetic resonance imaging; OATP , organic anion  transporting polypeptides; SPIO, super-paramagnetic iron oxide; US,  ultrasonographyINTRODUCTION  Hepatocellular carcinoma (HCC) is the most common primary  hepatic malignancy.1 The overall incidence of HCC is steadily rising  across the world: its overall incidence remains alarmingly high in  the developing countries and is increasing in most of the devel - oped countries as well.2 Early diagnosis and accurate assessment  of disease extent are crucial for appropriate clinical management  of patients with HCC to help support curative treatment and excel - lent prognosis.3 Of various clinical diagnostic tools, in particular,  imaging plays a vital role in surveillance, characterization, staging,  and treatment monitoring of HCC in recent clinical guidelines pro - posed by the Barcelona European Association for the Study of the  Liver (EASL) Conference, the Asian Pacific Association for the  Study of the Liver (APASL), and the American Association for  Study of Liver Diseases (AASLD) (Table 1).4-6It is widely accepted that hepatocarcinogenesis is a multistep  process.7 The two key events of the process developing simultane - ously are: (1) progressive cellular morphologic and functional  changes and (2) sequential changes in the intranodular blood sup - ply including progressive decrease of the portal supply and in - crease in the number of unpaired arteries.8-10 These carcinogenetic changes can be detected and character - ized by means of various clinical imaging techniques.",Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
"(Clin Mol Hepatol 2015;21:95-103) Keywords:  Hepatocellular carcinoma; Diagnostic imaging; Ultrasonography; Computed tomography; Magnetic  resonance imaging Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
"96 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.95Clin Mol Hepatol Volume _21  Number _1  March 2015paramagnetic iron oxide (SPIO) can depict the presence of Kupffer  cells in a nodule.12 Changes in signal intensity on hepatobiliary images  of Gd-EOB-DTPA-enhanced MRI correlate with organic anion trans - porting polypeptides 8 (OATP 8) expression.13 Multiphase CT and MRI  with contrast agents provide the information related to hemodynam - ic changes in a nodule that are currently regarded as the most impor - tant diagnostic criteria for HCC in routine clinical practice.4-6 Over the past few years, considerable technical advances were  made in imaging of HCCs.",Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
"Recent advances in the imaging of hepatocellular carcinoma http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.95the AASLD guideline to exclude contrast-enhanced US from the  list of diagnostic techniques that can be used to characterize le - sions suspicious for HCC.21,22 A recently introduced US contrast  agent, Sonazoid (GE healthcare) is phagocytosed by Kupffer cells  of the liver that can be seen during the postvascular phase or  Kupffer phase (starting 10 min after the injection) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
98 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.95Clin Mol Hepatol Volume _21  Number _1  March 2015supportive to increase the sensitivity for the diagnosis of HCCs  with atypical vascular profiles (Fig.,Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
Recent advances in the imaging of hepatocellular carcinoma http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.95The assessment of added diagnostic value of the hepatobiliary  phase imaging is currently in the field of active research.,Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
100 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.95Clin Mol Hepatol Volume _21  Number _1  March 2015and treatment strategy for these hepatobiliary hypointense nod - ules are yet to be determined.,Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
"As an initiative to address this problem,  the American College of Radiology proposed the Liver Imaging– Reporting and Data System (LI-RADS) (Accessed February 2015,  from http://www.acr.org/Quality-Safety/Resources/LIRADS/ ).",Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
Recent advances in the imaging of hepatocellular carcinoma http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.95cess are used to stratify individual observations according to the  level of concern for HCC.63 LI-RADS diagnostic algorithm is intended  only for individuals at increased risk for HCC regardless of presence  or absence of previous surveillance US or other imaging.,Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
102 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.95Clin Mol Hepatol Volume _21  Number _1  March 20152010;194:W396-400.,Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
Recent advances in the imaging of hepatocellular carcinoma http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.1.95hepatocellular carcinomas (< or =2 cm in diameter) from arterial  enhancing pseudolesions: special emphasis on hepatobiliary phase  imaging.,Non-OADS,/arxiv_data1/oa_pdf/29/4b/cmh-21-95.PMC4379204.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c4/a7/ircmj-17-02-21604.PMC4379326.pdf
e-mail: hiraga@center.equinst.go.jp ©2015 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/54/fb/jes-26-001.PMC4379327.pdf
e-mail: ynambo@obihiro.ac.jp ©2015 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/ab/31/jes-26-015.PMC4379328.pdf
e-mail: mirirfan441@gmail.com ©2015 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/e9/45/jes-26-021.PMC4379329.pdf
e-mail: kinoshita@epizoo.equinst.go.jp ©2015 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/cc/8a/jes-26-025.PMC4379330.pdf
"http://www.medicines.org.uk/ emc/medicine/10054/SPC/ (4 December 2014, date last ac- cessed) [date of revision of the text 19 February 2014] 28.",Non-OADS,/arxiv_data1/oa_pdf/4b/93/sfu080.PMC4379338.pdf
"Leo Labora- tories Ltd. https://www.medicines.org.uk/emc/medicine/ 2623/SPC (4 December 2014, date last accessed) [date of revision of the text 24 February 2014] 29.",Non-OADS,/arxiv_data1/oa_pdf/4b/93/sfu080.PMC4379338.pdf
"https://www.medicines.org.uk/ emc/medicine/26622/SPC (4 December 2014, date last ac- cessed) [date of revision of the text 28 June 2012] 41.",Non-OADS,/arxiv_data1/oa_pdf/4b/93/sfu080.PMC4379338.pdf
A Summary of Product Characteristics —Orgaran (Danapar- oid) Merck Sharp and Dohme LTD. https://www.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/4b/93/sfu080.PMC4379338.pdf
"https://www.medicines.org.uk/emc/medicine/15937/SPC (4 December 2014, date last accessed) [date of revision of the text 2 May 2013] 43.",Non-OADS,/arxiv_data1/oa_pdf/4b/93/sfu080.PMC4379338.pdf
"https://www.medicines.org.uk/emc/medicine/ 21265/SPC (4 December 2014, date last accessed) [date of revision of the text 6 January 2014] 49.",Non-OADS,/arxiv_data1/oa_pdf/4b/93/sfu080.PMC4379338.pdf
"Bristol-Myers Squibb-P ﬁzer.https://www.medicines.org.uk/emc/ medicine/27220/SPC (4 December 2014, date last accessed) [date of revision of the text 1 October 2013] 50.",Non-OADS,/arxiv_data1/oa_pdf/4b/93/sfu080.PMC4379338.pdf
https://www.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/4b/93/sfu080.PMC4379338.pdf
"Med Healthc Prod Regul Agency 2012; 5. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ CON175429 (4 December 2014, date last accessed) [date of revision of the text 21 july 2014] 52.",Non-OADS,/arxiv_data1/oa_pdf/4b/93/sfu080.PMC4379338.pdf
http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm 32.,Non-OADS,/arxiv_data1/oa_pdf/78/c6/AMS-11-24816.PMC4379380.pdf
Hepatitis C. WHO Fact sheet N° 164; http://www.who.int/mediacentre/factsheets/fs164/en/.,Non-OADS,/arxiv_data1/oa_pdf/78/c6/AMS-11-24816.PMC4379380.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/j.nicl.2015.02.020 2213-1582/Crown Copyright © 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1080/016886397084038709268816 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1037/0033-2909.111.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/j.conb.2010.02.01520359884 .,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1833-07.200717553991 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/j.bandc.2009.02.00219269079 .,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
"Cortex 19 (1), 72 –78.http://dx.doi.org/10.1093/cercor/bhn05918403396 .Guskiewicz, K.M., Marshall, S.W., Bailes, J., McCrea, M., Harding Jr., H.P., Matthews, A., et al., 2007.",OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1249/mss.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1038/nn.310122561454 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/j.nicl.2014.06.00425009772 .,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.06.00217658272 .,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1001/archpsyc.61.1.4214706943 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1080/0269905001000910811429086 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1089/neu.2008-064419331523 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/j.acn.2005.,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.3171/jns.1987.66.5.07063572497 .,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1097/01.HTR.0000271115.29954.2717510590 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1006/nimg.2001.,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/ 10.1080/0269905050044355816421060 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
"25 (15), 3962 – 3972. http://dx.doi.org/10.1523/ JNEUROSCI.4250-04.200515829648 .",Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1002/ar.b.2003515558781 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1038/nrn190316760917 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
"362 (1), 1 –5.http://dx.doi.org/10.1016/j.neulet.",OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1080/0954026031000160669215276952 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.1358-12.201223055501 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1038/ nrn313722233726 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.3171/2013.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1006/nimg.2001.097811771995 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
"Nature 447 (7140), 83–86.http://dx.doi.org/10.1038/nature0575817476267 .",Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1152/physrev.00035.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1089/neu.2006.020817518531 .,Non-OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2010.06.04120600983 .621 B.T.,OADS,/arxiv_data1/oa_pdf/ef/43/main.PMC4379387.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1016/j.nicl.2015.02.022 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"Segmentation and registration Brain gray matter segmentation and alignment were performed using the VBM8 toolbox ( http://dbm.neuro.uni-jena.de/vbm )a si m p l e - mented in SPM8 (Statistical Parametric Mapping, http://www.",OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"All diffusion image preprocessing was conducted using the Functional MRI of the Brain (FMRIB) software library (FSL, http://www.fmrib.ox.",OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"Supplementary data Supplementary material associated with this article can be found, in the online version, at http://dx.doi.org/doi:10.1016/j.nicl.2015.02.022 .",OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/ 10.1038/nrn346523531697 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.07.00717761438 .,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.02.01815955494 .,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1038/nn.,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1371/ journal.pone.002601022022493 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.1929-08.200818784304 .675 H. Kim et al.,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"Gen. Psychiatry 4, 561 –571.http://dx.doi.org/10.1001/archpsyc.",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"Probabilistic diffu- sion tractography with multiple ﬁb r eo r i e n t a t i o n s :w h a tc a nw eg a i n ?N e u r o i m a g e3 4 (1), 144 –155.http://dx.doi.org/10.1016/ j.neuroimage.2006.09.01817070705 .",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1038/nn107512808459 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"Pain 11 (1), 7 –20.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1016/0306-4522(79)90082-4106327 .,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1093/cercor/ bhn00318267952 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"1 (1), 86 –93.http://dx.doi.org/10.1002/ana.410010109560818 .",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1002/hbm.2133321769991 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1097/00002508-199706000-000069186019 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1007/s00234-007-0267-417701168 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1371/journal.pbio.006015918597554 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1097/ALN.000000000000001724343290 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0141-08.200818448652 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1016/S0304-3940(02)01164-312531467 .,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"65 (330), 904 –912.http://dx.doi.org/10.1080/01621459.1970.10481133 .",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.12.,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1371/ journal.pone.005125023227257 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1002/art.3819124449585 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/ 10.1371/journal.pone.002776422132136 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/ 10.1002/art.2407019035484 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"Clinical 2, 313 – 319.http://dx.doi.org/ 10.1016/j.nicl.2013.02.00123799199 .",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.0357-05.200516148238 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"65 (1), 14 –27.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"16 (5), 425. http://dx.doi.org/10.1186/s13075-014- 0425-025606591 .",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1002/art.3441222294427 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1002/art.2749720506181 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/ 10.1002/hbm.2113320853378 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1126/science.284.5422.197910373114 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"J Pain 3 (1), 28 –37.http://dx.doi.org/10.1054/jpai.2002.2714014622851 .",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1093/cercor/ bhj02416120793 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1002/syn.2096021638338 .676 H. Kim et al.,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1162/jocn.2009.,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1016/j.jpain.2013.03.00123685185 .,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/ 10.1136/gut.2010.23662021610272 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2144-07.200717881532 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1006/nimg.2001.097811771995 .,Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"Science 303 (5661), 1162 – 1167. http://dx.doi.org/10.1126/ science.109306514976306 .",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
http://dx.doi.org/10.1016/0304-3959(93)90155-I8309713 .,OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"62 (5), 600 –610.http://dx.doi.org/10.1002/acr.2014020461783 .",Non-OADS,/arxiv_data1/oa_pdf/62/d8/main.PMC4379388.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/20/msu341.PMC4379397.pdf
Supplementary Material Supplementary ﬁgure 1 and tables S1–S4 a r ea v a i l a b l ea t Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/8f/20/msu341.PMC4379397.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/31/msu395.PMC4379398.pdf
"Number of Human Paralogous Genes Identiﬁed from Synteny Database at Uoregon Site ( http://syntenydb.uoregon.edu/syn- teny_db/ , last accessed December 2014) Using ST3GAL Loci of GR1 as Seed Genes and Branchiostoma ﬂoridae as an Outgroup.",OADS,/arxiv_data1/oa_pdf/54/31/msu395.PMC4379398.pdf
"(2013) .Am a j o rs o u r c e of information came from the GT-29 family of the CAZydatabase ( http://www.cazy.org/GlycosylTransferases.html , last accessed December 2014; Cantarel et al.",OADS,/arxiv_data1/oa_pdf/54/31/msu395.PMC4379398.pdf
"The detection of paralogous blocks wasalso done using the latest ENSEMBL data set (ENS61) at the synteny database site ( http://teleost.cs.uoregon.edu/synteny_ db/, last accessed December 2014) ( Catchen et al.",OADS,/arxiv_data1/oa_pdf/54/31/msu395.PMC4379398.pdf
"Prediction of Coevolving Positions Coevolved positions were predicted using the MISTIC webserver with default parameters ( http://mistic.leloir.org.ar/ index.php , last accessed December 2014) ( Simonetti et al.",OADS,/arxiv_data1/oa_pdf/54/31/msu395.PMC4379398.pdf
Supplementary Material Supplementary tables S1–S3 and ﬁgures S1–S9 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/54/31/msu395.PMC4379398.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/14/msu396.PMC4379399.pdf
"Identifying the Mating-Type Chromosome Scaffolds on the a 1Reference Genome To determine which scaffolds of the M. lychnidis-dioicae genome belonged to the a 1mating-type chromosomes and which to non-MAT chromosomes, the assembled contigsfrom the gel-isolated matin g-type chromosomes were mapped against the M. lychnidis-dioicae reference genome using NUCmer ( http://mummer.sourceforge.net/ ).",OADS,/arxiv_data1/oa_pdf/ba/14/msu396.PMC4379399.pdf
"Paired-end and mate-pair reads were mapped on contigs using the glint software (Faraut T and CourcelleE, unpublished data; http://lipm-bioinfo.toulouse.inra.fr/ 937Degeneration of Mating-T ype Chromosomes in Fungi .doi:10.1093/molbev/msu396 MBE",OADS,/arxiv_data1/oa_pdf/ba/14/msu396.PMC4379399.pdf
"Assembled transcripts were compared between a 1and a 2 using blast to identify transcripts speciﬁc for each cell type: a1transcripts were mapped to the gene set based on the whole genome assembly; the a 2assembly is available at the Broad website, at http://www.broadinstitute.org/annotation/ genome/Microbotryum_violaceum/assets/Mvio_A2_trinity.fa.gz .",OADS,/arxiv_data1/oa_pdf/ba/14/msu396.PMC4379399.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/d5/msu403.PMC4379404.pdf
Supplementary Material Supplementary ﬁgures S1–S6 and tables S1–S5 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/50/d5/msu403.PMC4379404.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"Last but not least, we used the software SPLITREAD (http://splitread.sourceforge.net/ , last accessed December 10, 2014) to remap Neandertal and Denisovan reads to junc-tions of the deletion breakpoints as deﬁned in 1KG deletiondata set ( supplementary ﬁg.",OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"2012 )( a v a i l a b l ea t http://cdna.eva.mpg.de , last accessed December 10, 2014) as our main sta rting point.",Non-OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"To accomplish this, we used a custom bedtools(http://bedtools.readthedocs.org/ , last accessed December 10, 2014) script.",Non-OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"We used a modiﬁed version of SPLITREAD approach (http://splitread.sourceforge.net/ , last accessed December 10, 2014) to remap the Neande rtal and Denisovan reads to the junctions of the breakpo ints of deletions as deﬁned in 1KG deletion data set, rather than applying it to thewhole genome.",OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"We assessed the signiﬁcance of the depletion ofexonic deletion we observed using Genome StructureCorrection software ( https://www.encode project.org/soft- ware/gsc/ , last accessed December 10, 2014).",OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"Polymorphic data were converted to FASTAalignments using the human reference genome (hg19).Calculations of F STand Tajima’s Dwere performed by CoMuStats ( http://pop-gen.eu/wordpress/software/comus- coalescent-of-multiple-species , last accessed December 10, 2014).",OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"All source codes used for the calculations are available from http://gokcumenlab.org/data-and-codes/ (last accessed December 10, 2014).",OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"Statistical Tests and Graphs All other statistical tests and graphs were conductedusing base statistical and ggplot2 ( http://ggplot2.org/ ,l a s t accessed December 10, 2014) packages available through Rstatistical environment ( http://www.r-project.org/ ,l a s t accessed December 10, 2014).",OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"Hu Y, Wang Y, Ding Q, He Y, Wang M, Wang J, Xu S, Jin L. unpublished data, http://arxiv.org/abs/1404.7766 , last accessed December 12, 2014.",OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"unpublished data, http://biorxiv.org/con tent/early/2014/06/27/006684 , last accessed December 12, 2014.",OADS,/arxiv_data1/oa_pdf/cc/38/msu405.PMC4379406.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/08/msv037.PMC4379413.pdf
"We assembled timetreedata from 2,274 studies ( http://www.timetree.org/reference_ list.php ) that have been published between 1987 and April 2013, as well as two timetrees estimated herein(supplementary table S1 ,Supplementary Material online).",OADS,/arxiv_data1/oa_pdf/52/08/msv037.PMC4379413.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/52/08/msv037.PMC4379413.pdf
Available from: http://CRAN.R-project.org/package=caper .,Non-OADS,/arxiv_data1/oa_pdf/52/08/msv037.PMC4379413.pdf
Available from: http://cran.r-project.org/ package=laser .,Non-OADS,/arxiv_data1/oa_pdf/52/08/msv037.PMC4379413.pdf
Available from: http://CRAN.R-project.org/ package=TreePar .,OADS,/arxiv_data1/oa_pdf/52/08/msv037.PMC4379413.pdf
"Among the recognized  therapeutic properties of Loranthaceae  members in - clude antitumor actions [11, 12], cough treatment [13],  headache treatment [14], uterus tightening following  childbirth [14], and immunomodulatory [15, 16], an - Review articleISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[1]:007-018 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.001    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
"Tel: +61-4-2629-2791   Fax: +61-2-9812-3600 E-mail: omar_3m@yahoo.com ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1  The Australian School of Advanced Medicine, Macquarie University, Sydney, Australia 2    Department of Physiology & Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Malaysia Received:  Oct 08, 2014     Reviewed:  Nov 28, 2014     Accepted:  Dec 24, 2014",Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
"008  http://www.journal.ac Journal of Pharmacopuncture 2015;18(1):007-018 tioxidant [16-19], antiinflammatory [20, 21], antimicrobial  [22-24], antiviral [25], antidiarrhoeal [16, 26], anticancer  [23, 27], antinociceptive [21], antipyretic [21], antihyperg - lycemic, and antidiabetic [16, 18, 28, 29] activities and anti - hypertensive effects [30-32].",Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
http://www.journal.ac009  Journal of Pharmacopuncture 2015;18(1):007-018 ered with reddish scurf [54].,Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
010  http://www.journal.ac Figure 2   Schematic diagram for preparation of L. ferrugineus  crude extracts and fractionation of its methanolic extract (LFME).Journal of Pharmacopuncture 2015;18(1):007-018,Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
"http://www.journal.ac011 cardiovascular complications [63, 64].",Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
012  http://www.journal.ac active components may be maximally presented in LFME  rather than LFWE.,Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
http://www.journal.ac013 sor amino acid L-arginine (L-Arg) [88].,Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
"http://www.journal.ac014 tic ulceration, Chinese herbal medicine in irritable bowel  syndrome, opium derivatives in diarrhoea and senna, is - paghula and sterculia in constipation [98].",Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
http://www.journal.ac015 hemiparasite ligaria cuneifolia (R. et P .),Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
"http://www.journal.ac016 Studies on the constituents of Japanese mistletoes from  different host trees, and their antimicrobial and hypo - tensive properties.",Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
Available from: http://apps.who.int/iris/han - dle/10665/44579.,OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
http://www.journal.ac017 creased plasma total cholesterol and high density lipo - protein levels produced by the crude extract from the  leaves of Viscum album  (mistletoe).,Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
http://www.journal.ac018 dangers.,Non-OADS,/arxiv_data1/oa_pdf/4d/31/2093-6966-v18-n01-007.PMC4379471.pdf
"Increased synthesis of inflammatory cytokines in  the tumor’s microenvironment helps NSCLC cells  Original  articleISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[1]:019-026 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.002    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/5d/2093-6966-v18-n01-019.PMC4379472.pdf
"Tel: +91-33-2582-8750  Fax: +91-33-2582-8282 E-mail: prof_arkb@yahoo.co.in ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acCytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India Received:  Sep 30, 2014    Reviewed:  Nov 13, 2014    Accepted:  Dec 11, 2014",Non-OADS,/arxiv_data1/oa_pdf/84/5d/2093-6966-v18-n01-019.PMC4379472.pdf
"020  http://www.journal.ac Journal of Pharmacopuncture 2015;18(1):019-026 to maintain their survivability against all types of diverse  conditions [7, 8].",Non-OADS,/arxiv_data1/oa_pdf/84/5d/2093-6966-v18-n01-019.PMC4379472.pdf
"http://www.journal.ac021  Journal of Pharmacopuncture 2015;18(1):019-026 pellet for nucleus staining, and the pellets were kept in ice  for 10 minutes.",Non-OADS,/arxiv_data1/oa_pdf/84/5d/2093-6966-v18-n01-019.PMC4379472.pdf
022  http://www.journal.ac A significant number of TUNEL positive cells were present  after quercetin treatment (58.74% after 48 hours of treat - ment) as compared with untreated control cells (5.52%).,Non-OADS,/arxiv_data1/oa_pdf/84/5d/2093-6966-v18-n01-019.PMC4379472.pdf
"http://www.journal.ac023 A crucial step of mitochondrial apoptosis is alteration in  mitochondrial membrane polarization (MMP) and release  of cytochrome c in cytosol, which switches on the caspase  cascade [24].",Non-OADS,/arxiv_data1/oa_pdf/84/5d/2093-6966-v18-n01-019.PMC4379472.pdf
"024  http://www.journal.ac Figure 4   Effects of quercetin on (A) IL-6 titer, (B) NF- κB nuclear translocation and (C) p-STAT3 expressions in the A549 cancer cell line, as ob - tained from FACS analyses.",Non-OADS,/arxiv_data1/oa_pdf/84/5d/2093-6966-v18-n01-019.PMC4379472.pdf
"http://www.journal.ac025 Significant up-regulations of cleaved caspase 3 (17 kDa)  and PARP (89 kDa) expressions, especially at late hours  of quercetin treatment (24 – 48 hours), supported the in - volvement of caspase 3 during the apoptotic process.",Non-OADS,/arxiv_data1/oa_pdf/84/5d/2093-6966-v18-n01-019.PMC4379472.pdf
http://www.journal.ac026 apoptosis in polyamine-depleted cells.,Non-OADS,/arxiv_data1/oa_pdf/84/5d/2093-6966-v18-n01-019.PMC4379472.pdf
"Over the past 10 years,  Original  articleISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[1]:027-035 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.003    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
"Tel: +82-33-741-0344  Fax: +82-33-747-0409 E-mail: kimcb@yonsei.ac.kr  ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1  Department of Sasang Constitutional Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 2  Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea 3  Institute for Poverty Alleviation and International Development, Yonsei University, Wonju, Korea 4  Department of Nursing, Yonsei University Wonju College of Medicine, Wonju, Korea 5  Korea National Rehabilitation Research Institute, Seoul, Korea 6  Armed Forces Medical Research Institute, Daejeon, Korea Received:  Nov 03, 2014    Reviewed:  Nov 12, 2014    Accepted:  Dec 04, 2014",Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
028  http://www.journal.ac Journal of Pharmacopuncture 2015;18(1):027-035 the figures have been growing each year [2].,Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
"http://www.journal.ac029  Journal of Pharmacopuncture 2015;18(1):027-035 detail, 52.6% of the medical professionals responded that  they had had such experience, as did 29.6% of the other  CAM providers ( P = 0.128).",Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
030  http://www.journal.ac tive dispositions (Table 13).,Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
"http://www.journal.ac031 tor (6/19, 31.6%).",Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
"For an effective method to manage CAM pro - viders, 32.8% answered that legislation was needed and  25.0% answered that CAM qualifications/accreditation  were needed (Table 16).http://www.journal.ac 4.",Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
"http://www.journal.ac033 Table 12  Methods for payment of the procedure fee for patients  treated with CAMTable 13  Legal problems for patients treated with CAM (medical  disputes included) Table 14  Opinions on qualification method for CAM providersPayment Method   N   (%) Free of Charge 12 27.3 Paid totally by the patients  (100%)17 38.6 Procedure was free, but the  cost of materials  was paid by the patients11 25.0 Others 4  9.1 Total 44 100.0 CAM, complementary and alternative medicine.",Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
http://www.journal.ac034 icine.,Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
http://www.journal.ac035 Korea National Statistic Agency.,OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
Available from: http://www.index.,Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
Available from: http://cam.cancer.gov/ attachments/CAMAnnualReportFY2005-508_final.,Non-OADS,/arxiv_data1/oa_pdf/53/3d/2093-6966-v18-n01-027.PMC4379473.pdf
"The composition and  Original article Received:  Dec 12, 2014     Reviewed:  Dec 24, 2014     Accepted:  Dec 31, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[1]:044-055 DOI:  http://dx.doi.org/10.3831/KPI.2015.18.005    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
"Tel: +82-70-48888-6270    Fax: +82-70-8230-5765 E-mail: anna1001@hanmail.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Research & Development, Pharmacopuncture Research Laboratory, Korean Pharmacopuncture Institute, Seoul, Korea",Non-OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
"http://www.journal.ac045 the structure of centipede venom, including serotonin,  histamine, lipids, polysaccharides and polypeptides, have  been identified in crude extracts of centipede venom in  previous studies [5, 6].",OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
"http://www.journal.ac046  Journal of Pharmacopuncture 2015;18(1):044-055 Table 2  Program methods of the HPLC injector Table 3  Gradient condition methods for the stability test*HPLC, high-performance liquid chromatography; OPA,  O-phthaldialdehyde; FMOC, fluorenyl methoxy carbonyl chlo - ride.",Non-OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
http://www.journal.ac047 Figure 1(b)  Chromatograms of the pharmacopuncture from centipedes after 1 month.,Non-OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
http://www.journal.ac048  Journal of Pharmacopuncture 2015;18(1):044-055 Figure 1(e)  Chromatograms of the pharmacopuncture from centipedes after 6 months.,Non-OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
"http://www.journal.ac049 Table 4  Retention times (in minutes) and area values (in integral calculus) for the initial pharmacopuncture from centipedes prepared  by using the method of the KPI on August 30, 2013 Table 5  Retention times (in minutes) and area values (in integral calculus) for the initial pharmacopuncture from centipedes prepared  by using the method of the KPI on August 30, 2013 Table 6  Overall statistical data for the values of the area value for 3 conditions over 12 monthsKPI, Korean pharmacopuncture institute.",OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
"http://www.journal.ac050  Journal of Pharmacopuncture 2015;18(1):044-055 SD, standard deviation; RSD, relative standard deviation.",Non-OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
"http://www.journal.ac051 Figure 3(a)  Chromatograms of aspartate STD for concentrations of 400, 200, 100, and 10 ppm.",Non-OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
"052  http://www.journal.ac Journal of Pharmacopuncture 2015;18(1):044-055 Figure 3(d)  Chromatograms of leucine STD for concentrations of 400, 200, 100, and 10 ppm.Figure 3(b)  Chromatograms of arginine STD for concentrations of 400, 200, 100, and 10 ppm.",Non-OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
"http://www.journal.ac053 Figure 4(c)  Analytical calibration curve of alanine STD for con - centrations of 400, 200, 100, and 10 ppm.Figure 4(d)  Analytical calibration curve of leucine STD for con - centrations of 400, 200, 100, and 10 ppm.",OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
"http://www.journal.ac054  Journal of Pharmacopuncture 2015;18(1):044-055 STD, standard.Table 8(a)  Quantity of aspartate in the pharmacopuncture from  centipedes Table 8(b)  Quantity of arginine in the pharmacopuncture of cen - tipedes Table 8(c)  Quantity of alanine in pharmacopuncture from cen - tipedesTable 8(e)  Quantity of lysine in pharmacopuncture from centi - pedesTable 8(d)  Quantity of leucine in pharmacopuncture from cen - tipedes Aspartate STD ppm Area 400 359.1 200 189.2 100 97.5 10 10.4 Quantity of pharmacopuncture from centipedes in 1.86  min 34.37 ppm 27.62 Arginine STD ppm Area 400 412.4 200 203.4 100 92.3 10 8.1 Quantity of pharmacopuncture from centipedes in 8.33  min 123.72 ppm 129.81 Arginine STD ppm Area 400 878 200 450.9 100 217.6 10 22.5 Quantity of pharmacopuncture from centipedes in 8.55  min 170.63 ppm 169.74Lysine STD ppm Area 400 666 200 351 100 153 10 15 Quantity of pharmacopuncture from centipedes in 14.39  min 57 ppm 58.74Leucine STD ppm Area 400 612.8 200 303.9 100 154.3 10 15.2 Quantity of pharmacopuncture from centipedes in 13.95  min 59.55 ppm 59.63 in the human body in limited quantities; thus, their natu - ral concentrations in the human body must be increased  through the intake of food.",Non-OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
http://www.journal.ac055 5.,Non-OADS,/arxiv_data1/oa_pdf/7b/5d/2093-6966-v18-n01-044.PMC4379475.pdf
"Introduction  Pharmacopuncture is a unique acupuncture treat - ment of traditional Korean medicine (TKM) which  combines acupuncture based on the meridian theory  Original article Key Words acupuncture,  Angelica gigas nakai, Angelica gigantis ra - dix,  herbal medicine, pharmacopuncture, single-dose toxic - ity test Received:  Nov 17, 2014     Reviewed:  Dec 02, 2014     Accepted:  Dec 15, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[1]:056-062 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.006    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/09/2093-6966-v18-n01-056.PMC4379476.pdf
"Tel: +82-33-744-9304     Fax: +82-33-744-9305 E-mail: drkwon5031@daum.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1Department of Internal Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 2Department of Preventive Medicine, College of Korean Medicine, Daejeon University, Daejeon, Korea 3Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 4Department of Sasang Constitutional Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 5Department of Ophthalmology, Otolaryngology, and Dermatology, Korean Medicine Hospital, Pusan National University, Yangsan, Korea 6Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea",Non-OADS,/arxiv_data1/oa_pdf/cc/09/2093-6966-v18-n01-056.PMC4379476.pdf
http://www.journal.ac057 and herbal medicine based on Qi and flavor theory.,Non-OADS,/arxiv_data1/oa_pdf/cc/09/2093-6966-v18-n01-056.PMC4379476.pdf
"http://www.journal.ac058  Journal of Pharmacopuncture 2015;18(1):056-062 and any deaths were noted at 30 minutes, 1 hour, and 2  hours after the first injection, and at 30 minutes, 1, 2, 4 and  6 hours after the second injection.",Non-OADS,/arxiv_data1/oa_pdf/cc/09/2093-6966-v18-n01-056.PMC4379476.pdf
http://www.journal.ac059 Table 2  Summary of mortality Table 3  Summary of clinical signs by hour after dosingSexGroup /  Dose  (mL/ani - mal)No.,Non-OADS,/arxiv_data1/oa_pdf/cc/09/2093-6966-v18-n01-056.PMC4379476.pdf
"http://www.journal.ac060  Journal of Pharmacopuncture 2015;18(1):056-062 Table 4  Summary of clinical signs by day after dosing NOA, no observable abnormality; DGP , Danggui pharmacopuncture.",Non-OADS,/arxiv_data1/oa_pdf/cc/09/2093-6966-v18-n01-056.PMC4379476.pdf
http://www.journal.ac061  Journal of Pharmacopuncture 2015;18(1):056-062 Table 6  Summary of histopathological findings.,Non-OADS,/arxiv_data1/oa_pdf/cc/09/2093-6966-v18-n01-056.PMC4379476.pdf
http://www.journal.ac062  Journal of Pharmacopuncture 2015;18(1):056-062 Korean Pharmacopuncture Insitute.,Non-OADS,/arxiv_data1/oa_pdf/cc/09/2093-6966-v18-n01-056.PMC4379476.pdf
"Pharmacopuncture treatment requires dif - ferential diagnosis by a traditional Oriental medicine  practitioner to select a matching herbal extract, and  Original article Received:  Oct 21, 2014      Reviewed:  Oct 27, 2014     Accepted:  Nov 06, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[1]:063-071 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.007    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
"Tel: +82-62-670-6441  Fax: +82-62-670-6767 E-mail: kscndl@hanmail.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibustion Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 2 Nervous & Muscular System Disease Clinical Research Center of Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 3 Department of Neuropsychiatry, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 4 Department of Acupuncture & Moxibustion Medicine, Woosuk University Hospital of Korean Medicine, Jeonju, Korea 5 Department of nursing Kwang-Ju Women's University, Gwangju, Korea",Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
064  http://www.journal.ac Journal of Pharmacopuncture 2015;18(1):063-071 the injections are given at several acupoints to attain ben - efits of both acupuncture and herbal medicine [1].,Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
http://www.journal.ac065 (15 days after injection).,Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
http://www.journal.ac066 GroupDose  (mL/animal)SexMean   S.D.,Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
http://www.journal.ac067 G2 0.25MaleMean 7.11 14.5 40.7 57.2 20.4 35.7 1094 4.71 S.D.,Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
http://www.journal.ac068 GroupDose (mL/ani - mal) SexMean   S.D.,Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
http://www.journal.ac069 Table 7  Summary of necropsy findings Significantly different from control by Dunnett’s t-test: *P < 0.05.,Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
070  http://www.journal.ac 4.,Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
http://www.journal.ac071 Korean Pharmacopuncture Institute.,Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
Available from: http://lawwizice.wordpress.com/.1.,Non-OADS,/arxiv_data1/oa_pdf/6b/f1/2093-6966-v18-n01-063.PMC4379477.pdf
"One of the most important possible  causes of gastric ulcers is oxidative stress, which is  involved in the pathogenesis of gastric inflammation  and ulcerogenesis, but also in lifestyle related diseases  Original article Key Words chronic gastric ulcer, ethanol induced, functional dys - pepsia, Ganoderma lucidum , gastric mucosa, pharma - copuncture Received:  Jul 07, 2014         Reviewed:  Jul 24, 2014        Accepted:  Jul 25, 2014ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[1]:072-078 DOI:    http://dx.doi.org/10.3831/KPI.2014.18.008    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/0f/2093-6966-v18-n01-072.PMC4379478.pdf
"Tel: +82-51-850-8935     Fax: +82-51-867-5162 E-mail: 3rdmed@hanmail.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture & Moxibustion, College of Korean Medicine, Dong-Eui University, Busan, Korea 2 Department of Internal Medicine, College of Korean Medicine, Dong-Eui University, Busan, Korea",Non-OADS,/arxiv_data1/oa_pdf/62/0f/2093-6966-v18-n01-072.PMC4379478.pdf
"http://www.journal.ac073 including atherosclerosis, hypertension, diabetes mellitus,  ischemic heart diseases, and malignancies [4, 5].",Non-OADS,/arxiv_data1/oa_pdf/62/0f/2093-6966-v18-n01-072.PMC4379478.pdf
http://www.journal.ac074 mately 25 minutes in a hot oven.,Non-OADS,/arxiv_data1/oa_pdf/62/0f/2093-6966-v18-n01-072.PMC4379478.pdf
http://www.journal.ac075 Figure 2  Gastric mucosal injury index in chronic gastric ulcers.,Non-OADS,/arxiv_data1/oa_pdf/62/0f/2093-6966-v18-n01-072.PMC4379478.pdf
http://www.journal.ac076 Figure 7  Immunoactivities of BAX/Bcl-2 proteins in EtOH-in - duced chronic gastric ulcers in rats.Figure 9  Immunoreactivities of TGF- β1 proteins in EtOH-in - duced chronic gastric ulcers in rats.,Non-OADS,/arxiv_data1/oa_pdf/62/0f/2093-6966-v18-n01-072.PMC4379478.pdf
http://www.journal.ac077 4.,Non-OADS,/arxiv_data1/oa_pdf/62/0f/2093-6966-v18-n01-072.PMC4379478.pdf
http://www.journal.ac078 9.,Non-OADS,/arxiv_data1/oa_pdf/62/0f/2093-6966-v18-n01-072.PMC4379478.pdf
"VCFs of the thoraco lumbar  spine are common in the elderly, with approximately  1.5 million VCFs annually in the general US population  Original  articleISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[1]:079-085 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.009    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/94/2093-6966-v18-n01-079.PMC4379479.pdf
"ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1  Department of Acupuncture & Moxibustion, College of Oriental Medicine, Daegu Haany University, Daegu, Korea 2  Comprehensive and Integrative Medicine Institute, Daegu, Korea 3 Department of Internal Medicine, College of Oriental Medicine, Daegu Haany University, Daegu, Korea 4 Department of Medical Statistics, School of Medicine, Catholic University, Daegu, Korea 5 Department of Anesthesiology and Pain Medicine, School of Medicine, Catholic University, Daegu, Korea Received:  Oct 08, 2014      Reviewed:  Oct 15, 2014     Accepted:  Nov 24, 2014Key Words acupuncture, interlaminar epidural steroid injection,  vertebral compression fracture",Non-OADS,/arxiv_data1/oa_pdf/c7/94/2093-6966-v18-n01-079.PMC4379479.pdf
080  http://www.journal.ac Journal of Pharmacopuncture 2015;18(1):079-085 [3].,Non-OADS,/arxiv_data1/oa_pdf/c7/94/2093-6966-v18-n01-079.PMC4379479.pdf
http://www.journal.ac081  Journal of Pharmacopuncture 2015;18(1):079-085 dom number generator by an independent statistician  blinded to patient assignment in accordance with the Con - solidated Standards of Reporting Trials (CONSORT) state - ment.,Non-OADS,/arxiv_data1/oa_pdf/c7/94/2093-6966-v18-n01-079.PMC4379479.pdf
"082  http://www.journal.ac Sterilized disposable acupuncture needles (0.25 mm × 40  mm in size; DongBang Acupuncture Inc., Korea) will be  manually inserted into the acupoints.",Non-OADS,/arxiv_data1/oa_pdf/c7/94/2093-6966-v18-n01-079.PMC4379479.pdf
"http://www.journal.ac083 Any reported adverse events will be recorded throughout  the study, and vital signs will be monitored at each visit.",Non-OADS,/arxiv_data1/oa_pdf/c7/94/2093-6966-v18-n01-079.PMC4379479.pdf
"084  http://www.journal.ac Robinson Y, Heyde CE, Forsth P , Olerud C. Kyphoplasty  in osteoporotic vertebral compression fractures-guide - lines and technical considerations.",Non-OADS,/arxiv_data1/oa_pdf/c7/94/2093-6966-v18-n01-079.PMC4379479.pdf
"http://www.journal.ac085 JJ, et al .",OADS,/arxiv_data1/oa_pdf/c7/94/2093-6966-v18-n01-079.PMC4379479.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a0/c3/hepatmon-15-03-24173.PMC4379489.pdf
"Registering, Blasting and Alignment of Se - quences After registering of sequences in NCBI, data directed to  nucleotide similarity BLAST search (http://blast.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/a0/c3/hepatmon-15-03-24173.PMC4379489.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7e/42/ijem-13-02-22803.PMC4379513.pdf
Available from: http://www.nobelprize.org/nobel_prizes/medicine/ laureates/1998/press.html.,Non-OADS,/arxiv_data1/oa_pdf/6c/0e/IJNM-30-104.PMC4379667.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/6c/0e/IJNM-30-104.PMC4379667.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/6c/0e/IJNM-30-104.PMC4379667.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/1b/4e/IJNM-30-111.PMC4379668.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/76/10/IJNM-30-122.PMC4379670.pdf
Available  from: http://www2.msf.lu.se/simind/index.asp.,Non-OADS,/arxiv_data1/oa_pdf/bd/9a/IJNM-30-128.PMC4379671.pdf
Available from: http://www.umanitoba.ca/faculties/science/astronomy/ jwest/plugins.html.,Non-OADS,/arxiv_data1/oa_pdf/bd/9a/IJNM-30-128.PMC4379671.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/40/rjv027.PMC4379731.pdf
The study was approved by the Ethics Committee of the University Campus Bio-Medico of Rome (11/13 PAR ComEt CBM) and registered at http://www.ISRCTN.org(ISRCTN10467793).,Non-OADS,/arxiv_data1/oa_pdf/a1/ef/bmjdrc-2014-000079.PMC4379741.pdf
Avail-able at http://www.hcup-us.ahrq.gov.,Non-OADS,/arxiv_data1/oa_pdf/86/d5/e2014.00254.PMC4379870.pdf
To view please visit the journal (http://dx.doi.org/10.1136/openhrt-2014- 000052).,Non-OADS,/arxiv_data1/oa_pdf/16/0e/openhrt-2014-000052.PMC4379881.pdf
"The statistical programs StatXact, V .8 (http://www.cytel.com/software/statxact) and SPSS, V .20 (http://www.ibm.",OADS,/arxiv_data1/oa_pdf/f8/17/openhrt-2014-000204.PMC4379882.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/lupus-2014-000080).,Non-OADS,/arxiv_data1/oa_pdf/ed/84/lupus-2014-000080.PMC4379884.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/84/lupus-2014-000080.PMC4379884.pdf
"To view please visit the journal (http://dx.doi.org/ 10.1136/bmjresp-2014-000060) Received 18 August 2014 Revised 17 October 2014 Accepted 12 November 2014 Department of Public Health,Epidemiology & Biostatistics,School of Health and Population Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK Correspondence to Professor Peymane Adab; p.adab@bham.ac.ukABSTRACT Objectives: To develop and validate a clinical risk score to identify patients at risk of chronic obstructive pulmonary disease (COPD) using clinical factorsroutinely recorded in primary care.",Non-OADS,/arxiv_data1/oa_pdf/fc/fe/bmjresp-2014-000060.PMC4379885.pdf
"Competing interests All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work (except described above); no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years, no other relationships or activitiesthat could appear to have influenced the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/fc/fe/bmjresp-2014-000060.PMC4379885.pdf
All operators attended at least 2 days of didacticteaching and live case review and were encouraged to visit a website containing source material and case studies (http://www.ctofundamentals.org).,Non-OADS,/arxiv_data1/oa_pdf/18/3b/openhrt-2014-000228.PMC4379886.pdf
"To view please visit the journal (http://dx.doi.org/ 10.1136/lupus-2014-000074) Received 12 November 2014 Revised 11 February 2015Accepted 2 March 2015 1Center for Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset,New York, USA 2Center for Neurosciences, The Feinstein Institute for Medical Research, Manhasset, New York, USA Correspondence to Dr Meggan Mackay; mmackay@nshs.eduABSTRACT Objective: We investigated whether systemic lupus erythematosus (SLE) disease duration or serologyassociate with abnormal regional glucose metabolismas measured with [ 18F]2-fluoro-2-deoxy- D-glucose positron emission tomography (FDG-PET) and deficitson neuropsychological testing.",Non-OADS,/arxiv_data1/oa_pdf/48/81/lupus-2014-000074.PMC4379887.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/00/21/jjnpp-10-01-18396.PMC4379888.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/af/19/jjnpp-10-01-18820.PMC4379889.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/86/f9/jjnpp-10-01-17653.PMC4379890.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate- rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/14/01/jjnpp-10-01-19382.PMC4379891.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/51/44/jjnpp-10-01-20670.PMC4379902.pdf
"[66]    https://www.mlz-garching.de, neutron instruments at the Heinz- Maier-Leibnitz Zentrum (MLZ), accessed: December, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ee/70/adfm0024-3187.PMC4379906.pdf
"[67]    http://www.qtikws.de, SANS data treatment package, accessed:  December 2, 2013.",OADS,/arxiv_data1/oa_pdf/ee/70/adfm0024-3187.PMC4379906.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/00/dsu040.PMC4379978.pdf
"By random end-sequencing of 30,000 cDNA clones and comparison with allsequences in NCBI ( http://www.ncbi.nlm.nih.gov ), we chose 11 cDNAs with high similarities to Arabidopsis orPopulus trichocarpa sequences to examine the relationship with lignocellulosic biosynthesis(Supplementary Table S2).",OADS,/arxiv_data1/oa_pdf/d0/00/dsu040.PMC4379978.pdf
"Multi-SNP additive and dominance modelsfGWAS, version 2.0 ( http://statgen.psu.edu/software/fgwas-soft.html , Liet al.",OADS,/arxiv_data1/oa_pdf/d0/00/dsu040.PMC4379978.pdf
"33), in R ( http://cran.r-project.org/ ) was used to conduct multi-SNP association analyses.",OADS,/arxiv_data1/oa_pdf/d0/00/dsu040.PMC4379978.pdf
4.2 ( http://www.broad.mit.edu/mpg/haploview.html ).,Non-OADS,/arxiv_data1/oa_pdf/d0/00/dsu040.PMC4379978.pdf
Multi-gene associations under the epistasis model We used the MDR method ( http://phg.mc.vanderbilt.edu/Software/ MDR ) to detect and characterize SNP –SNP epistasis associated with these traits (Supplementary Tables S7 and S8).,OADS,/arxiv_data1/oa_pdf/d0/00/dsu040.PMC4379978.pdf
"All SNPs were identi ﬁed using the Bayesian hierarchical models in fGWAS, version 1.0 ( http://statgen.psu.edu/software/fgwas-soft.html )i nR( http://cran.r-project.org/ ).Q.",OADS,/arxiv_data1/oa_pdf/d0/00/dsu040.PMC4379978.pdf
2.0.1( http://www.maizegenetics.net/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/00/dsu040.PMC4379978.pdf
"R package version 1.4.4. http://CRAN.R-project.org/package=haplo.stats (1 August 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d0/00/dsu040.PMC4379978.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/12/dsu043.PMC4379981.pdf
"Thus far, the World Health Organization Collaborating Centre for Reference and Research on Escherichia andKlebsiella based at the Statens Serum Institut (SSI) in Denmark ( http://www.ssi.dk/English.",Non-OADS,/arxiv_data1/oa_pdf/c6/12/dsu043.PMC4379981.pdf
Phylogenetic analysis Multilocus sequence typing (MLST) was carried out according to theprotocol described on the E. coli MLST website ( http://mlst.warwick.,OADS,/arxiv_data1/oa_pdf/c6/12/dsu043.PMC4379981.pdf
"Phylogenetic groups (A, B1, B2, D, and E) were determined by comparing the sequences of the strains tested with the known sequences from the ECOR collection ( http://mlst.warwick.ac.uk/mlst/dbs/Ecoli ).A.",OADS,/arxiv_data1/oa_pdf/c6/12/dsu043.PMC4379981.pdf
Genome Track Analyzer is freely available at http://ancorr.eimb.ru/.,OADS,/arxiv_data1/oa_pdf/5a/cd/dsu044.PMC4379982.pdf
"This is an Open Access article distributed under th e terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/cd/dsu044.PMC4379982.pdf
Our package is freely available athttp://ancorr.eimb.ru/.,Non-OADS,/arxiv_data1/oa_pdf/5a/cd/dsu044.PMC4379982.pdf
"The data on CpG islands on human chromosomes were taken from URL http://rafalab.jhsph.edu/CGI/, 5whereas the data on TSS were taken from the Eukary- otic Promoter Database (http://epd.vital-it.ch/ H. Sapiens hg19 version EPDnew 003).3Our method supported the strong correlations between CpG islands and TSS with clear preceding ordering between 5 ′-ends of CpG islands and TSS.",OADS,/arxiv_data1/oa_pdf/5a/cd/dsu044.PMC4379982.pdf
The data on binding sites for TF associated with genes were taken from http://www.genecards.org.116 Genome-wide study of correlations between genome tracks,OADS,/arxiv_data1/oa_pdf/5a/cd/dsu044.PMC4379982.pdf
"arXiv, 2013. http://arxiv.org/pdf/1312.5186.pdf [accessed 27 January 2015].",Non-OADS,/arxiv_data1/oa_pdf/14/63/ihv009.PMC4379984.pdf
arXiv 2014. http://arxiv.org/abs/1409.6358 [accessed 27 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/14/63/ihv009.PMC4379984.pdf
J Glob Health 2014;4:010403. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073250/ [accessed 9 August 2014].D.,Non-OADS,/arxiv_data1/oa_pdf/59/cc/ihv011.PMC4379985.pdf
3 November 2011. http://www.theguardian.com/business/2011/nov/ 03/anglo-american-medical-of ﬁcer-brian-brink-interview?,Non-OADS,/arxiv_data1/oa_pdf/59/cc/ihv011.PMC4379985.pdf
"Pretoria: Statistics South Africa; 2014. http://beta2.statssa.gov.za/?p=2951 [accessed 24 October 2014].25 Corno L, Walque D de.",Non-OADS,/arxiv_data1/oa_pdf/59/cc/ihv011.PMC4379985.pdf
Geneva: World Health Organization; 2014. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/76/9e/ihv012.PMC4379986.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/57/nihms670769.PMC4379989.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/83/bht268.PMC4379993.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/6e/bht273.PMC4379994.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/fc/bht279.PMC4379995.pdf
"Supplementary Material Supplementary material can be found at: http://www.cercor.oxford- journals.org/ Funding This research was supported by an OeNB grant (Austrian Na- tional Bank, P12982) awarded to C. Windischberger and aFWF grant (Austrian Science Fund, P23021) awarded toR.",Non-OADS,/arxiv_data1/oa_pdf/cb/fc/bht279.PMC4379995.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/7f/bht280.PMC4379996.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/a3/bht284.PMC4379998.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/54/bht292.PMC4380001.pdf
(2007 ); icbm_fsl2tal.m downloaded from http://brainmap.org/icbm2tal/ )a n d shown to generate relatively good agreement between MNI and TAL space across the brain volume.,OADS,/arxiv_data1/oa_pdf/fe/54/bht292.PMC4380001.pdf
"Ward, http://afni.nimh.nih.gov/afni/docpdf/AlphaSim.pdf ) Experiment 1 (t> 3.5, voxelwise P< 0.01, cluster P< 0.05, equal to 35 voxels), Experiment 2 ( t> 3.25, voxelwise P< 0.01; cluster P< 0.05; equal to 37 voxels and 33 voxels for familiar and unfamiliar maps, respectively), Experiments 1 and 2 pooled ( t> 2.9, voxelwise P< 0.01; cluster P< 0.05, equal to 64 voxels).",OADS,/arxiv_data1/oa_pdf/fe/54/bht292.PMC4380001.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.oxford journals.org/ Funding F.W.S.,Non-OADS,/arxiv_data1/oa_pdf/fe/54/bht292.PMC4380001.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/37/bht305.PMC4380004.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/18/bht306.PMC4380005.pdf
"Running TERA on a set of 1099 homologous gene families from complete cyanobacterial genomes, we ﬁnd that incorporating knowledge of the species tree results in a two thirds reduction in the number of apparent transfer events.Availability and implementation: The algorithm is implemented in our program TERA , which is freely available from http://mbb.univ-montp2.fr/MBB/download_sources/16__TERA.",OADS,/arxiv_data1/oa_pdf/49/e9/btu728.PMC4380024.pdf
"841 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/e9/btu728.PMC4380024.pdf
"To compare the accuracy of our method to that of others, we reconstructed gene trees using six different ‘spe-cies tree aware’ methods: (i) the TERA algorithm described here, (ii)ALE ( Szo¨llo†siet al., 2013b ), (iii) TreeFix-DTL (Bansal et al., 2014, submitted for publication, http://compbio.mit.edu/treefix-dtl/), (iv)MowgliNNI ( Nguyen et al., 2013 ), (v) AnGST ( David and Alm, 2010 ) and (vi) JPrIME-DLTRS ( Sjo¨strand et al., 2014 ) as well as the species tree unaware method, PhyML ( Guindon et al., 2010 ).",OADS,/arxiv_data1/oa_pdf/49/e9/btu728.PMC4380024.pdf
Please visit http://www.cl.cam.ac.uk/ /C24mam211/ for user tutorial and download.,Non-OADS,/arxiv_data1/oa_pdf/02/41/btu731.PMC4380025.pdf
"969 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/41/btu731.PMC4380025.pdf
"To achieve a comprehensive study, we identify the comorbidity correlations ofdiseases based on the clinical information from the US Medicareclaims database, http://www.icd9data.com, and collected fromHidalgo et al.",OADS,/arxiv_data1/oa_pdf/02/41/btu731.PMC4380025.pdf
The package is freely available at http://zhoulab.usc.edu/Hi-Corrector/.,OADS,/arxiv_data1/oa_pdf/ef/6d/btu747.PMC4380031.pdf
"960 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/6d/btu747.PMC4380031.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/bf/syu088.PMC4380036.pdf
"1b; Supplementary Table S1 in online Appendix 1, availableathttp://dx.doi.org/10.5061/dryad.5845b).",Non-OADS,/arxiv_data1/oa_pdf/d3/bf/syu088.PMC4380036.pdf
"Distributional and Climatic Data Distribution data for extant Hypericum species were obtained from taxonomic monographs ( Robson 1981 - onwards), herbarium collections (e.g., MA), and onlinedatabases (GBIF, http://www.gbif.org).",OADS,/arxiv_data1/oa_pdf/d3/bf/syu088.PMC4380036.pdf
Fossil distribution data (143records; Supplementary Table S1 in online Appendix 1available at http://dx.doi.org/10.5061/dryad.5845b.),OADS,/arxiv_data1/oa_pdf/d3/bf/syu088.PMC4380036.pdf
"[12:27 3/2/2015 Sysbio-syu088.tex] Page: 219 215–2322015 MESEGUER ET AL.—FOSSILS, PHYLOGENIES, NICHE MODELS IN BIOGEOGRAPHY 219 were obtained from the literature ( Meseguer and Sanmartín 2012 ) and online resources (Paleobiology Database, http://paleodb.org/).",OADS,/arxiv_data1/oa_pdf/d3/bf/syu088.PMC4380036.pdf
2005 ;Ree and Smith 2008 ) using t h ef a s tC ++version ( Smith 2009 ;https://github.com/ rhr/lagrange-cpp).,Non-OADS,/arxiv_data1/oa_pdf/d3/bf/syu088.PMC4380036.pdf
S UPPLEMENTARY MATERIAL Data available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.5845b.,OADS,/arxiv_data1/oa_pdf/d3/bf/syu088.PMC4380036.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/3f/ddv004.PMC4380077.pdf
Web Resources BayGenomics database (now part of International Gene Trap Consortium: http://www.genetrap.org/) Developmental Genome Anatomy Project (DGAP) (http://www.,OADS,/arxiv_data1/oa_pdf/c8/3f/ddv004.PMC4380077.pdf
"bwhpathology.org/dgap/)Ensembl (http://www.ensembl.org/Homo_sapiens/)Eppig and Levan, 2007 (http://www.informatics.jax.org/mgihome/ nomen/gene.shtml#gtl) NCBI Human Genome Browser (http://www.ncbi.nlm.nih.gov/)Repeat Masker (http://www.repeatmasker.org)UCSC Genome Browser (http://genome.ucsc.edu) References 1.",OADS,/arxiv_data1/oa_pdf/c8/3f/ddv004.PMC4380077.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/5c/bht239.PMC4380081.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/d1/bht266.PMC4380084.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
The on- line supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201511363/DC1.,Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1124/mol.111.075234 Balla, T. 2013.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10 .1152/physrev.00028.2012 Behrens, R., A. Nolting, F. Reimann, M. Schwarz, R. Waldschütz,  and O. Pongs.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1016/S0014-5793(00)01584-2 Brenner, R., T.J. Jegla, A. Wickenden, Y. Liu, and R.W.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1073/ pnas.1313433110 Chen, X., J. Yan, and R.W.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"5:312. http://dx.doi.org/10.3389/fphys .2014.00312 Epand, R.M.",Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1016/ j.bbamem.2008.03.016 Evanson, K.W., J.P. Bannister, M.D.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/ 10.1161/CIRCRESAHA.115.303407 Flynn, G.E., and W.N.",Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi .org/10.1074/jbc.M110.214650 Gamper, N., and M.S.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1038/nrn2257 Gessner, G., Y.M.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1038/nature10370 Hite, R.K., J.A.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
http://dx.doi.org/10.7554/eLife.04366329RKK331 is neutralized.,Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi .org/10.1038/nature04880 Rittenhouse, A.R.",Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1085/jgp.200810053 Salkoff, L., A. Butler, G. Ferreira, C. Santi, and A. Wei.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1038/nrn1992 Slochower, D.R., P.J.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi .org/10.1074/jbc.M113.538033 Uebele, V.N., A. Lagrutta, T. Wade, D.J.",Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1085/jgp .200709913 Wallner, M., P. Meera, and L. Toro.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1016/j.chemphyslip.2014 .01.001 Wang, Y.W., J.P. Ding, X.M.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.6191-08.2009 Wu, R.S., G. Liu, S.I.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1085/jgp .201210891 Xia, X.M., J.P. Ding, and C.J.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1038/nature00956Horrigan, F.T., and R.W.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1085/jgp.20028605 Horrigan, F.T., S.H.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1085/jgp.200509262 Hoshi, T., A. Pantazis, and R. Olcese.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1152/physiol.00055.2012 Hoshi, T., Y. Tian, R. Xu, S.H.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1152/physiol.00032.2008 Knaus, H.G., A. Eberhart, G.J.",Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1085/jgp.201411337 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi .org/10.1038/nature06265 Morera, F.J., A. Alioua, P. Kundu, M. Salazar, C. Gonzalez, A.D.  Martinez, E. Stefani, L. Toro, and R. Latorre.",Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1016/j.febslet.2012.05.066 Nelson, M.T., and A.D. Bonev.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1172/JCI21388 Niu, X., X. Qian, and K.L.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1016/j.neuron.2004.05.001 Pian, P., A. Bucchi, R.B.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
http://dx.doi.org/10.1085/jgp.200609648,OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1085/jgp.20028667 Xu, Y., Y. Ramu, and Z. Lu.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1038/nature06618 Yan, J., and R.W.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi.org/10.1038/nature09162 Yan, J., and R.W.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
"http://dx.doi .org/10.1073/pnas.1111104108 Zhang, G., R. Xu, S.H.",OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
http://dx.doi .org/10.1073/pnas.1010124107,Non-OADS,/arxiv_data1/oa_pdf/15/3b/JGP_201511363.PMC4380209.pdf
This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
The online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201411309/DC1.,Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1016/ S0006-3495(97)78124-4 Jorquera, G., F. Altamirano, A. Contreras-Ferrat, G. Almarza, S.  Buvinic, V. Jacquemond, E. Jaimovich, and M. Casas.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10 .1242/jcs.116855 Kerr, J.P., A.P.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1016/0006-291X (89)91147-9 Kurokawa, T., S. Takasuga, S. Sakata, S. Yamaguchi, S. Horie, K.J.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi .org/10.1113/jphysiol.2011.216408 Lefebvre, R., C. Legrand, L. Groom, R.T. Dirksen, and V. Jacquemond.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1371/journal.pone.0054042 Legrand, C., E. Giacomello, C. Berthier, B. Allard, V. Sorrentino,  and V. Jacquemond.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi .org/10.1113/jphysiol.2007.145862 Lindinger, M.I., G.J.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10 .1016/0304-4157(94)00014-5 Murata, Y., H. Iwasaki, M. Sasaki, K. Inaba, and Y. Okamura.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1038/ nature03650 Nasuhoglu, C., S. Feng, Y. Mao, I. Shammat, M. Yamamato, S.  Earnest, M. Lemmon, and D.W. Hilgemann.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1152/ajpcell.00486.2001 Ogawa, Y., and H. Harafuji.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1007/s00232-001- 0179-x Blaauw, B., P. Del Piccolo, L. Rodriguez, V.H.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1085/jgp.201110747 Casas, M., R. Figueroa, G. Jorquera, M. Escobar, J. Molgó, and E.  Jaimovich.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1085/jgp.200910397 Cheng, H., W.J.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1126/ science.8235594 Chu, A., and E. Stefani.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1016/S0006-3495(03)74846-2 Collet, C., S. Pouvreau, L. Csernoch, B. Allard, and V. Jacquemond.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1385/CBB:40:2:225 Dulhunty, A.F.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
33:763– 772. http://dx.doi.org/10.1111/j.1440-1681.2006.04441.x,Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1139/y99-017 Pouvreau, S., and V. Jacquemond.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi .org/10.1113/jphysiol.2005.089599 Pouvreau, S., L. Csernoch, B. Allard, J.M.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1529/ biophysj.105.078089 Ríos, E., G. Pizarro, and E. Stefani.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi .org/10.1146/annurev.ph.54.030192.000545 Rodríguez, E.G., R. Lefebvre, D. Bodnár, C. Legrand, P. Szentesi, J.  Vincze, K. Poulard, J. Bertrand-Michel, L. Csernoch, A. Buj-Bello,  and V. Jacquemond.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1007/s00424-013-1346-5 Sakata, S., M.I.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1113/jphysiol.2011.208165 Schneider, M.F.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi .org/10.1146/annurev.ph.56.030194.002335 Stauffer, T.P., S. Ahn, and T. Meyer.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi .org/10.1016/S0960-9822(98)70135-6 Suh, B.C., K. Leal, and B. Hille.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1016/ j.neuron.2010.07.001 Suh, B.C., D.I.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1021/bi802242r Tjondrokoesoemo, A., N. Li, P.H.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1074/jbc .M112.425975 Treves, S., M. Vukcevic, M. Maj, R. Thurnheer, B. Mosca, and F.  Zorzato.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1113/ jphysiol.2009.171876 van der Wal, J., R. Habets, P. Várnai, T. Balla, and K. Jalink.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1074/jbc .M007194200 Várnai, P., and T. Balla.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"http://dx.doi.org/10.1113/ jphysiol.2010.191593 Yamaguchi, S., T. Kurokawa, I. Taira, N. Aoki, S. Sakata, Y. Okamura,  and K.J.",OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
http://dx.doi.org/10.1002/ jcp.24463,Non-OADS,/arxiv_data1/oa_pdf/96/7b/JGP_201411309.PMC4380211.pdf
"Therefore, it is critical to identify the release Revisiting the role of raphe and serotonin in neuropsychiatric disorders Albert Adell Institute of Biomedicine and Biotechnology of Cantabria, IBBTEC (CSIC, Universidad de Cantabria), 39011 Santander, Spain © 2015 Adell  This article is distributed under the terms of an Attribution–Noncommer­ cial–Share Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"After six months it is available under a Creative Com­ mons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by ­nc­sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1007/BF00251121 Adell, A., G.S.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"97:206– 212. http://dx.doi.org/10.1111/j.1476-5381.1989.tb11943.x Adell, A., P. Celada, M.T.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1016/S0166-2236(96)10037-0 Asberg, M., P. Thorén, L. Träskman, L. Bertilsson, and V. Ringberger.",OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10 .1126/science.1246632 Bortolozzi, A., A. Castañé, J. Semakova, N. Santana, G. Alvarado, R.  Cortés, A. Ferrés-Coy, G. Fernández, M.C.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1038/mp.2011.92 Colgan, L.A., S.L.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0020-12.2012 Commons, K.G.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1002/cne .23748 Covington, H.E., III, M.K.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi .org/10.1523/JNEUROSCI.1731-10.2010 Crespi, F. 2009.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi .org/10.1016/j.brainres.2009.05.021 Delgado, P.L., H.L.",OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1016/S0006-3223(99)00014-1 Gigliucci, V., G. O’Dowd, S. Casey, D. Egan, S. Gibney, and A. Harkin.",OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1007/s00213-013-3024-x Haddjeri, N., N. Lavoie, and P. Blier.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1038/sj.npp.1300489 Hamani, C., M. Diwan, C.E.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1016/0006-8993(92)90914-U Matos, F.F., C. Urban, and F.D.",OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1007/BF01292626 Mlinar, B., A. Montalbano, G. Baccini, F. Tatini, R. Berlinguer Palmini,  and R. Corradetti.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"145:225– 251. http://dx.doi.org/10.1085/jgp.201411330 Neff, C.D., V. Abkevich, J.C. Packer, Y. Chen, J. Potter, R. Riley, C.  Davenport, J. DeGrado Warren, S. Jammulapati, A. Bhathena, et al.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1002/(SICI)1096- 9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A Richardson-Jones, J.W., C.P.",OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1016/j.neuron.2009.12.003 Sachs, B.D., J.R. Ni, and M.G.",OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"22:1429– 1438. http://dx.doi.org/10.1016/0006-3223(87)90100-4 Sharp, T., S.R.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
"http://dx.doi.org/10.1111/j.1471-4159.1989.tb07319.x Stockmeier, C.A., L.A. Shapiro, G.E.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/JGP_201511389.PMC4380212.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"After six months it is available under a Creative Com- mons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/ 10.1529/biophysj.107.116467 Beam, K.G., and C. Franzini-Armstrong.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1016/S0091- 679X(08)60384-2 Beam, K.G., and C.M.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1085/jgp.91.6.781 Beam, K.G., B.A.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi .org/10.1021/bi953023c DiFranco, M., J. Capote, M. Quiñonez, and J.L.",Non-OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"130:581– 600. http://dx.doi.org/10.1085/jgp.200709831 DiFranco, M., P. Tran, M. Quiñonez, and J.L.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10 .1016/0034-5687(96)00031-X Fuller, M.D., M.A.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10 .1126/scisignal.2001152 Gao, T., A.E.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
http://dx.doi.org/10.1074/ jbc.M008000200because of the absence of the final 13 residues.,OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"127:591– 606. http://dx.doi.org/10.1016/j.cell.2006.10.017 Grabner, M., R.T. Dirksen, N. Suda, and K.G.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1074/jbc.274 .31.21913 Hamill, O.P., A. Marty, E. Neher, B. Sakmann, and F.J. Sigworth.",Non-OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1007/BF00656997 Held, B., D. Freise, M. Freichel, M. Hoth, and V. Flockerzi.",Non-OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1113/ jphysiol.2001.012745 Hulme, J.T., M. Ahn, S.D.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1074/jbc.M109814200 Hulme, J.T., T.W.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1113/jphysiol.2006.111799 Johnson, B.D., T. Scheuer, and W.A.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1016/j.abb.2004.04.007 Leung, A.T., T. Imagawa, and K.P.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1074/jbc .M405318200 Morrill, J.A., and S.C. Cannon.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10 .1085/jgp.116.3.341 Nakai, J., R.T. Dirksen, H.T.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1038/380072a0 Papadopoulos, S., V. Leuranguer, R.A. Bannister, and K.G.",Non-OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1074/jbc.M405317200 Pietrobon, D., and P. Hess.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1038/346651a0 Rotman, E.I., K.S.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.108.191387 Sculptoreanu, A., E. Rotman, M. Takahashi, T. Scheuer, and W.A.",Non-OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1038/364240a0 Tanabe, T., H. Takeshima, A. Mikami, V. Flockerzi, H. Takahashi,  K. Kangawa, M. Kojima, H. Matsuo, T. Hirose, and S. Numa.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10 .1038/328313a0 Tanabe, T., K.G.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
"http://dx.doi.org/10.1038/336134a0 Tanabe, T., B.A.",OADS,/arxiv_data1/oa_pdf/66/f4/JGP_201411292.PMC4380213.pdf
This article is distributed under the terms of an Attribution–Noncommer­ cial–Share Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/ 10.1016/S0896-6273(02)01126-1 Campos, F.V., B. Chanda, B. Roux, and F. Bezanilla.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/ 10.1073/pnas.0702638104 Cha, A., and F. Bezanilla.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1016/S0896- 6273(00)80403-1 Chowdhury, S., and B. Chanda.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1085/ jgp.201110722 Colquhoun, D., and F.J. Sigworth.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1007/978-1-4419-1229-9_19 Delemotte, L., M. Tarek, M.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1113/jphysiol.2003.046250 Gonzalez, C., E. Rosenman, F. Bezanilla, O. Alvarez, and R. Latorre.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi .org/10.1073/pnas.1000963107 Heginbotham, L., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1016/0076-6879(92)07009-D Hirschberg, B., A. Rovner, M. Lieberman, and J. Patlak.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10 .1085/jgp.106.6.1053 Islas, L.D., and F.J. Sigworth.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1085/jgp.114.5.723 Islas, L.D., and F.J. Sigworth.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1126/science.1216533 Jogini, V., and B. Roux.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80143-9 Ahern, C.A., and R. Horn.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1038/ nature06266 Almers, W. 1978.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
http://dx.doi.org/10.1007/BFb0030498,Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi .org/10.1016/0896-6273(88)90192-4 Khalili-Araghi, F., V. Jogini, V. Yarov-Yarovoy, E. Tajkhorshid, B.  Roux, and K. Schulten.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.02.056 Lainé, M., D.M.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/ 10.1085/jgp.113.3.389 Lin, M.C., J.Y.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1126/science.1116269 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1038/ nature06265 Mannuzzu, L.M., M.M.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi .org/10.1126/science.271.5246.213 Noceti, F., P. Baldelli, X. Wei, N. Qin, L. Toro, L. Birnbaumer, and  E. Stefani.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1085/jgp.108.3.143 O’Connell, K.M.S., R. Loftus, and M.M.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1073/ pnas.1003028107 Papazian, D.M., T.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"237:749– 753. http://dx.doi.org/10.1126/science.2441470 Pérez-Cornejo, P., and T. Begenisich.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"17:869– 875. http://dx.doi.org/10.1038/nsmb.1826 Rezazadeh, S., H.T.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1007/ s00232-004-0664-0 Schoppa, N.E., and F.J. Sigworth.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1085/jgp.111.2.271 Schoppa, N.E., and F.J. Sigworth.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi .org/10.1085/jgp.111.2.313 Schoppa, N.E., K. McCormack, M.A.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1126/ science.1553560 Seoh, S.A., D. Sigg, D.M.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1016/S0896- 6273(00)80142-7 Sigg, D., and F. Bezanilla.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10 .1113/jphysiol.1980.sp013426 Sigworth, F.J. 1994.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1017/S0033583500002894 Swartz, K.J.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1038/nature07620 Tao, X., A. Lee, W. Limapichat, D.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1126/science.1185954 Vargas, E., V. Yarov-Yarovoy, F. Khalili-Araghi, W.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi .org/10.1085/jgp.201210873 Villalba-Galea, C.A., W. Sandtner, D.M.",Non-OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1073/ pnas.0807387105 Yellen, G. 2002.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1038/nature00978 Zagotta, W.N., T. Hoshi, and R.W.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
"http://dx.doi.org/10.1085/jgp.103.2.321 Zagotta, W.N., T. Hoshi, J. Dittman, and R.W.",OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
http://dx.doi.org/10.1085/jgp.103.2.279,OADS,/arxiv_data1/oa_pdf/a7/df/JGP_201411300.PMC4380214.pdf
PF00005; http://pfam.sanger.ac.uk/family/ ABC_tran).,Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
© 2015 Chaves and Gadsby  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"The sizes of MTS reagents, NEM, nucleotides, and biotin–avidin complex were assessed using Jmol 13.0.14 (http://www.jmol.org/) to calculate minimum bounding box dimensions needed to fit each molecule (for rotamers in Fig.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
The online supplemental material is available at  http://www.jgp.org/cgi/content/full/jgp.201411347/DC1.,Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"116:163– 180. http://dx.doi.org/10.1085/jgp.116.2.163 Chen, T.Y., and T.C.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1152/physrev.00058.2006 Chen, J., G. Lu, J. Lin, A.L.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/ 10.1016/j.molcel.2003.08.004 Cotten, J.F., and M.J. Welsh.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/jbc.272.41.25617 Cotten, J.F., and M.J. Welsh.",Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi .org/10.1085/jgp.116.3.477 Csanády, L., A.C. Nairn, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1085/jgp.200609558 Csanády, L., P .",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi .org/10.1113/jphysiol.2005.099457 Davidson, A.L., E. Dassa, C. Orelle, and J. Chen.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1128/ MMBR.00031-07 Dawson, R.J., and K.P.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/ 10.1038/nature05155 Dawson, R.J., and K.P.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10 .1016/j.febslet.2007.01.073 Fetsch, E.E., and A.L.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1038/nature04712 Gao, M., H.R.",Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/ jbc.275.17.13098 Gunderson, K.L., and R.R.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/jbc.M111713200 Aleksandrov, L., A. Aleksandrov, and J.R. Riordan.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1042/BJ20081068 Aller, S.G., J. Yu, A.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1126/ science.1168750 Bai, Y., M. Li, and T.C.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1085/ jgp.201010480 Basso, C., P. Vergani, A.C. Nairn, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1085/ jgp.200308798 Baukrowitz, T., T.C.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1016/0896-6273(94)90206-2 Boël, G., P.C.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi .org/10.1038/nsmb.2740 Cai, Z., T.S.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/ 10.1085/jgp.200308921 Carson, M.R., S.M.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/ jbc.270.4.1711 Chan, K.W., L. Csanády, D. Seto-Young, A.C. Nairn, and D.C. Gadsby.",Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi .org/10.1074/jbc.274.49.34711 Lewis, H.A., S.G. Buchanan, S.K.",Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/jbc.C000222200 Lubelski, J., A. de Jong, R. van Merkerk, H. Agustiandari, O.P.",Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1111/j.1365-2958.2006.05267.x Matsuo, M., N. Kioka, T. Amachi, and K. Ueda.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/jbc.274.52.37479 Mense, M., P. Vergani, D.M.",Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1038/sj.emboj.7601373 Moody, J.E., L. Millen, D. Binns, J.F.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/ jbc.C200228200 Moradi, M., and E. Tajkhorshid.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi .org/10.1073/pnas.1313202110 Nagata, K., M. Nishitani, M. Matsuo, N. Kioka, T. Amachi, and K.  Ueda.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/ jbc.M000792200 Oldham, M.L., and J. Chen.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1126/science.1200767 Oldham, M.L., and J. Chen.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
http://dx.doi.org/10.1021/bi982243yfibrosis transmembrane regulator channel gating.,Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1016/0092-8674(95)90310-0 Hohl, M., C. Briand, M.G.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi .org/10.1038/nsmb.2267 Hohl, M., L.M.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1016/ S0959-440X(03)00037-X Hopfner, K.P., A. Karcher, D.S.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/jbc.M001109200 Hung, L.W., I.X.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1038/25393 Janas, E., M. Hofacker, M. Chen, S. Gompf, C. van der Does, and R.  Tampé.",Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/ jbc.M301227200 Jin, M.S., M.L.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1038/nature11448 Karlin, A., and M.H.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10 .1016/S0076-6879(98)93011-7 Khare, D., M.L.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1016/j .molcel.2009.01.035 Kim, J., S. Wu, T.M.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1038/nature13872 Kodan, A., T. Yamaguchi, T. Nakatsu, K. Sakiyama, C.J.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1085/jgp.115.1.59 Lamers, M.H., H.H.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1093/emboj/cdg064 Lee, J.Y., J.G.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
http://dx.doi.org/10.1126/ science.1246489,Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi .org/10.1016/0014-5793(95)01345-8 Shintre, C.A., A.C. Pike, Q. Li, J.I.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"285:7575– 7586. http://dx.doi.org/10.1074/jbc.M109.047290 Smith, P.C., N. Karpowich, L. Millen, J.E.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1016/ S1097-2765(02)00576-2 Srinivasan, V., A.J.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1126/ science.1246729 Szabó, K., G. Szakács, T. Hegeds, and B. Sarkadi.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/ jbc.274.18.12209 Szollosi, A., P. Vergani, and L. Csanády.",Non-OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"137:549– 562. http://dx.doi.org/10.1085/jgp.201110608 Tombline, G., and A.E.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1007/s10863-005-9498-4 Tsai, M.F., H. Shimizu, Y. Sohma, M. Li, and T.C.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1085/jgp .200810186Tsai, M.F., M. Li, and T.C.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1085/jgp.201010399 Urbatsch, I.L., B. Sankaran, S. Bhagat, and A.E.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/jbc .270.45.26956 Urbatsch, I.L., K. Gimi, S. Wilke-Mounts, N. Lerner-Marmarosh, M.E.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1074/jbc.M010829200 Verdon, G., S.V.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1016/ j.jmb.2003.08.065 Vergani, P., A.C. Nairn, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/10.1085/jgp.20028673 Vergani, P., S.W.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi .org/10.1038/nature03313 Ward, A., C.L.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
"http://dx.doi.org/ 10.1073/pnas.0709388104 Ward, A.B., P. Szewczyk, V. Grimard, C.W.",OADS,/arxiv_data1/oa_pdf/19/1a/JGP_201411347.PMC4380215.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/1/1/e1400205/DC1Materials and Methods Fig.,Non-OADS,/arxiv_data1/oa_pdf/0f/45/1400205.PMC4380226.pdf
"(Cell Mol Gastroenterol Hepatol 2015;1:87 –101; http://dx.doi.org/ 10.1016/j.jcmgh.2014.08.002 ) Keywords: Aganglionosis; Enteric Nervous System; Neural Crest.The enteric nervous system (ENS) regulates multiple gastrointestinal (GI) functions, including motility, secretion, and in ﬂammatory processes.1The ENS originates from neural crest-derived progenitors (NCPs) that migratefrom the neural tube to colonize the entire intestine.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC4380251.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC4380251.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2014.08.002,OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC4380251.pdf
"appl1  deletion in mice consistently leads to systemic insulin resistance and a significant reduction in  insulin-stimulated IRS1/2, but not IR, tyrosine phosphorylation, indicating that APPL1 sensitizes  © 2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a0/c7/nihms586761.PMC4380268.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/15/main.PMC4380274.pdf
http://dx.doi.org/10.1016/j.ijwd.2015.01.001 2352-6475/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/15/main.PMC4380274.pdf
"Furthermore, cer tain marketing information associ- ated with these devices must provide additional and speci ﬁc warning statements and contraindications ( http://www.fda.gov/NewsEvents/ Newsroom/PressAnnounc ements/ucm399222.htm ).",Non-OADS,/arxiv_data1/oa_pdf/bc/15/main.PMC4380274.pdf
"Equipment Design 3D surface images were obtained using a commercially available camera system  (3dMDtorso™ Imaging System, 3dMD® LLC, Atlanta, GA, http://www.3dMD.com ), which  for our purposes was custom designed by 3dMD to mount on a bariatric motorized tilt table.",Non-OADS,/arxiv_data1/oa_pdf/50/49/nihms661133.PMC4380553.pdf
2014 http://dx.doi.org/10.1016/j.medengphy.2014.09.016 .,OADS,/arxiv_data1/oa_pdf/50/49/nihms661133.PMC4380553.pdf
"Rockville MD: Agency  for Healthcare Research and Quality; 2013. http://www.guideline.gov/content.aspx?id=38359 Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG.",Non-OADS,/arxiv_data1/oa_pdf/76/1f/nihms660809.PMC4380555.pdf
Available from: http://www.cdc.gov/nchs/data/databriefs/ db131.pdf .,OADS,/arxiv_data1/oa_pdf/b9/03/nihms-661886.PMC4380576.pdf
"SAS code, designated Program C,  provided on the Web at http://dx.doi.org/10.1037/1082-989X.11.1.19.supp; MacCallum et al.24), p. 28), we calculated the critical value T for  the χ2 difference at the significance level of 0.05 based on a noncentral χ2 distribution using the difference in degrees of freedom between the  constrained and unconstrained model and the noncentrality parameter.",OADS,/arxiv_data1/oa_pdf/58/81/indhealth-53-113.PMC4380598.pdf
https://jyx.jyu.fi/dspace/ handle/123456789/42178.,Non-OADS,/arxiv_data1/oa_pdf/58/81/indhealth-53-113.PMC4380598.pdf
https://www.apa.org/helpcenter/ understanding-chronic-stress.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f5/dc/indhealth-53-132.PMC4380600.pdf
http://www.japanfs.org/en/news/archives/news_id026959.html.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/indhealth-53-152.PMC4380602.pdf
6) Japanese Nursing Association The Main Projects 2014. https://www.nurse.or.jp/jna/english/activities/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/indhealth-53-152.PMC4380602.pdf
7) Japanese Nursing Association Working Conditions for  Nurses 2014. https://www.nurse.or.jp/jna/english/activities/projects/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/indhealth-53-152.PMC4380602.pdf
Demographic Change in Japan 2014. http://www.mhlw.go.jp/english/policy/affairs/dl/01.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/indhealth-53-152.PMC4380602.pdf
Working Conditions/Labour Relations 2014. http://www.mhlw.go.jp/english/wp/wp-hw7/dl/04e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/indhealth-53-152.PMC4380602.pdf
Social Indicators by Prefecture (Population and Households) 2014. http://www.e-stat.go.jp/SG1/estat/ListE.do?bid=000001052146&cyccode=0.,OADS,/arxiv_data1/oa_pdf/9e/34/indhealth-53-152.PMC4380602.pdf
"Models were adjusted for daily mean temperature (9–17 h), estimated from hourly meteorological data avail-able from the Environment Canada Data Access Integration Team (http://loki.qc.ec.gc.ca/DAI/DAI-e.html).",OADS,/arxiv_data1/oa_pdf/99/98/indhealth-53-171.PMC4380604.pdf
"Research Triangle Park, NC http://cfpub.epa.gov/ncea/isa/ recordisplay.cfm?deid=247492.",OADS,/arxiv_data1/oa_pdf/99/98/indhealth-53-171.PMC4380604.pdf
http://www.uptodate.com/contents/silicosis?source=search_result&search=silicosis&selectedT itle=1%7E22.,OADS,/arxiv_data1/oa_pdf/c3/49/indhealth-53-178.PMC4380606.pdf
"Environ Health 9, 17 http://www.ehjournal.net/content/ pdf/1476-069X-9–17.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c3/49/indhealth-53-178.PMC4380606.pdf
"R  package version 0.84., In: http://CRAN.R-project.org/package=irr.",Non-OADS,/arxiv_data1/oa_pdf/25/a6/indhealth-53-184.PMC4380607.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/33/nihms670509.PMC4380664.pdf
2014 Jun 12. pii: S0091-3022(14)00055-7 http://dx.doi.org/10.1016/j.yfrne.,OADS,/arxiv_data1/oa_pdf/0b/33/nihms670509.PMC4380664.pdf
"http://www.nlm.nih.gov/medlineplus/magazine/magazineinfo.html 30 Institute of Medicine Committee on Advancing Pain Research, Care, and Education.",Non-OADS,/arxiv_data1/oa_pdf/54/22/sm20003-0014.PMC4380910.pdf
"Available at: http://www.unaids.org/en/resources/documents/2012/20121120_UNAIDS_Global_Report_2012(accessed January 13, 2015).4 Shao B, Li Y, Yu L, Wang K, Chang M, Wang B, Wang F. The HIV/AIDS epidemic characteristics in a northeast province ofChina–men who have sex with men have made a tremendouscontribution to the growth of the HIV epidemic.",Non-OADS,/arxiv_data1/oa_pdf/ba/a4/sm20003-0024.PMC4380911.pdf
"Available at: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_AU_Narrative_Report[1].pdf (accessedJanuary 13, 2015).",Non-OADS,/arxiv_data1/oa_pdf/ba/a4/sm20003-0024.PMC4380911.pdf
"Available at: http://www.cdcgov/hiv/resources/factsheets/PDF/statistics_basics_factsheet.pdf (accessed January 13, 2015).",Non-OADS,/arxiv_data1/oa_pdf/ba/a4/sm20003-0024.PMC4380911.pdf
"Available at: http://www.unaids.org/sites/default/ﬁles/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_CA_Narrative_Report[1].pdf (accessedJanuary 13,2015).",Non-OADS,/arxiv_data1/oa_pdf/ba/a4/sm20003-0024.PMC4380911.pdf
"Available at: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_UG_Narrative_Report[1].pdf(accessed January 13, 2015).",Non-OADS,/arxiv_data1/oa_pdf/ba/a4/sm20003-0024.PMC4380911.pdf
"Available at: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_ZA_Narrative_Report.pdf (accessed January13, 2015).",Non-OADS,/arxiv_data1/oa_pdf/ba/a4/sm20003-0024.PMC4380911.pdf
"Available at:http://www.gov.cn/gzdt/2012-11/29/content_2278527.htm (accessed January 13, 2015).",Non-OADS,/arxiv_data1/oa_pdf/ba/a4/sm20003-0024.PMC4380911.pdf
"Available at: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_CN_Narrative_Report[1].pdf (accessedDecember 4, 2013).",OADS,/arxiv_data1/oa_pdf/ba/a4/sm20003-0024.PMC4380911.pdf
"Ciamician”Universit/C224 di Bologna, Via Selmi 2, 40126 Bologna (Italy) E-mail: marco.lucarini@unibo.it alberto.credi@unibo.itelisabetta.mezzina@unibo.it Supporting information for this article is available on the WWW underhttp://dx.doi.org/10.1002/open.201402073.",Non-OADS,/arxiv_data1/oa_pdf/f4/09/open0004-0018.PMC4380948.pdf
R. China) Supporting information for this article is available on the WWW underhttp://dx.doi.org/10.1002/open.201402075.,Non-OADS,/arxiv_data1/oa_pdf/0e/93/open0004-0027.PMC4380950.pdf
"R. China) E-mail: huanpangchem@hotmail.com Homepage: http://huanpangchem.wix.com/advanced-material [b]Prof. H. Pang State Key Laboratory of Coordination ChemistryNanjing University, Nanjing, 210093 Jiangsu (P .",Non-OADS,/arxiv_data1/oa_pdf/7c/8e/open0004-0032.PMC4380951.pdf
R. China) Supporting information for this article is available on the WWW underhttp://dx.doi.org/10.1002/open.201402044.,Non-OADS,/arxiv_data1/oa_pdf/7c/8e/open0004-0032.PMC4380951.pdf
"Prof. Gama Pinto, 1649-003 Lisboa (Portugal) Supporting information for this article is available on the WWW underhttp://dx.doi.org/10.1002/open.201402066.",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/open0004-0039.PMC4380952.pdf
"J. Scammells Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences Monash University, 381 Royal Parade, Parkville, VIC 3052 (Australia) E-mail: Peter.Scammells@monash.edu [b]Dr. L. Munoz, Dr. R. M. Ryan Discipline of Pharmacology, School of Medical Sciences and Bosch Institute The University of Sydney, Sydney, NSW 2006 (Australia) [c]Dr. B. H. Wang, Prof. H. Krum Centre of Cardiovascular Research and Education in Therapeutics Department of Epidemiology and Preventative MedicineMonash University, 99 Commercial Road, Melbourne, VIC 3004 (Australia) Supporting information for this article is available on the WWW underhttp://dx.doi.org/10.1002/open.201402076.",Non-OADS,/arxiv_data1/oa_pdf/ce/fe/open0004-0056.PMC4380954.pdf
"[a]Dr. H. M. Abdelaal Ceramics Department, The National Research CentreAl-Buhouth St. Dokki, Cairo (Egypt) E-mail: hmaa_77@yahoo.com The full thesis is available as Supporting Information for this article on the WWW under http://dx.doi.org/10.1002/open.201402096.",Non-OADS,/arxiv_data1/oa_pdf/34/37/open0004-0072.PMC4380956.pdf
Dataaccess The RNA-seq and RNAPII ChIP-seq data sets gener- ated in this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/ geo/)under accession number GSE60462.,OADS,/arxiv_data1/oa_pdf/a8/1f/gku1365.PMC4381047.pdf
"in the range recommended by ENCODE forRNA-seq ( https://genome.ucsc.edu/ENCODE/protocols/ dataStandards/RNA standards v12011May.pdf), the performance of iRNA-seq is comparable to that of",OADS,/arxiv_data1/oa_pdf/a8/1f/gku1365.PMC4381047.pdf
"The ΔΔCtmethod was used to normal- ize all the transcription level to the internal control geneGAPDH.PCRprimersforGAPDH,DNMT1,DNMT3A andDNMT3BweredesignedandoptimizedwithinPrimer- BLAST online tools ( http://www.ncbi.nlm.nih.gov/tools/ primer-blast/ ).ThePCRprimersusedinthisstudyarelisted in SupplementaryTable S1.",OADS,/arxiv_data1/oa_pdf/55/3e/gkv098.PMC4381056.pdf
All thestatisticaltestsandcorrelationswerecalculatedusingRfunctions( http://cran.r-project.org ).,OADS,/arxiv_data1/oa_pdf/13/38/gkv144.PMC4381060.pdf
Differentially expressed genes between SA1-heterozygous and wild-type MEFs were ob- tained by Limma (Smyth GK; Bioconductor project; http://www.bioconductor.org ).,Non-OADS,/arxiv_data1/oa_pdf/13/38/gkv144.PMC4381060.pdf
Wedesigneda3.5-kbDNAsyntheticfragmentthatcon- tains five Open Reading Frames (ORFs) of S. cerevisiae KEOPS subunits and subcloned it into a pUC backbonevector (https://www.dna20.com/ ).,OADS,/arxiv_data1/oa_pdf/1d/3a/gkv155.PMC4381065.pdf
"The quality of the experimen- tal phases allowed automatic building of an almost com-pletemodelwiththeARP /WARPapplication( 30,31).This model was then refined against the 1.9 ˚A native data set using PHENIX ( 32) and then rebuilt with the ‘TURBO’ molecular modeling program ( http://www.afmb.univ-mrs. fr/-TURBO ).",OADS,/arxiv_data1/oa_pdf/1d/3a/gkv155.PMC4381065.pdf
and the SAXS-MoW method available at http://www.if.sc.,OADS,/arxiv_data1/oa_pdf/1d/3a/gkv155.PMC4381065.pdf
(C)The sequence conservation projected onto the surface as reported by ConSurf ( http://consurf.tau.ac.il/ ).,OADS,/arxiv_data1/oa_pdf/1d/3a/gkv155.PMC4381065.pdf
Data analysis SequencingdataisavailableundertheaccessionGSE52941 fromtheGEOwebsite( http://www.ncbi.nlm.nih.gov/geo/ ).,OADS,/arxiv_data1/oa_pdf/a2/1a/gkv182.PMC4381081.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website (http://www.nature.com/tpj)Gene signatures of drug resistance Y Zheng et al 143 © 2015 Macmillan Publishers Limited The Pharmacogenomics Journal (2015), 135 –143",Non-OADS,/arxiv_data1/oa_pdf/25/41/tpj201445a.PMC4381104.pdf
"The primary evidence supporting the use of onabotuli- numtoxinA ?BSC in adults with NDO comes from the pooled intention-to-treat (ITT) population of two pivotal phase III studies (NCT00461292 and NCT00311376; http://www.clinicaltrials.gov )[10,11].",Non-OADS,/arxiv_data1/oa_pdf/6f/dc/40273_2014_Article_245.PMC4381108.pdf
All statistical analyses were carried out using R statisticalsoftware ( http://cran.r-project.org/ ).,OADS,/arxiv_data1/oa_pdf/ea/5c/40273_2014_Article_249.PMC4381112.pdf
2013. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/ea/5c/40273_2014_Article_249.PMC4381112.pdf
"This is an open access article under theCC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: Hodgkin'sLymphomaKIRGenotypeLebanonMeta Gene 4 (2015) 57 –63 Abbreviations: KIR, Killer Cell Immunoglobulin-like Receptors; NK, Natural killer; HL, Hodgkin ’s Lymphoma; IRB, Institutional Review Board; DNA, Deoxyribonucleic acid; PCR, Polymerase Chain Reaction; SSP, Sequence Speci ﬁc Primers; LRC, leukocyte Receptor Complex; LPHL, Lymphocyte predominant Hodgkin ’s lymphoma; HLA, Human Leukocyte Antigens; MHC, Major Histocompatibility Complex; UV, Ultraviolet.",Non-OADS,/arxiv_data1/oa_pdf/c5/e5/main.PMC4381114.pdf
E-mail address: rm11@aub.edu.lb (R. Mahfouz) http://dx.doi.org/10.1016/j.mgene.2015.02.004 2214-5400/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/c5/e5/main.PMC4381114.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/e5/main.PMC4381114.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the most common malignant neoplasm  among women in Western Europe and North America, and is  a frequent cause of cancer death in recent years [1,2].",Non-OADS,/arxiv_data1/oa_pdf/d0/ea/jbc-18-1.PMC4381116.pdf
"It is thought that DUSP4 acts  either as a tumor suppressor or as a cancer progression factor Clinicopathological Significance of Dual-Specificity Protein Phosphatase 4  Expression in Invasive Ductal Carcinoma of the Breast Hyunsung Kim*, Se Min Jang*, Hyein Ahn, Jongmin Sim, Kijong Yi, Yumin Chung, Hulin Han, Abdul Rehman,   Min Sung Chung1, Kiseok Jang, Seung Sam Paik Departments of Pathology and 1Surgery, Hanyang University College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 1-7 http://dx.doi.org/10.4048/jbc.2015.18.1.1 Purpose:  Dual-specificity protein phosphatase 4 (DUSP4), also  known as mitogen-activated protein kinase phosphatase (MKP) 2  is a member of the inducible nuclear MKP group.",Non-OADS,/arxiv_data1/oa_pdf/d0/ea/jbc-18-1.PMC4381116.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.1[8].,Non-OADS,/arxiv_data1/oa_pdf/d0/ea/jbc-18-1.PMC4381116.pdf
DUSP4 Expression in Breast Cancer3 http://dx.doi.org/10.4048/jbc.2015.18.1.1  http://ejbc.krobtain the correlation coefficient.,OADS,/arxiv_data1/oa_pdf/d0/ea/jbc-18-1.PMC4381116.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.1and 266 cases of normal breast tissue, usual ductal hyperplasia,  ductal carcinoma in situ , and invasive ductal carcinoma, re - spectively.",Non-OADS,/arxiv_data1/oa_pdf/d0/ea/jbc-18-1.PMC4381116.pdf
DUSP4 Expression in Breast Cancer5 http://dx.doi.org/10.4048/jbc.2015.18.1.1  http://ejbc.krwith invasive ductal carcinoma was evaluated.,Non-OADS,/arxiv_data1/oa_pdf/d0/ea/jbc-18-1.PMC4381116.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.1curves for all 266 patients with invasive ductal carcinoma (Fig - ure 3A, B).",Non-OADS,/arxiv_data1/oa_pdf/d0/ea/jbc-18-1.PMC4381116.pdf
DUSP4 Expression in Breast Cancer7 http://dx.doi.org/10.4048/jbc.2015.18.1.1  http://ejbc.krregulator of cell growth within the MAPK pathway and may  cause enhanced cell growth in MSI-H colorectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/d0/ea/jbc-18-1.PMC4381116.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/60/jbc-18-101.PMC4381117.pdf
"This article was retracted on March 31, 2015  The online version of the original article can be found at  http://dx.doi.org/10.4048/jbc.2014.17.3.244Retraction note to: “Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy”  by Won Ho Kil, Jeong Eon Lee, Seok Jin Nam (Journal of Breast Cancer 2014;17(3):244-9)RETRACTIONJ Breast Cancer 2015 March; 18(1): 101-101  http://dx.doi.org/10.4048/jbc.2015.18.1.101 Journal of         BreastCancer",Non-OADS,/arxiv_data1/oa_pdf/d9/60/jbc-18-101.PMC4381117.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Triple-negative breast cancer (TNBC) has been associated  with poor clinical outcomes [1].",Non-OADS,/arxiv_data1/oa_pdf/b3/0e/jbc-18-16.PMC4381118.pdf
"Although high Ki-67 expres - sion was found to correlate with increased rates of clinical re - sponse and pCR following NAC [3,4], the association between  Ki-67 expression and outcomes in patients with TNBC has  not been determined, and Ki-67 has not been compared with  other putative biomarkers in the same patient cohorts.Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic  Complete Response after Neoadjuvant Chemotherapy for Triple-Negative  Breast Cancer Taeryung Kim, Wonshik Han1, Min Kyoon Kim1, Jun Woo Lee1, Jisun Kim1, Soo Kyung Ahn1, Han-Byoel Lee1,   Hyeong-Gon Moon1, Kyung-Hun Lee2, Tae-Y ong Kim2, Sae-Won Han2, Seock-Ah Im2, In Ae Park3, Ju-Y eon Kim4,   Dong-Y oung Noh1 Department of Surgery, Breast Cancer Center, Gachon University Gil Hospital, Incheon; 1Department of Surgery and Cancer Research Institute, Seoul  National University College of Medicine, Seoul; 2Department of Internal Medicine, Seoul National University Hospital, Seoul; 3Department of Pathology,  Seoul National University College of Medicine, Seoul; 4Department of Surgery, Gyeongsang National University Hospital, Jinju, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 16-21  http://dx.doi.org/10.4048/jbc.2015.18.1.16 Purpose:  Patients with triple-negative breast cancer (TNBC) with  pathologic complete response (pCR) to neoadjuvant chemother - apy (NAC) have superior survival outcomes compared to those  with residual disease after NAC.",Non-OADS,/arxiv_data1/oa_pdf/b3/0e/jbc-18-16.PMC4381118.pdf
"The Impact of p53 in Prediction of pCR17 http://dx.doi.org/10.4048/jbc.2015.18.1.16  http://ejbc.krBcl-2 has been found to inhibit apoptosis induced by chemo - therapeutic drugs, including doxorubicin, in cancer cells [5].",Non-OADS,/arxiv_data1/oa_pdf/b3/0e/jbc-18-16.PMC4381118.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.16Statistical analysis The associations between the clinicopathological character - istics and pathological response after NAC were calculated us - ing the chi-squared and Fisher exact tests.,OADS,/arxiv_data1/oa_pdf/b3/0e/jbc-18-16.PMC4381118.pdf
"The Impact of p53 in Prediction of pCR19 http://dx.doi.org/10.4048/jbc.2015.18.1.16  http://ejbc.krexpression ( < 25%) (27.1% vs. 6.8%, p< 0.001), and it was al - most significantly higher in patients with high Ki-67 expres - sion ( ≥ 10%) than in those with low Ki-67 expression ( < 10%)  (19.5% vs. 5.9%, p= 0.056).",Non-OADS,/arxiv_data1/oa_pdf/b3/0e/jbc-18-16.PMC4381118.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.16dict pCR prognosis accurately (Figure 3B).,Non-OADS,/arxiv_data1/oa_pdf/b3/0e/jbc-18-16.PMC4381118.pdf
The Impact of p53 in Prediction of pCR21 http://dx.doi.org/10.4048/jbc.2015.18.1.16  http://ejbc.krREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b3/0e/jbc-18-16.PMC4381118.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Accurate staging and proper management of axillary lymph  nodes (ALNs) are important for the treatment of breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/4e/91/jbc-18-22.PMC4381119.pdf
"As a result, questions are arising whether  removal of the lymph nodes with ALND is indeed needed for Sentinel Lymph Node Biopsy Alone after Neoadjuvant Chemotherapy in  Patients with Initial Cytology-Proven Axillary Node Metastasis Ji Y oung Kim*, Min Kuk Kim1, Jeong Eon Lee2,*, Y ongsik Jung, Soo Y oun Bae2, Se Kyung Lee2, Won Ho Kil2,   Seok Won Kim2, Ku Sang Kim3, Seok Jin Nam2, Sehwan Han Department of Surgery, Ajou University School of Medicine, Suwon; 1MD Hospital, Seoul; 2Department of Surgery, Sungkyunkwan University School of  Medicine, Seoul; 3Ulsan City Hospital, Ulsan, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 22-28  http://dx.doi.org/10.4048/jbc.2015.18.1.22 Purpose:  Neoadjuvant chemotherapy (NAC) has been recently  used to downstage breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/4e/91/jbc-18-22.PMC4381119.pdf
SLNB Alone after NAC in Initial Axillary Node Metastasis23 http://dx.doi.org/10.4048/jbc.2015.18.1.22  http://ejbc.krsuch patients.,Non-OADS,/arxiv_data1/oa_pdf/4e/91/jbc-18-22.PMC4381119.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.22performed using the Kaplan-Meir method and the p-value  was calculated by using the log-rank test.,OADS,/arxiv_data1/oa_pdf/4e/91/jbc-18-22.PMC4381119.pdf
"SLNB Alone after NAC in Initial Axillary Node Metastasis25 http://dx.doi.org/10.4048/jbc.2015.18.1.22  http://ejbc.krthan three retrieved SLNs was performed in more than half of  the patients (60.0%), there were no false negative SLNB find - ings in those patients.",OADS,/arxiv_data1/oa_pdf/4e/91/jbc-18-22.PMC4381119.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.22alone group, two patients with HER2-positive tumors devel - oped neurologic symptoms and were diagnosed with brain  metastases within 6 months after surgery.",Non-OADS,/arxiv_data1/oa_pdf/4e/91/jbc-18-22.PMC4381119.pdf
"SLNB Alone after NAC in Initial Axillary Node Metastasis27 http://dx.doi.org/10.4048/jbc.2015.18.1.22  http://ejbc.krcases were cytologically proven positive ALNs at presentation,  our study showed good results with an FNR of SLNB after  NAC of 10.0% and an identification rate of 95.8%.",Non-OADS,/arxiv_data1/oa_pdf/4e/91/jbc-18-22.PMC4381119.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.22and survival in patients with breast cancer following neoadjuvant che - motherapy.,Non-OADS,/arxiv_data1/oa_pdf/4e/91/jbc-18-22.PMC4381119.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the most common cancer in women world - wide, and survival is strongly determined by the presence of  distant metastases [1,2].",Non-OADS,/arxiv_data1/oa_pdf/99/f4/jbc-18-29.PMC4381120.pdf
"Therefore, there is an increasing need to standardize initial Local Control of Brain Metastasis: Treatment Outcome of Focal Brain  Treatments in Relation to Subtypes Jae Uk Chong*, Sung Gwe Ahn*, Hak Min Lee, Jong Tae Park, Seung Ah Lee1, Seho Park2, Joon Jeong, Seung Il Kim2 Department of Surgery, Gangnam Severance Hospital, Y onsei University College of Medicine, Seoul; 1Department of Surgery, Eulji General Hospital,   Eulji University College of Medicine, Seoul; 2Department of Surgery, Severance Hospital, Y onsei University College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 29-35  http://dx.doi.org/10.4048/jbc.2015.18.1.29 Purpose:  To investigate treatment options for local control of me - tastasis in the brain, we compared focal brain treatment (FBT)  with or without whole brain radiotherapy (WBRT) vs. WBRT alone,  for breast cancer patients with tumor relapse in the brain.",Non-OADS,/arxiv_data1/oa_pdf/99/f4/jbc-18-29.PMC4381120.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.29treatments for breast cancer BM.,Non-OADS,/arxiv_data1/oa_pdf/99/f4/jbc-18-29.PMC4381120.pdf
Local Control of Brain Metastasis 31 http://dx.doi.org/10.4048/jbc.2015.18.1.29  http://ejbc.krwas confirmed using magnetic resonance imaging and/or  computed tomography.,Non-OADS,/arxiv_data1/oa_pdf/99/f4/jbc-18-29.PMC4381120.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.29FBT ± WBRT for BM, while 50 (43.1%) received WBRT alone.",OADS,/arxiv_data1/oa_pdf/99/f4/jbc-18-29.PMC4381120.pdf
"Local Control of Brain Metastasis 33 http://dx.doi.org/10.4048/jbc.2015.18.1.29  http://ejbc.kr(95% CI, 12.6–24.3 months), respectively ( p= 0.006, the log-rank  test).",Non-OADS,/arxiv_data1/oa_pdf/99/f4/jbc-18-29.PMC4381120.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.29Treatment outcomes according to the subtypes As shown in Table 1, OSBM and BMPFS differed signifi - cantly with subtype.",Non-OADS,/arxiv_data1/oa_pdf/99/f4/jbc-18-29.PMC4381120.pdf
Local Control of Brain Metastasis 35 http://dx.doi.org/10.4048/jbc.2015.18.1.29  http://ejbc.kr62:220-41.,Non-OADS,/arxiv_data1/oa_pdf/99/f4/jbc-18-29.PMC4381120.pdf
http://www.nccn.org/professionals/physician_ gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/99/f4/jbc-18-29.PMC4381120.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The identification of prognostic and predictive factors for  specific treatments continues to be a major area of research.",Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jbc-18-36.PMC4381121.pdf
"METHODS Study population Data from 5,330 eligible patients with breast cancer who  were treated at Sun Y at-Sen University Cancer Center be - tween January 1997 and December 2008 were retrospectively Operable Breast Cancer of the Inner Hemisphere Is Associated with Poor  Survival  Cong Xue*, Rou Jun Peng*, Shu Sen Wang, Y an Xia Shi, Xin An, Fei Xu, Zhong Yu Yuan Department of Medical Oncology, Sun Yat-Sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation  Center of Cancer Medicine, Guangzhou, ChinaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 36-43  http://dx.doi.org/10.4048/jbc.2015.18.1.36 Purpose:  This study investigated the clinicopathological features  of operable breast cancer lesions located in different hemi - spheres of the breast and determined related survival outcomes.",Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jbc-18-36.PMC4381121.pdf
Tumor Location is an Independent Predictor of Survival 37 http://dx.doi.org/10.4048/jbc.2015.18.1.36  http://ejbc.kranalyzed.,Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jbc-18-36.PMC4381121.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.36respectively ( p< 0.001) (Figure 1A, B).",Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jbc-18-36.PMC4381121.pdf
Tumor Location is an Independent Predictor of Survival 39 http://dx.doi.org/10.4048/jbc.2015.18.1.36  http://ejbc.krprognostic factors applied to tumors in different locations  (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jbc-18-36.PMC4381121.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.36primary tumor size were independent unfavorable prognostic  factors for DFS in patients with breast cancer of the inner  hemisphere.,Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jbc-18-36.PMC4381121.pdf
"Tumor Location is an Independent Predictor of Survival 41 http://dx.doi.org/10.4048/jbc.2015.18.1.36  http://ejbc.krDISCUSSION Of the 5,330 patients with operable invasive ductal carcino - ma, 33.1% were located in the inner hemisphere and 66.9%  were located in the outer hemisphere of the breast.",Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jbc-18-36.PMC4381121.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.36node radiotherapy (IM-MS RT).,Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jbc-18-36.PMC4381121.pdf
Tumor Location is an Independent Predictor of Survival 43 http://dx.doi.org/10.4048/jbc.2015.18.1.36  http://ejbc.krbia.,Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jbc-18-36.PMC4381121.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Neoadjuvant chemotherapy (NAC) has been the accepted  standard of care for patients with operable or inoperable  breast cancers.",Non-OADS,/arxiv_data1/oa_pdf/cb/6c/jbc-18-44.PMC4381122.pdf
"For this reason, we studied the use of  surgical clips for tumor localization in breast cancer patients Ultrasonography-Guided Surgical Clip Placement for Tumor Localization in  Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer Inyoung Y oun, Seon Hyeong Choi, Shin Ho Kook, Y oon Jung Choi, Chan Heun Park1, Y ong Lai Park1, Dong Hoon Kim2 Departments of Radiology, 1Surgery, and 2Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 44-49  http://dx.doi.org/10.4048/jbc.2015.18.1.44 Purpose:  We investigated the feasibility of using surgical clips as  markers for tumor localization and their effect on the imaging  evaluation of treatment responses after neoadjuvant chemother - apy (NAC).",Non-OADS,/arxiv_data1/oa_pdf/cb/6c/jbc-18-44.PMC4381122.pdf
US-Guided Clip Placement in Breast Cancer with Neoadjuvant Chemotherapy45 http://dx.doi.org/10.4048/jbc.2015.18.1.44  http://ejbc.krwho were scheduled for surgery after preoperative NAC.,Non-OADS,/arxiv_data1/oa_pdf/cb/6c/jbc-18-44.PMC4381122.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.44surgical clips were passed through the inserted introducer,  and the inner stylet was reinserted to complete the clip place - ment (Figure 1B).",Non-OADS,/arxiv_data1/oa_pdf/cb/6c/jbc-18-44.PMC4381122.pdf
US-Guided Clip Placement in Breast Cancer with Neoadjuvant Chemotherapy47 http://dx.doi.org/10.4048/jbc.2015.18.1.44  http://ejbc.krcal evaluation of a specimen due to inserted surgical clips.,Non-OADS,/arxiv_data1/oa_pdf/cb/6c/jbc-18-44.PMC4381122.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.44DISCUSSION NAC is considered a standard step in the treatment of locally  advanced breast cancer in its early stages.,Non-OADS,/arxiv_data1/oa_pdf/cb/6c/jbc-18-44.PMC4381122.pdf
US-Guided Clip Placement in Breast Cancer with Neoadjuvant Chemotherapy49 http://dx.doi.org/10.4048/jbc.2015.18.1.44  http://ejbc.krdetection of breast cancer on mammography and it was help - ful for surgeons to explain breast cancer to their patients.,Non-OADS,/arxiv_data1/oa_pdf/cb/6c/jbc-18-44.PMC4381122.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the second most common malignancy in  women in the United States after skin cancer [1].",Non-OADS,/arxiv_data1/oa_pdf/fd/35/jbc-18-50.PMC4381123.pdf
"The clinical outcomes of PORT omission Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission  after Breast-Conserving Surgery in Women with Breast Cancer Jeong Il Yu, Doo Ho Choi, Seung Jae Huh, Won Park, Seok Jin Nam1, Seok Won Kim1, Jeong Eon Lee1, Won Ho Kil1,   Y oung-Hyuck Im2, Jin Seok Ahn2, Y eon Hee Park2 Departments of Radiation Oncology, 1Surgery, and 2Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 50-56  http://dx.doi.org/10.4048/jbc.2015.18.1.50 Purpose:  The present study was conducted to investigate the  proportion and clinical outcomes of breast cancer patients who  did not receive postoperative radiotherapy (PORT) after breast- conserving surgery (BCS).",Non-OADS,/arxiv_data1/oa_pdf/fd/35/jbc-18-50.PMC4381123.pdf
PORT Omission after BCS51 http://dx.doi.org/10.4048/jbc.2015.18.1.50  http://ejbc.krafter BCS have not been studied in a Korean population.,Non-OADS,/arxiv_data1/oa_pdf/fd/35/jbc-18-50.PMC4381123.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.50(n = 13), and it was optionally recommended for those with  small tumors with a wide margin (stage T1mi, surgical mar - gin ≥ 5 mm, ductal carcinoma in situ  smaller than 1 cm;  n = 7).",Non-OADS,/arxiv_data1/oa_pdf/fd/35/jbc-18-50.PMC4381123.pdf
PORT Omission after BCS53 http://dx.doi.org/10.4048/jbc.2015.18.1.50  http://ejbc.krPatterns of recurrence and salvage treatment LR with or without RR was the most frequent failure pat - tern in the study patients.,Non-OADS,/arxiv_data1/oa_pdf/fd/35/jbc-18-50.PMC4381123.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.50ed group ( p= 0.026).,Non-OADS,/arxiv_data1/oa_pdf/fd/35/jbc-18-50.PMC4381123.pdf
"PORT Omission after BCS55 http://dx.doi.org/10.4048/jbc.2015.18.1.50  http://ejbc.kra low-risk older population [13,19] predict favorable clinical  outcomes for the patients who were recommended PORT  omission in the present study, although the small number of  cases and short follow-up period preclude a concrete conclu - sion.",Non-OADS,/arxiv_data1/oa_pdf/fd/35/jbc-18-50.PMC4381123.pdf
http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/fd/35/jbc-18-50.PMC4381123.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.50small size ductal carcinoma in situ of the breast.,Non-OADS,/arxiv_data1/oa_pdf/fd/35/jbc-18-50.PMC4381123.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the second most common cancer in Korean  women based on the Korean National Cancer Screening Sur - vey.",Non-OADS,/arxiv_data1/oa_pdf/08/f7/jbc-18-57.PMC4381124.pdf
"Use of TomoDirect technique for breast can - cer can attain optimal planning target volume coverage and A Dosimetric Comparative Analysis of TomoDirect and Three-Dimensional  Conformal Radiotherapy in Early Breast Cancer Mi Joo Chung*, Sung Hwan Kim*, Jong Hoon Lee, Y oung Jin Suh1 Departments of Radiation Oncology and 1Surgery, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine, Suwon, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 57-62  http://dx.doi.org/10.4048/jbc.2015.18.1.57 Purpose:  The purpose of this study is to compare dosimetric pa - rameters of intensity-modulated mode of TomoDirect and three- dimensional conformal radiotherapy (3D-CRT) in patients with  early breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/08/f7/jbc-18-57.PMC4381124.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.57adequate normal tissue sparing in a pilot study [7].,Non-OADS,/arxiv_data1/oa_pdf/08/f7/jbc-18-57.PMC4381124.pdf
TomoDirect in Breast Cancer59 http://dx.doi.org/10.4048/jbc.2015.18.1.57  http://ejbc.krhanced dynamic wedge were used.,OADS,/arxiv_data1/oa_pdf/08/f7/jbc-18-57.PMC4381124.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.57Dose distribution of OAR The dosimetric parameters for the ipsilateral lung and heart  were summarized in Table 3.,Non-OADS,/arxiv_data1/oa_pdf/08/f7/jbc-18-57.PMC4381124.pdf
TomoDirect in Breast Cancer61 http://dx.doi.org/10.4048/jbc.2015.18.1.57  http://ejbc.krbidity may be raised by the use of the left sided breast irradia - tion with cobalt-60 or orthovaltage therapy which often in - cludes some coronary arteries and myocardium [18].,Non-OADS,/arxiv_data1/oa_pdf/08/f7/jbc-18-57.PMC4381124.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.577.,Non-OADS,/arxiv_data1/oa_pdf/08/f7/jbc-18-57.PMC4381124.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Invasive lobular carcinoma (ILC) is the second most com - mon breast cancer after invasive ductal carcinoma (IDC), ac - counting for 5% to 20% of all breast cancers [1-3].",Non-OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
"Although the value of 18F-fluorodeoxyglucose positron  emission tomography/computed tomography (18F-FDG PET/Effectiveness of Breast MRI and 18F-FDG PET/CT for the Preoperative Staging  of Invasive Lobular Carcinoma versus Ductal Carcinoma Na Y oung Jung, Sung Hoon Kim1, Sung Hun Kim1, Y e Y oung Seo2, Jin Kyoung Oh3, Hyun Su Choi1, Won Jong You Department of Radiology, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon; 1Department of Radiology, Seoul St.  Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul; 2Department of Radiology, Y eouido St. Mary’s Hospital, The Catholic  University of Korea College of Medicine, Seoul; 3Department of Radiology, Incheon St. Mary’s Hospital, The Catholic University of Korea College of  Medicine, Incheon, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 63-72  http://dx.doi.org/10.4048/jbc.2015.18.1.63 Purpose:  We evaluated the utility of magnetic resonance imaging  (MRI) and 18F-fluorodeoxyglucose positron emission tomography/ computed tomography (18F-FDG PET/CT) for the preoperative  staging of invasive lobular carcinoma (ILC) of the breast and  compared the results with those of invasive ductal carcinoma  (IDC).",Non-OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.63CT) for staging primary breast cancer has not yet been estab - lished, recent studies have shown its potential for the preoper - ative staging of breast cancer [14,15].",Non-OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
Effectiveness of MRI and 18F-FDC PET/CT in Breast Cancer Staging65 http://dx.doi.org/10.4048/jbc.2015.18.1.63  http://ejbc.krproven index lesion was considered the primary mass.,Non-OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.63 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
Effectiveness of MRI and 18F-FDC PET/CT in Breast Cancer Staging67 http://dx.doi.org/10.4048/jbc.2015.18.1.63  http://ejbc.krTable 3.,Non-OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.63Comparing 18F-FDG PET/CT between the ILC and IDC  groups, the sensitivity for ipsilateral lesion(s) was significantly  lower in the ILC group than the IDC group (0% vs. 37.5%,  p= 0.046).",OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
Effectiveness of MRI and 18F-FDC PET/CT in Breast Cancer Staging69 http://dx.doi.org/10.4048/jbc.2015.18.1.63  http://ejbc.kr Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.63MRI.,Non-OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
"Effectiveness of MRI and 18F-FDC PET/CT in Breast Cancer Staging71 http://dx.doi.org/10.4048/jbc.2015.18.1.63  http://ejbc.krlimited, especially in ILC, an ancillary role of the modality  could be possible in practice.",Non-OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.63CONFLICT OF INTEREST The authors declare that they have no competing interests.,Non-OADS,/arxiv_data1/oa_pdf/85/70/jbc-18-63.PMC4381125.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION 18F-fluorodeoxyglucose (FDG) positron emission tomogra - phy with computed tomography (PET/CT) is widely used in  the initial staging, evaluation of the therapeutic response, and  detection of recurrent disease [1-3].",Non-OADS,/arxiv_data1/oa_pdf/68/a1/jbc-18-73.PMC4381126.pdf
"Kyung Min Shin, Hye Jung Kim, Su Jin Jung1, Hyo Soon Lim1, Sang Woo Lee2, Seung Hyun Cho, Yun-Jin Jang3,   Hui Joong Lee3, Gab Chul Kim, Jin Hyang Jung4, Ji Y oung Park5 Department of Radiology, Kyungpook National University Medical Center, Daegu; 1Department of Radiology, Chonnam National University Hwasun  Hospital, Hwasun; 2Department of Nuclear Medicine, Kyungpook National University Medical Center, Daegu; 3Department of Radiology, Kyungpook  National University Hospital, Daegu; Departments of  4Surgery and  5Pathology, Kyungpook National University Medical Center, Daegu, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 73-79  http://dx.doi.org/10.4048/jbc.2015.18.1.73 Purpose:  The aim of our study was to evaluate the risk of malig - nancy and to determine which clinical variables differentiate be - tween benign and malignant focal breast lesions found inciden - tally on 18F-flourodeoxyglucose positron emission tomography  and computed tomography (FDG PET/CT).",Non-OADS,/arxiv_data1/oa_pdf/68/a1/jbc-18-73.PMC4381126.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.73mine the significant clinical variables differentiating benign  and malignant focal breast lesions, found incidentally on FDG  PET/CT by using multivariate analysis.",Non-OADS,/arxiv_data1/oa_pdf/68/a1/jbc-18-73.PMC4381126.pdf
Breast Incidentalomas at PET/CT 75 http://dx.doi.org/10.4048/jbc.2015.18.1.73  http://ejbc.krtients under 35 years of age did not undergo mammography  routinely.,Non-OADS,/arxiv_data1/oa_pdf/68/a1/jbc-18-73.PMC4381126.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.731).,Non-OADS,/arxiv_data1/oa_pdf/68/a1/jbc-18-73.PMC4381126.pdf
Breast Incidentalomas at PET/CT 77 http://dx.doi.org/10.4048/jbc.2015.18.1.73  http://ejbc.kron the linear-by-linear correlation ( p< 0.001) (Table 1).,OADS,/arxiv_data1/oa_pdf/68/a1/jbc-18-73.PMC4381126.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.73physiologic lactation, fibroadenoma, fat necrosis, and fibrocys - tic change, are well known to exhibit high FDG uptake on  PET/CT [23,27].",Non-OADS,/arxiv_data1/oa_pdf/68/a1/jbc-18-73.PMC4381126.pdf
Breast Incidentalomas at PET/CT 79 http://dx.doi.org/10.4048/jbc.2015.18.1.73  http://ejbc.kr23.,Non-OADS,/arxiv_data1/oa_pdf/68/a1/jbc-18-73.PMC4381126.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The Korean Breast Cancer Society (KBCS) publishes bien - nial reports on the characteristics of breast cancer in the coun - try, along with any evolving trends [1-4].",Non-OADS,/arxiv_data1/oa_pdf/cd/65/jbc-18-8.PMC4381127.pdf
"In this study, we have attempted to identify the clinicopath - ological and treatment factors that have exerted considerable Survival Improvement in Korean Breast Cancer Patients Due to Increases in  Early-Stage Cancers and Hormone Receptor Positive/HER2 Negative  Subtypes: A Nationwide Registry-Based Study Jee Man Y ou*, Yun Gyoung  Kim1,*, Hyeong-Gon Moon1, Seok Jin Nam2, Jong Won Lee3, Woosung Lim4, Mi-Ri Lee5,   Dong-Y oung Noh1, Wonshik Han1 Department of Surgery, Sun Medical Center, Daejeon; 1Department of Surgery, Seoul National University Hospital, Seoul; 2Department of Surgery, Samsung  Medical Center, Seoul; 3Department of Surgery, Asan Medical Center, Seoul; 4Department of Surgery, Ewha Womans University Mokdong Hospital, Seoul;   5Department of Surgery, Dong-A University College of Medicine, Busan, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 8-15  http://dx.doi.org/10.4048/jbc.2015.18.1.8 Purpose:  The aim of this study was to investigate whether the  observed changes over time in the survival rates vary according  to the intrinsic subtypes of breast cancer diagnosed.",Non-OADS,/arxiv_data1/oa_pdf/cd/65/jbc-18-8.PMC4381127.pdf
Survival Improvement in Korean Breast Cancer Patients9 http://dx.doi.org/10.4048/jbc.2015.18.1.8  http://ejbc.krinfluence upon the observed improvement in breast cancer  survival in Korea.,Non-OADS,/arxiv_data1/oa_pdf/cd/65/jbc-18-8.PMC4381127.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.8was received from the Seoul National University Hospital  Medical Research Collaborating Center.,OADS,/arxiv_data1/oa_pdf/cd/65/jbc-18-8.PMC4381127.pdf
Survival Improvement in Korean Breast Cancer Patients11 http://dx.doi.org/10.4048/jbc.2015.18.1.8  http://ejbc.krand multivariable analysis.,Non-OADS,/arxiv_data1/oa_pdf/cd/65/jbc-18-8.PMC4381127.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.8Cohort I in each subtype: 94.7% vs. 98.0% in HR+/HER2−;  89.7% vs. 96.2% in HR+/HER2+; 82.9% vs. 94.6% in HR−/ HER2+; and 87.0% vs. 94.5% in HR-/HER2−, respectively.We also performed multivariate analysis to explore the as - sociated prognostic factors of breast cancer according to its  subtypes (Table 3).",OADS,/arxiv_data1/oa_pdf/cd/65/jbc-18-8.PMC4381127.pdf
Survival Improvement in Korean Breast Cancer Patients13 http://dx.doi.org/10.4048/jbc.2015.18.1.8  http://ejbc.krTable 3.,Non-OADS,/arxiv_data1/oa_pdf/cd/65/jbc-18-8.PMC4381127.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.8was significantly associated with survival in all subtypes after  adjustment for other prognostic factors (HR+/HER2-: hazard  ratio, 0.467, 95% CI, 0.373–0.585, p< 0.001; HR+/HER2+:  hazard ratio, 0.458, 95% CI, 0.323–0.633, p< 0.001; HR-/ HER2+: hazard ratio, 0.449, 95% CI, 0.390–0.640, p< 0.001;  HR-/HER2-: hazard ratio, 0.582, 95% CI, 0.481–0.738,  p< 0.001).",Non-OADS,/arxiv_data1/oa_pdf/cd/65/jbc-18-8.PMC4381127.pdf
Survival Improvement in Korean Breast Cancer Patients15 http://dx.doi.org/10.4048/jbc.2015.18.1.8  http://ejbc.krwhich implies that an increase in early-stage detection and  less aggressive cancers contributed to this improvement.,Non-OADS,/arxiv_data1/oa_pdf/cd/65/jbc-18-8.PMC4381127.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the most common cancer, and is the leading  cause of cancer death among women worldwide [1].",Non-OADS,/arxiv_data1/oa_pdf/e1/c2/jbc-18-80.PMC4381128.pdf
"In this scoring method, the evaluation was con - ducted using eight items related to the breast forms (breast size,  breast shape, scar, breast firmness, nipple and areola size/shape, Cosmetic Evaluation Methods Adapted to Asian Patients after Breast- Conserving Surgery and Examination of the Necessarily Elements for  Cosmetic Evaluation Yuki Nohara, Noriko Hanamura, Hisamitsu Zaha1, Hiroko Kimura, Yumi Kashikura, Takashi Nakamura, Aya Noro,   Nao Imai, Mai Shibusawa, Tomoko Ogawa Department of Breast Surgery, Mie University Hospital, Mie; 1Department of Surgery, Nakagami Hospital, Okinawa, JapanORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 80-86  http://dx.doi.org/10.4048/jbc.2015.18.1.80 Purpose:  Although various strategies have been reported, there  are no defined criteria for cosmetic evaluation methods after  breast-conserving surgery (BCS).",Non-OADS,/arxiv_data1/oa_pdf/e1/c2/jbc-18-80.PMC4381128.pdf
"Cosmetic Evaluation Method for Asian Patients with Breast-Conserving Surgery 81 http://dx.doi.org/10.4048/jbc.2015.18.1.80  http://ejbc.krnipple and areola color tone, nipple position, and position of  the maximum descent point of the breast) [7].",Non-OADS,/arxiv_data1/oa_pdf/e1/c2/jbc-18-80.PMC4381128.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.80evaluation (BCE) [21], breast contour length difference, breast  area difference and breast overlap difference.",Non-OADS,/arxiv_data1/oa_pdf/e1/c2/jbc-18-80.PMC4381128.pdf
"Cosmetic Evaluation Method for Asian Patients with Breast-Conserving Surgery 83 http://dx.doi.org/10.4048/jbc.2015.18.1.80  http://ejbc.krof values are shown as follows: < 0.2 as “none, ” 0.2 to 0.4 as  “weak” , 0.4 to 0.7 as “moderate, ” and > 0.7 as “strong.",Non-OADS,/arxiv_data1/oa_pdf/e1/c2/jbc-18-80.PMC4381128.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.80as “poor.,Non-OADS,/arxiv_data1/oa_pdf/e1/c2/jbc-18-80.PMC4381128.pdf
"Cosmetic Evaluation Method for Asian Patients with Breast-Conserving Surgery 85 http://dx.doi.org/10.4048/jbc.2015.18.1.80  http://ejbc.krbreast cancer surgery for the affected breast and reduction  mammoplasty for the nonaffected breast is not covered by na - tional health insurance and is uncommon in Japan, and (2) the  Japanese often resist surgery for the nonaffected breast (differ - ence in the cultural backgrounds of Japan and Western coun - tries).",Non-OADS,/arxiv_data1/oa_pdf/e1/c2/jbc-18-80.PMC4381128.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.80apy: Subjective third party panel rating and objective BCCT .core soft - ware evaluation.,Non-OADS,/arxiv_data1/oa_pdf/e1/c2/jbc-18-80.PMC4381128.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Every year, more than 1 million women are diagnosed with  breast cancer worldwide.",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
"Effects of a 4-Week Multimodal Rehabilitation Program on Quality of Life,  Cardiopulmonary Function, and Fatigue in Breast Cancer Patients Junghwa Do, Y oungki Cho, Jaeyong Jeon Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2015 March; 18(1): 87-96  http://dx.doi.org/10.4048/jbc.2015.18.1.87 Purpose:  This study examines the effects of a rehabilitation pro - gram on quality of life (QoL), cardiopulmonary function, and fa - tigue in breast cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.87Recently, it has become clear that rehabilitation involving  physical activity is an important part of cancer treatment.",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
Effects of a Rehabilitation Program in Breast Cancer Patients 89 http://dx.doi.org/10.4048/jbc.2015.18.1.87  http://ejbc.krbreast cancer who had been prescribed multimodal rehabilita - tion after being evaluated by a physiatrist.,Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.87participants performed 5–10 repetitions.,OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
"Effects of a Rehabilitation Program in Breast Cancer Patients 91 http://dx.doi.org/10.4048/jbc.2015.18.1.87  http://ejbc.krComparison of the dimensions of QoL, cardiorespiratory  fitness, and fatigue at baseline mean difference In the baseline evaluation, there were no differences in the  QoL, functional aspects such as physical and emotional per - formance, and symptomatic aspects such as vomiting, fatigue,  pain, and dyspnea between the EEG and the DEG groups.",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.8732.5 30.0 27.5 25.0 22.5  Baseline 2 4 6 8 Time (wk)Cardiorespiratory function (mL/min/kg) Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
"Effects of a Rehabilitation Program in Breast Cancer Patients 93 http://dx.doi.org/10.4048/jbc.2015.18.1.87  http://ejbc.krteraction effects revealed that the EEG demonstrated a signifi - cant increase from baseline to week 4; conversely, scores for the  DEG decreased from baseline to week 4 but demonstrated a  borderline significant increase from week 4 to week 8 (Figure  3).",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.87physical functioning, weakness of muscles, and many social  and cognitive challenges (depression, cognitive deficiency, and  loneliness).",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
"Effects of a Rehabilitation Program in Breast Cancer Patients 95 http://dx.doi.org/10.4048/jbc.2015.18.1.87  http://ejbc.krHowever, the reason for this is unclear.",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.8721.,Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
http://hdl.handle.net/10755/165449.,Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jbc-18-87.PMC4381129.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Neurofibromatosis type 1 (NF1) is an autosomal dominant  disorder with an approximate incidence ranging from 1/2,500  to 1/3,000 and a prevalence ranging from 1/2,000 to 1/5,000  in the United States and United Kingdom [1,2].",Non-OADS,/arxiv_data1/oa_pdf/e8/35/jbc-18-97.PMC4381130.pdf
"The proband  was diagnosed with high-grade invasive lobular breast carci -Early-Onset Breast Cancer in a Family with Neurofibromatosis Type 1  Associated with a Germline Mutation in BRCA1 Y e Won Jeon, Ra Mi Kim1, Seung Taek Lim, Hyun Joo Choi2, Y oung Jin Suh Department of Surgery, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine, Suwon; 1Park Breast Clinic, Suwon; 2Department of  Pathology, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine, Suwon, KoreaCASE REPORTJ Breast Cancer 2015 March; 18(1): 97-100  http://dx.doi.org/10.4048/jbc.2015.18.1.97 Neurofibromatosis type 1 (NF1), which may occur as an autosom- al dominant disorder, is caused by the absence of neurofibromin  protein due to somatic mutations in the NF1 gene, and it has  been associated with an increased risk of breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/e8/35/jbc-18-97.PMC4381130.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.97noma (T2N1M0, estrogen receptor [ER] positive, progester - one receptor [PR] negative, human epidermal growth factor  receptor 2 [HER2] negative, and Ki-67 25%) after breastcon - serving surgery.",Non-OADS,/arxiv_data1/oa_pdf/e8/35/jbc-18-97.PMC4381130.pdf
"Breast Cancer of NF1 Is Associated with BRCA1  Mutation99 http://dx.doi.org/10.4048/jbc.2015.18.1.97  http://ejbc.kred into T) results in the conversion of the 1,206th amino acid,  a glutamate (GAG), into a premature stop codon (TAG).",Non-OADS,/arxiv_data1/oa_pdf/e8/35/jbc-18-97.PMC4381130.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2015.18.1.972.,Non-OADS,/arxiv_data1/oa_pdf/e8/35/jbc-18-97.PMC4381130.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/d7/main.PMC4381131.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2014.11.006 2049-0801/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/51/d7/main.PMC4381131.pdf
E-mail address: lrp537@mail.usask.ca http://dx.doi.org/10.1016/j.ijppaw.2015.03.001 2213-2244/© 2015 Published by Elsevier Ltd on behalf of Australian Society for Parasitology.,Non-OADS,/arxiv_data1/oa_pdf/1c/63/main.PMC4381132.pdf
CrownCopyright©2015PublishedbyElsevierLtdonbehalf of AustralianSocietyforParasitology.This isanopenaccessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/by-nc- nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/35/eb/main.PMC4381133.pdf
http://dx.doi.org/10.1016/j.ijppaw.2015.02.006 2213-2244/Crown Copyright © 2015 Published by Elsevier Ltd on behalf of Australian Society for Parasitology.,Non-OADS,/arxiv_data1/oa_pdf/35/eb/main.PMC4381133.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).International Journal for Parasitology: Parasites and Wildlife 4 (2015) 178–189 Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw,Non-OADS,/arxiv_data1/oa_pdf/35/eb/main.PMC4381133.pdf
"Key Words :  Mallory-Weiss; Endoscopy; TherapeuticsOpen Access Received:  February 17, 2015    Accepted:  February 25, 2015 Correspondence:  Hyun-Soo Kim Department of Internal Medicine, Chonnam National University Medical  School, 42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea Tel: +82-62-220-6215, Fax: +82-62-228-1330, E-mail:  dshskim@jnu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.102FOCUSED REVIEW SERIES:  Endoscopic Management of Upper Gastrointestinal Bleeding",Non-OADS,/arxiv_data1/oa_pdf/15/59/ce-48-102.PMC4381135.pdf
"Key Words :  Gastrointestnal bleeding; Peptic ulcer bleeding; EndoscopyOpen Access Received:  December 9, 2014    Revised:  March 6, 2015 Accepted:  March 11, 2015 Correspondence:  Byung-Wook Kim Division of Gastroenterology, Department of Internal Medicine, Incheon St.  Mary’s Hospital, College of Medicine, The Catholic University of Korea, 56  Dongsu-ro, Bupyeong-gu, Incheon 403-720, Korea Tel: +82-32-280-5051, Fax: +82-32-280-5082, E-mail:  gastro@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.106FOCUSED REVIEW SERIES:  Endoscopic Management of Upper Gastrointestinal Bleeding",Non-OADS,/arxiv_data1/oa_pdf/d6/2c/ce-48-106.PMC4381136.pdf
"Key Words :  Dieulafoy’s lesion; Endoscopic treatment; Gastrointestinal tractOpen Access Received: September 1, 2014    Revised: November 2, 2014 Accepted:  November 3, 2014 Correspondence: Gwang Ha KimDepartment of Internal Medicine, Pusan National University Hospital, Pusan  National University School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 602- 739, KoreaTel: +81-51-240-7869, Fax: +81-51-244-8180, E-mail: doc0224@pusan.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.112FOCUSED REVIEW SERIES:  Endoscopic Management of Upper Gastrointestinal Bleeding",Non-OADS,/arxiv_data1/oa_pdf/83/67/ce-48-112.PMC4381137.pdf
"Key Words :  Stomach neoplasms; Hemorrhage; Endoscopic therapyOpen Access Received:  January 9, 2015    Revised:  February 24, 2015 Accepted:  February 26, 2015 Correspondence:  Il Ju Choi Center for Gastric Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu,  Goyang 410-769, Korea Tel: +82-31-920-2282, Fax: +82-31-920-0069, E-mail:  cij1224@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.121FOCUSED REVIEW SERIES:  Endoscopic Management of Upper Gastrointestinal Bleeding",Non-OADS,/arxiv_data1/oa_pdf/29/7d/ce-48-121.PMC4381138.pdf
"Key Words :  Capsule endoscopy; Crohn’s disease; GuidelinesOpen Access Received:  April 9, 2014    Revised:  June 26, 2014 Accepted:  June 28, 2014 Correspondence:  Byong Duk Y e Department of Gastroenterology and Inflammatory Bowel Disease Center, Asan  Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3181, Fax: +82-2-476-0824, E-mail:  bdye@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.128",Non-OADS,/arxiv_data1/oa_pdf/a7/63/ce-48-128.PMC4381139.pdf
"Key Words :  Endoscopic mucosal resection; Double-channel gastroscope; Polypectomy; ColonoscopyOpen Access Received: July 29, 2014    Revised: September 23, 2014 Accepted:  October 11, 2014 Correspondence: Gregorios A. Paspatis Department of Gastroenterology, Benizelion General Hospital, L. Knossou,  Heraklion, Crete 71409, Greece Tel: +30-2810-368017, Fax: +30-2810-368017, E-mail: gpaspatis@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.136ORIGINAL ARTICLE See commentary on page 89-90",Non-OADS,/arxiv_data1/oa_pdf/51/13/ce-48-136.PMC4381140.pdf
"Key Words :  Light-emitting diode; Narrow band imaging; Endoscopy; Screening; Mouth neoplasmsOpen Access Received:  April 11, 2014    Accepted:  June 12, 2014 Correspondence:  Pa-Chun Wang Department of Otolaryngology, Cathay General Hospital, 280 Sec 4, Jen-Ai Rd,  106 Taipei, Taiwan Tel: +886-2-2708-2121, Fax: +886-2-6636-2836, E-mail:  drtony@seed.net.tw cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.142",Non-OADS,/arxiv_data1/oa_pdf/9c/b1/ce-48-142.PMC4381141.pdf
"Key Words :  Early gastric cancer; Recurrence; Endoscopic treatment; Argon plasma coagulationOpen Access Received:  February 27, 2014    Revised:  May 24, 2014 Accepted:  June 14, 2014 Correspondence:  Seong Woo Jeon Gastric Cancer Center, Kyungpook National University Medical Center, Kyung - pook National University School of Medicine, 807 Hoguk-ro, Buk-gu, Daegu  702-210, Korea Tel: +82-53-200-2602, Fax: +82-53-200-2028, E-mail:  sw-jeon@daum.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.147",Non-OADS,/arxiv_data1/oa_pdf/b1/8f/ce-48-147.PMC4381142.pdf
"Key Words :  Endosonography; Subepithelial tumors; Biopsy, large-core needle; Endoscopic ultrasound-guided fine needle aspiration;  StomachOpen Access Received:  April 29, 2014    Revised:  November 5, 2014 Accepted:  November 12, 2014 Correspondence:  Ho June Song Division of Gastroenterology, Department of Internal Medicine, Asan Medical  Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa- gu, Seoul 138-736, Korea Tel: +82-2-3010-3916, Fax: +82-2-485-5782, E-mail:  hjsong@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.152 See commentary on page 91-93",Non-OADS,/arxiv_data1/oa_pdf/87/e4/ce-48-152.PMC4381143.pdf
"cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.158 See commentary on page 94-95",Non-OADS,/arxiv_data1/oa_pdf/d9/c3/ce-48-158.PMC4381144.pdf
"Key Words :  Adrenal mass; Endosonography; Fine-needle aspiration cytology; TuberculosisOpen Access Received:  April 25, 2014    Revised:  July 22, 2014 Accepted:  October 17, 2014 Correspondence:  Ragesh Babu Thandassery Department of Gastroenterology, Medanta Institute of Digestive & Hepatobil - iary Sciences, Medanta-The Medicity, Sector 38, CH Bakhtawar Singh Road,  Islampur Colony, Near Rajiv Chowk, Gurgaon 122 001, India Tel: +91-999-9411125, Fax: +91-124-4834445, E-mail:  doc.ragesh@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.165 INTRODUCTION Endoscopic ultrasound-guided fine-needle aspiration cy - tology (EUS-FNA) has been used in clinical practice for  nearly 2 decades.1 EUS-FNA enables detailed imaging and  sampling of both intramural and extramural structures and  abnormal lesions of the gastrointestinal tract and of various  intra-abdominal, mediastinal, and pelvic organs.",Non-OADS,/arxiv_data1/oa_pdf/b8/c7/ce-48-165.PMC4381145.pdf
"Key Words :  Facial paralysis; Compression; EndoscopyOpen Access Received:  January 16, 2014    Revised:  March 17, 2014 Accepted:  April 21, 2014 Correspondence:  Jun Lee Department of Internal Medicine, Chosun University School of Medicine, 365  Pilmun-daero, Dong-gu, Gwangju 501-717, Korea Tel: +82-62-220-3012, Fax: +82-62-224-5494, E-mail:  leejun@chosun.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.171 INTRODUCTION Peripheral facial nerve palsy (FNP) can result from idio - pathic (primary) or detectable (secondary) causes.",Non-OADS,/arxiv_data1/oa_pdf/a5/c9/ce-48-171.PMC4381146.pdf
"Key Words :  Eosinophilic enteropathy; Rhus; Gastrointestinal hemorrhageOpen Access Received:  January 29, 2014    Revised:  February 17, 2014 Accepted:  February 17, 2014 Correspondence:  Seon-Y oung Park Department of Internal Medicine, Chonnam National University Medical School,  42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea Tel: +82-62-220-6215, Fax: +82-62-228-1330, E-mail:  drpsy@naver.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.174",Non-OADS,/arxiv_data1/oa_pdf/00/99/ce-48-174.PMC4381147.pdf
"Key Words :  Cat scratch colon; Colonoscopy; Barotrauma; Ischemia; ColitisOpen Access Received:  March 9, 2014    Accepted:  April 27, 2014 Correspondence:  Joon Seong Lee Institute for Digestive Research and Digestive Disease Center, Department of  Internal Medicine, Soonchunhyang University College of Medicine, 59 Dae - sagwan-ro, Y ongsan-gu, Seoul 140-743, Korea Tel: +82-2-709-9202, Fax: +82-2-709-9696, E-mail:  joonlee@hosp.sch.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.178",Non-OADS,/arxiv_data1/oa_pdf/cc/27/ce-48-178.PMC4381148.pdf
"Open Access Received:  March 1, 2015    Revised:  March 5, 2015 Accepted:  March 5, 2015 Correspondence:  Kwang An Kwon Department of Internal Medicine, Gachon University Gil Medical Center, Ga - chon University of Medicine and Science, 21 Namdong-daero 774beon-gil, Nam - dong-gu, Incheon 405-760, Korea Tel: +82-32-460-3778, Fax: +82-32-460-3408 E-mail:  toptom@gilhospital.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Is the Double Channel Gastroscope Useful in Endoscopic Mucosal  Resection for Large Sessile Colon Polyps?",Non-OADS,/arxiv_data1/oa_pdf/12/50/ce-48-89.PMC4381149.pdf
"Kwang An Kwon Department of Gastroenterology, Gachon University Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea See “Use of a Double-Channel Gastroscope Reduces Procedural Time in Large Left-Sided Colonic Endoscopic Mucosal Resec - tions” by Evangelos Voudoukis, Georgios Tribonias, Aikaterini Tavernaraki, et al., on page 136-141.Clin Endosc  2015 ;48:89-90COMMENTARY Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.89",Non-OADS,/arxiv_data1/oa_pdf/12/50/ce-48-89.PMC4381149.pdf
"In the absence of informa - tion regarding the endosonographers’ experience, it may be  speculated that EUS-TCBs were performed more frequently at  a later stage, once endosonographers had gained sufficient ex -Open Access Received:  March 2, 2015    Accepted:  March 3, 2015 Correspondence:  Eun Y oung Kim Department of Internal Medicine, Catholic University of Daegu School of Medi - cine, 33 Duryugongwon-ro, Nam-gu, Daegu 705-718, Korea Tel: +82-53-650-4092, Fax: +82-53-624-3281, E-mail:  kimey@cu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Which Needle Is Better for Diagnosing Subepithelial Lesions?",Non-OADS,/arxiv_data1/oa_pdf/57/8b/ce-48-91.PMC4381150.pdf
"Eun Young Kim Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea  See “Yields and Utility of EUS-Guided 19-Gauge Trucut Biopsy versus 22-Gauge Fine Needle Aspiration for Diagnosing  Gastric Subepithelial Tumors” by Hee Kyong Na, Jeong Hoon Lee, Y oung Soo Park, et al., on page 152-157.Clin Endosc  2015 ;48:91-93COMMENTARY Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.91",Non-OADS,/arxiv_data1/oa_pdf/57/8b/ce-48-91.PMC4381150.pdf
"Another study reported that the sensitivity,  specificity, positive predictive value, and negative predictive val - ue of EUS-FNA were 86%, 97%, 96%, and 89%, respectively, for  the diagnosis of malignant adrenal gland lesions.10Open Access Received:  March 5, 2015    Accepted:  March 10, 2015 Correspondence:  Tae Hyeon Kim Division of Gastroenterology, Department of Internal Medicine, Wonkwang Uni - versity School of Medicine & Hospital, 895 Muwang-ro, Iksan 570-974, Korea Tel: +82-63-859-2670, Fax: +82-63-855-2025, E-mail:  kth@wonkwang.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Is Endoscopic Ultrasonography-Guided Fine Needle Aspiration  Trailblazing in Tissue Sampling of Adrenal Masses?",Non-OADS,/arxiv_data1/oa_pdf/9d/63/ce-48-94.PMC4381151.pdf
"Tae Hyeon Kim Division of Gastroenterology, Department of Internal Medicine, Wonkwang University School of Medicine & Hospital, Iksan, Korea  See “Endoscopic Ultrasound-Guided Fine-Needle Aspiration of the Adrenal Glands: Analysis of 21 Patients” by Rajesh Puri,  Ragesh Babu Thandassery, Narendra S. Choudhary, et al., on page 158-164.Clin Endosc  2015 ;48:94-95COMMENTARY Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.94",Non-OADS,/arxiv_data1/oa_pdf/9d/63/ce-48-94.PMC4381151.pdf
"Key Words :  Hemorrhage; Hemostasis; Equipment and supplies   Open Access Received: January 5, 2015    Accepted:  January 17, 2015 Correspondence: Naoki Muguruma Department of Gastroenterology and Oncology, Institute of Health Biosciences, The University of Tokushima Graduate School, 3-18-15, Kuramoto-cho, Tokushi- ma 770-8503, Japan Tel: +81-88-633-7124, Fax: +81-88-633-9235 E-mail: muguruma.clin.med@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2015.48.2.96FOCUSED REVIEW SERIES:  Endoscopic Management of Upper Gastrointestinal Bleeding",Non-OADS,/arxiv_data1/oa_pdf/b7/55/ce-48-96.PMC4381152.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/04/rjv033.PMC4381272.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/85/rjv029.PMC4381274.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/8b/rjv037.PMC4381279.pdf
"It is dedicated to the Bombay  Psychiatric Society, in short, BPS (http://www.bombaypsych.org), which completes  50 years, 2015 being its Golden Jubilee year.",Non-OADS,/arxiv_data1/oa_pdf/19/aa/MSM-13-1.PMC4381303.pdf
"Available  from: http://www.oxcheps.new.ox.ac.uk/casebook/Resources/BOLAMV_1%20DOC.pdf,  Available from: http://www.e-lawresources.co.uk/Bolam-v--Friern-Hospital-Management- Committee.php.",Non-OADS,/arxiv_data1/oa_pdf/74/5c/MSM-13-105.PMC4381305.pdf
Available from:  http://www.un.org/disabilities/convention/conventionfull.shtml.,Non-OADS,/arxiv_data1/oa_pdf/74/5c/MSM-13-105.PMC4381305.pdf
Available  from: http://www.telegraphindia.com/archives/archive.html.,Non-OADS,/arxiv_data1/oa_pdf/74/5c/MSM-13-105.PMC4381305.pdf
Available  from: http://www.vakilno1.com/bareacts/familycourtsact1984/familycourtsact1984.html.,Non-OADS,/arxiv_data1/oa_pdf/74/5c/MSM-13-105.PMC4381305.pdf
Available from: https://www.nls.ac.in/ccl/jjdocuments/mahjj.pdf.,Non-OADS,/arxiv_data1/oa_pdf/74/5c/MSM-13-105.PMC4381305.pdf
Available from: http://www.dc-siwan.bih.nic.in/senior_citizens_act.pdf.,Non-OADS,/arxiv_data1/oa_pdf/74/5c/MSM-13-105.PMC4381305.pdf
Available from: http://www.icf.indianrailways.gov.in/uploads/files/Narcotic%20drugs.,Non-OADS,/arxiv_data1/oa_pdf/74/5c/MSM-13-105.PMC4381305.pdf
Available from: http://www.indiacode.nic.in/acts2014/16%20 of%202014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/74/5c/MSM-13-105.PMC4381305.pdf
Available from: http://www.vikaspedia.in/social-welfare/differently-abled-welfare/ disabilitiesrules1996.,Non-OADS,/arxiv_data1/oa_pdf/74/5c/MSM-13-105.PMC4381305.pdf
Available from: http://www.prsindia.org/ billtrack/the-right-of-persons-with-disabilities-bill-2014-3122.,Non-OADS,/arxiv_data1/oa_pdf/74/5c/MSM-13-105.PMC4381305.pdf
Available from:  http://www.psychclassics.yorku.ca/Maslow/motivation.htm.,Non-OADS,/arxiv_data1/oa_pdf/77/79/MSM-13-125.PMC4381307.pdf
Available from: http://www.brainyquote.com/ quotes/quotes/r/rabindrana104535.html.,Non-OADS,/arxiv_data1/oa_pdf/77/79/MSM-13-125.PMC4381307.pdf
Available from: http://www.news.bbc.co.uk/2/hi/8473515.stm.,Non-OADS,/arxiv_data1/oa_pdf/2f/e4/MSM-13-156.PMC4381311.pdf
Available from: http://www.mciindia.org/RulesandRegulations/ CodeofMedicalEthicsRegulations2002.aspx.,Non-OADS,/arxiv_data1/oa_pdf/2f/e4/MSM-13-156.PMC4381311.pdf
Available from: http://www.timesofindia.indiatimes.com/india/ Student-suicides-soar-26-in-5-years-education-system-blamed/articleshow/10573202.cms.,Non-OADS,/arxiv_data1/oa_pdf/2f/e4/MSM-13-156.PMC4381311.pdf
Available from:  http://www.who.int/mental_health/suicide-prevention/world_report_2014/en/.,Non-OADS,/arxiv_data1/oa_pdf/2f/e4/MSM-13-156.PMC4381311.pdf
Available from: http://www.wfme.org/ standards/cpd/16-continuing-professional-development-cpd-of-medical-doctors-english/ file.,Non-OADS,/arxiv_data1/oa_pdf/2f/e4/MSM-13-156.PMC4381311.pdf
Available from: http://www.indiankanoon.org/ doc/100472805.,Non-OADS,/arxiv_data1/oa_pdf/d3/e0/MSM-13-171.PMC4381314.pdf
Available from: http://www.newindia.,Non-OADS,/arxiv_data1/oa_pdf/d3/e0/MSM-13-171.PMC4381314.pdf
Available from: http://www.mhrd.,Non-OADS,/arxiv_data1/oa_pdf/d3/e0/MSM-13-171.PMC4381314.pdf
Available from:  http://www.telegraph.co.uk/news/worldnews/asia/india/8552279/Mumbai-votes-to- increase-alcohol-age-limit.html.,Non-OADS,/arxiv_data1/oa_pdf/d3/e0/MSM-13-171.PMC4381314.pdf
Available from: http://www.nytimes.com/2011/10/04/ science/04nobel.html?_r=3&.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from: http://www.bhagavad-gita.org/Gita/ verse-02-46.html.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available  from: http://www.bbc.com/future/story/20121008-winning-formula-for-nobel-prizes.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from: http://www.edition.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from: http://www.timeshighereducation.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from: http://www.nobelprize.org/alfred_nobel/biographical/ articles/frangsmyr/.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from http://www.ehow.com/how_7348206_ win-nobel-prize.html.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from:  http://www.slate.com/articles/arts/egghead/2003/09/exit_pursued_by_a_lobster.html.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from: http://www.archives.digitaltoday.in/ businesstoday/20060115/columns19.html.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from: http://www.nobelprize.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from: http://www.nobelprize.org/nobel_prizes/facts/ medicine.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from: http://www.nobelprize.org/nobel_ prizes/literature/laureates/1964/press.html.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available  from: http://www.theparisreview.org/blog/2014/10/09/how-to-win-the-nobel-prize/.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available  from: http://www.nobelprize.org/nobel_prizes/medicine/laureates/2000/press.html.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available  from: http://www.nobelprize.org/nobel_prizes/medicine/laureates/2014/press.html.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from: http://www.ref.ac.uk [Last  accessed on 2015 Feb 03].,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
Available from: http://www.paperpkblog.com/shayari/dastur- ibadat-ka-duniya-se-nirala-ho-dalip-tahir.,Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
"MSM : www.msmonographs.org207 A. R. Singh, (2014), Blueprint for an Indian Nobel Laureate in Psychiatry About the Author Ajai R. Singh, MD, is a Psychiatrist and Editor, Mens Sana Monographs  (http://www.msmonographs.org).",Non-OADS,/arxiv_data1/oa_pdf/c9/49/MSM-13-187.PMC4381316.pdf
"It is based on, but replaces, Template for MSM Submissions (Singh, 2011b 2) at http://www.msmonographs.org/article.asp?issn=0973-1229;year=2011;vol ume=9;issue=1;spage=320;epage=323;aulast=Singh .",Non-OADS,/arxiv_data1/oa_pdf/3c/56/MSM-13-225.PMC4381317.pdf
"msmonographs.org/contributors.asp, and detailed article on MSM Referencing (Singh, 2012), which appears on p184-8 of MSM 2012, and at http://www.msmonographs.org/article.",Non-OADS,/arxiv_data1/oa_pdf/3c/56/MSM-13-225.PMC4381317.pdf
More  details are also available at About Us  at http://msmonographs.org/aboutus.asp Template 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/56/MSM-13-225.PMC4381317.pdf
Available at http://www.iep.utm.edu/brainvat  [Last  accessed on 2011 Dec 26] vi.,Non-OADS,/arxiv_data1/oa_pdf/3c/56/MSM-13-225.PMC4381317.pdf
Available at: http://www.hindustantimes.com/Don-t-blame- superbug-on-Indiait-s-everywhere/Article1-585926.aspx [Last accessed on 2011  Jan 13].,Non-OADS,/arxiv_data1/oa_pdf/3c/56/MSM-13-225.PMC4381317.pdf
Available at: http://www.bbc.co.uk/news/world-south- asia-10954890  .,Non-OADS,/arxiv_data1/oa_pdf/3c/56/MSM-13-225.PMC4381317.pdf
"Typical Paper, Editorial, and other submissions   For a typical review article, see  http://msmonographs.org/article.asp?issn=0973-1229;year=2012;volume=10;issue=1;spa ge=20;epage=32;aulast=Englisch  And/or  http://msmonographs.org/article.asp?issn=0973-1229;year=2012;volume=10;issue=1;sp age=122;epage=133;aulast=Maturo   For a typical editorial, see   http://msmonographs.org/article.asp?issn=0973-1229;year=2012;volume=10;issue=1;sp age=4;epage=12;aulast=Andrade  Or  http://msmonographs.org/article.asp?issn=0973-1229;year=2012;volume=10;issue=1;spa ge=13;epage=19;aulast=Carpenter  For a typical Book review, see  http://msmonographs.org/article.asp?issn=0973-1229;year=2007;volume=5;issue=1;spag e=228;epage=232;aulast=McHenry  or  http://www.msmonographs.org/article.asp?issn=0973-1229;year=2010;volume=8;issue= 1;spage=146;epage=150;aulast=Andrade   For typical MSM  Poem, see  http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue= 1;spage=277;epage=278;aulast=Brenner  For a typical Journalology article, see  http://msmonographs.org/article.asp?issn=0973-1229;year=2012;volume=10;issue=1;sp age=158;epage=180;aulast=Tharyan  For a typical article in the Looking Glass, see   http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue",Non-OADS,/arxiv_data1/oa_pdf/3c/56/MSM-13-225.PMC4381317.pdf
"13(1), Jan - Dec 2015 =1;spage=41;epage=47;aulast=Gilman  For a typical article in Reflections, see   http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue =1;spage=135;epage=145;aulast=Narlikar  For a typical article in Musings, see   http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue =1;spage=131;epage=134;aulast=Arnold  For typical obituary, see   http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue =1;spage=281;epage=284;aulast=Raveh26.",Non-OADS,/arxiv_data1/oa_pdf/3c/56/MSM-13-225.PMC4381317.pdf
Available from: http://www.mciindia.org/ RulesandRegulations/PGMedicalEducationRegulations2000.aspx.,Non-OADS,/arxiv_data1/oa_pdf/0d/7c/MSM-13-52.PMC4381322.pdf
Ltd. (http://www.knowledgeisotopes.com) for writing support.,Non-OADS,/arxiv_data1/oa_pdf/17/4e/JHRS-8-13.PMC4381376.pdf
http://www.icmr.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/b8/d7/JHRS-8-3.PMC4381379.pdf
Available from: http://www.behdasht.gov.,Non-OADS,/arxiv_data1/oa_pdf/e6/71/JHRS-8-48.PMC4381383.pdf
Available from: http://www.UNAIDS.org/2012 [Last  accessed on 2015 Jan 09].,Non-OADS,/arxiv_data1/oa_pdf/e6/71/JHRS-8-48.PMC4381383.pdf
"Available from URL: (http://www.mcclurenet.com)  How to cite this article:  Madan JR, Pawar KT, Dua K. Solubility  enhancement studies on lurasidone hydrochloride using mixed hydrotropy.",Non-OADS,/arxiv_data1/oa_pdf/83/34/IJPI-5-114.PMC4381388.pdf
Avai lable from: http://www.en.wikipedia.org/wiki/ gastroesophageal reflux disease.,Non-OADS,/arxiv_data1/oa_pdf/1f/ed/IJPI-5-92.PMC4381392.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.186684.114.© 2015 Karmin et al.",OADS,/arxiv_data1/oa_pdf/a6/74/459.PMC4381518.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a6/74/459.PMC4381518.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 25:459 –466 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 459 www.genome.org",OADS,/arxiv_data1/oa_pdf/a6/74/459.PMC4381518.pdf
Data access The raw read data on the Y chromosomes extracted from the whole genome sequences from this study have been submitted to the European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena/)under accession number PRJEB8108.,OADS,/arxiv_data1/oa_pdf/a6/74/459.PMC4381518.pdf
The data are also available at the data repository of the Estonian Biocentre (http://www.ebc.,OADS,/arxiv_data1/oa_pdf/a6/74/459.PMC4381518.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.180240.114.© 2015 Agirre et al.",OADS,/arxiv_data1/oa_pdf/6b/b9/478.PMC4381520.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/6b/b9/478.PMC4381520.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/ 4.0/.Research 478 Genome Research 25:478 –487 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/6b/b9/478.PMC4381520.pdf
Standard protocols generated within the Blueprint Consortium were followed.Protocol details can be found at http://www.blueprint-epigenome .eu/index.cfm?p=7BF8A4B6-F4FE-861A-2AD57A08D63D0B58.,Non-OADS,/arxiv_data1/oa_pdf/6b/b9/478.PMC4381520.pdf
Mapped reads of the ChIP-seq data for H3K4me1 and H3K27ac as well as DNase-seq data from the cell lines GM12878 and H1 were downloaded from the UCSC Genome Browser(GRCh37/hg19 Assembly; http://genome-euro.ucsc.edu).,OADS,/arxiv_data1/oa_pdf/6b/b9/478.PMC4381520.pdf
Analysis of transcription factor binding sites We used ChIP-seq data from the ENCODE Project available at the UCSC Genome Browser (http://genome.ucsc.edu/cgi-bin/ hgTrackUi?db=hg19&g=wgEncodeHaibTfbs) to obtain informa- tion on transcription factor binding sites (TFBS) of a total of163 TFs.,OADS,/arxiv_data1/oa_pdf/6b/b9/478.PMC4381520.pdf
"Data access WGBS, HumanMethylation450 BeadChip, and RNA-seq datahave been submitted to the European Genome-phenome Archive (https://www.ebi.ac.uk/ega/) under accession numbers EGAD00001000672, EGAS00001000841, and EGAS00001001110, respectively.",OADS,/arxiv_data1/oa_pdf/6b/b9/478.PMC4381520.pdf
"ChIP-seq and DNase-seq data from the U266 cell line have been submitted to the European Nucleotide Archive(https://www.ebi.ac.uk/ena/) under sample accession numbers SAMEA2165292 and SAMEA2165299, respectively.",OADS,/arxiv_data1/oa_pdf/6b/b9/478.PMC4381520.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.184986.114.© 2015 Ing-Simmons et al.",OADS,/arxiv_data1/oa_pdf/36/7f/504.PMC4381522.pdf
This article is distributed exclusively by Cold Spring Harbor LaboratoryPressfor thefirstsixmonths afterthefull-issuepublicationdate(see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/36/7f/504.PMC4381522.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 504 Genome Research 25:504 –513 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/36/7f/504.PMC4381522.pdf
"Reads of 38 bases were aligned to the Mus musculus mm9 ge- nome assembly using ELAND (Illumina), and WIG files generated with FindPeaks (http://vancouvershortr.sourceforge.net) (Fejeset al.",OADS,/arxiv_data1/oa_pdf/36/7f/504.PMC4381522.pdf
2008) were visualized with the UCSC Genome Browser(http://www.genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/36/7f/504.PMC4381522.pdf
Geneexpression estimates and normalized count equivalents were ob-tained using MMSEQ version 0.11.2 (http://github.com/eturro/ mmseq) (Turro et al.,OADS,/arxiv_data1/oa_pdf/36/7f/504.PMC4381522.pdf
"2011), and we used the Bioconductor R package DESeq version 1.6.1 (http://bioconductor.org/packages/release/bioc/html/DESeq.html) (Anders and Huber 2010) to deter-mine significantly differentially expressed genes in control versuscohesin-deficient thymocytes at FDR = 0.05 as described in Seitan et al.",OADS,/arxiv_data1/oa_pdf/36/7f/504.PMC4381522.pdf
The HOMER Hi-C software analysis pipeline(http://homer.salk.edu/homer/interactions/index.html) was usedto determine significant interactions and differential interactionsand to perform structured interaction matrix analysis (Lin et al.,OADS,/arxiv_data1/oa_pdf/36/7f/504.PMC4381522.pdf
Identification of super-enhancers Super-enhancers were defined using ROSE (https://bitbucket.org/young_computation/rose) (Whyte et al.,OADS,/arxiv_data1/oa_pdf/36/7f/504.PMC4381522.pdf
Data access ChIP-seq data from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE61428.,OADS,/arxiv_data1/oa_pdf/36/7f/504.PMC4381522.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.181305.114.© 2015 Schertel et al.",OADS,/arxiv_data1/oa_pdf/1e/5f/514.PMC4381523.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/1e/5f/514.PMC4381523.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Research 514 Genome Research 25:514 –523 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/1e/5f/514.PMC4381523.pdf
Data access The ChIP-seq data fromthis study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE59769.,OADS,/arxiv_data1/oa_pdf/1e/5f/514.PMC4381523.pdf
http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/1e/5f/514.PMC4381523.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.183905.114.© 2015 VanBuren et al.",OADS,/arxiv_data1/oa_pdf/11/fa/524.PMC4381524.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/11/fa/524.PMC4381524.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Research 524 Genome Research 25:524 –533 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/11/fa/524.PMC4381524.pdf
"The CpGAT, A Comprehensive Pipeline for Genome Annotation on PlantGDB webserver (http://www.plantgdb.org), was used for additional MSY gene annotation.",OADS,/arxiv_data1/oa_pdf/11/fa/524.PMC4381524.pdf
"Fifty million Markov chain Monte Carlo (MCMC) chains were run for the BEAST analysis and, after discarding the burn-in, convergence was verified using the program TRACER(http://tree.bio.ed.ac.uk/software/tracer/).",OADS,/arxiv_data1/oa_pdf/11/fa/524.PMC4381524.pdf
Data access Trimmed and quality-filtered Illumina reads for the 36 rese- quenced papaya genomes with alignment files and MSY se-quence have been deposited in the NCBI BioProject database (http://www.ncbi.nlm.nih.gov/bioproject) under accession num- ber PRJNA271489 and GenBank (http://www.ncbi.nlm.nih.gov/ genbank) under accession number CP010988.,OADS,/arxiv_data1/oa_pdf/11/fa/524.PMC4381524.pdf
http://www.r-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/11/fa/524.PMC4381524.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.183012.114.© 2015 Sharon et al.",OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
This article isdistributedexclusivelyby ColdSpring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
"After six months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 534 Genome Research 25:534 –543 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
Reads were trimmed using Sickle(https://github.com/najoshi/sickle) with default parameters.,OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
Refer to the Supplemental Information for a complete description of the pro- gram; the code is available in Supplemental File Lola-1.02.tar.gzand is maintained under https://github.com/CK7/Lola.,Non-OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
Code for the software implementing the algorithm is availablein Supplemental File synteny-1.02.tar.gz and is maintained un-der https://github.com/CK7/synteny.,OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
Verification of overlap-based clusters through ESOM Reads from the 4- and 5-m samples were clustered separately using the Databionic implementation of ESOM (Ultsch andMoerchen 2005; http://databionic-esom.sourceforge.net/) with3-mer frequencies (Dick et al.,OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
The perl script prepare_ esom_files.pl (available as a Supplemental File and maintained under https://github.com/CK7/esom/blob/master/prepare_esom_files.pl) was used for preparing the input files for ESOM with pa-rameters –k3–m 5000 –w 100000.,OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
A preliminary set of proteins annotatedas glycosyl hydrolases was identified using the ggKBase platform(http://ggkbase.berkeley.edu/) with a list of glycosyl hydrolase- related terms (Supplemental Table S19; http://ggkbase.berkeley.,OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
Data access Synthetic long reads for the Rifle sediment metagenome have been submitted to the NCBI BioProject database (http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
Informationfor genome architectures described in the paper as well as synthetic long-read data for the three samples and the GWC2 Deltaproteo- bacteria genome is available in Supplemental Material and at http://ggkbase.berkeley.edu.Multi-kb reads for metagenomics Genome Research 541 www.genome.org,OADS,/arxiv_data1/oa_pdf/80/00/534.PMC4381525.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.184341.114.© 2015 Libbrecht et al.",OADS,/arxiv_data1/oa_pdf/56/57/544.PMC4381526.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/56/57/544.PMC4381526.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Method 544 Genome Research 25:544 –557 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/56/57/544.PMC4381526.pdf
Data access Domain annotations and code for Segway with GBR are available as Supplemental Material and online at http://noble.gs.washing- ton.edu/proj/gbr.,OADS,/arxiv_data1/oa_pdf/56/57/544.PMC4381526.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.176099.114.© 2015 Kunnev et al.",OADS,/arxiv_data1/oa_pdf/ba/25/558.PMC4381527.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ba/25/558.PMC4381527.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Method 558 Genome Research 25:558 –569 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/ba/25/558.PMC4381527.pdf
Data access NSCR-SNS sequence data from this study have been submit-ted to the NCBI BioProject database (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/ba/25/558.PMC4381527.pdf
Wiggle fi- les have been submitted to the NCBI Gene Expression Omnibus(GEO; http://www.ncbi.nlm.nih.gov/geo) under accession num- ber GSE64933.,OADS,/arxiv_data1/oa_pdf/ba/25/558.PMC4381527.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.181966.114.© 2015 Huang et al.",OADS,/arxiv_data1/oa_pdf/e0/a6/570.PMC4381528.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e0/a6/570.PMC4381528.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Method 570 Genome Research 25:570 –581 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/e0/a6/570.PMC4381528.pdf
2013) according to the definitions from theEMAP eMouse Atlas Project (http://www.emouseatlas.org).,Non-OADS,/arxiv_data1/oa_pdf/e0/a6/570.PMC4381528.pdf
"Methods Image curation Selected raw images and their annotations (as of January 9, 2012) were downloaded from the website http://www.eurexpress.org.After gray-scale conversion and cropping of the head region, the images were sequentially and randomly displayed for visual exam- ination of their quality.",OADS,/arxiv_data1/oa_pdf/e0/a6/570.PMC4381528.pdf
"(2014)was downloaded from http://brainspan.org on April 6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e0/a6/570.PMC4381528.pdf
"Hi-C data processing The normalized intrachromosomal interaction matrices (40-kbbin, mm9) of Hi-C data for the 8-wk mouse cortex were down- loaded from http://chromosome.sdsc.edu/mouse/hi-c/download.",OADS,/arxiv_data1/oa_pdf/e0/a6/570.PMC4381528.pdf
The algorithm is available online (http://www.picb.ac.cn/hanlab/cociter) (Qiao et al.,OADS,/arxiv_data1/oa_pdf/e0/a6/570.PMC4381528.pdf
the online Implicit Association Testat http://www.implicit.harvard.edu).,Non-OADS,/arxiv_data1/oa_pdf/8c/ef/obr0016-0319.PMC4381543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/db/nihms-673233.PMC4381552.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four figures, and one table and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2014.08.010 .",OADS,/arxiv_data1/oa_pdf/72/db/nihms-673233.PMC4381552.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/22/ijn-10-2417.PMC4381627.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2417–2421International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2417Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJN.S7718 6Docetaxel-loaded solid lipid nanoparticles as a  basis for a targeted and dose-sparing personalized  breast cancer treatment strategy Natalia V Danilova1,2 Zhomart r Kalzhanov3 Nina A Nefedova2 Pavel G Mal’kov2 Ioannis P Kosmas1,4 Marina Y eliseeva1,5 Ospan A Mynbaev1,5,6 1International translational  Medicine and Biomodeling research  team, MIP t Center for Human  Physiology, Laboratory of Cellular  and Molecular technologies,   Moscow Institute of Physics  and technology, State University,   2Department of Physiology and Basic  Pathology, Faculty of Fundamental  Medicine, Lomonosov Moscow  State University, Moscow, russia;   3Department of Human Metabolism,   Academic Unit of  reproductive  and Developmental Medicine, Sheffield  University, Sheffield, UK; 4Department  of Obstetrics and  Gynecology,   Ioannina State General Hospital  G Chatzikosta, Ioannina, Greece;   5Department of Obstetrics,   Gynecology and reproductive  Medicine, Peoples’ Friendship  University of russia, 6Laboratory of  Immunology, Moscow State University  of Medicine and Dentistry named  after AI evdokimov, Moscow, russiaDear editor The long-term survival rate of patients with breast cancer was improved by the  application of systemic adjuvant chemotherapy,1 although the primary breast cancer  treatment strategy consists of mastectomy with lymphadenectomy and radiotherapy  followed by breast reconstruction.2–5 Unfortunately, most adjuvant chemotherapeutic  agents trigger major side effects.1,6 Therefore, we have read with great interest an article  in the International Journal of Nanomedicine  on the design of docetaxel-loaded solid  lipid nanoparticles (DSNs) aimed at reducing the systemic toxicity of standardized  docetaxel treatment.7  Our congratulation to the authors7 for their clear demonstration of the reduced cyto - toxicity of DSNs and significantly decreased myelosuppressive toxicity by recovering  the proliferation and differentiation of bone marrow progenitor cells, while triggering  more apoptosis in MCF-7 cells at a low dose compared with the commercial formula  of docetaxel by an arrested cell cycle progression in the G2/M stage.",Non-OADS,/arxiv_data1/oa_pdf/e3/22/ijn-10-2417.PMC4381627.pdf
"Overall, the same trends exist for all cancer patients, in the same time.Correspondence: Ospan A Mynbaev Moscow Institute of Physics and  technology, State University,  Dolgoprudny, 9 Instituskii Lane,  Dolgoprudny, Moscow 141700, russia email ospanmynbaev@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Letter Y ear: 2015 Volume: 10 Running head verso: Danilova et al Running head recto: DSNs in breast cancer DOI: http://dx.doi.org/10.2147/IJN.S77186",Non-OADS,/arxiv_data1/oa_pdf/e3/22/ijn-10-2417.PMC4381627.pdf
"Available from: http://www.mednet.ru/en.htm l. Accessed November 14, 2014.9",Non-OADS,/arxiv_data1/oa_pdf/e3/22/ijn-10-2417.PMC4381627.pdf
All authors are members of the Inter - national Translational Medicine and Biomodeling Research  Team ( http://mathbiomed.crec.mipt.r u).,Non-OADS,/arxiv_data1/oa_pdf/e3/22/ijn-10-2417.PMC4381627.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs297/en /.,Non-OADS,/arxiv_data1/oa_pdf/e3/22/ijn-10-2417.PMC4381627.pdf
"Available from: http://www.mednet.ru/en.htm l. Accessed November 14,  2014.",Non-OADS,/arxiv_data1/oa_pdf/e3/22/ijn-10-2417.PMC4381627.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e3/22/ijn-10-2417.PMC4381627.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/22/ijn-10-2417.PMC4381627.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/62/ijn-10-2391.PMC4381629.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2391–2401International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2391OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7233 7Poloxamer-based binary hydrogels for delivering  tramadol hydrochloride: sol-gel transition studies,  dissolution-release kinetics, in vitro toxicity, and  pharmacological evaluation ana claudia Mendonça dos  santos1 alessandra cristina santos  akkari1 Iasmin rosanne silva  Ferreira2 cintia rodrigues  Maruyama3 Monica Pascoli3 Viviane aparecida  guilherme4 eneida de Paula4 leonardo Fernandes  Fraceto5 renata de lima3 Patrícia da silva Melo2 Daniele ribeiro de araujo1 1centro de ciências Naturais e  humanas, Universidade Federal  do aBc , santo andré, 2Faculdades  Integradas Metropolitanas de  campinas, campinas, 3Departamento  de Biotecnologia, Universidade de  sorocaba, sorocaba, 4Departamento  de Bioquímica, Universidade  estadual de campinas, campinas,   5Departamento de engenharia  ambiental, Universidade estadual  ‘Júlio de Mesquita Filho’, sorocaba,   são Paulo, BrazilAbstract:  In this work, poloxamer (PL)-based binary hydrogels, composed of PL 407 and  PL 188, were studied with regard to the physicochemical aspects of sol-gel transition and phar - maceutical formulation issues such as dissolution-release profiles.",Non-OADS,/arxiv_data1/oa_pdf/24/62/ijn-10-2391.PMC4381629.pdf
"Among the several delivery systems reported in the literature, correspondence: Daniele ribeiro de  araujo centro de ciências Naturais e  humanas, Universidade Federal do aBc,  UFaBc av dos estados, 5001 Bairro  Bangú Bloco a, Torre 3, sala 623-3,  santo andré, são Paulo, Brazil email  daniele.araujo@ufabc.edu.b r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: dos Santos et al Running head recto: Poloxamer-based binary hydrogels for delivering tramadol hydrochloride DOI: http://dx.doi.org/10.2147/IJN.S72337",Non-OADS,/arxiv_data1/oa_pdf/24/62/ijn-10-2391.PMC4381629.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/24/62/ijn-10-2391.PMC4381629.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/62/ijn-10-2391.PMC4381629.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/ce/ijn-10-2403.PMC4381630.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2403–2416International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2403OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7952 2self-nanoemulsifying drug delivery systems  ameliorate the oral delivery of silymarin in rats  with roux-en-Y gastric bypass surgery chun-han chen1,2 cheng-chih chang1 Tsung-hsien shih2 Ibrahim a aljuffali3 Ta-sen Yeh4,5 Jia-Y ou Fang6–8 1Division of general surgery,   Department of surgery, chang gung  Memorial hospital, chiayi, 2graduate  Institute of clinical Medical sciences,   college of Medicine, chang gung  University, Kweishan, Taoyuan, Taiwan;   3Department of Pharmaceutics,   college of Pharmacy, King saud  University, riyadh, saudi arabia;   4Department of surgery, chang gung   Memorial hospital, 5school of  Medicine, college of Medicine,   6Pharmaceutics laboratory, graduate  Institute of Natural Products,   7chinese herbal Medicine research  T eam, healthy aging research center,   chang gung University, 8research  center for Industry of human  ecology, chang gung University of  science and T echnology, Kweishan,   Taoyuan, TaiwanAbstract:  Roux-en-Y gastric bypass (RYGB) is a popular surgery to reduce the body weight of  obese patients.",Non-OADS,/arxiv_data1/oa_pdf/7b/ce/ijn-10-2403.PMC4381630.pdf
"The stomach pouch is then connected to  the middle of the jejunum by circumventing the rest of the stomach, duodenum, and correspondence: Ta-sen Yeh Department of surgery, chang gung  Memorial hospital, 5 Fuxing street,  Kweishan, Taoyuan 333, Taiwan Tel +886 3328 1200 ext 2745 email tsy471027@cgmh.org.t w  Jia-You Fang Pharmaceutics laboratory, graduate  Institute of Natural Products, chang  gung University, 259 Wen-hwa 1st  road, Kweishan, Taoyuan 333, Taiwan Tel +886 3211 8800 Fax +886 3211 8236 email fajy@mail.cgu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chen et al Running head recto: SNEDDS in Roux-en-Y gastric bypass surgery DOI: http://dx.doi.org/10.2147/IJN.S79522",Non-OADS,/arxiv_data1/oa_pdf/7b/ce/ijn-10-2403.PMC4381630.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7b/ce/ijn-10-2403.PMC4381630.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/ce/ijn-10-2403.PMC4381630.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e9/29/ijn-10-2441.PMC4381632.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2441–2450International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2441OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7616 8alendronate-coated long-circulating liposomes  containing 99mtechnetium-ceftizoxime used to  identify osteomyelitis Diego dos santos Ferreira1 Fernanda alves Boratto1 Valbert Nascimento  cardoso2 rogéria serakides3 simone Odília Fernandes2 lucas antônio Miranda  Ferreira1 Mônica cristina Oliveira1 1Department of Pharmaceutical  Products, Faculty of Pharmacy,   2Department of clinical and   Toxicological analyses, Faculty  of Pharmacy, 3Veterinary school,   Universidade Federal de Minas gerais,   Belo horizonte, Minas gerais, BrazilAbstract:  Osteomyelitis is a progressive destruction of bones caused by microorganisms .",Non-OADS,/arxiv_data1/oa_pdf/e9/29/ijn-10-2441.PMC4381632.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e9/29/ijn-10-2441.PMC4381632.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/29/ijn-10-2441.PMC4381632.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/4f/ijn-10-2377.PMC4381633.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2377–2389International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2377OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7619 1Mechanism of enhanced antiosteoporosis  effect of circinal–icaritin by self-assembled  nanomicelles in vivo with suet oil and sodium  deoxycholate Jun Jiang1,2 Jie li1,2 Zhenhai Zhang1,2 e sun1,2 liang Feng1,2 Xiaobin Jia1,2 1Key laboratory of New Drug  Delivery system of chinese  Materia Medica, Jiangsu Provincial  academy of chinese Medicine,   2college of Pharmacy, Nanjing  University of chinese Medicine,   Nanjing, People’s republic of chinaBackground:  Circinal–icaritin (CIT), one new active aglycone of Epimedium , can exert a  beneficial effect on osteoporotic bone.",Non-OADS,/arxiv_data1/oa_pdf/32/4f/ijn-10-2377.PMC4381633.pdf
"Keywords:  circinal–icaritin (CIT), nanomicelles, antiosteoporosis effect, bioavailability,  intestinal absorption Introduction Epimedium  has been frequently prescribed for osteoporotic patients in the People’s  Republic of China (PRC) for a long time.1–3 Among Epimedium -derived flavonoids,  aglycone (icaritin) contains the potential to treat osteoporosis in postmenopausal women correspondence: Xiaobin Jia college of Pharmacy, Nanjing University  of chinese Medicine, 138 Xianlin avenue,  Qixia, Nanjing, Jiangsu 210023, People’s  republic of china Tel +86 25 8563 7809 email xiaobinjia_nj@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Jiang et al Running head recto: Suet oil enhanced antiosteoporosis effect of circinal–icaritin DOI: http://dx.doi.org/10.2147/IJN.S76191",Non-OADS,/arxiv_data1/oa_pdf/32/4f/ijn-10-2377.PMC4381633.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/32/4f/ijn-10-2377.PMC4381633.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/4f/ijn-10-2377.PMC4381633.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/05/ijn-10-2423.PMC4381634.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2423–2439International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2423OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7162 2Nanoscale TiO2 nanotubes govern the biological  behavior of human glioma and osteosarcoma cells correspondence: Xiangxin Xue liaoning Provincial Universities Key  laboratory of Boron resource ecological  Utilization Technology and Boron  Materials, Northeastern University, lane  11, 3 Wenhua road, heping District,  shenyang 110819, People’s republic of  china  Tel +86 024 8368 7371 Fax +86 024 2390 6316 email x uexx@mail.neu.edu.c n  anhua Wu Department of Neurosurgery, The First  Affiliated Hospital of China Medical  University, 155 North Nanjing street,  heping District, shenyang 110001,  People’s republic of china  Tel +86 024 2351 7484 Fax +86 024 8328 3301 email wuanhua@yahoo.co m ang Tian,1 Xiaofei Qin,2  anhua  Wu,2 hangzhou Zhang,3  Quan Xu,4 Deguang  Xing,2  he Yang,1 Bo Qiu,2  Xiangxin Xue,1 Dongyong  Zhang,2 chenbo  Dong5 1liaoning Provincial Universities  Key laboratory of Boron resource  ecological Utilization T echnology  and Boron Materials, Northeastern  University, 2Department of  Neurosurgery, The First affiliated  hospital of china Medical University,   3Department of sports Medicine  and Joint surgery, The First affiliated  hospital of china Medical University,   shenyang, 4Institute of New energy,   state Key laboratory of heavy Oil  Processing, china University of  Petroleum, Beijing, People’s republic  of china; 5Department of civil and  environmental engineering, rice  University, houston, TX, UsaAbstract:  Cells respond to their surroundings through an interactive adhesion process that has  direct effects on cell proliferation and migration.",Non-OADS,/arxiv_data1/oa_pdf/93/05/ijn-10-2423.PMC4381634.pdf
"In tissue engineering,  the surface properties of biological materials usually impose crucial impacts on cell  culture,7 healing of wounds,8 and tissue restoration and reconstruction.9 Specifically,  cell behavior can be manipulated by altering their material properties, including  chemical,10,11 nonmechanical physical,12,13 and mechanical properties in vitro.14  Nanopatternization has been applied effectively to regulate the nonmechanical and  physical properties of materials, such as topological structure,15 roughness,16 geomet - ric properties,17 and surface energy.18 It has been demonstrated that it is important to  unveil the mechanisms of cell-material interactions on nanopatterned surfaces at the  biomolecular level.5Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Tian et al Running head recto: TiO2 nanotubes and behavior of human glioma and osteosarcoma DOI: http://dx.doi.org/10.2147/IJN.S7162 2",Non-OADS,/arxiv_data1/oa_pdf/93/05/ijn-10-2423.PMC4381634.pdf
Or use: http://dvpr.es/1BpjXU GVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/93/05/ijn-10-2423.PMC4381634.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/93/05/ijn-10-2423.PMC4381634.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/05/ijn-10-2423.PMC4381634.pdf
Available at:http://www.who.int/vaccine_safety/ publications/aevi_manual.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3b/25/piu025.PMC4381742.pdf
"Availableat:http://www.medicaid.gov/Medicaid- CHIP-Program-Information/By-Topics/ Bene ﬁts/Prescription-Drugs/Downloads/URA-FOR-S-OR-I.pdf Accessed March 21, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3b/25/piu025.PMC4381742.pdf
Available at: http://www.bls.,Non-OADS,/arxiv_data1/oa_pdf/3b/25/piu025.PMC4381742.pdf
"Available at:http://hcupnet.ahrq.gov/ Accessed March 21, 2014.",OADS,/arxiv_data1/oa_pdf/3b/25/piu025.PMC4381742.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/7f/ddu564.PMC4381753.pdf
Materials and Methods GEO DNAm data All GEO data series which used the Illumina In ﬁnium Human- Methylation450 BeadChip platform (GPL13534) were searched through the GEO website ( http://www.ncbi.nlm.nih.gov/geo/ ) and considered for this analysis ( 32).,OADS,/arxiv_data1/oa_pdf/06/7f/ddu564.PMC4381753.pdf
"Add-itionally, the X chromosome data associated with a previously unpublished dataset were used in this study and deposited in GEO (Series ID: GSE60275; http://www.ncbi.nlm.nih.gov/geo/ query/acc.cgi?acc=GSE60275 ).",OADS,/arxiv_data1/oa_pdf/06/7f/ddu564.PMC4381753.pdf
"Determining outlier females based on level of escape from XCI was done using Iglewica and Hoaglin ’s outlier test ( http://contchart.com/outliers.aspx ), two sided with a modi ﬁedZscore cut-off of 3.5 to identify females who were outliers with respect to the percentage of TSSs thatshowing escape from XCI.",OADS,/arxiv_data1/oa_pdf/06/7f/ddu564.PMC4381753.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/40/ddu571.PMC4381754.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/d4/euu319.PMC4381834.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/4e/euu349.PMC4381835.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC4381844.pdf
http://dx.doi.org/10.1016/j.dcn.2015.01.005 1878-9293/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC4381844.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC4381844.pdf
"A  pitch  analysis  was  performed for  each  sound  based  on  an  autocorrelation  method  using Praat  software  (http://www.fon.hum.uva.nl/praat/ ),  with standard  default  settings  (75  Hz  pitch  ﬂoor  and  600  Hz  ceil- ing).",OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC4381844.pdf
"2,  64,  http://dx.doi.org/10.3389/fpsyg.",Non-OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC4381844.pdf
"Science  298, http://dx.doi.org/10.1126/science.1077066 .",Non-OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC4381844.pdf
"Neurosci., http://dx.doi.org/10.3389/fnsys.2012.00027 .",OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC4381844.pdf
"23,  2521–2532, http://dx.doi.org/10.1162/jocn.2010.21598 .",Non-OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC4381844.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/a0/main.PMC4381845.pdf
Although  this  was  a  reasonable  criticism  of the  original  study  this  alternative  interpretation  cannot account  for  the  conceptual  replications  of  this  method  that http://dx.doi.org/10.1016/j.dcn.2015.01.006 1878-9293/© 2015  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/50/a0/main.PMC4381845.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/a0/main.PMC4381845.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f1/52/ijgm-8-125.PMC4381882.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 125–130International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  125OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S7321 6Pattern of arrhythmias among nigerians   with congestive heart failure Olufemi e ajayi1 Olugbenga O abiodun1 anthony O akintomide1 rasaaq a adebayo1 suraj a Ogunyemi1 Michael O Balogun1 Olaniyi J Bamikole1 adeola O ajibare1 adesuyi a ajayi2,3 1cardiac care unit, Department  of Medicine, Obafemi awolowo  University Teaching hospitals  complex, Ile-Ife, Osun state, nigeria;   2T exas southern University, houston,   TX, Usa; 3The saba University school  of Medicine, The Bottom, saba, Dutch  caribbean correspondence: Olufemi e ajayi   cardiac care unit, Department   of Medicine, Obafemi awolowo   University Teaching hospitals complex,   PMB 5538 Ile-Ife, Osun state, nigeria   Tel +234 80 3713 5360   email oeajayi99@hotmail.co mBackground:  In patients with heart failure, death is often sudden due to life-threatening  arrhythmias.",Non-OADS,/arxiv_data1/oa_pdf/f1/52/ijgm-8-125.PMC4381882.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/f1/52/ijgm-8-125.PMC4381882.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/52/ijgm-8-125.PMC4381882.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/a1/ndt-11-835.PMC4381883.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 835–842Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  835OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7629 2effects of prolonged head-down bed rest  on working memory Qing liu1,2 renlai Zhou1–4 Xin Zhao5 Tian Po s Oei6 1Beijing Key lab of applied  experimental Psychology, school  of Psychology, 2research center  of emotion regulation, 3state  Key laboratory of cognitive  Neuroscience and learning,   international Data group/Mcgovern  institute for Brain research, Beijing  Normal University, Beijing, People’s  republic of china; 4Department  of Psychology, school of social  and Behavioral science, Nanjing  University, Nanjing, People’s republic  of china; 5Behavior rehabilitation  Training research institution, school  of Psychology, Northwest Normal  University, lanzhou, People’s republic  of china; 6school of Psychology,   University of Queensland, Brisbane,   QlD, australiaBackground:  The weightlessness caused by prolonged bed rest results in changes in cerebral  circulation and thus, brain functions, which is of interest.",Non-OADS,/arxiv_data1/oa_pdf/37/a1/ndt-11-835.PMC4381883.pdf
"Specifically, the mental arithmetic task induced the changes of vagal nerve activity  for the astronauts, with an increase of sympathetic nervous activity and a decrease of correspondence: renlai Zhou Department of Psychology, school of  social and Behavioral sciences, Nanjing  University, Nanjing, 210023, People’s  republic of china Tel +86 025 89680960 ext 418 email rlzhou@nju.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Liu et al Running head recto: Working memory and bed rest DOI: http://dx.doi.org/10.2147/NDT.S76292",Non-OADS,/arxiv_data1/oa_pdf/37/a1/ndt-11-835.PMC4381883.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/37/a1/ndt-11-835.PMC4381883.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/a1/ndt-11-835.PMC4381883.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/4a/ceor-7-173.PMC4381884.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 173–184ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  173ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8042 4The impact of chronic pain on direct medical  utilization and costs in chronic obstructive  pulmonary disease Melissa h Roberts1 Douglas W Mapel1 heather n Thomson2 1lovelace Clinic Foundation,  albuquerque, nM, Usa; 2Endo  Pharmaceuticals, Malvern, P a, Usa Correspondence: Douglas W Mapel   lovelace Clinic Foundation,   2309 Renard Place sE, suite 103,   albuquerque, nM 87106, Usa   Tel +1 505 235 1434   Fax +1 505 938 9940   Email dmapel@comcast.ne tObjective:  To examine how pain affects health care utilization and direct medical costs in  individuals with chronic obstructive pulmonary disease (COPD) compared to patients with  other chronic diseases.",Non-OADS,/arxiv_data1/oa_pdf/10/4a/ceor-7-173.PMC4381884.pdf
"Available from: http://www.goldcopd.org/uploads/users/ files/GOLD_Report_2011_Feb21.pd f. Accessed January 5, 2012.",OADS,/arxiv_data1/oa_pdf/10/4a/ceor-7-173.PMC4381884.pdf
"Available from: http://www.nhlbi.nih.gov/ files/docs/research/2012_ChartBook.pd f. Accessed February 27, 2015.",OADS,/arxiv_data1/oa_pdf/10/4a/ceor-7-173.PMC4381884.pdf
Available from: http://www.meps.ahrq.gov/mepsweb/data_files/ publications/st318/stat318.pdf.,OADS,/arxiv_data1/oa_pdf/10/4a/ceor-7-173.PMC4381884.pdf
Available from: http://www.meps.ahrq.gov/mepsweb/data_files/  publications/st331/stat331.shtml .,OADS,/arxiv_data1/oa_pdf/10/4a/ceor-7-173.PMC4381884.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/10/4a/ceor-7-173.PMC4381884.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/4a/ceor-7-173.PMC4381884.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/bf/imcrj-8-081.PMC4381885.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 81–85International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  81Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8177 0thrombocytopenia absent radius syndrome   with tetralogy of Fallot: a rare association Chetan Kumar1 Deepak sharma2 aakash pandita2 sanjay Bhalerao1 1Department of pediatrics, Madras  Institute of orthopedic and  trauma, Manapakkam, Chennai,  India;  2Department of Neonatology,  Fernandez Hospital, Hyderabad, India Correspondence: Deepak sharma   Department of Neonatology,   Fernandez Hospital, opposite old MLa  quarters, Hyderguda, Hyderabad, India   email dr.deepak.rohatk@gmail.co mAbstract:  Thrombocytopenia absent radius (TAR) syndrome is a very rare and infrequently seen  congenital disorder with an approximate frequency of  0.42/100,000 live births.",Non-OADS,/arxiv_data1/oa_pdf/aa/bf/imcrj-8-081.PMC4381885.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/aa/bf/imcrj-8-081.PMC4381885.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/bf/imcrj-8-081.PMC4381885.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f6/6f/ijwh-7-321.PMC4381886.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 321–330International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  321RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5001 6Clinical utility of ulipristal acetate for the  treatment of uterine fibroids: current evidence Alice Trefoux Bourdet Dominique Luton Martin Koskas Department of Obstetrics and  Gynecology, Bichat University  Hospital, Paris Diderot University,   Paris, FranceAbstract:  Uterine myoma is the most common benign uterine tumor in women of reproductive  age and occurs in 20%–25% of the worldwide population.",Non-OADS,/arxiv_data1/oa_pdf/f6/6f/ijwh-7-321.PMC4381886.pdf
"Correspondence: Martin Koskas Department of Obstetrics and  Gynecology, Bichat University  Hospital, 46 Rue Henri Huchard,  75018 Paris, France  Tel +33 1 40 25 76 73 Fax +33 1 40 25 76 96 email martin.koskas@wanadoo.f r Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Trefoux Bourdet et al Running head recto: Ulipristal acetate for the treatment of uterine fibroids DOI: http://dx.doi.org/10.2147/IJWH.S50016",Non-OADS,/arxiv_data1/oa_pdf/f6/6f/ijwh-7-321.PMC4381886.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/f6/6f/ijwh-7-321.PMC4381886.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/6f/ijwh-7-321.PMC4381886.pdf
Available from: http://www.ema.europa.eu/ema.,Non-OADS,/arxiv_data1/oa_pdf/f6/6f/ijwh-7-321.PMC4381886.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/a6/idr-8-039.PMC4381887.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 39–47Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  39REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S5754 0Lymphogranuloma venereum: diagnostic   and treatment challenges Romana Ceovic1 Sandra Jerkovic Gulin2 1Department of Dermatology and  Venereology, University Hospital  Center Zagreb and School  of Medicine, Zagreb, Croatia;   2Department of Dermatology and  Venereology, General Hospital Sibenik,   Sibenik, Croatia Correspondence: Romana Ceovic   Department of Dermatology and  Venereology, School of Medicine,  University Hospital Center Zagreb,  10000 Zagreb, Salata 4, Croatia   Tel +385 1236 8917   Fax +385 1237 9925   Email romana.ceovic@zg.htnet.h rAbstract:  Lymphogranuloma venereum is a sexually transmitted disease caused by L1, L2, and  L3 serovars of Chlamydia trachomatis .",Non-OADS,/arxiv_data1/oa_pdf/b6/a6/idr-8-039.PMC4381887.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/b6/a6/idr-8-039.PMC4381887.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/a6/idr-8-039.PMC4381887.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/7c/tcrm-11-475.PMC4381888.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 475–480Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  475ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8185 2P-wave and QT dispersion in patients  with conversion disorder Filiz izci1 hilal hocagil2 servet izci3 Vedat izci4 Merve iris Koc5 Rezzan Deniz acar3 1Department of Psychiatry, istanbul  Bilim University, Sısli Florence  nightingale hospital; 2Department  of emergency, Faculty of Medicine  hospital Zonguldak Bulent ecevit  University, Zonguldak, T urkey;   3Department of Cardiology, Kosuyolu   high specialization Training  and Research hospital, istanbul,   T urkey; 4Department of emergency,   Kartal Training and Research hospital,   istanbul, T urkey; 5Department  of Psychiatry, erenköy Training  and Research hospital for Psychiatry,   istanbul, T urkeyObjective:  The aim of this study was to investigate QT dispersion (QTd), which is the noninvasive  marker of ventricular arrhythmia and sudden cardiac death, and P-wave dispersion, which is the  noninvasive marker of atrial arrhythmia, in patients with conversion disorder (CD).",Non-OADS,/arxiv_data1/oa_pdf/75/7c/tcrm-11-475.PMC4381888.pdf
"no:164 sisli, 34381 istanbul, Turkey Tel +90 505 450 3013 email drfiliz2008@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Izci et al Running head recto: P-wave and QT dispersion in patients with CD DOI: http://dx.doi.org/10.2147/TCRM.S81852",Non-OADS,/arxiv_data1/oa_pdf/75/7c/tcrm-11-475.PMC4381888.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/75/7c/tcrm-11-475.PMC4381888.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/7c/tcrm-11-475.PMC4381888.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/58/6c/cpaa-7-057.PMC4381889.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Pharmacology: Advances and Applications 2015:7 57–68Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  57Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S7976 0expanding antitumor therapeutic windows   by targeting cancer-specific nicotinamide adenine  dinucleotide phosphate-biogenesis pathways Gaurab Chakrabarti1,2,4 David e Gerber3,4 David A Boothman1,2,4 1Department of Pharmacology,  2Department of Radiation Oncology,  3Division of Hematology and  Oncology, 4Harold C Simmons  Comprehensive Cancer Center, UT  Southwestern Medical Center, Dallas,  TX, USA Correspondence: Gaurab Chakrabarti;  David A Boothman   UT Southwestern Medical Center,   6001 Forest Park Drive,   ND2.210K, Mailstop 8807, Dallas,   TX 75390-8807, USA   Tel +1 214 645 6371   Fax +1 214 645 6347   email g aurab.chakrabarti@ utsouthwestern.ed u; david.boothman@ utsouthwestern.ed uAbstract:  Nicotinamide adenine dinucleotide phosphate (NADPH) biogenesis is an essential  mechanism by which both normal and cancer cells maintain redox balance.",Non-OADS,/arxiv_data1/oa_pdf/58/6c/cpaa-7-057.PMC4381889.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/58/6c/cpaa-7-057.PMC4381889.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/6c/cpaa-7-057.PMC4381889.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdolescent Health, Medicine and Therapeutics 2015:6 37–45Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  37OriginAl reseArcHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S6490 3social disparities among youth and the impact   on their health catherine Kreatsoulas1,* Areej Hassan2,* sV subramanian1 eric W Fleegler3 1Department of social and Behavioral  sciences, Harvard school of Public  Health, Boston, MA, UsA; 2Division  of Adolescent/Y oung Adult Medicine,   Boston children’s Hospital Boston,   Boston, MA, UsA; 3Division of  emergency Medicine, Boston  children’s Hospital Boston, Boston,   MA, UsA *These authors contributed equally   to this work correspondence: catherine Kreatsoulas   Department of social and Behavioral  sciences, Harvard school of Public  Health, 1137 Massachusetts Ave (37),  cambridge, MA, 02138, UsA   email ckreats@hsph.harvard.ed uPurpose:  Social disparities among youth have been recognized as an important influence on  disease risk later in the life cycle.",Non-OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
"Available from: http://www.mchb.hrsa.gov/chusa07/hstat/hsc/ pages/210h.htm l. Accessed October 28, 2013.",OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
Available from: http://www.gutsweb.org /.,Non-OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
Available from:  http://www.census.gov/content/census/en/programs-surveys/ahs/data.,OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
Available from: http://www.cpc.,Non-OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
Available from: http://www.cdc.gov/brfss/.,OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
"Available from: http://www.cdc.gov/nchs/data/ databriefs/db137.pd f. Accessed November 19, 2014.",OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
Available from: http://www.ceasar-boston.org/CRAFFT /.,Non-OADS,/arxiv_data1/oa_pdf/f9/8b/ahmt-6-037.PMC4381890.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/4a/clep-7-235.PMC4381891.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 235–242Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  235Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S8051 4Validity of reaction to severe stress and  adjustment disorder diagnoses in the Danish  Psychiatric Central research registry Elisabeth svensson1 Timothy l lash1,2 Patricia a resick3 Jens georg hansen1 Jaimie l gradus4–6 1Department of Clinical Epidemiology,  institute of Clinical Medicine,  aarhus University hospital,  aarhus, Denmark;  2Department  of Epidemiology, rollins school of  Public health, Emory University,  atlanta, ga, Usa;  3Department of  Psychiatry and Behavioral sciences,  Duke University, Durham, nC, Usa;   4national Center for PTsD, Va   Boston healthcare system, Boston,  Ma, Usa ; 5Department of Psychiatry,   6Department of Epidemiology, Boston  University, Boston, M a, Usa Correspondence: Elisabeth svensson   Department of Clinical Epidemiology,  aarhus University hospital, Olof Palmes  allé 43–45,  8200 aarhus n, Denmark   Tel +45 8716 7607  Fax +45 8716 7215  Email elisabeth.svensson@clin.au.d kAims:  To assess the validity of reaction to severe stress and adjustment disorder diagnoses  registered in the Danish Psychiatric Central Research Register (DPCRR), to examine the  documentation of stressful and traumatic events in the medical records, and to investigate the  occurrence of stress diagnoses among persons not registered in the DPCRR.",Non-OADS,/arxiv_data1/oa_pdf/6b/4a/clep-7-235.PMC4381891.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/6b/4a/clep-7-235.PMC4381891.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/51/copd-10-689.PMC4381892.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 689–702International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  689OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7627 3systemic cytokine signaling via Il-17 in smokers  with obstructive pulmonary disease: a link  to bacterial colonization?,Non-OADS,/arxiv_data1/oa_pdf/f5/51/copd-10-689.PMC4381892.pdf
"In mammalian airway models, IL-17 induces the release  of neutrophil-mobilizing cytokines as well as an accumulation of neutrophils and their  antibacterial compounds.6–8 Studies on endotoxin exposure and bacterial infections in  human airways provide additional support for this idea.9,10 From a logical point of view,  this indirectly implies that impaired cytokine signaling via IL-17 predisposes for bacterial Correspondence: anders lindén Unit of lung and airway research,  Institute of environmental Medicine,  Karolinska Institutet, PO Box 210,  se-17177, stockholm, sweden email anders.linden@ki.s e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Andelid et al Running head recto: Systemic cytokine signaling via IL-17 in smokers with OPD-CB DOI: http://dx.doi.org/10.2147/COPD.S76273",Non-OADS,/arxiv_data1/oa_pdf/f5/51/copd-10-689.PMC4381892.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f5/51/copd-10-689.PMC4381892.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/51/copd-10-689.PMC4381892.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/8b/tcrm-11-489.PMC4381893.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 489–499Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  489ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8079 3Regular inhaled corticosteroids in adult-onset   asthma and the risk for future cancer: a  population-based cohort study with proper  person-time analysis Correspondence: Victor C Kok Kuang Tien general hospital, 117 shatien  Road, shalu, Taichung 43303, Taiwan Tel +886 919 524 909 email victorkok@asia.edu.t w  Jorng-Tzong horng national Central University, 300 Jhongda  Road, Jhongli, Taoyuan 32001, Taiwan Tel +886 919 057 555 email horng@db.csie.ncu.edu.t w Victor C Kok1,2 Jorng-Tzong horng2,3 hsu-Kai huang3 Tsung-Ming Chao4 Ya-Fang hong5 1Division of Medical Oncology,   Department of internal Medicine,   Kuang Tien general hospital, Taichung,   Taiwan; 2Department of Biomedical  informatics, asia University Taiwan,   Taichung, Taiwan; 3Department of  Computer science and information  engineering, national Central  University, Jhongli, Taiwan; 4statistics  Unit, Department of applied  geomatics, Chien hsin University,   Jhongli, Taiwan; 5institute of Molecular  Biology, academia sinica, nankang,   Taipei, TaiwanBackground:  Recent studies have shown that inhaled corticosteroids (ICS) can exert  anti-inflammatory effects for chronic airway diseases, and several observational studies suggest  that they play a role as cancer chemopreventive agents, particularly against lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/55/8b/tcrm-11-489.PMC4381893.pdf
"It has been dem - onstrated that ICS can exert their beneficial anti-inflammatory effects by inhibiting  the synthesis of leukotriene C4 and prostaglandin D2 in the airway, reducing serum Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kok et al Running head recto: Association between inhaled corticosteroids and cancer risk in asthma  DOI: http://dx.doi.org/10.2147/TCRM.S80793",Non-OADS,/arxiv_data1/oa_pdf/55/8b/tcrm-11-489.PMC4381893.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/55/8b/tcrm-11-489.PMC4381893.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/8b/tcrm-11-489.PMC4381893.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/d0/cia-10-611.PMC4381894.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 611–619Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  611OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7234 8Behavioral activation for dementia caregivers:  scheduling pleasant events and enhancing  communications Alma Au1,2 Dolores gallagher- Thompson3 Meng-Kong Wong4 Jess leung4 Wai-Chi Chan5 Chun Chung Chan6 hui-Jing lu1 Man Kin lai1 Kevin Chan1 1Department of Applied social  sciences, 2Institute of Active Aging,  The hong Kong Polytechnic University,  hong Kong, People’s republic of China;  3Department of Psychiatry and  Behavioral sciences and geriatric  education Centre, school of Medicine,  stanford University, stanford, CA, UsA;  4Department of Psychiatry, United  Christian hospital, 5Department  of  Psychiatry, University of hong  Kong, 6Department of Medicine and  geriatrics, United Christian hospital,  hong Kong, People’s republic of ChinaBackground:  Dementia caregiving is often associated with increase in depressive symptoms and  strained relationships.",Non-OADS,/arxiv_data1/oa_pdf/6f/d0/cia-10-611.PMC4381894.pdf
"Converging evidence suggests that while informal caregiving Correspondence: Alma Au Department of Applied social sciences,  The hong Kong Polytechnic University,  11 Yuk Choi street, hung hom,  Kowloon, hong Kong, People’s republic  of China Tel +852 2766 7944 email ssalma@polyu.edu.h k Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Au et al Running head recto: Behavioral activation for dementia caregivers DOI: http://dx.doi.org/10.2147/CIA.S72348",Non-OADS,/arxiv_data1/oa_pdf/6f/d0/cia-10-611.PMC4381894.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6f/d0/cia-10-611.PMC4381894.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6f/d0/cia-10-611.PMC4381894.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/d5/cia-10-621.PMC4381895.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 621–624Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  621Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S8243 5Personalized therapeutics of α1-blockers  in patients with lower urinary tract symptoms  suggestive of benign prostatic hyperplasia Ling-ling Zhu1 Zhi-jun Feng2 Quan Zhou3 1Geriatric VIP Ward, Division  of Nursing, 2Department of Urology  Surgery, 3Department of Pharmacy,   the Second Affiliated Hospital, School  of Medicine, Zhejiang University,   Hangzhou, People’s republic of ChinaDear editor We read with great interest the multicenter, prospective, comparative cohort study by  Zhang et al1 who suggested that patients with uncontrolled or untreated hypertension  and lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH/ LUTS) should be warned about a decrease in blood pressure on initiation of alfuzosin  10 mg therapy alone or concomitantly with antihypertensive medication.",Non-OADS,/arxiv_data1/oa_pdf/a2/d5/cia-10-621.PMC4381895.pdf
"Tamsulosin hydrochloride was more effective in patients with dominant Correspondence: Quan Zhou Department of Pharmacy, the Second  Affiliated Hospital, School of Medicine,  Zhejiang University, 88 Jiefang road,  Shangcheng District, Hangzhou, Zhejiang  310009, People’s republic of China tel +86 571 8778 4615 Fax +86 571 8702 2776 email zhouquan142602@zju.edu.c nJournal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2015 Volume: 10 Running head verso: Zhu et al Running head recto: Alpha1-blockers for benign prostatic hyperplasia DOI: http://dx.doi.org/10.2147/CIA.S82435",Non-OADS,/arxiv_data1/oa_pdf/a2/d5/cia-10-621.PMC4381895.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a2/d5/cia-10-621.PMC4381895.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a2/d5/cia-10-621.PMC4381895.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/33/prom-6-103.PMC4381897.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2015:6 103–115Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  103ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PROM.S7936 8Pragmatic measurement of health satisfaction   in people with type 2 diabetes mellitus using   the current health satisfaction Questionnaire shana B Traina1 hilary h colwell2 Ross D crosby2,3 susan D Mathias2 1Janssen global services, llc,  Raritan, nJ, 2health Outcomes  solutions, Winter Park, F l,  3neuropsychiatric Research institute  and University of north Dakota  school of Medicine and health  sciences, Fargo, nD, Usa correspondence: shana B Traina   cardiovascular and Metabolism, Janssen  global services, llc, 700 Route 202 s,  Raritan, nJ 08869, Usa   Tel +1 908 927 7759   Fax +1 908 253 3784   email straina@its.jnj.co mBackground:  The concept of diabetes-related health satisfaction encompasses issues specifi - cally related to living with diabetes (eg, blood glucose, blood pressure levels, body weight).",Non-OADS,/arxiv_data1/oa_pdf/6b/33/prom-6-103.PMC4381897.pdf
"Both stages of the study received approval  from the Copernicus Group Institutional Review Board  (Durham, NC, USA; http://www.cgirb.co m).",Non-OADS,/arxiv_data1/oa_pdf/6b/33/prom-6-103.PMC4381897.pdf
Available from: https://www.iom.edu/ Reports/2001/Crossing-the-Quality-Chasm-A-New-Health-System- for-the-21st-Century.aspx.,Non-OADS,/arxiv_data1/oa_pdf/6b/33/prom-6-103.PMC4381897.pdf
"Available from: http://www.harrisinteractive.com/ MethodsTools/DataCollection/HarrisPollOnlinePanel.asp x. Accessed  February 23, 2015.",OADS,/arxiv_data1/oa_pdf/6b/33/prom-6-103.PMC4381897.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/33/prom-6-103.PMC4381897.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6b/33/prom-6-103.PMC4381897.pdf
"Available from: http://www.fda.gov/down - loads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ UCM193282.pd f. Accessed February 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6b/33/prom-6-103.PMC4381897.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/fd/ijn-10-2363.PMC4381898.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2363–2375International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2363OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8065 5Fluoromica nanoparticle cytotoxicity  in macrophages decreases with size  and extent of uptake Nicolin T ee1 Yingdong Zhu2 gysell M Mortimer1 Darren J Martin2 rodney F Minchin1 1school of Biomedical science,   University of Queensland, Brisbane,   QlD, australia; 2australian  Institute of  Bioengineering and  Nanotechnology, University of  Queensland, Brisbane, QlD, australiaAbstract:  Polyurethanes are widely used in biomedical devices such as heart valves, pacemaker  leads, catheters, vascular devices, and surgical dressings because of their excellent mechanical  properties and good biocompatibility.",Non-OADS,/arxiv_data1/oa_pdf/e5/fd/ijn-10-2363.PMC4381898.pdf
"This has been shown for amorphous silica,9 silver,10 and metal oxides.11,12  The relationship between size and toxicity is, in part, related to the increased surface  area and reactivity associated with the smaller diameter particles.13–15 Nanoparticles correspondence: rodney F Minchin school of Biomedical sciences, University  of Queensland, st lucia, Brisbane,  QlD 4072, australia Tel +61 7 3365 1894 Fax +61 7 3365 1766 email r.minchin@uq.edu.a u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Tee et al Running head recto: Fluoromica toxicity in macrophages DOI: http://dx.doi.org/10.2147/IJN.S80655",Non-OADS,/arxiv_data1/oa_pdf/e5/fd/ijn-10-2363.PMC4381898.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e5/fd/ijn-10-2363.PMC4381898.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/fd/ijn-10-2363.PMC4381898.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/fb/dddt-9-1797.PMC4381899.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1797–1804Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1797Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7734 1Recent progress in fungus-derived bioactive  agents for targeting of signaling machinery  in cancer cells Xiukun Lin1 Ammad Ahmad Farooqi2 Muhammad ismail2 1Department of Pharmacology, Capital  Medical University, Beijing, People’s  Republic of China; 2institute of  Biomedical and Genetic engineering,   islamabad, PakistanAbstract:  It is becoming increasingly understood that tumor cells may have different mutations  and dependencies on diverse intracellular signaling cascades for survival or metastatic potential.",Non-OADS,/arxiv_data1/oa_pdf/6f/fb/dddt-9-1797.PMC4381899.pdf
"When administered intraperitoneally Correspondence: Ammad Ahmad  Farooqi institute of Biomedical and Genetic  engineering (iBGe), KRL Hospital, Mauve  Area, G-9/1, islamabad, Pakistan email ammadahmad638@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Lin et al Running head recto: Fungus-derived agents for targeting cancer cells DOI: http://dx.doi.org/10.2147/DDDT.S77341",Non-OADS,/arxiv_data1/oa_pdf/6f/fb/dddt-9-1797.PMC4381899.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/6f/fb/dddt-9-1797.PMC4381899.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/fb/dddt-9-1797.PMC4381899.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/35/ppa-9-509.PMC4381900.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 509–515Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  509OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7817 8Development of the coMac Adherence  Descriptor™: a linguistically-based survey  for segmenting patients on their worldviews Ulla M connor1 robert s Mac neill Jr1 howard r Mzumara2 robert sandy1 1international center for intercultural  communication ( icic), indiana  University – Purdue University,   indianapolis, in, UsA; 2Testing  center – Division of Planning and  institutional improvement, indiana  University – Purdue University,   indianapolis, in, UsAAbstract:  Nonadherence to prescribed medication and healthy behaviors is a pressing health  care issue.",Non-OADS,/arxiv_data1/oa_pdf/5f/35/ppa-9-509.PMC4381900.pdf
"In response to this concern, van Dulmen et al2 have called for patient perspec - tives to be included in future research.correspondence: Ulla connor international center for intercultural  communication (icic), iU school of  liberal Arts, indiana University–Purdue  University indianapolis (iUPUi), 334 n  senate Ave, suite gl-A, indianapolis,  in 46204, UsA Tel +1 317 278 2441 Fax +1 317 274 2525 email uconnor@iupui.ed uJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Connor et al Running head recto: Adherence descriptor DOI: http://dx.doi.org/10.2147/PPA.S78178",Non-OADS,/arxiv_data1/oa_pdf/5f/35/ppa-9-509.PMC4381900.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/5f/35/ppa-9-509.PMC4381900.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/tcrm-11-501.PMC4381901.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 501–505Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  501ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8225 1Distribution and resistance of pathogens   in liver transplant recipients with Acinetobacter  baumannii  infection Fei gao1 Qifa Ye2,3 Qiquan Wan2 shan liu4 Jiandang Zhou5 1infectious Disease Department of  henan Province People’s hospital,   Zhengzhou, 2Department of  Transplant surgery, Third Xiangya  hospital, Central south University,   Changsha, 3Department of Transplant  surgery, Zhongnan hospital, Wuhan  University, Wuhan, People’s Republic  of China; 4adelphi University College  of nursing and Public health, new  Y ork, nY, Usa; 5Department of  Clinical laboratory of Microbiology,   Third Xiangya hospital, Central  south University, Changsha, People’s  Republic of ChinaBackground:  Drug-resistant Acinetobacter baumannii  has become a major problem in liver  transplant recipients.",Non-OADS,/arxiv_data1/oa_pdf/6f/b9/tcrm-11-501.PMC4381901.pdf
"Previous studies dem - onstrated that 0.8%–15.9% of liver recipients  developed  A. baumannii  bacteremia,6–15  and Nie et al reported that 3.7% of liver recipients developed intra-abdominal infection Correspondence: Qiquan Wan Department of Transplant surgery,  Third Xiangya hospital, Central south  University, no 138 Tongzipo Road,  Changsha 410013, hunan, People’s  Republic of China Tel +86 731 8861 8312 Fax +86 731 8861 8312 email 13548685542@163.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Gao et al Running head recto: Liver transplant recipients with Acinetobacter baumannii  infection DOI: http://dx.doi.org/10.2147/TCRM.S82251",Non-OADS,/arxiv_data1/oa_pdf/6f/b9/tcrm-11-501.PMC4381901.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/6f/b9/tcrm-11-501.PMC4381901.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/tcrm-11-501.PMC4381901.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/8a/cia-10-635.PMC4381902.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 635–642Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  635OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8066 8repeated vertebral augmentation for new  vertebral compression fractures of postvertebral  augmentation patients: a nationwide cohort study Cheng-loong liang1 hao-Kwan Wang1 Fei-Kai syu2 Kuo-Wei Wang1 Kang lu1 Po-Chou liliang1 1Department of n eurosurgery,   e-Da hospital, I-shou University,   Kaohsiung City, Taiwan; 2Department  of Pharmacy, China Medical University  hospital, Taichung City, TaiwanPurpose:  Postvertebral augmentation vertebral compression fractures are common; repeated  vertebral augmentation is usually performed for prompt pain relief.",Non-OADS,/arxiv_data1/oa_pdf/d8/8a/cia-10-635.PMC4381902.pdf
"Keywords:  vertebroplasty, kyphoplasty, comorbidity, bisphosphonate, old age Introduction Osteoporotic vertebral compression fracture (VCF) with refractory pain is a crippling  disorder frequently resulting in severe and prolonged back pain, lengthy hospitaliza - tion, physical decline, and increased risk of death.1,2 Bed rest, opioid analgesia, and  external bracing have had limited success.3 Percutaneous vertebral augmentation  was introduced as an alternative for acute VCFs refractory to conventional medical  therapy.4–6 Although there is still debate over the effects of vertebral augmentation,7,8  it has gained acceptance as a minimally invasive method for pain relief.3–6 There  has been a significant increase in the number of vertebral augmentation procedures  performed in Taiwan in the past decade.9Correspondence: Po-Chou liliang Department of neurosurgery, e-Da  hospital, I-shou University, 1 Yi-Da road,  Yan-Chau shiang, Kaohsiung City 824,  Taiwan Tel +866 7 615 0011 Fax +866 7 615 0982 email ed100172@edah.org.t w Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Liang et al Running head recto: Vertebral augmentation for new vertebral compression fractures DOI: http://dx.doi.org/10.2147/CIA.S80668",Non-OADS,/arxiv_data1/oa_pdf/d8/8a/cia-10-635.PMC4381902.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d8/8a/cia-10-635.PMC4381902.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d8/8a/cia-10-635.PMC4381902.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/10/cia-10-625.PMC4381903.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 625–633Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  625OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7967 9Cognitive fluctuations in connection to  dysgraphia:  a comparison of Alzheimer’s disease with dementia  lewy bodies emanuela Onofri Marco Mercuri giuseppe Donato serafino ricci Department of Anatomy, histology,   legal Medicine and Orthopaedics,   sapienza University of rome,   rome,  ItalyBackground:  The purpose of the present study was to examine the relationship between  cognitive impairment and the performance of handwritten scripts presented as “letter-writing”  to a close relative by patients with dementia Lewy bodies (DLB), as fluctuations of the symp - toms phase, and in a matched group of patients with Alzheimer’s disease (AD).",Non-OADS,/arxiv_data1/oa_pdf/cd/10/cia-10-625.PMC4381903.pdf
"Worldwide there are currently 25 to 35 million individuals with these illnesses,  with five to seven million new cases diagnosed each year, or one new case every 7  seconds.4,5 According to the World Health Organization it has been estimated that by the  year 2050 the number of people presenting with dementia will be 115.4 million.6 Correspondence: emanuela Onofri Department of Anatomy, histology,  legal Medicine and Orthopaedics,  sapienza University of rome, Viale regina  elena 335, rome 00161, Italy Tel +39 33 9500 7557 email emanuela.onofri@uniroma1.i tJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Onofri et al Running head recto: Dysgraphia comparison of Alzheimer’s and dementia Lewy bodies patients DOI: http://dx.doi.org/10.2147/CIA.S79679",Non-OADS,/arxiv_data1/oa_pdf/cd/10/cia-10-625.PMC4381903.pdf
Available from: http://www.who.int/mental_health/publications/ dementia_report_2012/en /.,Non-OADS,/arxiv_data1/oa_pdf/cd/10/cia-10-625.PMC4381903.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/cd/10/cia-10-625.PMC4381903.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/cd/10/cia-10-625.PMC4381903.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/2f/copd-10-677.PMC4381904.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 677–687International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  677RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S7652 0Clinical potential of aclidinium bromide in chronic   obstructive pulmonary disease Paul w Jones Institute for Infection and Immunity,   Faculty of Respiratory Medicine,   St George’s, University of London,   London, UKAbstract:  Three long-acting muscarinic antagonists (LAMAs) are now available in Europe,  providing clinicians and patients with a choice of interventions, which is important in COPD,  which is clinically a heterogeneous disease.",Non-OADS,/arxiv_data1/oa_pdf/09/2f/copd-10-677.PMC4381904.pdf
"It has been extensively studied in patients with COPD – a recent  Cochrane review identified 22 studies of good methodological quality that had enrolled Correspondence: Paul w Jones Institute for Infection and Immunity,  Faculty of Respiratory Medicine,   St George’s, University of London,  Cranmer Terrace, London Sw17 0Re, UK Tel +44 20 8725 5372 Fax +44 20 8725 5955 email pjones@sgul.ac.u kJournal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Jones Running head recto: Aclidinium bromide in COPD DOI: http://dx.doi.org/10.2147/COPD.S76520",Non-OADS,/arxiv_data1/oa_pdf/09/2f/copd-10-677.PMC4381904.pdf
"Available from: http://www.goldcopd.com/guidelines-global-strategy- for-diagnosis-management.htm l. Accessed November 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/09/2f/copd-10-677.PMC4381904.pdf
"Available  from: http://www.goldcopd.org/uploads/users/files/GOLD_Report2014_ Feb07.pd f. Accessed December 12, 2014.",OADS,/arxiv_data1/oa_pdf/09/2f/copd-10-677.PMC4381904.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/09/2f/copd-10-677.PMC4381904.pdf
"Available from: http://www.access - data.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction =Search.Drug - Detail s. Accessed December 1, 2014.",OADS,/arxiv_data1/oa_pdf/09/2f/copd-10-677.PMC4381904.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/09/2f/copd-10-677.PMC4381904.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/2f/copd-10-677.PMC4381904.pdf
"July 20, 2012. http://www.accessdata.fda.gov/ drugsatfda_docs/nda/2012/202450Orig1s000SumR.pd f. Accessed  February 25, 2015 53.",Non-OADS,/arxiv_data1/oa_pdf/09/2f/copd-10-677.PMC4381904.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/02/imcrj-8-077.PMC4381905.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 77–79International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  77Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S6377 8a case of isolated adrenocorticotropic   hormone deficiency: a rare but possible   cause of hypercalcemia Yumi Harano1 atsuko Kitano2 Yurika Akiyama1 Lisa Kotajima1 Kazufumi Honda1 Hiroko arioka1 1Department of General Internal  Medicine,  2Department of Medical  Oncology, St Luke’s International  Medical Center, T okyo, Japan Correspondence: Yumi Harano   Department of General Internal  Medicine, St. Luke’s International Medical  Center, 9-1 Akashi-cho, Chuo-ku, Tokyo   104-8560, Japan   tel +81 3 5550 7166  Fax +81 3 5550 2436  email yuhar@luke.",Non-OADS,/arxiv_data1/oa_pdf/dd/02/imcrj-8-077.PMC4381905.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/dd/02/imcrj-8-077.PMC4381905.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/02/imcrj-8-077.PMC4381905.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/ce/prom-6-091.PMC4381906.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2015:6 91–101Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  91ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PROM.S7934 8The feasibility of using electronic clinical outcome  assessments in people with schizophrenia   and their informal caregivers chloe T olley1 Diana Rofail2 adam gater1 Justine K lalonde3 1adelphi Values ltd, Bollington, UK;   2Roche Products ltd, Welwyn garden  city, UK;  3Roche s.a.s, Paris, France correspondence: chloe Tolley   adelphi Values ltd, adelphi Mill,  grimshaw lane, Bollington,   cheshire, sK10  5JB, UK   Tel +44 1625 578 897  Fax +44 1625 577 328  email chloe.tolley@adelphivalues.co mAbstract:  Many clinical outcome assessments (COAs) were originally developed for completion  via pen and paper.",Non-OADS,/arxiv_data1/oa_pdf/80/ce/prom-6-091.PMC4381906.pdf
Email: PRO-information@mapi-trust.or g. Website:  http://www.proqolid.or g. Disclosure This project was funded by F .,Non-OADS,/arxiv_data1/oa_pdf/80/ce/prom-6-091.PMC4381906.pdf
"Available from: http://www.census.gov/content/dam/Census/ library/publications/2014/acs/acs-28.pd f. Accessed February 10, 2015.",OADS,/arxiv_data1/oa_pdf/80/ce/prom-6-091.PMC4381906.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/80/ce/prom-6-091.PMC4381906.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/80/ce/prom-6-091.PMC4381906.pdf
2011. http://publications.nice.org.uk/ generalised-anxiety-disorder-and-panic-disorder-with-or-without-agorap hobia-in-adults-cg113 .A c c e s s e d 29 July 2013.,Non-OADS,/arxiv_data1/oa_pdf/95/20/40120_2014_Article_16.PMC4381915.pdf
"http://clinicaltrials.gov/show/ NCT01707992 (last accessed April 9, 2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/0a/40120_2014_Article_17.PMC4381916.pdf
http://www.stm.ﬁ/ en/social_and_health_services/pharmacotherapy .,Non-OADS,/arxiv_data1/oa_pdf/3b/f6/40120_2013_Article_14.PMC4381918.pdf
Available at: http://clinicaltrials.gov/show/NCT01 324232 .,Non-OADS,/arxiv_data1/oa_pdf/68/54/40120_2014_Article_18.PMC4381919.pdf
"First published online January 23, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(3): 191-197, http://dx.doi.org/10.1590/1414-431X20143744 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 48(3) 2015",Non-OADS,/arxiv_data1/oa_pdf/ee/da/1414-431X-bjmbr-48-03-00191.PMC4381938.pdf
"First published online January 13, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(3): 198-206, http://dx.doi.org/10.1590/1414-431X20144270 ISSN 1414-431X Review Braz J Med Biol Res 48(3) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/f6/7b/1414-431X-bjmbr-48-03-00198.PMC4381939.pdf
http://www.who.int/healthinfo/global_burden_ disease/GBD_report_2004update_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f6/7b/1414-431X-bjmbr-48-03-00198.PMC4381939.pdf
"First published online January 20, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(3): 207-213, http://dx.doi.org/10.1590/1414-431X20144051 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 48(3) 2015",Non-OADS,/arxiv_data1/oa_pdf/da/4d/1414-431X-bjmbr-48-03-00207.PMC4381940.pdf
"First published online December 19, 2014.Brazilian Journal of Medical and Biological Research (2015) 48(3): 214-225, http://dx.doi.org/10.1590/1414-431X20144171 ISSN 1414-431X Braz J Med Biol Res 48(3) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/02/d1/1414-431X-bjmbr-48-03-00214.PMC4381941.pdf
"First published online January 13, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(3): 226-233, http://dx.doi.org/10.1590/1414-431X20144212 ISSN 1414-431X Braz J Med Biol Res 48(3) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/97/dd/1414-431X-bjmbr-48-03-00226.PMC4381942.pdf
"First published online February 3, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(3): 234-239, http://dx.doi.org/10.1590/1414-431X20144184 ISSN 1414-431X Braz J Med Biol Res 48(3) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/bf/90/1414-431X-bjmbr-48-03-00234.PMC4381943.pdf
"First published online February 13, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(3): 240-244, http://dx.doi.org/10.1590/1414-431X20144210 ISSN 1414-431X Short Communication Braz J Med Biol Res 48(3) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/49/b8/1414-431X-bjmbr-48-03-00240.PMC4381944.pdf
"First published online December 12, 2014.Brazilian Journal of Medical and Biological Research (2015) 48(3): 245-253, http://dx.doi.org/10.1590/1414-431X20144074 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 48(3) 2015",Non-OADS,/arxiv_data1/oa_pdf/a7/89/1414-431X-bjmbr-48-03-00245.PMC4381945.pdf
"First published online December 12, 2014.Brazilian Journal of Medical and Biological Research (2015) 48(3): 254-260, http://dx.doi.org/10.1590/1414-431X20144102 ISSN 1414-431X Braz J Med Biol Res 48(3) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/91/ee/1414-431X-bjmbr-48-03-00254.PMC4381946.pdf
"First published online January 23, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(3): 261-266, http://dx.doi.org/10.1590/1414-431X20144043 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 48(3) 2015",Non-OADS,/arxiv_data1/oa_pdf/86/88/1414-431X-bjmbr-48-03-00261.PMC4381947.pdf
"First published online February 3, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(3): 267-272, http://dx.doi.org/10.1590/1414-431X20144137 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 48(3) 2015",Non-OADS,/arxiv_data1/oa_pdf/9e/b0/1414-431X-bjmbr-48-03-00267.PMC4381948.pdf
"First published online January 20, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(3): 273-279, http://dx.doi.org/10.1590/1414-431X20143432 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 48(3) 2015",Non-OADS,/arxiv_data1/oa_pdf/9c/a8/1414-431X-bjmbr-48-03-00273.PMC4381949.pdf
"First published online January 21, 2015.Brazilian Journal of Medical and Biological Research (2015) 48(3): 280-285, http://dx.doi.org/10.1590/1414-431X20144362 ISSN 1414-431X Braz J Med Biol Res 48(3) 2015 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/40/9d/1414-431X-bjmbr-48-03-00280.PMC4381950.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/27/nihms668372.PMC4382079.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/a4/main.PMC4382514.pdf
"However, one notable disadvantage to the use of these bacterial exotoxins is the require- ment that the toxin be internalized by the targeted cell to exert its http://dx.doi.org/10.1016/j.fob.2015.03.005 2211-5463/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/09/a4/main.PMC4382514.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: EGF, epidermal growth factor; IL-2, interleukin 2; MBP, maltose binding protein ⇑Corresponding author at: Department of Biological Sciences, Eck Institute for Global Health, Galvin Life Science Building, Notre Dame, IN 46556, USA.",Non-OADS,/arxiv_data1/oa_pdf/09/a4/main.PMC4382514.pdf
< http://www.bioinformatics.,Non-OADS,/arxiv_data1/oa_pdf/09/a4/main.PMC4382514.pdf
< http://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/Devic eApprovalsandClearances/Recently- ApprovedDevices/ucm234142.htm >.,Non-OADS,/arxiv_data1/oa_pdf/09/a4/main.PMC4382514.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/cf/main.PMC4382515.pdf
"Thus, by consuming H+and exporting positive charges, the decarboxylase and the antiporter make up an efﬁcient molecular system which protects the bacteria http://dx.doi.org/10.1016/j.fob.2015.03.006 2211-5463/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ea/cf/main.PMC4382515.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: Abs, absorbance; GABA, c-aminobutyrate; GadB, glutamate decarboxylase (B isoform); BmGadB, Brucella microti GadB; EcGadB, Escherichia coli GadB; GDAR, glutamate-dependent acid resistance; PLP, pyridoxal 50-phosphate ⇑Corresponding author at: Department of Medico-Surgical Sciences and Biotech- nologies, Sapienza University of Rome, Corso della Repubblica 79, 04100 Latina,Italy.",Non-OADS,/arxiv_data1/oa_pdf/ea/cf/main.PMC4382515.pdf
Bioinformatic analysis Sequence alignments were performed using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/ ).,OADS,/arxiv_data1/oa_pdf/ea/cf/main.PMC4382515.pdf
Secondary structure predictions and protein parameters were obtained using resources accessible from Expasy ( http://expasy.org/proteomics ).,OADS,/arxiv_data1/oa_pdf/ea/cf/main.PMC4382515.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/bd/main.PMC4382516.pdf
"In this study, http://dx.doi.org/10.1016/j.fob.2015.03.007 2211-5463/ /C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/9a/bd/main.PMC4382516.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AUC, area under ROC curve; BIRC5, baculoviral IAP repeat- containing protein 5 isoform 2; HPV, human papillomavirus; IgG, immunoglobulinG; MYC, myc proto-oncogene protein; ROC, receiver operating characteristic curve; SBI, speciﬁc binding index; SCC, squamous cell carcinoma; TAAs, tumor-associated antigens ⇑Corresponding authors at: Department of Internal Medicine, Second Hospital of Jilin University, 218 Ziqiang Street, Changchun 130041, China.",Non-OADS,/arxiv_data1/oa_pdf/9a/bd/main.PMC4382516.pdf
Available online at URL: http://www.ema.europa.eu/docs/ en_GB/document_library/Scientiﬁc_guideline/2010/01/WC5000 70039.pdf .,Non-OADS,/arxiv_data1/oa_pdf/99/a9/40265_2015_Article_377.PMC4382528.pdf
Available from: http://www.who.int/ageing/a bout/facts/en/ [2] Swedish Ministry of Health and Social Affairs.,Non-OADS,/arxiv_data1/oa_pdf/18/1b/TONURSJ-8-79.PMC4382558.pdf
Available from: http://www.regeringen.se/sb/d/108/a/138285 (in Swedish).,Non-OADS,/arxiv_data1/oa_pdf/18/1b/TONURSJ-8-79.PMC4382558.pdf
Available from: http://www.riksdagen.se/sv/Dokument-Lagar/Laga r/Svenskforfattningssamling/Socialtjanstlag-2001453_sfs-2001- (in Swedish).,Non-OADS,/arxiv_data1/oa_pdf/18/1b/TONURSJ-8-79.PMC4382558.pdf
"Available from: http://www.orebro.se/download/18.47c6f44f12dd9e9713780 002115/1392724621772/S%C3%A4rskilda+boenden+f%C3%B6r+%C3%A4ldre,+deras+anh%C3%B6riga+och+hemv%C3%A5rden+ hela+unders%C3%B6kningen+-+brukarunders%C3%B6kning+2010.",OADS,/arxiv_data1/oa_pdf/18/1b/TONURSJ-8-79.PMC4382558.pdf
"Available from: http://ora.research.ucla.edu/OHRPP/Documents/Policy/9/Co gnitive_Impairments.pdf [46] Slater P, McCormack B, Bunting B.",OADS,/arxiv_data1/oa_pdf/18/1b/TONURSJ-8-79.PMC4382558.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/1b/TONURSJ-8-79.PMC4382558.pdf
"All complete mitochondrial genomes (45 species) that were available were collected in our previous study [22] from the National Center for Biotechnology Information (NCBI, http://www.ncbi.nlm.nih.gov/sites).",OADS,/arxiv_data1/oa_pdf/ec/9c/CCGTM-9-1.PMC4382559.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/CCGTM-9-1.PMC4382559.pdf
Roma; 2013. http://www.salute.gov.it/imgs/C_17_pubblicazioni_1901_allegato.pdf [15] Italian Medicines Agency: Linee guida per la classificazione e conduzione degli studi osservazionali sui farmaci.,Non-OADS,/arxiv_data1/oa_pdf/d3/b9/TONURSJ-9-10.PMC4382560.pdf
"76, 31/03/2008.http://www.agenziafarmaco.gov.it/ allegati/det_20marzo2008.pdf [16] Italian Law decree n. 196, 30 June 2003 (article 24).",Non-OADS,/arxiv_data1/oa_pdf/d3/b9/TONURSJ-9-10.PMC4382560.pdf
"http://www.ca mera.it/parlam/leggi/deleghe/03196dl.htm [17] Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low- and middle-income countries: A systematic review.",Non-OADS,/arxiv_data1/oa_pdf/d3/b9/TONURSJ-9-10.PMC4382560.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/b9/TONURSJ-9-10.PMC4382560.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/ - licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproductio n in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/94/TOBEJ-8-142.PMC4382561.pdf
"Green and orange-red fluorescent images were captured using an integrated Pixera Penguin 600CL  camera (Pixera, San Jose, CA) and processed using ImageJ  software (NIH, http://imagej.nih.gov/ij) to create merged picture overlays.",OADS,/arxiv_data1/oa_pdf/50/71/CCGTM-9-6.PMC4382562.pdf
"Available from URL:  http://www.biotechniques.com/Posters/Cell_a nd_Tissue_Analysis/ Development-and-Characterization-of-Human-iPSC-derived- Neurons-for-Drug----Discovery-Applications/biotechniques- 329002.html   Received: August 08, 2014 Revised: January 21, 2015 Accepted: January 26, 2015  © Hancock  et al.",Non-OADS,/arxiv_data1/oa_pdf/50/71/CCGTM-9-6.PMC4382562.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/71/CCGTM-9-6.PMC4382562.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License  (http://creativecommons.org/ -licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribut ion and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/b3/TOBEJ-8-131.PMC4382563.pdf
"Received  14  July  2014 Accepted 27  August  2014 Available  online  31  January  2015 http://dx.doi.org/10.1016/j.bjhh.2014.08.003 1516-8484/© 2015 Associac ¸ã o  Brasileira  de  Hematologia, Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/91/19/main.PMC4382567.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.01.005 1516-8484/© 2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/fd/49/main.PMC4382568.pdf
Available  from: http://globin.bx.psu.edu/hbvar/menu.html  [cited  30.04.14].,Non-OADS,/arxiv_data1/oa_pdf/fd/49/main.PMC4382568.pdf
Available from:  http://www.pnud.org.br  [cited  26.04.14].,Non-OADS,/arxiv_data1/oa_pdf/fd/49/main.PMC4382568.pdf
"As  a  result  of this rearrangement, the  myc  proto-oncogene  in  chromosome 8  is  translocated  to  the  immunoglobulin  heavy  chain  locus  in chromosome 14.6 http://dx.doi.org/10.1016/j.bjhh.2014.11.002 1516-8484/©  2014  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/65/c2/main.PMC4382569.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.02.003 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/12/84/main.PMC4382570.pdf
"She  was refractory to  treatment  using  corticosteroids,  azathioprine, http://dx.doi.org/10.1016/j.bjhh.2015.01.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/92/7d/main.PMC4382571.pdf
"Immunophenotyping of  peripheral  blood  (Figure  2)  showed  23.2%  of  B  lymphocytes http://dx.doi.org/10.1016/j.bjhh.2015.01.003 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",OADS,/arxiv_data1/oa_pdf/f9/7b/main.PMC4382572.pdf
"This  approach  is  recommended  to  exclude http://dx.doi.org/10.1016/j.bjhh.2015.01.007 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/9c/d1/main.PMC4382573.pdf
"They http://dx.doi.org/10.1016/j.bjhh.2014.11.003 1516-8484/©  2014  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",OADS,/arxiv_data1/oa_pdf/c6/d0/main.PMC4382574.pdf
"Received 14 May 2014 Accepted  21  October  2014 Available  online  2  February  2015 http://dx.doi.org/10.1016/j.bjhh.2015.01.004 1516-8484/© 2015 Associac ¸ã o Brasileira  de  Hematologia, Hemoterapia e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4382575.pdf
"Flores-Nascimento).endothelial  cells.1,2The  ﬁrst  studies,  performed  by  two  groups, reported that  human  CD34+cells,  isolated  from  circulating peripheral blood,  umbilical  cord  blood  and  bone  marrow,  could differentiate into endothelial  cells  in  vitro  and  in  vivo  in  mouse models,  thereby contributing  to  neoendothelialization  and neovascularization  in  the  adult  organism.3,4 Nowadays  these  circulating  endothelial  cells  (CEC)  are  well described  as  originating  from  the  vascular  wall  or  recruited from the  bone  marrow  (progenitor  endothelial  cells).3 http://dx.doi.org/10.1016/j.bjhh.2014.11.014 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/74/7c/main.PMC4382576.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.02.004 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/b9/42/main.PMC4382577.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.01.006 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/12/c7/main.PMC4382578.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.01.001 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/24/76/main.PMC4382579.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.11.010 1516-8484/©  2014  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/0f/f2/main.PMC4382580.pdf
"Immature  reticulocyte  fraction  (IRF)  assesses  retic- ulocyte maturation  by  the  intensity  of  the  staining  of  reticu- locytes,  which  reﬂects  mRNA  content.8IRF  seems  to  be  useful for the  evaluation  of  engraftment  in  bone  marrow  or  stem  cell transplantation.9 http://dx.doi.org/10.1016/j.bjhh.2015.02.005 1516-8484/©  2015  Associac ¸ão  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4382584.pdf
"2014, http://dx.doi.org/10.1016/j.cll.2014.10.004 .",OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4382584.pdf
Available  from: http://www.kidney.org/professionals/kdoqi/guidelines anemia/cpr12.htm33.,Non-OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4382584.pdf
Available from: http://www.sipmel.it/download/100124-documento.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4382584.pdf
"Torres).can  affect  the  production  rate  of  globin  chains  and  cause thalassemia,  or  they  can  modify  molecule  structure  and  gen- erate hemoglobin  variants.1,2 Hemoglobin variants  usually  are  the  consequence  of  sin- gle  amino  acid  substitutions  caused  by  point  mutations http://dx.doi.org/10.1016/j.bjhh.2015.02.007 1516-8484/©  2015  Associac ¸ão  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/a0/f6/main.PMC4382585.pdf
"2  0  1  5;3  7(2) :120–126  121 in  genes  encoding  globin  chains,  resulting  in  a  tetramer with  different  physicochemical  characteristics.3According  to the Globin  Gene  Server  database  (http://globin.cse.psu.edu/ ), 1198 hemoglobin  variants  were  described  until  Septem- ber  2014.",Non-OADS,/arxiv_data1/oa_pdf/a0/f6/main.PMC4382585.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2015, 10: 27488 - http://dx.doi.org/10.3402/ljm.v10.27488 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/96/af/LJM-10-27488.PMC4382593.pdf
"2013; 8: 20233, doi: http://dx.doi.org/10.3402/ljm.v8i0.202332.",Non-OADS,/arxiv_data1/oa_pdf/96/af/LJM-10-27488.PMC4382593.pdf
Available from: http://www.bis.gov.uk/ﬁles/ﬁle52215.pdf [cited 9 February 2015].,Non-OADS,/arxiv_data1/oa_pdf/96/af/LJM-10-27488.PMC4382593.pdf
Available from: http://www.hqip.org.uk/assets/ Images/Uploads/HQIP-What-is-Clinical-Audit-Nov-09.pdf [cited 9 February 2015].,Non-OADS,/arxiv_data1/oa_pdf/96/af/LJM-10-27488.PMC4382593.pdf
Available from: http://www.lpft.nhs.uk/assets/ﬁles/ Accessing our information/Policies and Procedures/Operational/ OPR50.pdf [cited 10 February 2015].,Non-OADS,/arxiv_data1/oa_pdf/96/af/LJM-10-27488.PMC4382593.pdf
"Available from: http:// www.fairwork.gov.au/about-us/policies-and-guides/best-practice- guides/managing-underperformance [cited 10 February 2015].Nuri Attagour 2 (page number not for citation purpose)Citation: Libyan J Med 2015, 10: 27488 - http://dx.doi.org/10.3402/ljm.v10.27488",Non-OADS,/arxiv_data1/oa_pdf/96/af/LJM-10-27488.PMC4382593.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2015, 7: 27847 - http://dx.doi.org/10.3402/jom.v7.27847 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/34/2e/JOM-7-27847.PMC4382595.pdf
"Microbe 2014; 9: 487 /C192.Ingar Olsen 2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 27847 - http://dx.doi.org/10.3402/jom.v7.27847",Non-OADS,/arxiv_data1/oa_pdf/34/2e/JOM-7-27847.PMC4382595.pdf
Available from: http://www.cancer.gov [Last accessed  on 2013 Mar 20].10.,Non-OADS,/arxiv_data1/oa_pdf/78/7b/NMJ-56-109.PMC4382599.pdf
Available from:  http://www.who.int/hdp [Last accessed on 2012 Jul 26].,OADS,/arxiv_data1/oa_pdf/d7/88/NMJ-56-113.PMC4382600.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/1c/95/NMJ-56-122.PMC4382602.pdf
Available from:  http://health.bih.nic.in/Docs/Guidelines-NPCDCS.pdf [Last  accessed on 2013 Mar 10].,Non-OADS,/arxiv_data1/oa_pdf/1c/95/NMJ-56-122.PMC4382602.pdf
Available from: http://globocan.iarc.fr  [Last accessed on 2014 Jun 27].,Non-OADS,/arxiv_data1/oa_pdf/79/51/NMJ-56-126.PMC4382603.pdf
"Updated December 7,  2010 Available from: http://emedicine.medscape.com/ article/278744-overview [Last accessed on 2011 Jan 16].",Non-OADS,/arxiv_data1/oa_pdf/79/51/NMJ-56-126.PMC4382603.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/79/51/NMJ-56-126.PMC4382603.pdf
Available from: http://www.cdc.gov/vhf/Ebola/resources/ pdfs/Ebola-factsheet.pdf [Last assessed on 2014 Sept 6].,OADS,/arxiv_data1/oa_pdf/84/84/NMJ-56-138.PMC4382605.pdf
Available from: http://crofsblogs.typepad.com/h5n1/2014/  08/who-Ebola-update-cases-.html [Last assessed on 2014  Sept 6].,Non-OADS,/arxiv_data1/oa_pdf/84/84/NMJ-56-138.PMC4382605.pdf
Available from: http://beid.ddc.moph.go.th/th/ images/news/cheraton2122_10_52/ poster/Rassamee_ poster01.pdf [Last accessed on 2014 Aug 27].,Non-OADS,/arxiv_data1/oa_pdf/84/84/NMJ-56-138.PMC4382605.pdf
Available from: https://www.osha.gov/SLTC/Ebola/control_ prevention.html [Last accessed on 2014 Sept 1].,Non-OADS,/arxiv_data1/oa_pdf/84/84/NMJ-56-138.PMC4382605.pdf
Available from: https://www.ndhan.gov/data/mrFacts/Ebola.,OADS,/arxiv_data1/oa_pdf/84/84/NMJ-56-138.PMC4382605.pdf
Available from: http://www.pedorthopath.com/about.html  [Last accessed on 2013 Mar 15].,Non-OADS,/arxiv_data1/oa_pdf/37/01/NMJ-56-153.PMC4382608.pdf
Available from: http://en.m.wikipedia.org/wiki/fibroma.,Non-OADS,/arxiv_data1/oa_pdf/37/01/NMJ-56-153.PMC4382608.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"The peakvalue of the pulse should remain consistent across theparticle path through the focused laser beam and shouldonly reflect the scattering properties of the particle, withsmall or no regard to the length of the path (or exposure time) (18).Dedicated flow cytometry of extracellular vesicles Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"When using the reference bead mix ,it is possible to gate on the beadsDedicated flow cytometry of extracellular vesicles Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"P, pellet; S, supernatant.Dedicated flow cytometry of extracellular vesicles Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"F; S14 ﬁltered through 0.22 mm ﬁlter; NF, S14 non-ﬁltered.Dedicated flow cytometry of extracellular vesicles Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"/C1NF, 0.22 mm non-ﬁltered.Dedicated flow cytometry of extracellular vesicles Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"Using this approach, we were able to show by the PE-labeled primaryDedicated flow cytometry of extracellular vesicles Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530 13 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"2013;2:19671, doi: http://dx.doi.org/10.3402/jev.v2i0.19671 11.",Non-OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"2013;2:20360, doi: http://dx.doi.org/10.3402/jev.v2i0.20360 12.",Non-OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"2014;3:26913, doi: http://dx.doi.org/10.3402/jev.v3.26913 27.",Non-OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
"2012;83:1484 /C194.Dedicated flow cytometry of extracellular vesicles Citation: Journal of Extracellular Vesicles 2015, 4: 25530 - http://dx.doi.org/10.3402/jev.v4.25530 15 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/2d/bb/JEV-4-25530.PMC4382613.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/88/9d/NJS-21-21.PMC4382637.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/c0/e4/NJS-21-43.PMC4382642.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/8e/06/NJS-21-56.PMC4382645.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/8e/06/NJS-21-56.PMC4382645.pdf
http://www.vh.org/providers/textbooks/ Anatomic variants/AnatomyHP.html.,Non-OADS,/arxiv_data1/oa_pdf/1b/cc/NJS-21-60.PMC4382647.pdf
Available from: http://www.vh.org.,Non-OADS,/arxiv_data1/oa_pdf/1b/cc/NJS-21-60.PMC4382647.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Chok αand choline metabolism in TCL J Xiong et al 10 Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/92/6e/bcj201510a.PMC4382653.pdf
"8 The purpose of the BONAFIDE study described herein was to further assess the skeletal response to cinacalcetclinical trial http://www.kidney-international.org &2014 International Society of Nephrology Correspondence: Patrick C. D’Haese, Laboratory of Pathophysiology, University of Antwerp Campus Drie Eiken, Universiteitsplein 1 Building T(Room 0.56), B-2610 Wilrijk, Belgium.",Non-OADS,/arxiv_data1/oa_pdf/14/9c/ki2014349a.PMC4382689.pdf
Lesions were categorized using referencevalues for bone formation (BFR/T.Ar) as determined from healthychildren and adolescents or using published values for BFR/T.Ar from normal adults.Supplementary material is linked to the online version of the paper athttp://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/14/9c/ki2014349a.PMC4382689.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 856 Kidney International (2015) 87,8 4 6 – 8 5 6clinical trial GJ Behets et al.",Non-OADS,/arxiv_data1/oa_pdf/14/9c/ki2014349a.PMC4382689.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interest.,Non-OADS,/arxiv_data1/oa_pdf/a0/0b/ncomms7403.PMC4382705.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Fu, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/a0/0b/ncomms7403.PMC4382705.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7403 ARTICLE NATURE COMMUNICATIONS | 6:6403 | DOI: 10.1038/ncomms7403 | www.nature.com/naturecommunications 7 &2015 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/a0/0b/ncomms7403.PMC4382705.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/14/153912 Access this article online Quick Response Code: Website:    www.jpathinformatics.org,Non-OADS,/arxiv_data1/oa_pdf/79/ad/JPI-6-14.PMC4382755.pdf
"J Pathol Inform 2015, 1:14  http://www.jpathinformatics.org/content/6/1/14This involves a team approach and centers on the  pathologist/cytotechnologist providing this at the site  of the procedure.",Non-OADS,/arxiv_data1/oa_pdf/79/ad/JPI-6-14.PMC4382755.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/13/153906 Access this article online Quick Response Code: Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.153906,Non-OADS,/arxiv_data1/oa_pdf/60/76/JPI-6-13.PMC4382756.pdf
"J Pathol Inform 2015, 1:13  http://www.jpathinformatics.org/content/6/1/13of care” and are by no means all‑encompassing, they  nonetheless provide new and prospective users with  a helpful list of issues, duties, and responsibilities to  consider when implementing and using the technology  of interest in their own practice.",Non-OADS,/arxiv_data1/oa_pdf/60/76/JPI-6-13.PMC4382756.pdf
"J Pathol Inform 2015, 1:13  http://www.jpathinformatics.org/content/6/1/13as the committee members felt that WSI was the most  promising modality for certain telepathology applications.",Non-OADS,/arxiv_data1/oa_pdf/60/76/JPI-6-13.PMC4382756.pdf
Available  from: http://www.rcpath.org.,Non-OADS,/arxiv_data1/oa_pdf/60/76/JPI-6-13.PMC4382756.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2015/5/1/16/153974CASE REPORT Received : 25‑01‑2015 Accepted : 09‑03‑2015 Published : 25‑03‑2015 Dr. Berna Dirim Mete,Non-OADS,/arxiv_data1/oa_pdf/c9/8b/JCIS-5-16.PMC4382757.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/17/153917 Access this article online Website:    www.jpathinformatics.org DOI: 10.4103/2153-3539.153917 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/29/21/JPI-6-17.PMC4382758.pdf
"J Pathol Inform 2015, 1:17  http://www.jpathinformatics.org/content/6/1/17for the delay in processing network data were often hard  to determine and, therefore, resolve.",OADS,/arxiv_data1/oa_pdf/29/21/JPI-6-17.PMC4382758.pdf
"J Pathol Inform 2015, 1:17  http://www.jpathinformatics.org/content/6/1/17movement of digital data.",OADS,/arxiv_data1/oa_pdf/29/21/JPI-6-17.PMC4382758.pdf
"J Pathol Inform 2015, 1:17  http://www.jpathinformatics.org/content/6/1/17at Internet gateways China are able to analyze and  manipulate Internet traffic.",OADS,/arxiv_data1/oa_pdf/29/21/JPI-6-17.PMC4382758.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/16/153916 Access this article online Website:    www.jpathinformatics.org DOI: 10.4103/2153-3539.153916 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/35/d6/JPI-6-16.PMC4382759.pdf
"J Pathol Inform 2015, 1:16  http://www.jpathinformatics.org/content/6/1/16INTRODUCTION Computerized physician order entry (CPOE) systems  have become commonplace in the hospital setting.",Non-OADS,/arxiv_data1/oa_pdf/35/d6/JPI-6-16.PMC4382759.pdf
"J Pathol Inform 2015, 1:16  http://www.jpathinformatics.org/content/6/1/16additional intervention by the clinician.",Non-OADS,/arxiv_data1/oa_pdf/35/d6/JPI-6-16.PMC4382759.pdf
"J Pathol Inform 2015, 1:16  http://www.jpathinformatics.org/content/6/1/16default in the order set.",Non-OADS,/arxiv_data1/oa_pdf/35/d6/JPI-6-16.PMC4382759.pdf
"J Pathol Inform 2015, 1:16  http://www.jpathinformatics.org/content/6/1/164.",Non-OADS,/arxiv_data1/oa_pdf/35/d6/JPI-6-16.PMC4382759.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2015/5/1/15/153971CASE REPORT Received : 17‑01‑2015 Accepted : 26‑02‑2015 Published : 25‑03‑2015 Access this article online Quick Response Code: Website: www.clinicalimagingscience.org DOI: 10.4103/2156-7514.153971,Non-OADS,/arxiv_data1/oa_pdf/1e/42/JCIS-5-15.PMC4382760.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/15/153914,Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"J Pathol Inform 2015, 1:15  http://www.jpathinformatics.org/content/6/1/15INTRODUCTION The advent of computer‑aided diagnosis dates  back to 1980s with the emergence of digital  mammography.",Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"J Pathol Inform 2015, 1:15  http://www.jpathinformatics.org/content/6/1/15enlarged blood vessels in the tissue which is known as  microvascular proliferation (MVP).",Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"J Pathol Inform 2015, 1:15  http://www.jpathinformatics.org/content/6/1/15analytical methods that can automatically find and  identify necrosis and MVP regions from an analysis of the  tissue images.",Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"J Pathol Inform 2015, 1:15  http://www.jpathinformatics.org/content/6/1/15technique and obtain Figure 4b which is the segmented  image in binary format.",OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"J Pathol Inform 2015, 1:15  http://www.jpathinformatics.org/content/6/1/15the best results.",Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"J Pathol Inform 2015, 1:15  http://www.jpathinformatics.org/content/6/1/15the clinician input and using a set of 10 training ROIs  from each class representing Necrosis, MVP , and LGG.",Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"J Pathol Inform 2015, 1:15  http://www.jpathinformatics.org/content/6/1/15T able 1: Recognition rate (%) of our proposed  method for necrosis detection Tissue type Necrosis Not necrosis Necrosis 95.2 4.8 Not necrosis 17.1 82.9 T able 2: Recognition rate (%) of our proposed  method for MVP detection Tissue type MVP Not MVP MVP 75.0 25.0 Not MVP 26.4 73.6 MVP: Micro‑vascular proliferation T able 3: Recognition rate (%) for HGG versus  LGG classification Tissue type HGG LGG Method HGG 66.6 33.4 SVM + WND‑CHARM 88.2 11.8 Proposed method LGG 29.9 70.1 SVM + WND‑CHARM 17.2 82.8 Proposed method HGG: High‑grade gliomas, LGG: Low‑grade gliomas, SVM: Support vector machinein Table 3 that is showing significant accuracies in HGG  versus LGG classification problem.",Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"Regarding feature selection from the WND‑CHARM  set, we picked the most relevant features to  histopathology offered by[33] including histogram  information, morphological features and statistics,  wavelet coefficients, image statistics, etc., The source  code for WND‑CHARM is made available online by the  National Institutes of Health at: http://ome.grc.nia.nih.",OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"J Pathol Inform 2015, 1:15  http://www.jpathinformatics.org/content/6/1/15 Figure 8: Receiver Operating Characteristics (ROC) curves for different methods.",OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"J Pathol Inform 2015, 1:15  http://www.jpathinformatics.org/content/6/1/15to the best overall accuracy and (2) the accuracy varies  gracefully over the range of parameter values indicating  that the proposed method is robust  to slight  changes  in  parameter values.",Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
The  MATLAB code for the algorithms developed is posted  online at: http://signal.ee.psu.edu/hgglgg.html.,OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"J Pathol Inform 2015, 1:15  http://www.jpathinformatics.org/content/6/1/153.",Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
Available  from: http://tcga.lbl.gov/biosig/tcgadownload.do [Last cited on 2014 May 15].,OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
Available from:  http://www.cancergenome.nih.gov.,Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
Available  from: http://www.bioconductor.org/packages/release/extra/vignettes/nlcv/inst/ doc/nlcv.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/bd/JPI-6-15.PMC4382761.pdf
"(Accessed May 3, 2013,  at http://www.fda.gov/cder/guidence/index.htm).",Non-OADS,/arxiv_data1/oa_pdf/2a/75/NAJMS-7-100.PMC4382763.pdf
"(Accessed August 15, 2014, at http://www.who.int/ mediacentre/factsheets/fs380/en/).",Non-OADS,/arxiv_data1/oa_pdf/2a/ae/NAJMS-7-104.PMC4382764.pdf
"(Accessed June 15, 2014,  at http://www.nlm.nih.gov/medlineplus/cervicalcancer.html).",Non-OADS,/arxiv_data1/oa_pdf/2a/ae/NAJMS-7-104.PMC4382764.pdf
"( Accessed June 15, 2014, at http://www.cancer.org/cancer/cervicalcancer/moreinformation/cervicalcancerpreventionandearlydetection/cervical-cancerprevention-and-early-detection-cervical-cancer-risk-factors).",Non-OADS,/arxiv_data1/oa_pdf/2a/ae/NAJMS-7-104.PMC4382764.pdf
"(Accessed May 7, 2014, at http://www.mona.uwi.edu/reports/health/JHLSII_ ﬁ nal_may09.pdf).",Non-OADS,/arxiv_data1/oa_pdf/2a/ae/NAJMS-7-104.PMC4382764.pdf
Available from: http://www.nccn.org/professionals/physician_gls/pdf/fatigue.,Non-OADS,/arxiv_data1/oa_pdf/8f/73/SAJC-4-21.PMC4382777.pdf
[7] A study testing different doses of the  drug to see which dose is safer in children and adolescents is  going on (http://clinicaltrials.gov/ct2/show/NCT01943682).,Non-OADS,/arxiv_data1/oa_pdf/24/87/SAJC-4-38.PMC4382783.pdf
Available from:  http://www.celatorpharma.com/new/files/poster_2011_Cortes%20 et%20al%20205%20ASH%202011.pdf [Last accessed on 2014 Feb 10].,Non-OADS,/arxiv_data1/oa_pdf/24/87/SAJC-4-38.PMC4382783.pdf
Available  from: http://clinicaltrials.gov/ct2/show/results/NCT01696084 [Last  accessed on 2014 Feb 10].,Non-OADS,/arxiv_data1/oa_pdf/24/87/SAJC-4-38.PMC4382783.pdf
Available from: http://www.nccn.org/professionals/physician_ gls/PDF/antiemesis.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/12/SAJC-4-7.PMC4382794.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ jmedgenet-2014-102907).,OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
Apache Hadoop (http://hadoop.apache.org/) is an open-source infrastructure that allows for reliable andscalable distributed processing of large data sets acrossclusters of computers using MapReduce programmingmodels.,OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
"Apache HBase (http://hbase.apache.org/) is anopen-source, distributed, versioned and non-relationaldatabase modelled after Google ’sB i g t a b l e .",OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
"It can host very large tables, eachcapable of billions of rows with millions of columns.This capacity can be applied to manipulate hundredsof thousands of WGS samples, which will soonbecome reality, such as the 100K Genomes Project(http://www.genomicsengland.co.uk/).",Non-OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
"These include the Hadoop-BAM 14library for manipulating BAM ﬁles based on Hadoop, and SeqPig,15which is a library based on Apache Pig (http://pig.apache.org/) for using the advanced high-level features of Pig to manipulate aligned andunaligned sequence data via writing scripts.However, there is a critical need for a reliable com-putational toolset that can ef ﬁciently manipulate genome-wide sets of variants, their functional anno-tations and every-site coverage (read depth), as wellas analyse NGS data to detect disease-contributinggenes based on a scalable big data infrastructure.Leveraging Apache Hadoop and HBase, we havecreated SeqHBase, a big data-based toolset designedfor analysing large family based sequencing data todetect mutations that may be disease-contributing.",Non-OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
SeqHBase was developed in Java and it isfreely available for use by academic or non-pro ﬁt organisations at http://seqhbase.omicspace.org/.,OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
"The ﬁles are used for extracting variant information, including chromosomenumber, start position, end position, reference allele, alternativeallele, frequency in the 1000 Genome Project 19and/or the EPS6500 project (http://evs.gs.washington.edu/EVS/), ClinVar,20 Combined Annotation Dependent Depletion (CADD) score,21 biological function and multiple diverse function-relevantscores, such as PolyPhen-2 score, 22Sorting Intolerant From T olerant (SIFT) score23and others; (2) VCF ﬁles for extracting variation information, including sample family ID, individualID, called variant genotypes, coverage (read depth) and Phredquality scores; (3) BAM ﬁles for extracting coverage of each site (∼3 billion sites in a WGS) of every sequencing sample.",OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
"Therefore, the design of SeqHBase can be applied tolarge number of family and/or population-based sequencingstudies that are ongoing, such as Epi4K (http://www.epi4k.org/),UK10K (http://www.uk10k.org/) and the 100K Genomes Project(http://www.genomicsengland.co.uk/).",Non-OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
"Other commonly used annotation programmes include snpEff (http://snpeff.sourceforge.net/), SV A (http://www.svaproject.org/), VEP (http://www.ensembl.org/info/docs/tools/vep/index.html) andothers.",Non-OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, DiLullo NM, Parikshak NN, Stein JL, Walker MF, Ober GT, Teran NA, Song Y, El-Fishawy P, Murtha RC, Choi M, Overton JD, Bjornson RD, CarrieroNJ, Meyer KA, Bilquvar K, Mane SM, Sestan N, Lifton RP, Günel M, Roeder K,Geschwind DH, Devlin B, State MW.",Non-OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
"http://static.usenix.org/events/osdi06/tech/ chang/chang_html/?em_x=22 He M, et al .J Med Genet 2015; 52:282 –288.",OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
"http://static.googleusercontent.com/ media/research.google.com/en/us/archive/gfs-sosp2003.pdf 8 Robinson T, Killcoyne S, Bressler R, Boyle J. SAMQA: error classi ﬁcation and validation of high-throughput sequenced read data.",OADS,/arxiv_data1/oa_pdf/9d/b5/jmedgenet-2014-102907.PMC4382803.pdf
PublishedbyElsevierLtdonbehalf of AustralianSocietyforParasitology.Thisisanopenaccessarticle undertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/a7/main.PMC4382861.pdf
http://dx.doi.org/10.1016/j.ijppaw.2015.02.003 2213-2244/Published by Elsevier Ltd on behalf of Australian Society for Parasitology.,Non-OADS,/arxiv_data1/oa_pdf/75/a7/main.PMC4382861.pdf
"1160 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/1e/btv081.PMC4382909.pdf
"  J-W Lee, YM Lee, J-H Lee, JK Noh, HC Kim, C-J Park, J-W Park, IJ Hwang,  SY Kim    was examined  using BLASTX  search  of GenBank  and  sequence  alignment  was performed  with the ClustalW   program  (http://www.ch.emb  net.org/software/ClustalW.",OADS,/arxiv_data1/oa_pdf/88/af/devrep-17-311.PMC4382953.pdf
Supplementary Material:  Access the most recent supplemental material at: http://mct.aacrjournals.org/content/suppl/ 2014/06/16/1535-7163.MCT-13-0963.DC1.html Authors' Contributions : Conception and design:  M.L.,Non-OADS,/arxiv_data1/oa_pdf/78/8a/nihms672602.PMC4383047.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/82/prom-6-117.PMC4383147.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2015:6 117–126Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  117ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PROM.S7895 5Finalizing a measurement framework   for the burden of treatment in complex   patients with chronic conditions David T eton1,2 Jennifer l Ridgeway1,2 Jason s egginton1,2 Kristina Tiedje3 Mark linzer4,5 Deborah h Boehm4 sara Poplau6 Djenane Ramalho de  Oliveira7 laura Odell8 Victor M Montori1,9 carl R May10 Roger T anderson11 1Division of health care Policy and  Research, Department of health sciences  Research, Mayo clinic, Rochester, M n,  Usa;  2Robert D and Patricia e Kern  center for the science of health care  Delivery, Mayo clinic, Rochester, M n,  Usa;  3Department of sociology and  anthropology, Université lumière lyon  2,  lyon, France;  4Division of general internal  Medicine, hennepin county Medical  center, Minneapolis, M n, Usa;  5University  of Minnesota Medical school, University  of Minnesota, Minneapolis, M n, Usa;   6Minneapolis Medical Research Foundation,  Minneapolis, M n, Usa;  7Department of  social Pharmacy, Universidade Federal  de Minas gerais, Belo horizonte, Minas  gerais, Brazil;  8Pharmacy services, Mayo  clinic, Rochester, M n, Usa;  9Knowledge  and evaluation Research Unit, Mayo clinic,  Rochester, M n, Usa;  10Faculty of health  sciences and nihR clah Rc Wessex,  University of southampton, southampton,  UK; 11school of Medicine, University of  Virginia, charlottesville, Va, Usa correspondence: David T eton   Division of health care Policy and  Research, Department of health   sciences Research, Mayo clinic,  200 First  street sW, Rochester, Mn  55905, Usa   Tel +1 507 293 1353  Fax +1 507 284 1731  email eton.david@mayo.ed uPurpose:  The workload of health care and its impact on patient functioning and well-being is  known as treatment burden.",Non-OADS,/arxiv_data1/oa_pdf/0d/82/prom-6-117.PMC4383147.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/0d/82/prom-6-117.PMC4383147.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/0d/82/prom-6-117.PMC4383147.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/4c/vhrm-11-211.PMC4383148.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 211–217 Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  211ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S7310 4Experimental study of sutureless vascular  anastomosis with use of glued prosthesis   in rabbits Lulzim Vokrri1–3,5 Arsim Qavdarbasha1–3 Hajriz Rudari1–3 Halil Ahmetaj1–3 Suzana Manxhuka-Kërliu1–3 Nexhmi Hyseni1–3 Paolo Porcu4 Philippe Cinquin4,5 Carmine Sessa4,6 1Department of Vascular Surgery,   University Clinical Center of Kosovo,   2Medical Faculty, University of  Pristina,  3Veterinary Institute, Pristina,   Republic of Kosovo;  4Department of  Vascular Surgery, University Clinical  Center of Grenoble,  5University of  Grenoble Alpes/CNRS/TIMC-IMAG  UMR 5525 (GMCAO team), Grenoble,   38000, 6University of Grenoble Alpes,   Grenoble 38000, France Correspondence: Lulzim Vokrri   Department of Vascular Surgery,  University Clinical Center of Kosovo,  Lagja e Spitalit Street NN,  10000 Pristina,  Republic of Kosovo   Tel +381 38 55 4863  Fax +381 38 60 3754  Email lvokrri@yahoo.co mObjective:  The objective of this study is to explore the feasibility and efficacy of a new tech - nique for sutureless vascular anastomosis, using glued prosthesis, as a sole anastomosis fixation  method in rabbits.",Non-OADS,/arxiv_data1/oa_pdf/69/4c/vhrm-11-211.PMC4383148.pdf
Available from: http://www.accessdata.fda.gov/./ P010003b.pd f. 6.,Non-OADS,/arxiv_data1/oa_pdf/69/4c/vhrm-11-211.PMC4383148.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/69/4c/vhrm-11-211.PMC4383148.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/4c/vhrm-11-211.PMC4383148.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/da/ppa-9-517.PMC4383149.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 517–528Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  517OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7822 5simplicity, safety, and acceptability of insulin pen  use versus the conventional vial/syringe device  in patients with type 1 and type 2 diabetes  mellitus in lebanon Wijdan h ramadan1 noura A Khreis2 Wissam K Kabbara1 1Department of Pharmacy Practice,   school of Pharmacy, lebanese  American University, Byblos, lebanon;   2King Faisal specialist hospital and  research center, riyadh, saudi ArabiaBackground:  The aim of the study was to evaluate the simplicity, safety, patients’ preference,  and convenience of the administration of insulin using the pen device versus the conventional  vial/syringe in patients with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/f9/da/ppa-9-517.PMC4383149.pdf
"Type 2 diabetes mellitus often requires multiple oral antidiabetic correspondence: Wijdan h ramadan Department of Pharmacy Practice school of Pharmacy lebanese American University PO Box 36 - F 53, Byblos, lebanon Tel +961 9 547 249 ext 2267 Fax +961 9 547 256 ext 2897 email wramadan@lau.edu.lbJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ramadan et al Running head recto: Insulin pens versus vial/syringe devices in patients with diabetes DOI: http://dx.doi.org/10.2147/PPA.S78225",Non-OADS,/arxiv_data1/oa_pdf/f9/da/ppa-9-517.PMC4383149.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/f9/da/ppa-9-517.PMC4383149.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f9/da/ppa-9-517.PMC4383149.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/dc/jmdh-8-157.PMC4383218.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 157–165Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  157Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S7776 3Morbid obese adults increased their sense   of coherence 1 year after a patient education   course: a longitudinal study May solveig Fagermoen1 glenys Hamilton2 anners lerdal1,3 1Department of n ursing science,   institute of Health and society,   University of Oslo, Oslo, norway;   2gaH consulting, Boston, M a, Usa;   3Department of research, lovisenberg  Diakonale Hospital, Oslo, norway correspondence: May solveig Fagermoen   Department of nursing science, institute  of Health and society, University of Oslo,  nedre Ullevål 9, PO Box 1130 Blindern,  0850 Oslo, norway   Tel +47 412 34 630   Fax +47 22 85 05 90   email m.s.fagermoen@medisin.uio.n oBackground:  Personal factors are key elements to understand peoples’ health behavior.",Non-OADS,/arxiv_data1/oa_pdf/ea/dc/jmdh-8-157.PMC4383218.pdf
Available from:  http://apps.who.int/bmi/index.jsp.,OADS,/arxiv_data1/oa_pdf/ea/dc/jmdh-8-157.PMC4383218.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs311/en /.,Non-OADS,/arxiv_data1/oa_pdf/ea/dc/jmdh-8-157.PMC4383218.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/ea/dc/jmdh-8-157.PMC4383218.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/0a/ccide-7-055.PMC4383219.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dentistry 2015:7 55–64Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  55OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCIDE.S8046 2Does the use of a novel self-adhesive flowable  composite reduce nanoleakage?",Non-OADS,/arxiv_data1/oa_pdf/94/0a/ccide-7-055.PMC4383219.pdf
"Available from: http://www.kerrdental.com/ cms-filesystem-action/KerrDental-products-techinfo/vertiseflow_ techbulletin_34929b.pd f. Accessed January 28, 2015.",OADS,/arxiv_data1/oa_pdf/94/0a/ccide-7-055.PMC4383219.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/94/0a/ccide-7-055.PMC4383219.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/94/0a/ccide-7-055.PMC4383219.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/e3/ijn-10-2451.PMC4383220.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2451–2459International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2451RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S6860 0Graphene-based nanovehicles for photodynamic  medical therapy Yan Li1 Haiqing Dong1 Y ongyong Li1 Donglu Shi1,2 1Shanghai east Hospital, The Institute  for Biomedical engineering and Nano  Science (iNANO), T ongji University  School of Medicine, Shanghai, People’s  Republic of China; 2The Materials  Science and engineering Program,   Department of Mechanical and  Materials engineering, College of  engineering and Applied Science,   University of Cincinnati, Cincinnati,   OH, USAAbstract: Graphene and its derivatives such as graphene oxide (GO) have been widely explored  as promising drug delivery vehicles for improved cancer treatment.",Non-OADS,/arxiv_data1/oa_pdf/a3/e3/ijn-10-2451.PMC4383220.pdf
"155 Mailbox, Tongji  University, 1239 Siping Road, Shanghai,  200092, People’s Republic of China   Tel +86 21 6598 8029   email yongyong_li@tongji.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Li et al Running head recto: Graphene nanovehicles for photodynamic therapy DOI: http://dx.doi.org/10.2147/IJN.S68600",Non-OADS,/arxiv_data1/oa_pdf/a3/e3/ijn-10-2451.PMC4383220.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a3/e3/ijn-10-2451.PMC4383220.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/e3/ijn-10-2451.PMC4383220.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/76/ijn-10-2461.PMC4383221.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2461–2473International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2461OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7898 8Fabrication of genistein-loaded biodegradable  TPgs- b-Pcl nanoparticles for improved  therapeutic effects in cervical cancer cells hongling Zhang1,2,* gan liu1,2,* Xiaowei Zeng1,2 Yanping Wu1,2 chengming Yang3 lin Mei1,2 Zhongyuan Wang2,4 laiqiang huang1,2 1school of life sciences, Tsinghua  University, Beijing, People’s republic  of china; 2The shenzhen Key  laboratory of gene and antibody  Therapy, center for Biotechnology  and Biomedicine and Division of life  and health sciences, graduate  school at shenzhen, Tsinghua  University, shenzhen, guangdong,   People’s republic of china; 3Xili  hospital, shenzhen, guangdong,   People’s republic of china; 4school  of Medicine, shenzhen University,   shenzhen, People’s republic of china *These authors contributed equally  to this workAbstract:  Genistein is one of the most studied isoflavonoids with potential antitumor efficacy,  but its poor water solubility limits its clinical application.",Non-OADS,/arxiv_data1/oa_pdf/a7/76/ijn-10-2461.PMC4383221.pdf
"However,  it is still the leading cause of cancer death in women in developing nations.1 Many kinds of natural compounds derived from traditional Chinese medicine  have been confirmed to have antitumor properties and also have little or no toxicity  compared with synthetic chemicals.2 Flavonoids, including isoflavones, are natural  polyphenolic compounds present ubiquitously in many plants and have antioxidant,  anti-inflammatory, and antitumor properties.3,4 Genistein (4 ′,5,7-trihydroxyisoflavone,  Figure 1) is one of the most abundant and best studied soy isoflavones and has received correspondence: Zhongyuan Wang;  laiqiang huang The shenzhen Key laboratory of gene  and antibody Therapy, center for  Biotechnology and Biomedicine and  Division of life and health sciences,  graduate school at shenzhen, Tsinghua  University, l401, Tsinghua campus, Xili  University Town, shenzhen, guangdong  518055, People’s republic of china email wangzhongyuan@szu.edu.cn ;  huangl@sz.tsinghua.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhang et al Running head recto: TPGS- b-PCL-based nanomedicine for cancer therapy DOI: http://dx.doi.org/10.2147/IJN.S78988",Non-OADS,/arxiv_data1/oa_pdf/a7/76/ijn-10-2461.PMC4383221.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a7/76/ijn-10-2461.PMC4383221.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/76/ijn-10-2461.PMC4383221.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/31/dddt-9-1815.PMC4383222.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1815–1823Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1815Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7938 3Paracellular permeation-enhancing effect  of aT1002 c-terminal amidation in nasal delivery Keon-hyoung song1 sang-Bum Kim2 chang-Koo shim2 suk-Jae chung2 Dae-Duk Kim2 sang-Ki rhee1 guang J choi1 chul-hyun Kim3 Kiyoung Kim4 1Department of Pharmaceutical  engineering, soonchunhyang  University, asan, republic of Korea;  2college of Pharmacy and research  institute of Pharmaceutical sciences,   seoul national University, seoul,   republic of Korea; 3Department  of sports Medicine, 4Department  of Medical Biotechnology,   soonchunhyang University, asan,   republic of KoreaBackground:  The identification of permeation enhancers has gained interest in the development  of drug delivery systems.",Non-OADS,/arxiv_data1/oa_pdf/c7/31/dddt-9-1815.PMC4383222.pdf
"AT1002 was identified from modifications of the zonula  occludens toxin (Zot, 399 amino acids, 44.8 kDa), which binds to a specific recep - tor on the luminal membrane surface, and reversibly opens tight junctions between  epithelial cells in a nontoxic manner.3–11 The Zot fragment of AT1002 (amino acid  residues 288–293) enhances the transport of molecular weight markers or agents correspondence: Keon-hyoung song Department of Pharmaceutical  engineering, soonchunhyang University,  22 soonchunhyang road, asan,  republic of Korea Tel +82 41 530 1656 Fax +82 41 530 3085 email beophyen@sch.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Song et al Running head recto: C-terminal-amidated AT1002 DOI: http://dx.doi.org/10.2147/DDDT.S79383",Non-OADS,/arxiv_data1/oa_pdf/c7/31/dddt-9-1815.PMC4383222.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c7/31/dddt-9-1815.PMC4383222.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/31/dddt-9-1815.PMC4383222.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/25/ijn-10-2207.PMC4383223.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 2207–2218International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2207OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6794 7Novel Plga-based nanoparticles for the oral  delivery of insulin correspondence: sengottuvelan  Balasubramanian Department of Inorganic chemistry,  guindy campus, University of Madras,  chennai 600 025, Tamil Nadu, India Tel +91 44 2220 2794 Fax +91 44 2230 0488 email bala2010@yahoo.co m sampath Malathi1 Perumal Nandhakumar2 Velayudham Pandiyan2 Thomas J Webster3 sengottuvelan  Balasubramanian1 1Department of Inorganic chemistry,   guindy campus, University of  Madras, chennai, Tamil Nadu,   India; 2Department of Veterinary  Biochemistry, Madras Veterinary  college, chennai, Tamil Nadu, India;   3Department of chemical engineering,   Northeastern University, Boston, UsaBackground:  Insulin is the drug therapy for patients with insulin-dependent diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/0d/25/ijn-10-2207.PMC4383223.pdf
"Low pH and protease hydrolysis are the  major limitations for intact insulin intestinal absorption and transport into systemic  circulation, which is further reduced by its larger molecular weight and hydrophilic  nature.3–8 The oral administration of insulin is a preferred route for patients on chronic Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Malathi et al Running head recto: Novel PLGA-based nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S67947",Non-OADS,/arxiv_data1/oa_pdf/0d/25/ijn-10-2207.PMC4383223.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0d/25/ijn-10-2207.PMC4383223.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/25/ijn-10-2207.PMC4383223.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/95/dddt-9-1825.PMC4383224.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1825–1841Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1825Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7588 6Pharmacoinformatics approach for investigation  of alternative potential hepatitis c virus  nonstructural protein 5B inhibitors Muhammad Usman Mirza1 noor-Ul-huda ghori2 nazia ikram3 abdur rehman adil4 sadia Manzoor3 1centre for research in Molecular   Medicine ( criMM), The University  of lahore, lahore, 2atta-ur- rehman  school of applied Biosciences  (asaB), national University of  science and T echnology, islamabad,   3institute of Molecular Biology and  Biotechnology ( iMBB), The  University  of lahore, lahore, Pakistan; 4centre  for excellence in Molecular Biology  (ceMB), The University of Punjab,   lahore, PakistanAbstract:  Hepatitis C virus (HCV) is one of the major viruses affecting the world today.",Non-OADS,/arxiv_data1/oa_pdf/65/95/dddt-9-1825.PMC4383224.pdf
"The HCV genome has conserved 5 ′ and 3′ untranslated regions (UTRs) where  5′ UTR possesses an internal ribosome entry site that recruits host ribosome to translate  its genome and 3 ′ UTR is involved in viral replication and its packaging.2 Among all  HCV proteins, NS3, NS5A, and NS5B are potential drug targets for the development  of anti-HCV agents.3 Phylogenetically, HCV is classified into seven major groups and further  subclassified into 67 subtypes.4 Among these variants, genotype 3 is rather dominant correspondence: Muhammad Usman  Mirza centre for research in Molecular  Medicine, The University of lahore,  Defense road, lahore 54000, Pakistan Tel +92 333 839 6037 email usmanmirzapk@yahoo.co m;  muhammad.usman@imbb.uol.edu.p k Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Mirza et al Running head recto: Investigation of HCV -NS5B inhibitors DOI: http://dx.doi.org/10.2147/DDDT.S75886",Non-OADS,/arxiv_data1/oa_pdf/65/95/dddt-9-1825.PMC4383224.pdf
"A total of 84 ligands were short listed, and their structures  were downloaded in SDF format from different small- compound databases including PubChem,40 Chemspider,41  Zinc,42 and Drug Bank.43 The SDF format was converted to 3D  Mol format using ChemOffice 2012 (Cambridge Soft Corp.,  Cambridge, MA, USA, http://www.cambridgesoft.co m).",OADS,/arxiv_data1/oa_pdf/65/95/dddt-9-1825.PMC4383224.pdf
"This was simply  done by using Mcule,45 Cresset, and Molinspiration server  (http://www.molinspiration.com/cgi-bin/propertie s) for cal - culation of their physicochemical properties.",OADS,/arxiv_data1/oa_pdf/65/95/dddt-9-1825.PMC4383224.pdf
The drug like - ness of screened compounds was further confirmed by using  Marvinsketch ( http://www.chemaxon.com/marvin/sketch/ index.js p).,OADS,/arxiv_data1/oa_pdf/65/95/dddt-9-1825.PMC4383224.pdf
"These include OSIRIS prop - erty explorer ( http://www.organic-chemistry.org/prog/peo /), Discovery Studio 4.0 (Accelrys Software Inc.), Cresset,  admetSAR ( http://1mmd.ecust.edu.cn:8000 /),27 ADMET  prediction suite by ACD/Labs, and Molsoft ( http://molsoft.",OADS,/arxiv_data1/oa_pdf/65/95/dddt-9-1825.PMC4383224.pdf
http://Mcule.co m: a public web service  for drug.,Non-OADS,/arxiv_data1/oa_pdf/65/95/dddt-9-1825.PMC4383224.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/65/95/dddt-9-1825.PMC4383224.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/95/dddt-9-1825.PMC4383224.pdf
"This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial  (unported, v3.0) http://dx.doi.org/10.2147/GICTT.S72274  License.",Non-OADS,/arxiv_data1/oa_pdf/20/5b/nihms-673040.PMC4383253.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Correspondence: Autumn J McRee University of North Carolina at Chapel Hill, 170 Manning Drive, CB 7305, Chapel Hill, NC  27599, USA Tel +1 919 843 7719 Fax +1 919 966 6735 autumn_mcree@med.unc.edu.",Non-OADS,/arxiv_data1/oa_pdf/20/5b/nihms-673040.PMC4383253.pdf
"Expression data were refined to include only known members of the HIF pathway or only a  set of genes related to fatty liver compiled from previously published data.20–23 Using either  the list of HIF pathway genes or the set of fatty liver genes, clustering was performed using  Cluster 3.0 ( http://www.bonsai.ims.u-tokyo.ac.jp/~mdehoon/software/cluster/ ).",OADS,/arxiv_data1/oa_pdf/20/5b/nihms-673040.PMC4383253.pdf
Heat maps  were constructed in Java Treeview ( http://www.jtreeviewsource-forge.net/ ).,OADS,/arxiv_data1/oa_pdf/20/5b/nihms-673040.PMC4383253.pdf
Boxplots used to compare expression of specific genes were constructed in R v2.4.1  (http://www.rproject.org ).,OADS,/arxiv_data1/oa_pdf/20/5b/nihms-673040.PMC4383253.pdf
ISD Scotland/National Health Services Scotland; 2009[cited 2012 June 11]; Available from: http://www.isdscotland.,Non-OADS,/arxiv_data1/oa_pdf/88/91/apa0103-0436.PMC4383348.pdf
2013 [cited 2013 08 Feb]; Available from: http://www.smittskyddsinstitutet.se/nyhetsarkiv/2013/stor-andel-ﬂickor-vaccinerade-sig-mot-hpv/.,OADS,/arxiv_data1/oa_pdf/88/91/apa0103-0436.PMC4383348.pdf
: Medical Products Agency [L €akemedelsverket]; 2012 [cited 2013 07 June]; Available from: http://www.lakemedelsverket.se/OVRIGA-SIDOR/Den-nya-inﬂuensan-H1N1/ Fragor-och-svar-om-narkolepsi-efter-pandemivaccination/.,OADS,/arxiv_data1/oa_pdf/88/91/apa0103-0436.PMC4383348.pdf
Available at:http://omop.org/Vocabularies .,Non-OADS,/arxiv_data1/oa_pdf/6c/23/yic-30-151.PMC4383368.pdf
Available at: http://omop.org/sites/default/files/OMOP-Establishing%20a%20Drug%20Era%20Persistence%20Window%20for%20Active%20Surveillance-Jan%202010.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6c/23/yic-30-151.PMC4383368.pdf
"Innovative solutions to help millions breathe easier, 2013. http://www.boehrin-ger-ingelheim.com/content/dam/internet/opu/com_EN/document/01_news/05_Media_Material/Pipeline_backgrounder_2013.PDF (accessed 25October 2013).",Non-OADS,/arxiv_data1/oa_pdf/1f/8a/ijcp0069-0072.PMC4383643.pdf
"EMC, 2013. http://www.medicines.org.uk/emc/medicine/10039 (accessed 25October 2013).",Non-OADS,/arxiv_data1/oa_pdf/1f/8a/ijcp0069-0072.PMC4383643.pdf
"EMC, 2013. http://www.medicines.org.uk/emc/medicine/20134 (accessed 19July 2013).4 van Noord JA, Cornelissen PJ, Aumann JL, Platz J, Mueller A, Fogarty C. The efﬁcacy of tiotropiumadministered via Respimat Soft Mist Inhaler orHandiHaler in COPD patients.",Non-OADS,/arxiv_data1/oa_pdf/1f/8a/ijcp0069-0072.PMC4383643.pdf
"Available at https://www.ccwdata.org/web/ guest/condition-categories Accessed October 4, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ce/9d/jgs0062-2369.PMC4383646.pdf
"Available at http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and- Reports/MedicareMedicaidStatSupp/ 2008.html Accessed August 4, 2014.",OADS,/arxiv_data1/oa_pdf/ce/9d/jgs0062-2369.PMC4383646.pdf
"(1997-2014) ImageJ, National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/.",Non-OADS,/arxiv_data1/oa_pdf/13/e9/jmi0257-0142.PMC4383648.pdf
Accessible at: http://www.who.int/hpr/NPH/docs/hp_glos- sary_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/hir0030-0278.PMC4383652.pdf
Accessible at: http://www.pewinternet.org/Reports/2009/8-The-Social-Life-of-Health-Information.aspx.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/hir0030-0278.PMC4383652.pdf
Accessible at: http://www.pewinternet.org/PPF/r/190/report_display.asp.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/hir0030-0278.PMC4383652.pdf
Accessible at: http://ec.europa.eu/public_opinion/archives/ ebs/ebs_179_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/hir0030-0278.PMC4383652.pdf
Accessible at: http://www.etikkom.no/no/Forskningsetikk/.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/hir0030-0278.PMC4383652.pdf
Accessible at: http://deci-sionaid.ohri.ca/docs/das/OPDG.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/hir0030-0278.PMC4383652.pdf
Acces- sible at: http://www.ssb.no/english/subjects/10/03/ikthus_en/ tab-2010-09-24-04-en.html.,Non-OADS,/arxiv_data1/oa_pdf/d7/f8/hir0030-0278.PMC4383652.pdf
"Another advance in the assembly area are the occurrence of ‘Assemblathons’ (https://genome10k.soe.ucsc.edu/assemblathon; Bradnam et al., 2013).",OADS,/arxiv_data1/oa_pdf/1a/a4/imb0024-0139.PMC4383654.pdf
An updated list of read mapping software is provided by http://wwwdev.ebi.ac.uk/fg/hts_mappers/.Comparative transcriptomics of non-model insects 3 © 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/a4/imb0024-0139.PMC4383654.pdf
Tree modiﬁed after Bugwood (http://wiki.bugwood.org/ Main_Page).,OADS,/arxiv_data1/oa_pdf/1a/a4/imb0024-0139.PMC4383654.pdf
"Each order with transcriptomes generated independent of 1KITE (http://www.1kite.org) and surveyed as part of our literature search (key words: ‘transcriptome’, ‘RNA-Seq’, ‘microarray’, or ‘454’; November 2013) has a pie graph associated with it.",OADS,/arxiv_data1/oa_pdf/1a/a4/imb0024-0139.PMC4383654.pdf
The green (dark) section of the graph represents the number of species with transcriptomesgenerated for that order by 1KITE (http://www.1kite.org/downloads/1KITE_species.txt; November 2013).,OADS,/arxiv_data1/oa_pdf/1a/a4/imb0024-0139.PMC4383654.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/73/main.PMC4383669.pdf
http://dx.doi.org/10.1016/j.fob.2015.03.002 2211-5463/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/70/73/main.PMC4383669.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author at: School of Physics, University of Sydney, Sydney, NSW 2006, Australia.",Non-OADS,/arxiv_data1/oa_pdf/70/73/main.PMC4383669.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.03.002 .",OADS,/arxiv_data1/oa_pdf/70/73/main.PMC4383669.pdf
©2015TheAuthors.PublishedbyElsevierLtdonbehalf of AustralianSocietyforParasitology.Thisis anopenaccessarticleundertheCCBY-NC-SAlicense( http://creativecommons.org/licenses/by-nc-sa/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9c/f5/main.PMC4383760.pdf
http://dx.doi.org/10.1016/j.ijppaw.2015.03.002 2213-2244/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/f5/main.PMC4383760.pdf
This is an open access article under the CC B Y-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/4.0/ ).International Journal for Parasitology: Parasites and Wildlife 4 (2015) 198–205 Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw,Non-OADS,/arxiv_data1/oa_pdf/9c/f5/main.PMC4383760.pdf
http://www.iucnredlist.org .AccessedMarch2013.,Non-OADS,/arxiv_data1/oa_pdf/9c/f5/main.PMC4383760.pdf
e-mail: hamada@kdu.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/37/b4/jvms-77-265.PMC4383771.pdf
e-mail: ihliu@ntu.edu.tw ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/6f/00/jvms-77-273.PMC4383772.pdf
e-mail: yamasita@rakuno.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/34/95/jvms-77-281.PMC4383773.pdf
e-mail: yamasita@rakuno.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d0/57/jvms-77-289.PMC4383774.pdf
e-mail: m.bridge8484@gmail.com ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ab/14/jvms-77-297.PMC4383775.pdf
e-mail:	ykiso@yamaguchi-u.ac.jp ©2015	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/10/53/jvms-77-305.PMC4383776.pdf
e-mail: mizuno@onbich.med.osaka-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/80/9d/jvms-77-313.PMC4383777.pdf
e-mail: drneaw@gmail.com ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the creative  commons Attribution Non-commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ea/4f/jvms-77-321.PMC4383778.pdf
e-mail: parksch@knu.ac.kr ©2015	The	Japanese	Society	of	 Veterinary	Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2c/be/jvms-77-327.PMC4383779.pdf
e-mail: t-aoki@azabu-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f1/0d/jvms-77-331.PMC4383780.pdf
e-mail: mtakagi@agri.kagoshima-u.ac.jp ©2015	The	Japanese	Society	of	 Veterinary	Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/32/01/jvms-77-337.PMC4383781.pdf
e-mail:	sakoda@vetmed.hokudai.ac.jp ©2015	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b9/75/jvms-77-341.PMC4383782.pdf
e-mail: kimie@brain.riken.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d3/c0/jvms-77-345.PMC4383783.pdf
e-mail: anaphy@dankook.ac.kr ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/68/e7/jvms-77-349.PMC4383784.pdf
e-mail: jsuto@affrc.go.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/86/53/jvms-77-353.PMC4383785.pdf
Reported genetic map positions were  retrieved from the Mouse Genome Informatics database  (http://www.informatics.jax.org).,OADS,/arxiv_data1/oa_pdf/86/53/jvms-77-353.PMC4383785.pdf
e-mail: yhoshino@vetmed.hokudai.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/fd/8f/jvms-77-359.PMC4383786.pdf
e-mail:	gary@unam.mx ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/35/49/jvms-77-365.PMC4383787.pdf
"Vet.,	 http://www.veterinaria.org/revis- tas/redvet/n040409.html.",Non-OADS,/arxiv_data1/oa_pdf/35/49/jvms-77-365.PMC4383787.pdf
"Translate	 Tool	Swiss	 Institute	of	Bioinformatics,	 http://web.expasy.org/translate/.",Non-OADS,/arxiv_data1/oa_pdf/35/49/jvms-77-365.PMC4383787.pdf
"NetPrimer Primer Analysis Software,  http://www.premierbiosoft.com/servlet/com.pbi.crm.clientside.FreeToolLoginServlet#.",OADS,/arxiv_data1/oa_pdf/35/49/jvms-77-365.PMC4383787.pdf
"Primer3	on	the	www	for	 general	users	and	for	biologist	 programmers,	 http://frodo.wi.mit.",Non-OADS,/arxiv_data1/oa_pdf/35/49/jvms-77-365.PMC4383787.pdf
"MEGA5: Molecular Evolutionary Genetics Analysis	 using	Maximum	 Likelihood,	 Evolutionary	 Distance, 	 and	Maximum	 Parsimony	 Method,	 http://www.megasoftware.",OADS,/arxiv_data1/oa_pdf/35/49/jvms-77-365.PMC4383787.pdf
e-mail: achamber@mail.ecc.u-tokyo.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/14/39/jvms-77-371.PMC4383788.pdf
e-mail: akuwam@mail.ecc.u-tokyo.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e8/d4/jvms-77-375.PMC4383789.pdf
e-mail: masema@affrc.go.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5a/14/jvms-77-381.PMC4383790.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/25/main.PMC4383791.pdf
Available treatments serve only to alleviate symptoms and slightly delay disease http://dx.doi.org/10.1016/j.fob.2015.03.008 2211-5463/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/25/main.PMC4383791.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: bFGF, basic ﬁbroblast growth factor; EB, embryoid body; ES, embryonic stem; iPSCs, induced pluripotent stem cells; KSR, Knock-out SerumReplacement; MEF, mouse embryonic ﬁbroblast; MELAS, mitochondrial myopathy,encephalomyopathy, lactic acidosis, and stroke-like episodes; mtDNA, mitochon-drial DNA; OXPHOS, oxidative phosphorylation system ⇑Corresponding author at: Department of Cardiology, Keio University School of Medicine, 35-Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.",Non-OADS,/arxiv_data1/oa_pdf/b5/25/main.PMC4383791.pdf
http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/UCM394522.htm .,Non-OADS,/arxiv_data1/oa_pdf/63/b8/40271_2015_Article_120.PMC4383814.pdf
http://ec.europa.,Non-OADS,/arxiv_data1/oa_pdf/63/b8/40271_2015_Article_120.PMC4383814.pdf
http://www.fda.gov/downloads/Drugs/Guidances/ UCM193282.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/b8/40271_2015_Article_120.PMC4383814.pdf
"Menopausal status and post-menopausal hormone use As reported previously [ 32], menopause is assessed on each follow-up questionnaire ( http://www.channing.har vard.edu/nhs/questionnaires/index.shtml ).",Non-OADS,/arxiv_data1/oa_pdf/85/e8/10549_2015_Article_3344.PMC4383816.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/6c/ddv026.PMC4383868.pdf
"http://web.expasy.org/variant_pages/VAR_009968.html).However, the p.Cys169Tyr allele has been recently singled out in a consanguineous Arabian family from the Middle East; basedon the use of in silico predictor tools, p.Cys169Tyr has been as- sumed as causative ( 18).",Non-OADS,/arxiv_data1/oa_pdf/64/6c/ddv026.PMC4383868.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/93/ddv028.PMC4383869.pdf
"Publishedonline21October2014 NucleicAcidsResearch,2015,Vol.43,Databaseissue D771–D776 doi:10.1093/nar/gku1001 DBTMEE: a database of transcriptome in mouse early embryos Sung-Joon Park1, Katsuhiko Shirahige2, Miho Ohsugi3and Kenta Nakai1,* 1Human Genome Center, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan,2Laboratory of Genome Structure & Function, Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Y ayoi, Bunkyo-ku, Tokyo 113-0032, Japan and3Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan Received August 14, 2014; Revised September 26, 2014; Accepted October 07, 2014 ABSTRACT DBTMEE ( http://dbtmee.hgc.jp/ ) is a searchable and browsable database designed to manipulate geneexpression information from our ultralarge-scale whole-transcriptome analysis of mouse early em- bryos.",OADS,/arxiv_data1/oa_pdf/ff/b0/gku1001.PMC4383872.pdf
"Here,wepresentanoveldatabase,DBTMEE(DataBase ofTranscriptomeinMouseEarlyEmbryos),whichcentral- izes gene expression profile at early developmental stages (http://dbtmee.hgc.jp/ ).",OADS,/arxiv_data1/oa_pdf/ff/b0/gku1001.PMC4383872.pdf
"2.4.3, http://www.mongodb.com/ ) coupled with PHP language ( http://php.net/ ).",Non-OADS,/arxiv_data1/oa_pdf/ff/b0/gku1001.PMC4383872.pdf
Genomic information was pre- paredfromNCBI( http://www.ncbi.nlm.nih.gov/gene/ )and MGI (http://www.informatics.jax.org/ ).,OADS,/arxiv_data1/oa_pdf/ff/b0/gku1001.PMC4383872.pdf
"The mouse refer- encegenome,mm9assembly,wasdownloadedfromUCSC genome browser ( http://genome.ucsc.edu/ ).",OADS,/arxiv_data1/oa_pdf/ff/b0/gku1001.PMC4383872.pdf
"Although experimental validations are required, this result might be helpful to identify genes that are affected by sperm transmission and to determine the roles ofepigenetic inheritancefrom sperm.Users can find more introductory working examples from the tutorial web page ( http://dbtmee.hgc.jp/tutorial/ tutorial.php ).",Non-OADS,/arxiv_data1/oa_pdf/ff/b0/gku1001.PMC4383872.pdf
"D1064–D1070 NucleicAcidsResearch,2015,Vol.43,Databaseissue Publishedonline27October2014 doi:10.1093/nar/gku1002 HAMAP in 2015: updates to the protein family classiﬁcation and annotation system Ivo Pedruzzi1,†, Catherine Rivoire1,†, Andrea H. Auchincloss1, Elisabeth Coudert1, Guillaume Keller1, Edouard de Castro1, Delphine Baratin1,B´eatrice A. Cuche1, Lydie Bougueleret1, Sylvain Poux1, Nicole Redaschi1, Ioannis Xenarios1,2,3,4and Alan Bridge1,* 1Swiss-Prot Group, SIB Swiss Institute of Bioinformatics, CMU, 1 rue Michel-Servet, CH-1211 Geneva 4, Switzerland,2Vital-IT Group, SIB Swiss Institute of Bioinformatics, CH-1015, Lausanne, Switzerland,3Center for Integrative Genomics, University of Lausanne, CH-1015, Lausanne, Switzerland and4Department of Biochemistry, University of Geneva, CH-1211 Geneva 4, Switzerland Received September 07, 2014; Revised October 6, 2014; Accepted October 07, 2014 ABSTRACT HAMAP (High-quality Automated and Manual Anno- tation of Proteins––available at http://hamap.expasy.",Non-OADS,/arxiv_data1/oa_pdf/5d/db/gku1002.PMC4383873.pdf
The tree was visualized with Archaeopteryx ( https://sites.google.com/site/cmzmasek/home/software/archaeopteryx ).Protein sequences and multiple sequence alignments are provided insupplementaryfileS2.,OADS,/arxiv_data1/oa_pdf/5d/db/gku1002.PMC4383873.pdf
"During curation of the multiple sequence alignment erroneous sequences and misaligned positions are corrected where necessary (described in ( 4), complete workflow ftp://ftp.expasy.org/databases/hamap/ SOP HAMAP profilecreation.pdf included as supple- mentary file S1).",OADS,/arxiv_data1/oa_pdf/5d/db/gku1002.PMC4383873.pdf
"Profiles are generated using the pftools package (available at http://web.expasy.org/pftools/ )a sd e - scribed in ( 14,15).",OADS,/arxiv_data1/oa_pdf/5d/db/gku1002.PMC4383873.pdf
"expasy.org/profile/ <ProfileAC >(e.g.http://hamap.expasy.org/profile/MF 00339forprokaryoticcladeB1PFKs).Thetablesummarizesthecharacteristics ofthedifferentsubfamiliesandtheannotationsthatarepropagatedtomatchingtargetproteinsequences.Characterizedtemplateproteinsforeac hprotein family are listed together with their origin (A =Archaea, B =Bacteria, E =Eukaryota) and the experimentally determined phosphoryl donor (ATP, PPi=inorganic phosphate, Reg =non-catalytic regulatory subunit).",OADS,/arxiv_data1/oa_pdf/5d/db/gku1002.PMC4383873.pdf
The full name and taxonomy of the species and the references describing protein characterization can be obtained from corresponding entries on the UniProt website via http://www.uniprot.org/uniprot/ <UniProtKB AC >(e.g.http: //www.uniprot.org/uniprot/P0A796 forEscherichiacoli ATP-PFKpfkA).,Non-OADS,/arxiv_data1/oa_pdf/5d/db/gku1002.PMC4383873.pdf
"In this process we used publicly available mapping ta-bles(UniProt( 24)andHPRD( 27)).For30%ofproteinnamesweapplied manually built mapping tables with the help of online ID cross-reference services (PICR ( 25) and Synergizer ( http://llama.mshri.on.ca/synergizer/ translate/ ))(3).AfterdataintegrationLocalizationandInteractionScores werecalculated(fordetaileddescriptionseeFigure 2).Asanillustrationwe showtheexampleofFigure 2withtwointeractingproteins(nodesAandB correspondingtoHSP90-alphaA2andSurvivin,respectively)withsharedcytosolicandnuclearlocalizations(lightblueandorange).NodeBhasanadditionalmembrane(yellow)subcellularlocalizationandanextracellular localization(green).NumbersinthecirclesofnodesAandBrefertotheir Localization Scores.",OADS,/arxiv_data1/oa_pdf/9f/d7/gku1007.PMC4383876.pdf
"As the final result, the webpage http://ComPPI.LinkGroup.hu is available for search and download options in order to extract the biological information in auser-friendlyway.",OADS,/arxiv_data1/oa_pdf/9f/d7/gku1007.PMC4383876.pdf
"New interfaces can be addedwithoutlimitations.Theincomingdataaremergedtoform a consistent internal data pool using a comprehensive pro- tein name mapping algorithm, in order to deal with the re-dundancy in the input data sets ( http://comppi.linkgroup.",OADS,/arxiv_data1/oa_pdf/9f/d7/gku1007.PMC4383876.pdf
The source code is available in a revision controlled repository at http://bificomp2.sote.hu: 22422/comppi/summary .,OADS,/arxiv_data1/oa_pdf/9f/d7/gku1007.PMC4383876.pdf
"Third-party tools and technologies were selected with open accessibility and scientific reproducibility in mind in- cluding the Ubuntu Linux 14.04 operating system ( http: //ubuntu.com/ ), the nginx HTTP server ( http://nginx.org/ ), the MySQL 5 Community Edition database server ( http: //www.mysql.com/ ), the git version control system ( http: //git-scm.com/ ), the PHP 5 scripting language ( https://php.",Non-OADS,/arxiv_data1/oa_pdf/9f/d7/gku1007.PMC4383876.pdf
"net/),theSymfony2PHPframework( http://symfony.com/ ), the jQuery JavaScript framework ( http://jquery.com/ ), the D3.js JavaScript library for network visualization ( http: //d3js.org/ ) and the Python3 scripting language ( https:// python.org/ ).",OADS,/arxiv_data1/oa_pdf/9f/d7/gku1007.PMC4383876.pdf
"The internally hyper-linked web applica- tion of ComPPI enables even those users, who have no bioinformaticsexpertise,tosearchfortheinteractionsofin- dividualproteins.Searchoptions( http://comppi.linkgroup.",OADS,/arxiv_data1/oa_pdf/9f/d7/gku1007.PMC4383876.pdf
"ComPPI is available at http://ComPPI.LinkGroup.hu , andhasanopensourcecode,whichallowsfurtherimprove-ment and the construction of ‘ComPPI-based databases’.",OADS,/arxiv_data1/oa_pdf/9f/d7/gku1007.PMC4383876.pdf
"ACKNOWLEDGEMENT Authors acknowledge the members of the LINK-Group (http://LinkGroup.hu ) and Cellular Network Biology Group (http://NetBiol.elte.hu ) for their advice, as well as Judit Gyurk ´o forthedesign oftheComPPI website.FUNDING Hungarian Science Foundation [OTKA-K83314]; Fellow- ship in computational biology at The Genome Analysis Centre (Norwich, UK) in partnership with the Institute of Food Research (University of Norwich, UK); Biotechno-logical and Biosciences Research Council, UK [to T.K.",Non-OADS,/arxiv_data1/oa_pdf/9f/d7/gku1007.PMC4383876.pdf
To support the research on phosphatase–kinase–substrate networks we presenthere an update on the human DEPhOsphorylation Database: DEPOD ( http://www.depod.org orhttp:// www.koehn.embl.de/depod ).,OADS,/arxiv_data1/oa_pdf/20/00/gku1009.PMC4383878.pdf
"Third, the predicted 3D struc- ture models were presented in the interactive JSmol applet (http://jsmol.sourceforge.net/ ).Finally,generalannotations extractedfromtheUniProtdatabasewerealsoshowninthe resultpage.",OADS,/arxiv_data1/oa_pdf/0b/20/gku1023.PMC4383882.pdf
AVAILABILITY WDSPdbisfreelyavailableat http://wu.scbb.pkusz.edu.cn/ wdsp/.,Non-OADS,/arxiv_data1/oa_pdf/0b/20/gku1023.PMC4383882.pdf
"Detailed information of the literature cu- ration process of the NHGRI GWAS catalog is described athttp://www.genome.gov/gwastudies/ , which we followed basically.",OADS,/arxiv_data1/oa_pdf/20/65/gku1037.PMC4383886.pdf
The UniPROBE database is available at http://uniprobe.org .,OADS,/arxiv_data1/oa_pdf/ee/04/gku1045.PMC4383892.pdf
The link for this tool is found conveniently inaheadernearthetopofthefrontpageorbyaccessingitdirectly by URL at http://thebrain.bwh.harvard.edu/pbms/ webworks pubdev/admin.php .,Non-OADS,/arxiv_data1/oa_pdf/ee/04/gku1045.PMC4383892.pdf
"AVAILABILITY As before, the data in UniPROBE are freely available at the database web site ( http://uniprobe.org ), and the se- quencesofthe60-merDNAprobesonthecustom-designed oligonucleotide arrays are available under the terms of anacademic research use license available at http://thebrain.",OADS,/arxiv_data1/oa_pdf/ee/04/gku1045.PMC4383892.pdf
We also welcome their direct submission to REBASE and have an interface specifically for this purpose ( http://rebase.neb.com ).,Non-OADS,/arxiv_data1/oa_pdf/b4/8e/gku1046.PMC4383893.pdf
Implementation AlltheroutinesinSASBDBareimplementedinpython2.7 (http://www.python.org ).Theuserwebinterfacewasdevel- Figure 2.,OADS,/arxiv_data1/oa_pdf/69/1a/gku1047.PMC4383894.pdf
"oped in the Django 1.6 ( https://djangoproject.com ) frame- work and displays plots and model images are automati-cally generated using gnuplot ( http://gnuplot.info ) and Py- MOL (The PyMOL Molecular Graphics System, Version 1.7.0.1Schr ¨odinger,LLC),respectively.JSmolisusedtovi- sualize the model structures interactively ( http://wiki.jmol.",OADS,/arxiv_data1/oa_pdf/69/1a/gku1047.PMC4383894.pdf
"We preferred JSmol to the more widely used Jmol ( http://www.jmol.org ) because, be- ing a JavaScript applet, it does not require any Java autho- rization.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/gku1047.PMC4383894.pdf
The search is implemented using the Django extension Haystack2.0( http://haystacksearch.org/ )andElasticsearch 0.90.2 (http://www.elasticsearch.org/ ) as the search back- end engine.,OADS,/arxiv_data1/oa_pdf/69/1a/gku1047.PMC4383894.pdf
The metadata from UniProt ( 29) and PubMed (http://www.ncbi.nlm.nih.gov/pubmed ) are automatically retrieved using a the WSDbfetch API from PDBe ( 30)f o r thefirst and aBioPython ( 31) toolfor thesecond source.,OADS,/arxiv_data1/oa_pdf/69/1a/gku1047.PMC4383894.pdf
RESULTS Availability and searching SASBDB is publicly accessible via the http://www.sasbdb.,OADS,/arxiv_data1/oa_pdf/69/1a/gku1047.PMC4383894.pdf
"The standard search is provided by de- fault on each page, where single search terms can be used, while a dedicated advanced search is available through thehttp://www.sasbsb.org/search/advanced where it is possible to select one or more fields to restrict the search.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/gku1047.PMC4383894.pdf
"D720–D725 NucleicAcidsResearch,2015,Vol.43,Databaseissue Publishedonline05November2014 doi:10.1093/nar/gku1054 iBeetle-Base: a database for RNAi phenotypes in the red ﬂour beetle Tribolium castaneum J¨urgen D ¨onitz1,*, Christian Schmitt-Engel1,3, Daniela Grossmann1, Lizzy Gerischer4, Maike Tech2, Michael Schoppmeier3, Martin Klingler3and Gregor Bucher1 1Johann-Friedrich-Blumenbach Institute of Zoology and Anthropology, GZMB, Department of Evolutionary Developmental Genetics, Georg-August-University G ¨ottingen, 37075 G ¨ottingen, Germany,2Institute of Microbiology and Genetics, Department of Bioinformatics, Georg-August-University G ¨ottingen, 37073 G ¨ottingen, Germany, 3Department of Biology, Friedrich-Alexander University, 91058 Erlangen, Germany and4Institute for Mathematics and Computer Science, Ernst Moritz Arndt University, 17487 Greifswald, Germany Received August 25, 2014; Revised September 29, 2014; Accepted October 14, 2014 ABSTRACT The iBeetle-Base ( http://ibeetle-base.uni-goettingen.",Non-OADS,/arxiv_data1/oa_pdf/61/70/gku1054.PMC4383896.pdf
In detailthese are: iBeetle IDs: http://ibeetle-base.uni-goettingen.de/details/ iB 00000,Non-OADS,/arxiv_data1/oa_pdf/61/70/gku1054.PMC4383896.pdf
TC numbers: http://ibeetle-base.uni-goettingen.de/details/ TC000000 Ontology terms: http://ibeetle-base.uni-goettingen.de/ ontology/tron/TrOn 0000000 FUTURE DIRECTIONS iBeetle-Base is the first and currently only resource giving accesstoRNAiphenotypesgatheredinanhypothesisinde- pendentwayinanyinsectoutside Drosophila .Itisintended asacentralresourcefortheincreasingcommunityworkingon aspects of the emerging model organism Triboliumcas- taneum.,OADS,/arxiv_data1/oa_pdf/61/70/gku1054.PMC4383896.pdf
"Here, we present LNCipedia 3.0 ( http://www.lncipedia.org ), the latest version of the publicly available human lncRNAdatabase.",OADS,/arxiv_data1/oa_pdf/2a/d9/gku1060.PMC4383901.pdf
Two technical replicates of both treatments were pooled (Bioproject http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/2a/d9/gku1060.PMC4383901.pdf
"The third and final module uses PeptideShaker (http://peptide-shaker.googlecode.com ) and the compomics-utilities library ( 40) to collect, process and analyze theresultsgenerated bySearchGUI.",OADS,/arxiv_data1/oa_pdf/2a/d9/gku1060.PMC4383901.pdf
Adverse Drug Reaction Classiﬁcation Sys- tem (ADReCS; http://bioinf.xmu.edu.cn/ADReCS )i s a comprehensive ADR ontology database that pro-vides not only ADR standardization but also hierar- chical classiﬁcation of ADR terms.,OADS,/arxiv_data1/oa_pdf/ba/6c/gku1066.PMC4383906.pdf
"DATABASE CONSTRUCTION Data extraction The drug-ADR information of ADReCS was mainly extracted from the drug labels in the DailyMed (http://dailymed.nlm.nih.gov/dailymed/about.cfm ), a websitemanagedbytheU.S.NationalLibraryofMedicine (NLM) to provide comprehensive information about marketed drugs.",OADS,/arxiv_data1/oa_pdf/ba/6c/gku1066.PMC4383906.pdf
DATA ACCESS Data retrieval The ADReCS database can be accessed through a sim- ple and user-friendlyinterface at: http://bioinf.xmu.edu.cn/ ADReCS .,OADS,/arxiv_data1/oa_pdf/ba/6c/gku1066.PMC4383906.pdf
"Users can freely download the full ADReCS data at theDOWNLOAD page ( http://bioinf.xmu.edu.cn/ADReCS/ download.jsp ).Loginisrequiredtoproceedthedownload- ing; however, registration is completely free for academicusers.",OADS,/arxiv_data1/oa_pdf/ba/6c/gku1066.PMC4383906.pdf
"The updated database version, Dr.VIS v2.0 (http://www.bioinfo.org/drvis orbminfor.tongji.edu.",OADS,/arxiv_data1/oa_pdf/9a/c1/gku1074.PMC4383912.pdf
"The annotations and genomicmapping information of coding genes and non-coding se- quencesreliedondatafromoriginalpapers,thesupplemen- tary materials of papers, the NCBI RefSeq database ( http: //www.ncbi.nlm.nih.gov/RefSeq/ )(19), the NONCODEv4 database( 20)orBLATattheUniversityofCaliforniaSanta Cruz(UCSC)( http://genome.ucsc.edu/ )(21).Wenextiden- tifiedthegenesthatwereclosesttoVISes.GenBankannota- tionswereusedtocreatefiguresforallVISestoenablevisu-alizationoftheirlocationinthegenomeorwithinaspecific DNAfragment,togetherwithregulatoryelementsinflank- ingsequences.",OADS,/arxiv_data1/oa_pdf/9a/c1/gku1074.PMC4383912.pdf
The database can be accessed through the following URL:http://www.bioinfo.org/drvis orbminfor.tongji.edu.,OADS,/arxiv_data1/oa_pdf/9a/c1/gku1074.PMC4383912.pdf
The en-tire Dr.VIS v2.0 dataset can be directly downloaded from http://www.bioinfo.org/drvis/download.php .,OADS,/arxiv_data1/oa_pdf/9a/c1/gku1074.PMC4383912.pdf
"Publishedonline05November2014 NucleicAcidsResearch,2015,Vol.43,Databaseissue D87–D91 doi:10.1093/nar/gku1080 DBTSS as an integrative platform for transcriptome, epigenome and genome sequence variation data Ayako Suzuki1, Hiroyuki Wakaguri2, Riu Yamashita3, Shin Kawano4, Katsuya Tsuchihara5, Sumio Sugano1, Yutaka Suzuki2,*and Kenta Nakai6,* 1Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan,2Department of Computational Biology, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan,3Tohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan,4Database Center for Life Science, Research Organization of Information and Systems, Chiba, Japan,5Division of TR, The Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan and6Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan Received September 15, 2014; Revised October 16, 2014; Accepted October 16, 2014 ABSTRACT DBTSS ( http://dbtss.hgc.jp/ ) was originally con- structed as a collection of uniquely determined tran- scriptional start sites (TSSs) in humans and someother species in 2002.",OADS,/arxiv_data1/oa_pdf/90/0a/gku1080.PMC4383915.pdf
ICGC 43ofICGCDCCProjectCodes 6590 https://dcc.icgc.org/ Meyerson’sLab.,Non-OADS,/arxiv_data1/oa_pdf/90/0a/gku1080.PMC4383915.pdf
"HGVD Normaltissues(Japanese) 1208 http://www.genome.med.kyoto-u.ac.jp/SnpDB Total 11,322",OADS,/arxiv_data1/oa_pdf/90/0a/gku1080.PMC4383915.pdf
"In addition, we have collected SNVs from various public resources, such as ICGC ( https: //icgc.org/ )(11) and TCGA ( http://cancergenome.nih.gov/ ) (12)aswellasthegermlinevariationdataof1000Japanese individuals (Table 2; also see our website for the data content and references).",Non-OADS,/arxiv_data1/oa_pdf/90/0a/gku1080.PMC4383915.pdf
We also considered representative cancer mutations in COSMIC ( http://cancer.sanger.ac.uk/ cancergenome/projects/cosmic/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/0a/gku1080.PMC4383915.pdf
"SAMPLE USAGES (i) Basic Tour Atthetoppage( http://dbtss.hgc.jp/ ;Figure1A),users canspecifyanyhumangenenameintheKeywordfield on the top left (keyword is case insensitive).",Non-OADS,/arxiv_data1/oa_pdf/90/0a/gku1080.PMC4383915.pdf
( http://www.cellsignal.,Non-OADS,/arxiv_data1/oa_pdf/90/0a/gku1080.PMC4383915.pdf
"com/), and the KEGG pathways ( http://www.genome.",Non-OADS,/arxiv_data1/oa_pdf/90/0a/gku1080.PMC4383915.pdf
"NucleicAcidsResearch,2015,Vol.43,Databaseissue D91 (http://dbtss.hgc.jp/docs/data contents 2014.html ).",OADS,/arxiv_data1/oa_pdf/90/0a/gku1080.PMC4383915.pdf
All of theshortreadsequencesusedforthedatabasehavebeende- posited in the Short Read Archives and JGA Database for Control Access in DDBJ ( http://www.ddbj.nig.ac.jp/index- e.html).,OADS,/arxiv_data1/oa_pdf/90/0a/gku1080.PMC4383915.pdf
"We developed several methods based on residue co-evolution andproximity to predict the functional associations of pairs of PTMs that we apply to modiﬁcations in the same protein and between two interacting proteins.In order to make data available for understudied or- ganisms, PTMcode v2 ( http://ptmcode.embl.de )i n - cludes a new strategy to propagate PTMs from val-idated modiﬁed sites through orthologous proteins.",OADS,/arxiv_data1/oa_pdf/dc/d7/gku1081.PMC4383916.pdf
"In total, we provide PTM func- tionalannotationformorethan100000proteins.Foreach of them, PTMcode outlines its known and predicted post- translationalregulatorylandscapewhichincludesthefunc-tionallinksbetweenitsmodifiedresiduesandfromthissec- ondreleasealsothefunctionalassociationsbetweenPTMs thatmayregulateitsinteractionwithotherproteins.PTM-code v2 is accessible through the url http://ptmcode.embl.",OADS,/arxiv_data1/oa_pdf/dc/d7/gku1081.PMC4383916.pdf
"Publishedonline06November2014 NucleicAcidsResearch,2015,Vol.43,Databaseissue D465–D469 doi:10.1093/nar/gku1088 Recent improvements to Binding MOAD: a resource for protein–ligand binding afﬁnities and structures Aqeel Ahmed, Richard D. Smith, Jordan J. Clark, James B. Dunbar, Jr and Heather A. Carlson* Department of Medicinal Chemistry, University of Michigan, 428 Church St, Ann Arbor, MI 48109-1065, USA Received September 15, 2014; Revised October 13, 2014; Accepted October 15, 2014 ABSTRACT For over 10 years, Binding MOAD (Mother of All Databases; http://www.BindingMOAD.org ) has been one of the largest resources for high-quality protein– ligand complexes and associated binding afﬁnity data.",OADS,/arxiv_data1/oa_pdf/43/74/gku1088.PMC4383918.pdf
"Since 2010, the affinity data from Bind- ing MOAD have been cross-linked with the PDB website (http://www.rcsb.org ) for a quick and direct access.",OADS,/arxiv_data1/oa_pdf/43/74/gku1088.PMC4383918.pdf
"The Apache server on a Linuxplatformisusedtohostthenewimplementationwrit- teninPHPforthenewBindingMOADwebsite.Inadditionto the LAMP software bundle, we have used CakePHP 2.4 (http://cakephp.org ),therapiddevelopmentofPHPframe- work that is based on a Model–View–Controller (MVC) software architecture pattern, which is well suited for web- sites.",OADS,/arxiv_data1/oa_pdf/43/74/gku1088.PMC4383918.pdf
"We have embedded commonly used third-party plugins into the website to in- crease the functionality: Jmol (an open-source Java viewer for chemical structures in 3D; http://www.jmol.org )i su s e d to view the protein–ligand complex; MarvinView (Mar- vin 5.12.3, 2013, ChemAxon; http://www.chemaxon.com ) is used to view the ligand’s 2D structure and JChem Base(JChem 6.0.0, 2013, ChemAxon; http://www.chemaxon.com)withMarvinSketchisusedforstructure-basedsearch- ing ofligands.",OADS,/arxiv_data1/oa_pdf/43/74/gku1088.PMC4383918.pdf
"Publishedonline06November2014 NucleicAcidsResearch,2015,Vol.43,Databaseissue D321–D327 doi:10.1093/nar/gku1091 MatrixDB, the extracellular matrix interaction database: updated content, a new navigator and expanded functionalities G. Launay1,R .S a l z a1, D. Multedo1, N. Thierry-Mieg2and S. Ricard-Blum1,* 1UMR 5086 CNRS - Universit ´e Lyon 1, 69367 Lyon Cedex 07, France and2TIMC- IMAG /BCM, UMR 5525 CNRS - Universit ´e Grenoble 1, Facult ´ed eM ´edecine, 38706 La Tronche Cedex, France Received September 12, 2014; Revised October 17, 2014; Accepted October 20, 2014 ABSTRACT MatrixDB ( http://matrixdb.ibcp.fr )i saf r e e l ya v a i l - able database focused on interactions established by extracellular proteins and polysaccharides.",OADS,/arxiv_data1/oa_pdf/96/3f/gku1091.PMC4383919.pdf
"INTRODUCTION MatrixDB ( http://matrixdb.ibcp.fr ) is a freely available in- teraction database, first released in 2009, which focuseson interactions established by extracellular proteins and polysaccharides( 1,2).MatrixDBisanactivememberofthe International Molecular Exchange (IMEx) consortium, aninternational collaboration between a group of major pub- lic interaction data providers who have agreed to share cu- ration effort and to capture full details of an interaction ina‘deep’curationmodel.ThemembersoftheIMExconsor- tiumuseasinglesetofcurationruleswhencapturinginter- actiondatafrompublicationsinpeer-reviewedjournals( 3).",OADS,/arxiv_data1/oa_pdf/96/3f/gku1091.PMC4383919.pdf
"They are termed MULT xs (for multimers, again x is a number and s a species).ProteindatawereimportedfromUniProtKB,and enrichedbyparsingadditionalannotationsfromGeneOn- tology,InterPro,PfamandUniGene( http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/96/3f/gku1091.PMC4383919.pdf
"Implementation iNavigator has been developed using two well-established JavaScript libraries, namely D3 ( 37) and jQuery ( https:// jquery.com/ ).ThetablesofthereportpagesusetheDataT- ables plugin ( http://www.datatables.net/ ) and the visual- ization component for 3D structures of biomolecules re-lies on GLmol ( http://sourceforge.jp/projects/webglmol/ ).",OADS,/arxiv_data1/oa_pdf/96/3f/gku1091.PMC4383919.pdf
INTRODUCTION FlyBase ( http://flybase.org ) is a database of Drosophila- related genetic and genomic information ( 1).,OADS,/arxiv_data1/oa_pdf/da/db/gku1099.PMC4383921.pdf
"From late- 2006 until mid-2014, the reference genome assembly for the biomedical model organism, Drosophila melanogaster , hasbeentheBerkeleyDrosophilaGenomeProject(BDGP, http://fruitfly.org ) Release 5 genome assembly ( 2).",OADS,/arxiv_data1/oa_pdf/da/db/gku1099.PMC4383921.pdf
"All versions of FlyBase on the Release 5 genome assembly are also available for download on the FlyBase FTP site, available from the ‘Files’ menu of the FlyBase navigation bar (ftp://ftp.flybase.net/releases/ ).DATA MIGRATION TO THE RELEASE 6 REFERENCE GENOME ASSEMBLY Feature migration FlyBaserepresentsasmanyfeatureslocatedonthegenome as possible.",OADS,/arxiv_data1/oa_pdf/da/db/gku1099.PMC4383921.pdf
"Assembly-to-assemblyalignmentsbetweenRelease5and Release 6 were generated by NCBI ( 4), using previously described methods ( http://www.ncbi.nlm.nih.gov/genome/ tools/remap/docs/alignments ) ,a n dp r o v i d e dt oF l y B a s e .",OADS,/arxiv_data1/oa_pdf/da/db/gku1099.PMC4383921.pdf
RNA-Seq coverage datasetsaredisplayedinGBrowseandareusedtocalculateRPKM gene expression values ( 20) .T h e s eR P K Mv a l u e s are presented in the High-Throughput Expression sections of gene reports and can be queried extensively using the RNA-Seq Search tool ( http://flybase.org/static pages/rna- seq/rna-seq search.html ).,OADS,/arxiv_data1/oa_pdf/da/db/gku1099.PMC4383921.pdf
from the ‘Documents’ menu of the FlyBase navigation bar (http://flybase.org/static pages/docs/release notes.html ).,OADS,/arxiv_data1/oa_pdf/da/db/gku1099.PMC4383921.pdf
"ACCESS TO DATA ON FLYBASE Download of the Release 6 genome assembly sequence Sequence data for the D. melanogaster genome assem- bly can be downloaded from the FlyBase FTP site, ac- cessible from the ‘Files’ menu in the FlyBase navigation bar (ftp://ftp.flybase.net/ ).",OADS,/arxiv_data1/oa_pdf/da/db/gku1099.PMC4383921.pdf
"Various cuts of the data areprovided in multiple formats, ranging from GFF3 ( http: //www.sequenceontology.org/gff3.shtml ), FASTA ( 21)a n d GTF (http://mblab.wustl.edu/GTF2.html ) files to Chado XML (22) data sliced into portions such as scaffolds, gene models, etc.",OADS,/arxiv_data1/oa_pdf/da/db/gku1099.PMC4383921.pdf
BLAST FlyBase provides a stand-alone BLAST ( 15)s e r v e rf o r 50 different arthropod genomes ( http://flybase.org/blast/ ).,OADS,/arxiv_data1/oa_pdf/da/db/gku1099.PMC4383921.pdf
"Lluis Companys 23, 08010 Barcelona, Spain Received August 15, 2013; Revised October 7, 2014; Accepted October 23, 2014 ABSTRACT MyMpn ( http://mympn.crg.eu )i sa no n l i n er e - source devoted to studying the human pathogen Mycoplasma pneumoniae , a minimal bacterium causing lower respiratory tract infections.",Non-OADS,/arxiv_data1/oa_pdf/75/55/gku1105.PMC4383923.pdf
"NucleicAcidsResearch,2015,Vol.43,Databaseissue D619 The MyMpn database, available at http://mympn.crg.eu , aims to provide access to properly structured and well or- ganized data for M. pneumoniae .",OADS,/arxiv_data1/oa_pdf/75/55/gku1105.PMC4383923.pdf
"MATERIALS AND METHODS MyMpn architecture and implementation MyMpndataisstoredwithinarelationaldatabasemanage- ment system, MySQL ( http://www.mysql.com ).",OADS,/arxiv_data1/oa_pdf/75/55/gku1105.PMC4383923.pdf
Computational analyses wererunonaLinuxclusterrunningtheGentooLinuxdis-tribution ( http://www.gentoo.org ) and the PBS scheduling system (http://www.openpbs.org ).,OADS,/arxiv_data1/oa_pdf/75/55/gku1105.PMC4383923.pdf
"Images are generated on the fly using a Perl script that is based on sequence object methods available in BioPerl (http://www.bioperl.org (28)) and on image drawing func- tionalitiesfromBio::Graphics(availableattheComprehen-sivePerlArchiveNetwork, http://www.cpan.org/modules/ ).",OADS,/arxiv_data1/oa_pdf/75/55/gku1105.PMC4383923.pdf
"Starting from a manually-curated model map in CellDesigner ( http://www.celldesigner.org/ (29)), a GoogleMaps-based zoomable webpage was generated us-ing the CellPublisher online interface ( http://cellpublisher.",OADS,/arxiv_data1/oa_pdf/75/55/gku1105.PMC4383923.pdf
"We present PyIgClassify (for Python- based immunoglobulin classiﬁcation; available at http://dunbrack2.fccc.edu/pyigclassify/ ), a database and web server that provides access to assignments of all CDR structures in the PDB to our classiﬁcation system.",OADS,/arxiv_data1/oa_pdf/09/61/gku1106.PMC4383924.pdf
"Databases and web site Theinternaland‘downloadable’databasesforPyIgClassify a r eS Q l i t e( http://www.sqlite.org ) relational databases due to its support and straightforward integration in a variety ofcomputationallanguagesandmolecularmodelingsuitesincluding R, Python, C++, BioPython and Rosetta ( https: //www.rosettacommons.org ).Tab-delimitedtextversionsof each database are also available.",OADS,/arxiv_data1/oa_pdf/09/61/gku1106.PMC4383924.pdf
"Publishedonline06November2014 NucleicAcidsResearch,2015,Vol.43,Databaseissue D1057–D1063 doi:10.1093/nar/gku1113 The GOA database: Gene Ontology annotation updates for 2015 Rachael P. Huntley*, Tony Sawford, Prudence Mutowo-Meullenet, Aleksandra Shypitsyna, Carlos Bonilla, Maria J. Martin and Claire O’Donovan European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK Received September 22, 2014; Revised October 22, 2014; Accepted October 23, 2014 ABSTRACT The Gene Ontology Annotation (GOA) resource (http://www.ebi.ac.uk/GOA ) provides evidence- based Gene Ontology (GO) annotations to proteins in the UniProt Knowledgebase (UniProtKB).",OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
"Our recent annotation projects have included curating proteins involved in kidney development andrelatedprocesses( 7),proteinslocatedintheperoxisome (8)andthoselocatedintheexosome( http://www.ebi.ac.uk/ GOA/exosome ).",Non-OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
"We incorporate annotations from 41 ex-ternal groups and the level of contribution from each group can vary widely; since 2011 we have incorpo- rated manual annotation datasets from the following groups:Aspergillus Genome Database ( 12),Pseudomonas Genome Database ( 13), the Community Assessment of Community Annotation with Ontologies Project (CA- CAO; http://gowiki.tamu.edu/wiki/index.php/Category: CACAO), Microbial Energy Processes Gene Ontology Project (MENGO; http://mengo.vbi.vt.edu/ ), the Syscilia Annotation Project ( http://syscilia.org/ ), Parkinson’s UK-University College London ( http://www.ucl.ac.uk/ functional-gene-annotation/neurological ), the Alzheimer’s Disease Annotation Project at the University of Toronto(http://wiki.geneontology.org/index.php/Alzheimer% 27s DiseaseAnnotation Project), as well as annotations for two new species ( Trypanosoma brucei andLeishmania major) from GeneDB( 14).",Non-OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
"GO ConsortiumcollaborativeprojectscanbefoundontheGOConsortium website(http://geneontology.org/collaborations ).GOterms created as part of these collaborations are indicated in theQuickGO browser ( 17) with the logo of the appropriate funding agency, e.g.",Non-OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
http://www.ebi.ac.uk/QuickGO-Beta/ term/GO:1901207 .,Non-OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
"We continue to support smaller annotation groups by providing Protein2GO and incor- porating their annotation directly into the GOA database.Since 2011, we have provided access to Protein2GO for curatorsfromthefollowinggroups:theAlzheimer’sProject at the University of Toronto ( http://wiki.geneontology.org/ index.php/Alzheimer%27s DiseaseAnnotation Project), the Community Assessment of Community An- notation with Ontologies project (CACAO; http: //gowiki.tamu.edu/wiki/index.php/Category:CACAO ), Parkinson’s UK-University College London ( http: //www.ucl.ac.uk/functional-gene-annotation/neurological ) and theSyscilia Annotation Project( http://syscilia.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
The subunits /components of the complex are specified in the IntAct Complex Portal entry ( http://www.ebi.ac.uk/intact/ complex/details/EBI-9008420 ).,OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
"The GOA web browser QuickGO The GOA browser, QuickGO (( 17);http://www.ebi.ac.uk/ QuickGO ), is currently undergoing improvements to its user interface in order to provide a more intuitive experi- ence for users.",Non-OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
"However, it was not obvious how to use certain features and this was confirmed by user experiencetestingwithQuickGOusersandnon-users.Inordertopro- vide more flexible searching, filtering and display, we have changed the underlying infrastructure of QuickGO to theApache Solr TMsearch platform ( http://lucene.apache.org/ solr/).",OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
This has enabled us to include faceted filtering of the data (Figure 2) that is inline with the recent changes to the UniProt website ( www.uniprot.org ) .Ab e t av e r s i o n oftheimprovedQuickGOisavailableat http://www.ebi.ac.,Non-OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
"Aslight change to this annotation prediction would lead to the correct term, ‘host cell cytoplasm’ (GO:0044165), being supplied in accordance with the GO taxon rules,which require the term ‘cytoplasm’ (GO:0005737) only be applied to cellular organisms ( http://www.ebi.ac.uk/ QuickGO-Beta/term/GO:0005737 ).",Non-OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
All automatic annota- tions that are transformed by the GOA post-processing will use a ‘GO REF’ reference that indicates to the user that such changes have occurred and which points users to thereferencedescription: http://www.geneontology.org/cgi- bin/references.cgi .,Non-OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
to re- trieveallblacklistentriesfortaxonidentifier9031(chicken); http://www.ebi.ac.uk/QuickGO-Beta/ws/validate?type=taxon&taxon id=9031&action=get blacklist).,OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
"DATA ACCESS QuickGO ( http://www.ebi.ac.uk/QuickGO )(17) is the pri- mary location for GOA data, where a full GO annotation setismadefreelyavailabletoview,filteranddownload.An- notationdatawithinQuickGOareupdatedonaweeklyba-sis.",OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
"We addition- ally provide webservices for the annotation blacklist, e.g.toretrieveallblacklistentriesfortaxonidentifier9606(hu- man); http://www.ebi.ac.uk/QuickGO-Beta/ws/validate?",OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
These are identified by the following file name formats: gene association.goa ref <species > gpassociation.goa ref <species > gpinformation.goa ref <species > Thesefilesarelocatedalongsideallofourannotationfiles onthe GOAftpsite: ftp://ftp.ebi.ac.uk/pub/databases/GO/goa/ and on theGOConsortium ftpsite(GAF formatonly):ftp://ftp.geneontology.org/pub/go/gene-associations/ Annotation groups who wish to be considered for ac- cess to Protein2GO or who wish to provide annota- tions for inclusion into our database should contact us at goa@ebi.ac.uk.,Non-OADS,/arxiv_data1/oa_pdf/3e/21/gku1113.PMC4383930.pdf
"ValidatorDB (freely available at http://ncbr.muni.cz/ValidatorDB )o f f e r sa new step in this direction, in the form of a databaseof validation results for all ligands and non-standard residues from the Protein Data Bank (all molecules with seven or more heavy atoms).",OADS,/arxiv_data1/oa_pdf/43/bb/gku1118.PMC4383933.pdf
"ValidatorDBisupdatedweekly,andisfreelyavailableviatheInternetat: http://ncbr.muni.cz/ValidatorDB .",OADS,/arxiv_data1/oa_pdf/43/bb/gku1118.PMC4383933.pdf
"Publishedonline11November2014 NucleicAcidsResearch,2015,Vol.43,Databaseissue D283–D289 doi:10.1093/nar/gku1119 Expediting topology data gathering for the TOPDB database L´aszl´o Dobson, Tam ´as Lang ´o, Istv ´an Rem ´enyi and G ´abor E. Tusn ´ady* ‘Momentum’ Membrane Protein Bioinformatics Research Group, Institute of Enzymology, RCNS, HAS, Budapest PO Box 7, H-1518, Hungary Received September 12, 2014; Revised October 9, 2014; Accepted October 24, 2014 ABSTRACT The Topology Data Bank of Transmembrane Proteins (TOPDB, http://topdb.enzim.ttk.mta.hu ) contains ex- perimentally determined topology data of transmem- brane proteins.",OADS,/arxiv_data1/oa_pdf/cc/22/gku1119.PMC4383934.pdf
"Altogether, more than 75 000 topology data were collected by extracting information from about 4200 publicationsthatresultedintopologyfor4190proteins.The database is available at http://topdb.enzim.ttk.mta.hu .",OADS,/arxiv_data1/oa_pdf/cc/22/gku1119.PMC4383934.pdf
"We have found similar distribution in the HTP ( http://htp.enzim.hu )(37), which indicates that the /H9251-helical bitopic TMPs are not over-representedintheTOPDBdatabase.However,wehave to note that while in the HTP database ( 37) the second more abundant class of proteins contain 7 TM segments, in the TOPDB the second and third most prevalent classes of TMPs are those that contain 2 or 12 TM segments.",Non-OADS,/arxiv_data1/oa_pdf/cc/22/gku1119.PMC4383934.pdf
"Publishedonline11November2014 NucleicAcidsResearch,2015,Vol.43,Databaseissue D583–D587 doi:10.1093/nar/gku1121 VirHostNet 2.0: surﬁng on the web of virus /host molecular interactions data Thibaut Guirimand1,S t´ephane Delmotte1,2and Vincent Navratil1,* 1PRABI, Rh ˆone Alpes Bioinformatics Center, UCBL, Lyon1, Universit ´e de Lyon, Lyon, France and2UMR5558, UCBL, Lyon1, Universit ´e de Lyon, Lyon, France Received September 22, 2014; Revised October 24, 2014; Accepted October 24, 2014 ABSTRACT VirHostNet release 2.0 ( http://virhostnet.prabi.fr )i sa knowledgebase dedicated to the network-based ex- ploration of virus–host protein–protein interactions.",OADS,/arxiv_data1/oa_pdf/9d/b8/gku1121.PMC4383936.pdf
INTRODUCTION Infectiousdiseasescausedbyvirusesareresponsibleformil- lions of death every year as surveyed by the World HealthOrganization ( http://www.who.int ).,Non-OADS,/arxiv_data1/oa_pdf/9d/b8/gku1121.PMC4383936.pdf
AVAILABILITY AccesstoVirHostNet2.0ismadepubliclyavailableat http: //virhostnet.prabi.fr .TheVirHostNet2.0dataaresharedin PSI-MI TAB 2.5 format at http://virhostnet.prabi.fr:9090/ psicquic/webservices/current/search/query/ ∗.,OADS,/arxiv_data1/oa_pdf/9d/b8/gku1121.PMC4383936.pdf
"D698–D706 NucleicAcidsResearch,2015,Vol.43,Databaseissue Publishedonline11November2014 doi:10.1093/nar/gku1128 Helminth.net: expansions to Nematode.net and an introduction to Trematode.net John Martin1,†, Bruce A. Rosa1,†, Philip Ozersky1, Kymberlie Hallsworth-Pepin1, Xu Zhang1, Veena Bhonagiri-Palsikar1, Rahul Tyagi1, Qi Wang1, Young-Jun Choi1,X i nG a o1, Samantha N. McNulty1, Paul J. Brindley2and Makedonka Mitreva1,3,* 1The Genome Institute, Washington University School of Medicine, St. Louis, MO 63108, USA,2Department of Microbiology, Immunology & Tropical Medicine, and Research Center for Neglected Diseases of Poverty, School of Medicine & Health Sciences, The George Washington University, Washington, DC 20037, USA and3Department of Internal Medicine and Department of Genetics, Washington University School of Medicine, St. Louis, MO 63108, USA Received September 22, 2014; Revised October 24, 2014; Accepted October 25, 2014 ABSTRACT Helminth.net ( http://www.helminth.net ) is the new moniker for a collection of databases: Nematode.net and Trematode.net.",OADS,/arxiv_data1/oa_pdf/f6/de/gku1128.PMC4383941.pdf
For over a decade we have provided resources for studying nematodes viaour veteran site Nematode.net ( http://nematode.net ).,Non-OADS,/arxiv_data1/oa_pdf/f6/de/gku1128.PMC4383941.pdf
"This re- port describes updates to Nematode.net since its last description in NAR, 2012, and also introduces andpresents its new sibling site, Trematode.net.INTRODUCTION Parasitic helminth infections are considered ‘the great neglected tropical diseases (NTDs)’ ( 1), accounting for 8 of the 17 most important NTDs, resulting in a col- lective burden rivaling that of the major high-mortalityconditionsm such as HIV /AIDS or malaria (according to the WHO Factsheet on NTDS; http://www.who.int/ neglected diseases/2010report/en/ ).",Non-OADS,/arxiv_data1/oa_pdf/f6/de/gku1128.PMC4383941.pdf
SEG ( ftp://ftp.ncbi.nih.gov/pub/seg/seg/ ) and Re- peatMasker( http://www.repeatmasker.org )filtersareavail- able if the user wishes to screen out low-complexity se- quence or mask repeats in their query.,OADS,/arxiv_data1/oa_pdf/f6/de/gku1128.PMC4383941.pdf
"We will provide links to the complete RNAseq read data set(s), either as accession IDswithinNCBI’sSRA( http://www.ncbi.nlm.nih.gov/sra ) or as direct links if the data is pending official release.",OADS,/arxiv_data1/oa_pdf/f6/de/gku1128.PMC4383941.pdf
"ACKNOWLEDGEMENTS We sincerely thank the numerous collaborators in the helminth community ( nematode.net/collaborators.html andtrematode.net/collaborators.html ), for providing invaluable worm material and being involved in datageneration /analysis activities, and the dedicated mem- bers of the production group at The Genome Institute (http://genome.wustl.edu/ ) for the library construction and sequencing.",Non-OADS,/arxiv_data1/oa_pdf/f6/de/gku1128.PMC4383941.pdf
"Publishedonline11November2014 NucleicAcidsResearch,2015,Vol.43,Databaseissue D335–D338 doi:10.1093/nar/gku1131 RaftProt: mammalian lipid raft proteome database Anup Shah1, David Chen2, Akash R. Boda1, Leonard J. Foster3, Melissa J. Davis4and Michelle M. Hill1,* 1The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, QLD, Australia,2School of Information and Communication Technology, Grifﬁth University, Brisbane, QLD, Australia,3Centre for High-Throughput Biology, University of British Columbia, British Columbia, Canada and 4Systems Biology Laboratory, Melbourne School of Engineering, The University of Melbourne, Parkville, VIC, Australia Received August 15, 2014; Revised October 07, 2014; Accepted October 25, 2014 ABSTRACT RaftProt ( http://lipid-raft-database.di.uq.edu.au/ )i sa database of mammalian lipid raft-associated pro- teins as reported in high-throughput mass spectrom- etry studies.",OADS,/arxiv_data1/oa_pdf/c5/21/gku1131.PMC4383944.pdf
The database is deployed on Apache server 2.2.15 ( http://www.apache.org ).,OADS,/arxiv_data1/oa_pdf/c5/21/gku1131.PMC4383944.pdf
All the data were stored in a relational database schema in MySQL server 5.1.73 (http://www.mysql.com ).,OADS,/arxiv_data1/oa_pdf/c5/21/gku1131.PMC4383944.pdf
"In order to integrate these related re- sults and facilitate the researches for the community, we conducted manual text-mining from published lit-erature and built a database named as PubAngio- Gen ( http://www.megabionet.org/aspd/ ).",OADS,/arxiv_data1/oa_pdf/e3/c0/gku1139.PMC4383947.pdf
"Cell Signaling Technology Path- way Database, http://www.cellsignal.com/ ).",OADS,/arxiv_data1/oa_pdf/e3/c0/gku1139.PMC4383947.pdf
"Raghava* Bioinformatics Centre, CSIR-Institute of Microbial Technology, Chandigarh 160036, India Received August 15, 2014; Revised September 27, 2014; Accepted October 27, 2014 ABSTRACT AHTPDB ( http://crdd.osdd.net/raghava/ahtpdb/ )i sa manually curated database of experimentally val- idated antihypertensive peptides.",OADS,/arxiv_data1/oa_pdf/5b/bc/gku1141.PMC4383949.pdf
"ACEpepDB(http://www.cftri.com/pepdb/ ), EROP-Moscow database and BIOPEP ( 22) database.",OADS,/arxiv_data1/oa_pdf/5b/bc/gku1141.PMC4383949.pdf
"Here, we focus on spatio-temporal gene expression pat- terns during early development in several dipteran in- sects (dipterans include flies, midges and mosquitoes).Specifically, our SuperFly database ( http://superfly.crg.eu ) includes expression data for segmentation genes during the cleavage and blastoderm stages of development inthree species: our reference, the vinegar fly Drosophila melanogaster (family:Drosophilidae )(3–5), as well as two emerging non-drosophilid model organisms, the scuttle flyMegaselia abdita (Phoridae )(6–11) and the moth midge Clogmia albipunctata (Psychodidae )(10,12–14).",Non-OADS,/arxiv_data1/oa_pdf/c9/96/gku1142.PMC4383950.pdf
DATABASE STRUCTURE AND CONTENT SuperFly is implemented as a MySQL ( http://www.mysql.,OADS,/arxiv_data1/oa_pdf/c9/96/gku1142.PMC4383950.pdf
"DATABASE ACCESS AND WEB SITE FEATURES The web interface of SuperFly is implemented using PHP (http://php.net ), JavaScript and GNUPlot ( http:// www.gnuplot.info ).",OADS,/arxiv_data1/oa_pdf/c9/96/gku1142.PMC4383950.pdf
CONCLUSION SuperFly( http://superfly.crg.eu )providesadetailedandac- curate dataset on spatio-temporal expression of segmenta- tion genes in various dipteran species.,OADS,/arxiv_data1/oa_pdf/c9/96/gku1142.PMC4383950.pdf
"We thank Victor Jim´enez-Guri ( http://www.sihaycolor.com ) for creating the SuperFlylogo.Inaddition,wewouldliketothanktheICTdepartmentof theCRG for theirsupport.",Non-OADS,/arxiv_data1/oa_pdf/c9/96/gku1142.PMC4383950.pdf
"D856–D861 NucleicAcidsResearch,2015,Vol.43,Databaseissue Publishedonline14November2014 doi:10.1093/nar/gku1151 MethHC: a database of DNA methylation and gene expression in human cancer Wei-Yun Huang1,2, Sheng-Da Hsu2, Hsi-Yuan Huang2, Yi-Ming Sun2, Chih-Hung Chou1,2, Shun-Long Weng1,2,3,4,5and Hsien-Da Huang1,2,6,7,* 1Department of Biological Science and Technology, National Chiao Tung University, Hsin-Chu 300, Taiwan,2Institute of Bioinformatics and Systems Biology, National Chiao Tung University, Hsin-Chu 300, Taiwan,3Department of Obstetrics and Gynecology, Hsinchu Mackay Memorial Hospital, Hsin-Chu 300, Taiwan,4Mackay Medicine, Nursing and Management College, Taipei 112, Taiwan,5Department of Medicine, Mackay Medical College, New Taipei City 252, Taiwan,6Center for Bioinformatics Research, National Chiao Tung University, Hsin-Chu 300, Taiwan and 7Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung 807, Taiwan Received August 15, 2014; Revised October 11, 2014; Accepted October 28, 2014 ABSTRACT We present MethHC ( http://MethHC.mbc.nctu.edu.",Non-OADS,/arxiv_data1/oa_pdf/51/fc/gku1151.PMC4383953.pdf
"D1010–D1017 NucleicAcidsResearch,2015,Vol.43,Databaseissue doi:10.1093/nar/gku1155 GEM2Net: from gene expression modeling to -omics networks, a new CATdb module to investigate Arabidopsis thaliana genes involved in stress response Rim Zaag1,2,†, Jean Philippe Tamby1,2,†,C´ecile Guichard1,2,†, Zakia Tariq1,2, Guillem Rigaill1,2, Etienne Delannoy1,2, Jean-Pierre Renou1,2, Sandrine Balzergue1,2, Tristan Mary-Huard3,4,5,S´ebastien Aubourg1,2, Marie-Laure Martin-Magniette1,2,3,4and V´eronique Brunaud1,2,* 1INRA, Unit ´e de Recherche en G ´enomique V ´eg´etale, UMR 1165, ERL CNRS 8196, Saclay Plant Sciences, CP 5708, F-91057 Evry, France,2UEVE, Unit ´e de Recherche en G ´enomique V ´eg´etale, UMR 1165, ERL CNRS 8196, Saclay Plant Sciences, CP 5708, F-91057 Evry, France,3INRA, UMR 518 MIA, 75005 Paris, France,4AgroParisTech, UMR 518 MIA, 75005 Paris, France and5UMRGV, INRA, Universit ´e Paris-Sud, CNRS, F-91190 Gif-sur-Yvette, Paris, France Received September 12, 2014; Revised October 17, 2014; Accepted October 29, 2014 ABSTRACT CATdb ( http://urgv.evry.inra.fr/CATdb ) is a database providing a public access to a large collection of tran- scriptomic data, mainly for Arabidopsis but also for other plants.",OADS,/arxiv_data1/oa_pdf/5e/bd/gku1155.PMC4383956.pdf
"NucleicAcidsResearch,2015,Vol.43,Databaseissue D1011 transcriptomic platform ( http://www-urgv.versailles.inra.",OADS,/arxiv_data1/oa_pdf/5e/bd/gku1155.PMC4383956.pdf
"Finally, since its first release, the information sys- temofCATdbhasbeenupgradedtofollowthetechnologi- caldevelopmentsoftheplatform.Currently,CATdbstores transcriptomic data for 20 distinct species obtained with four DNA chip technologies and totalizing 4838 CATMA,1464Affymetrix,1208NimbleGenand48Agilentmicroar- rays.Atpresent,thedatabaseincludes282projects(231for Arabidopsis and 51 for other species) and contains almost10000hybridizedsamples(fivetimesmorethanin2008for the first CATdb publication ( 1)), which are publicly acces- sible athttp://urgv.evry.inra.fr/CATdb .",OADS,/arxiv_data1/oa_pdf/5e/bd/gku1155.PMC4383956.pdf
"A Web interface for accessing GEM2Net content was developed with the PHP (release 5.3.3) language to benefit from its integration as a moduleofApacheHTTPserver( https://httpd.apache.org/ ).Object- oriented programming concepts were applied to take ad- vantage of the easy maintainability qualities in develop-mentofacomplexinterface.Dynamicrenderingwasadded using Javascript libraries (Jquery, Json) and functions, in order to facilitate the navigation between pages and thenimprove the user experience.",OADS,/arxiv_data1/oa_pdf/5e/bd/gku1155.PMC4383956.pdf
Visualization of meta-data The GEM2Net Web interface ( http://urgv.evry.inra.fr/ GEM2NET ) allows users to query the database by stress category or to submit a list of genes of interest to retrieve the stress categories they are implicated in.,OADS,/arxiv_data1/oa_pdf/5e/bd/gku1155.PMC4383956.pdf
"Here in this updated YM500v2 database (http://ngs.ym.edu.tw/ym500/ ), we focus on the can- cer miRNome to make the database more disease- orientated.",Non-OADS,/arxiv_data1/oa_pdf/0a/5a/gku1156.PMC4383957.pdf
"Especially, dozens of CLIP-seq datasets are provided as experimental evidence for insilico predictednovelmiRNAs.RegardingisomiRs,twonewsta- tisticalchartsareprovidedforaspecificisomiR.YM500v2 also contains a new function ‘Meta-analysis’, which allows researcherstoidentifydifferentiallyexpressedmiRNAsand arm-switching events in two customer-defined groups ofsamples.DATA COLLECTION AND PRE-PROCESSING There are 8105 smRNA-seq datasets from TCGA, includ- ing those of primary tumors, paired normal tissues, pe- ripheral blood mononuclear cell (PBMC), recurrent tu- mors and metastatic tumors, incorporated into YM500v2 (SupplementalTableS1).Rawdataweredownloadedfrom CGHub ( https://cghub.ucsc.edu/ ) and were pre-processed by in-house scripts.",OADS,/arxiv_data1/oa_pdf/0a/5a/gku1156.PMC4383957.pdf
"In this report we present lncRNAWiki (http://lncrna.big.ac.cn ), a wiki-based platform that is open-content and publicly editable and aimed at community-based curation and collection of informa- tion on human lncRNAs.",OADS,/arxiv_data1/oa_pdf/65/80/gku1167.PMC4383965.pdf
"Wikipedia ( http://www.wikipedia.org ), an online encyclo- pedia, is an extraordinarily successful example that relies on the community knowledge in information integration andallowspeoplefromallovertheworldtocreate /editany content.Wikipediafeaturescollaborativeinformationinte- gration, huge coverage, up-to-date content as well as low- maintenancecost.Manyattemptshavebeenmadeinappli-cation of wiki for biological data integration ( 22–25).",Non-OADS,/arxiv_data1/oa_pdf/65/80/gku1167.PMC4383965.pdf
"IMPLEMENTATION LncRNAWiki is built based on MediaWiki version 1.19.1 (http://www.mediawiki.org ), which is an open source wiki engine, MySQL version 5.1.58 ( http://www.mysql.org )a popular and free relational database management system, and PHP version 5.2.17 ( http://www.php.net ), which is a scripting language.",OADS,/arxiv_data1/oa_pdf/65/80/gku1167.PMC4383965.pdf
"In order to make lncRNAWiki more attractive for participants from the broader scien-tific community in tasks of collaborative curation of lncR- NAs, we installed ‘AuthorReward’ ( http://www.mediawiki.",Non-OADS,/arxiv_data1/oa_pdf/65/80/gku1167.PMC4383965.pdf
All exten- sionsandsoftwareimplementedinlncRNAWikiareacces- sible at http://lncrna.big.ac.cn/index.php/Special:Version .,OADS,/arxiv_data1/oa_pdf/65/80/gku1167.PMC4383965.pdf
"ScreenshotsofthelncRNAWikipageforthelncRNAtranscript MALAT-1 ,availableat http://lncrna.big.ac.cn/index.php/ENST00000534336.1 .",OADS,/arxiv_data1/oa_pdf/65/80/gku1167.PMC4383965.pdf
‘Ref- erences’ provides publications related to the lncRNA and they are automatically formatted using the ‘Cite’ extension(http://www.mediawiki.org/wiki/Extension:Cite ).,OADS,/arxiv_data1/oa_pdf/65/80/gku1167.PMC4383965.pdf
"For example, we added to lncRNAWiki (http://lncrna.big.ac.cn/index.php/LUNAR1 )LUNAR1 ,a recently discovered human lncRNA, immediately after the relevant paper was published online.",Non-OADS,/arxiv_data1/oa_pdf/65/80/gku1167.PMC4383965.pdf
"Therefore, we devel-oped DDMGD database ( http://www.cbrc.kaust.edu.",Non-OADS,/arxiv_data1/oa_pdf/99/2c/gku1168.PMC4383966.pdf
MeInfoText 2.0 is used to extract such associations be- tween methylated human genes and cancers from PubMed (http://www.ncbi.nlm.nih.gov/pubmed )abstractsusingtwo maximum entropy models ( 8).,OADS,/arxiv_data1/oa_pdf/99/2c/gku1168.PMC4383966.pdf
Data sources We used scientific literature (PubMed and Open Access Subset (OAS) of PubMed Central ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/99/2c/gku1168.PMC4383966.pdf
The instructions page ( http://www.cbrc.kaust.,Non-OADS,/arxiv_data1/oa_pdf/99/2c/gku1168.PMC4383966.pdf
"Al-ternatively, users can save the search results and the search queriesintheiraccounts(Figure 3).Additionally,userscan download the whole database from http://www.cbrc.kaust.",OADS,/arxiv_data1/oa_pdf/99/2c/gku1168.PMC4383966.pdf
"Herein, we describe a curated database named LncRNA2Target ,w h i c h stores lncRNA-to-target genes and is publicly ac-cessible at http://www.lncrna2target.org .Ag e n ew a s considered as a target of a lncRNA if it is differ- entially expressed after the lncRNA knockdown oroverexpression.",Non-OADS,/arxiv_data1/oa_pdf/e3/ad/gku1173.PMC4383967.pdf
"To address the scarcity of single nucleotide polymorphism (SNP) data provided by authorized databases and to makeSNP data more easily /friendly usable and available, we propose DoGSD ( http://dogsd.big.ac.cn ), the ﬁrst canidae-speciﬁc database which focuses on wholegenome SNP data from domesticated dogs and grey wolves.",Non-OADS,/arxiv_data1/oa_pdf/4c/fd/gku1174.PMC4383968.pdf
"Todate,thelatestandmostwidelyuseddogSNPdataset is from dbSNP (build139: ftp://ftp.ncbi.nlm.nih.gov/snp/ ), where ∼80%ofthe ∼2.7MSNPswerecalledfromtwodogs, one Boxer ( 14) and one Standard Poodle ( 15).",Non-OADS,/arxiv_data1/oa_pdf/4c/fd/gku1174.PMC4383968.pdf
Picard (version:1.87)(downloadedfrom http://picard.sourceforge.,Non-OADS,/arxiv_data1/oa_pdf/4c/fd/gku1174.PMC4383968.pdf
"After that, we used the tools in GATK (version:2.5–2-gf57256b) ( 19,20) to realign reads around known indels (downloaded from Ensembl ftp://ftp.ensembl.org/ pub/release-73/variation/vcf/canis familiaris/ ), and recali- brate base quality score to obtain more accurate quality score for each base.",OADS,/arxiv_data1/oa_pdf/4c/fd/gku1174.PMC4383968.pdf
"SNPs were then an- notatedtogenes,transcriptsandproteinsdownloadedfromtheEnsemblFTPsite( ftp://ftp.ensembl.org/pub/release-75/ fasta/canis familiaris/ ).",OADS,/arxiv_data1/oa_pdf/4c/fd/gku1174.PMC4383968.pdf
"Publishedonline17November2014 NucleicAcidsResearch,2015,Vol.43,Databaseissue D1145–D1151 doi:10.1093/nar/gku1175 Beyond protein expression, MOPED goes multi-omics Elizabeth Montague1,2,3,4, Imre Janko2,3,4, Larissa Stanberry1,2,3,4, Elaine Lee2,3,4, John Choiniere1,2,4, Nathaniel Anderson1,2,4, Elizabeth Stewart1,4, William Broomall2,3,4, Roger Higdon1,2,3,4, Natali Kolker2,3,4and Eugene Kolker1,2,3,4,5,6,* 1Bioinformatics and High-Throughput Analysis Laboratory, Center for Developmental Therapeutics, Seattle Children’s Research Institute, Seattle, WA, USA 98101,2High-Throughput Analysis Core, Seattle Children’s Research Institute, Seattle, WA, USA 98101,3CDO Analytics, Seattle Children’s, Seattle, WA, USA 98101,4Data-Enabled Life Sciences Alliance (DELSA Global), Seattle, WA, USA 98101,5Departments of Biomedical Informatics and Medical Education and Pediatrics, University of Washington, Seattle, WA, USA 98109 and6Department of Chemistry and Chemical Biology, College of Science, Northeastern University, Boston, MA 02115 Received September 02, 2014; Revised October 23, 2014; Accepted November 02, 2014 ABSTRACT MOPED (Multi-Omics Proﬁling Expression Database; http://moped.proteinspire.org ) has transitioned from solely a protein expression database to a multi-omics resource for human and model organisms.",Non-OADS,/arxiv_data1/oa_pdf/5d/94/gku1175.PMC4383969.pdf
"proteomexchange.org ,https://www.proteomicsdb.org/ ).",OADS,/arxiv_data1/oa_pdf/5d/94/gku1175.PMC4383969.pdf
"MOPED is continually expanding by moni- toring and downloading new experimental data from public repositories: PRIDE, PeptideAtlas,proteomeXchange, ProteomicsDB and GEO ( 19– 21), ( http://proteomecentral.proteomexchange.org , https://www.proteomicsdb.org/ ).",OADS,/arxiv_data1/oa_pdf/5d/94/gku1175.PMC4383969.pdf
"apache.org/ ;EclipseFoundation, http://eclipse.org/aspectj/ ; Google,http://www.google.com/analytics/ ).Thequeriesare built and executed via the Basic Search (Figure 2Aa n dB ) and Advanced Search (Figure 3) options.",OADS,/arxiv_data1/oa_pdf/5d/94/gku1175.PMC4383969.pdf
"ExternalsourcesforMOPEDdata Datatype Expressiondata Names,descriptionsandmappings Protein PRIDE,PeptideAtlas,proteomeXchange, ProteomicsDB,IndividualLabsUniProt Gene GEO Ensembl,Entrez Pathway BioCyc,PANTHER,Reactome Expressiondatacomefrompublicrepositoriesandindividuallabs( 13–21)(http://proteomecentral.proteomexchange.org, https://www.proteomicsdb.org/ ).",OADS,/arxiv_data1/oa_pdf/5d/94/gku1175.PMC4383969.pdf
"MOPED provides a conve- nient venue for researchers to both make their data pub- lic and share these privately with collaborators and review-ers(1,3).PrivateMOPEDprovidesthesamefeatures,tools and conveniences as the public MOPED but enables the owner of the data to both limit access and make the datapublicwhenappropriate.Ifinterestedinsubmittingdatato MOPED,pleasecontacttheMOPEDteamthroughtheFo- rum:http://moped-forum.proteinspire.org .",OADS,/arxiv_data1/oa_pdf/5d/94/gku1175.PMC4383969.pdf
"Publishedonline26November2014 NucleicAcidsResearch,2015,Vol.43,Databaseissue D1049–D1056 doi:10.1093/nar/gku1179 Gene Ontology Consortium: going forward The Gene Ontology Consortium* List of authors of the Gene Ontology Consortium is provided in the Appendix Received September 24, 2014; Revised October 30, 2014; Accepted October 31, 2014 ABSTRACT The Gene Ontology (GO; http://www.geneontology.",OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"Here we describe the latest im- provementstothetoolsandresourcesoftheGOC.Ontolo- gies, annotations, and tools are freely available via the In-ternetat http://www.geneontology.org .",OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"The GOC is also currently working with the SYSCILIAConsortium(( 5);http://syscilia.org/ )toimprove the representation of ciliary substructures in the GO cellu- lar component branch, with plans to also improve the bi- ological process branch.",Non-OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"We have commenced an effort to temporally delimit cellular pro-cesses using logical definitions such as the starts withand endswithrelationships from the OBO Relations Ontology (http://obo-relations.googlecode.com ).Forexample,‘apop- toticprocess’ startswith‘apoptoticsignaling pathway’ and endswith‘executionphaseofapoptosis’.Ourgoalistoap- ply this pattern throughout the cellular process branch of the GO, in order to better enforce annotator consistency across different GO annotation sources, and to allow fora limited form of temporal reasoning over the ontology, all of which results in greater interpretability of GO-based analyses for all users.",Non-OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"The execution phase is the last step of an apoptoticprocess, and is typically characterized by rounding-up ofthecell,retractionofpseudopodes,reductionofcel- lular volume (pyknosis), chromatin condensation, nu-clear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies.Whentheexecutionphaseiscompleted,thecellhas died.’ SubClassOf: ’programmed cell death’ start withsome ‘apoptoticsignaling pathway’ endswithsome ‘executionphase ofapoptosis’ Aversionoftheontologycontainingallrelationships,in- cluding information from the Uberon anatomy (or stage)ontology ( 7), the Chemical Entities of Biological Inter- est ontology (ChEBI; ( 8)), the Plant Ontology for plant structure /stage (PO; ( 9)), the Phenotypic Quality Ontol- ogy (PATO; ( 10)) and the Sequence Ontology (SO; ( 11)), iscalledgo-plusandisavailableat http://geneontology.org/ page/download-ontology .",Non-OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"At present, there are over 40 available templateformsforrequestingnewterms,andthisnumbercontinues togrow.Examplesincludetemplatesforcreatingnewterms to describe relationships such as ‘regulation of biological process’or‘chemicalresponseto’.TermGeniecanbefound athttp://go.termgenie.org/ ,thesourcecodeisavailablefrom",OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
Googlecodeat https://code.google.com/p/termgenie andall changes to the repository are listed at https://code.google.,OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"Asreportedbefore,theGOCuses an open-source continuous integration system (Jenkins; http://jenkins-ci.org/ ) to validate the ontology.",OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"For example, a recent collaboration with the Transcription Factor Checkpointdatabase ( http://www.tfcheckpoint.org/ ) has expanded an- notation to human, mouse, and rat transcription factors (21), and the Developmental Functional Annotation at Tufts (DFLAT) project improved the quality of annota- tions of genes involved in fetal development curating hu- man fetal gene functions using both manual and semi-automated annotation ( 22).",OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
In a joint collaboration be- tween Gramene ( www.gramene.org ) and Ensembl Plants (http://plants.ensembl.org ) initial GO annotations are now providedfor ∼37sequencedplantgenomesasofthecurrent release (23).,OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"This reorganization aims to keep all content consistent and up to date, as well as clar-ifying use policies and licensing, which were standardized on CC-BY 4.0 ( https://creativecommons.org/licenses/by/4.",Non-OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"To accomplish this, the new GOwebsiteisbasedonthelateststableversionofDrupal(Dru- pal7;http://drupal.org ),arobustopen-sourcecontentman- agement system that offers a flexible and extensible wayto design and organize content.",OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"In the case of social me- dia data, the Facebook feed is pulled into our aggregator, and the Twitter feed (including the widget currently avail-able on the front page), is updated through an automatic ‘publish’actionthatfeedstheGOTwitterprofilewhennew ‘article’pagesarecreatedontheGOwebsite.Thisdatabase-backed environment also allows for better control of revi- sionsthroughtimeaswellasenforcedworkflowsthatenable the GOC to allow the consortium members to keep infor-mationuptodateindependentofdeveloperavailability.We encouragethepublictoaccessandcontributetotheefforts oftheGOC at http://geneontology.org .",Non-OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"The AmiGO 2 set of tools also pro- videsaJavaScriptAPIforbetteraccessandintegrationwithother tools, and both provides and consumes REST APIs to help better integrate resources, such as the PANTHER database ( http://pantherdb.org ,(24))forenrichmentanaly- sis.",OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"For the backend, the data store for AmiGO 2 has moved away from a MySQL relational database backend and in- stead uses a specially generated schema for the Solr search platform ( http://lucene.apache.org/solr/ ; dubbed GOlr) to allow forcomplexand efficientontologyand dataqueries.",OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"The GOC pro- vides platforms of interaction and welcomes participa- tion from the community through our Helpdesk ( http:// geneontology.org/form/contact-go ), to address general in- quiries,andtheSourceforgetracker( http://sourceforge.net/ p/geneontology/ontology-requests/ ) to address specific re- questsfor theontology.",Non-OADS,/arxiv_data1/oa_pdf/90/b4/gku1179.PMC4383973.pdf
"Here we present do- RiNA 2.0, available at http://dorina.mdc-berlin.de .I n this highly improved new version, we have com- pletely reworked the user interface and expanded the database to improve the usability of the website.",Non-OADS,/arxiv_data1/oa_pdf/db/4a/gku1180.PMC4383974.pdf
The web server is based on the Python-based Flask micro-framework ( http://flask.pocoo.org ).,OADS,/arxiv_data1/oa_pdf/db/4a/gku1180.PMC4383974.pdf
"The web application is writteninJavaScript,usingJQuery( http://jquery.com )and Knockout.js ( http://knockoutjs.com ) to control the single- page HTML5 user interface in a Model-View-Viewmodel architecture.Webserverandwebapplicationexchangedataasynchronously, passing JSON objects around via AJAX requests.",OADS,/arxiv_data1/oa_pdf/db/4a/gku1180.PMC4383974.pdf
"The web server processes in- coming requests, scheduling them for analysis by the anal- ysislibraryviaawork-queuesystembasedonRedisQueue (http://python-rq.org ).Afterresultsarecalculated,theyare cached in a Redis in-memory database, allowing the webservertoquicklyreturnresultsforpopularquerieswithout havingtorepeattheanalysisstep.Aserver-sidesessionhan- dling takes care ofremoving uploaded regulator files.",OADS,/arxiv_data1/oa_pdf/db/4a/gku1180.PMC4383974.pdf
Custom data upload DoRiNA 2.0 enables users to upload their own data in the widelyacceptedBEDformat.Theuserdecidesatthebegin- ningofadoRiNAsessionifheorshewantstouploadacus-tomBEDfile.Thecontainedfeaturesaredisplayedasaddi- tionalregulator(uploadedcustomregulator)onthewebin- terface (see http://dorina.mdc-berlin.de/tutorials#custom- regulator ) and can be used as any other datasets for search operations in doRiNA2.Interfaces and APIs for access by third-party tools Third-party tools may interact with doRiNA 2.0 on mul- tiple layers.,OADS,/arxiv_data1/oa_pdf/db/4a/gku1180.PMC4383974.pdf
"ingthefollowingURL( http://www.circbase.org/download/ hsahg19Memczak2013 HEK293.bed ) Ourideaistotestthecustomregulatorset(circRNAloci) for overlap with Argonaute binding sites, which would beindicative of a putative sponge function.",OADS,/arxiv_data1/oa_pdf/db/4a/gku1180.PMC4383974.pdf
AVAILABILITY The doRiNA database is available at http://dorina.mdc- berlin.de under an OSI-approved Open Source license.Therearenoaccessrestrictionsforacademicorcommercial use.,OADS,/arxiv_data1/oa_pdf/db/4a/gku1180.PMC4383974.pdf
Source code of the analysis library and the web server areavailableat https://github.com/dieterich-lab/dorina .W e kindly ask researchers to cite the doRiNA manuscript iftheyincluderesultsintheirpublications.Theuserscanalso get help by visiting the user forum https://groups.google.,Non-OADS,/arxiv_data1/oa_pdf/db/4a/gku1180.PMC4383974.pdf
"To address this issue and serve as bridge to integrate genomic and proteomicsdatasets, CMPD ( http://cgbc.cgu.edu.tw/cmpd )c o l - lected over 2 millions genetic alterations, which not only facilitates the conﬁrmation and examination ofpotential cancer biomarkers but also provides an in- valuable resource for translational medicine research and opportunities to identify mutated proteins en- coded by mutated genes.INTRODUCTION Cancer is a genetic disease, which arise as a consequence of genomic abnormalities stemming from somatically ac-quiredmutationsorinheritedgenemutations.Genomicse- quence can be altered on difference scales, which include single nucleotide variations (SNVs), small insertions anddeletions (INDELs), rearrangements of genome segments and changes in the copy number of DNA fragments.",Non-OADS,/arxiv_data1/oa_pdf/04/7d/gku1182.PMC4383976.pdf
"Tothisend,theNCICancerGenomeAtlas(TCGA)project has sequencedthegenomesofover10000tumoursamplesin 33 cancer types ( https://tcga-data.nci.nih.gov/tcga/ )(1).",OADS,/arxiv_data1/oa_pdf/04/7d/gku1182.PMC4383976.pdf
"The Variant Call Format (VCF) as well as the Mu- tation Annotation Format (MAF) files corresponded to these sequencing projects can be downloaded from CellMiner ( http://discover.nci.nih.gov/cellminer/ ), CCLE website (http://www.broadinstitute.org/ccle/home ), and the MAF Dashboard ( https://confluence.broadinstitute.org/ display/GDAC/MAF+Dashboard ) of the Broad Institute’s Genome Data Analysis Center (GDAC), respectively.Gene information and FASTA-formatted sequence files at both protein and mRNA levels can be downloaded from ENSEMBL ( 22) and UCSC through BioMart ( 23) and UCSC Table Browser ( 24), respectively.",OADS,/arxiv_data1/oa_pdf/04/7d/gku1182.PMC4383976.pdf
"The web in-terface is built with PHP and JQuery ( http://jquery.com ), which allows users to query and explore the content of database.",OADS,/arxiv_data1/oa_pdf/04/7d/gku1182.PMC4383976.pdf
Dynamic tables and Summary charts are imple- mentedusingGoogleChartAPI( https://developers.google.,OADS,/arxiv_data1/oa_pdf/04/7d/gku1182.PMC4383976.pdf
Datasourcesanddatabasestatistics Datasources NCI-60panel CCLE TCGA No.ofcelllinesorno.ofsamples 61celllines 947cell lines 5625tumoursamples(from20 tumourtypes) Variantidentificationapproaches Whole-exomesequencing DNAsequencing(1651 cancer-associatedgenes)Whole-exomesequencingor whole-genomesequencing No.ofcodingvariants 63288 64433 1 533435 No.ofSNVs(%) 61632(97.38%) 59855 (92.89%) 725434(47.30%) No.ofINDELs(%) 1656(2.62%) 4578 (7.11%) 808001(52.70%) Mutantproteinsequences depositedin CMPD135286 291662 2 952174 References ( 2)( 3)( 1) Linkstorawdata Rawdataat CellMineraRawdataat CCLEbTCGAMutationAnnotationFormat (MAF)filesdownloadablefromthe MAFDashboardoftheBroad Institute’sGenomeDataAnalysisCenter c ahttp://discover.nci.nih.gov/cellminer/loadDownload.do.,Non-OADS,/arxiv_data1/oa_pdf/04/7d/gku1182.PMC4383976.pdf
bhttp://www.broadinstitute.org/ccle/data/browseData?conversationPropagation=begin.,OADS,/arxiv_data1/oa_pdf/04/7d/gku1182.PMC4383976.pdf
chttps://confluence.broadinstitute.org/display/GDAC/MAF ±Dashboard.,OADS,/arxiv_data1/oa_pdf/04/7d/gku1182.PMC4383976.pdf
Users can use these attributions to obtain more informationontheinterestedproteins.Detaileddescription on the header content can be found at http://cgbc.cgu.edu.,OADS,/arxiv_data1/oa_pdf/04/7d/gku1182.PMC4383976.pdf
"A real-example on using CMPD As a proof-of-principle experiment, LC–MS files of the COLO-205cellproteomedownloadedfrompreviousstudy(http://wzw.tum.de/proteomics/NCI60/ )(4) were searched against the mutated tryptic peptide database generated by CMPDusingMascotsearchengine.Thesearchresultiden- tified10matchingpeptidesspecificfortheirrelevantmutant proteins (Table 2), providing strong evidence that CMPD",OADS,/arxiv_data1/oa_pdf/04/7d/gku1182.PMC4383976.pdf
"InChiTaRS-2.1,wehaveaddedananalysisandcompar- isonofthejunctionsites,rankandconsistencybetweendif-ferent chimeric transcripts ( 18) in all eight studied organ- isms.Thisnewfeatureprovidesuserstheabilitytostudythe evolution of chimeric transcripts and conservation of thejunctionsitesforanychimera,includingthe2337chimeras conservedbetweenhumanandmouse.Anewimprovedin- terface allows users to ‘Compare and Analyze’ chimerasfromdifferentorganisms(seealinkattheTopMenuofthe database webpage: http://chitars.bioinfo.cnio.es/ ).",OADS,/arxiv_data1/oa_pdf/d9/66/gku1199.PMC4383979.pdf
The database is now pub- licly accessible at http://chitars.bioinfo.cnio.es/ and the old version of the database is accessible at http://chitars-old.,OADS,/arxiv_data1/oa_pdf/d9/66/gku1199.PMC4383979.pdf
"The newer version of the Classifier wastrained with the rrnDB pan-taxa statistics and is available from RDP ( http://rdp.cme.msu.edu/ ) and the RDP repos- itory on SourceForge ( http://sourceforge.net/projects/rdp- classifier/ ).The‘Estimate’featureofthe rrnDBwebsiteisan on-line interface to the RDP Classifier, including 16S copy number adjustment of taxon abundance for user-uploaded16S sequencefiles.",OADS,/arxiv_data1/oa_pdf/7f/7c/gku1201.PMC4383981.pdf
KEGGsourcedataareaccessedbyusthroughpaidaca- demic subscription to the KEGG data via their FTP site(http://www.kegg.jp/kegg/download/ ).,OADS,/arxiv_data1/oa_pdf/7f/7c/gku1201.PMC4383981.pdf
The inte-grated taxonomy also supports the computation of statis- tics from the rrnDB records aggregated at any node of the NCBItaxonomictree.TheNCBItaxonomydatawillbeup-datedtogetherwitheachupdateofKEGGgenomes.NCBI taxonomy data are freely available at the NCBI FTP site (http://www.be-md.ncbi.nlm.nih.gov/taxonomy/ ).,OADS,/arxiv_data1/oa_pdf/7f/7c/gku1201.PMC4383981.pdf
"Sonnhammer*and Gabriel ¨Ostlund Stockholm Bioinformatics Center, Department of Biochemistry and Biophysics, Stockholm University, Science for Life Laboratory, Box 1031, SE-17121 Solna, Sweden Received September 25, 2014; Revised November 03, 2014; Accepted November 05, 2014 ABSTRACT The InParanoid database ( http://InParanoid.sbc.su.",OADS,/arxiv_data1/oa_pdf/a3/fa/gku1203.PMC4383983.pdf
"On the online orthology benchmarks at http://orthology.benchmarkservice.org ,I n - Paranoidisgenerallyrankedamongthebestmethods,espe- ciallywhenlookingatbothcoverageandaccuracy.Adraw- back of InParanoid’s pairwise approach, which it shareswithmostotherorthologinferencemethods,ishoweverthe quadraticruntimescalingwiththenumberofspecies.With 273 species, this has become a tangible practical problem.In the future, more attention needs to be given to ways to reducethecomputational burden.",Non-OADS,/arxiv_data1/oa_pdf/a3/fa/gku1203.PMC4383983.pdf
"As this is a general problem in the orthology field, the ‘Quest for Orthologs’ (QFO; http://questfororthologs.org/ ) community has agreed on establishing and using standard- ized reference proteomes that are curated at the EBI ( http: //www.ebi.ac.uk/reference proteomes ).",Non-OADS,/arxiv_data1/oa_pdf/a3/fa/gku1203.PMC4383983.pdf
"D470–D478 NucleicAcidsResearch,2015,Vol.43,Databaseissue Publishedonline26November2014 doi:10.1093/nar/gku1204 The BioGRID interaction database: 2015 update Andrew Chatr-aryamontri1, Bobby-Joe Breitkreutz2, Rose Oughtred3, Lorrie Boucher2, Sven Heinicke3, Daici Chen1, Chris Stark2, Ashton Breitkreutz2, Nadine Kolas2, Lara O’Donnell2, Teresa Reguly2, Julie Nixon4, Lindsay Ramage4, Andrew Winter4, Adnane Sellam5, Christie Chang3, Jodi Hirschman3, Chandra Theesfeld3, Jennifer Rust3, Michael S. Livstone3, Kara Dolinski3and Mike Tyers1,2,4,* 1Institute for Research in Immunology and Cancer, Universit ´e de Montr ´eal, Montr ´eal, Quebec H3C 3J7, Canada, 2The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada, 3Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA,4School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3JR, UK and5Centre Hospitalier de l’Universit ´eL a v a l (CHUL), Qu ´ebec, Qu ´ebec G1V 4G2, Canada Received September 26, 2014; Revised November 4, 2014; Accepted November 5, 2014 ABSTRACT The Biological General Repository for Interaction Datasets (BioGRID: http://thebiogrid.org ) is an open access database that houses genetic and protein in- teractions curated from the primary biomedical lit- erature for all major model organism species and humans.",OADS,/arxiv_data1/oa_pdf/f8/b8/gku1204.PMC4383984.pdf
The Biological General Repository for Interaction Datasets (BioGRID: http://thebiogrid.org ) was established in order to help cap- ture biological interaction data from the primary biomed- ical literature and to provide this data in a readily com- putable format ( 40).,OADS,/arxiv_data1/oa_pdf/f8/b8/gku1204.PMC4383984.pdf
"A second major curation theme undertaken recently at BioGRIDisthearachidonicacidpathway(AAP)aspartof the Personalized NSAID Therapeutics Consortium (PEN- TACON)project( http://www.pentaconhq.org ).TheAAPis theprimarycellularmechanismforproductionofpainand inflammationmediators,andisalsoinvolvedinrenalfunc-tionand homeostasis ( 67) Coregenes involved in theAAP, as well as AAP-related genes and genes involved in blood pressure(BP)regulation,wereidentifiedusingcuratedpath-way resources such as KEGG ( 68) and Reactome ( 69), as well as Gene Ontology ( 63) annotations.",OADS,/arxiv_data1/oa_pdf/f8/b8/gku1204.PMC4383984.pdf
All evidence codes are fully documented on the Bi- oGRID help wiki section ( http://wiki.thebiogrid.org/doku.,OADS,/arxiv_data1/oa_pdf/f8/b8/gku1204.PMC4383984.pdf
The BioGRID Cytoscape plugin version 2.3 has also been redesigned to take ad- vantage of the improvements made to the REST API andcan be downloaded directly from the BioGRID website at http://wiki.thebiogrid.org/doku.php/tools .,Non-OADS,/arxiv_data1/oa_pdf/f8/b8/gku1204.PMC4383984.pdf
"CFam Chemical Family database http://bidd2.cse.nus.edu.sg/cfam was developed to hierarchically cluster drugs, bioactive molecules, hu-man metabolites, natural products, patented agents and other molecules into functional families, su- perfamilies and classes of structurally similar com- pounds based on the literature-reported high, inter- mediate and remote similarity measures.",OADS,/arxiv_data1/oa_pdf/ce/dd/gku1212.PMC4383987.pdf
We therefore developed the CFam Chemical Fam- ily database ( http://bidd2.cse.nus.edu.sg/cfam ) both as a database of function-based chemical families and as a re- *Towhomcorrespondenceshouldbeaddressed.Tel:+6565166877;Fax:+6567746756;Email:yzchen@cz3.nus.edu.sg CorrespondencemayalsobeaddressedtoL.Tao.Tel +6565166877;Fax:+6567746756;Email:linntaoo@hotmail.com C/circlecopyrtTheAuthor(s) 2014.,OADS,/arxiv_data1/oa_pdf/ce/dd/gku1212.PMC4383987.pdf
"(2011) InChIversion1(softwareversion1.04forStandardand Non-StandardInChI /InChIKey), http://www.iupac.org/InChI/ .",OADS,/arxiv_data1/oa_pdf/ce/dd/gku1212.PMC4383987.pdf
"NucleicAcidsResearch,2015,Vol.43,Databaseissue D565 Guide, http://www.inchi-trust.org/download/104/InChI UserGuide.pdf .",OADS,/arxiv_data1/oa_pdf/ce/dd/gku1212.PMC4383987.pdf
"DIANA-TarBasev7.0 ( http://www.microrna.gr/tarbase )a i m st op r o - vide for the ﬁrst time hundreds of thousands of high-quality manually curated experimentally vali-dated miRNA:gene interactions, enhanced with de- tailed meta-data.",OADS,/arxiv_data1/oa_pdf/66/12/gku1215.PMC4383989.pdf
"D512–D520 NucleicAcidsResearch,2015,Vol.43,Databaseissue Publishedonline16December2014 doi:10.1093/nar/gku1267 PhosphoSitePlus, 2014: mutations, PTMs and recalibrations Peter V. Hornbeck*, Bin Zhang, Beth Murray, Jon M. Kornhauser, Vaughan Latham and Elzbieta Skrzypek Cell Signaling Technology, 3 Trask Lane, Danvers, MA 01923, USA Received November 14, 2014; Accepted November 19, 2014 ABSTRACT PhosphoSitePlusR/circlecopyrt(PSP, http://www.phosphosite.",OADS,/arxiv_data1/oa_pdf/3d/e9/gku1267.PMC4383998.pdf
"These were described in the 2012 article ( 8), are de- scribed in the online tutorial ( http://www.phosphosite.org/ staticTrainingTutorial.do ) and will notbe addressed here.",Non-OADS,/arxiv_data1/oa_pdf/3d/e9/gku1267.PMC4383998.pdf
"Molecular structures Since2011,thenumberofPDBfiles(proteinstructuralfiles from ProteinDataBank,http://www.rcsb.org/ )correspond- ingtoproteinsinPSPhasincreasedfrom22958(4500pro- teins) to 33 204 (5989 proteins).",OADS,/arxiv_data1/oa_pdf/3d/e9/gku1267.PMC4383998.pdf
"These include: the Human Pro- tein Atlas ( http://www.proteinatlas.org/ ) for protein ex- pression levels and subcellular localization based on im- munohistochemistry, and transcript expression levels for a large number of human tissues, cancers and cell lines(16); BioGPS ( http://biogps.org/ ) for tissue-specific pattern of mRNA expression ( 17); Wikipedia pages include infor- mation about protein function, RNA expression, interac-tions, clinical significance, references and further reading (e.g.",OADS,/arxiv_data1/oa_pdf/3d/e9/gku1267.PMC4383998.pdf
"http://en.wikipedia.org/wiki/ANXA2 ); neXtProt ( 18), a human protein resource from Swiss Institute of Bioinfor-matics and GeneBio that integrates information from the UniProtKB /Swiss-Prot Knowledgebase, the HUPO Hu- man Proteome Project ( 19) and other post-proteomic re- sources; and Reactome for the visualization, interpretation andanalysisofpathwayknowledge( 20).Also,thechromo- somallocationofthegeneencodingeachhumanproteininPSP is now included on Protein Pages and in many down- loads.",OADS,/arxiv_data1/oa_pdf/3d/e9/gku1267.PMC4383998.pdf
PTMVar currently contains variant data from monthly downloadsof ‘humsavar.txt’ from UniProtKB ( http://www.uniprot.,OADS,/arxiv_data1/oa_pdf/3d/e9/gku1267.PMC4383998.pdf
"nih.gov/), cBIO ( 22), COSMIC ( http://cancer.sanger.ac.",Non-OADS,/arxiv_data1/oa_pdf/3d/e9/gku1267.PMC4383998.pdf
"The current PTMVar dataset includes 17 551 modificationsites associated with 24 592 mutations, of which 39% are classifiedasDiseasemutations(including1250discreetdis- eases and genetic disorders from Online Mendelian Inher-itance in Man ( http://omim.org/ )), 44% as polymorphisms, and17%asunclassified.Ourgoalistoincludesomaticmu- tations from cancer genomes only when observed in threeto fiveindependentcancer patientsamples.",OADS,/arxiv_data1/oa_pdf/3d/e9/gku1267.PMC4383998.pdf
Logos were generated using the Frequency Change algorithm at http://www.phosphosite.org/ sequenceLogoAction.do .,OADS,/arxiv_data1/oa_pdf/3d/e9/gku1267.PMC4383998.pdf
"To im- prove access to these ﬁndings and facilitate meta- analyses, we developed the Candidate Cancer GeneDatabase (CCGD, http://ccgd-starrlab.oit.umn.edu/ ).",OADS,/arxiv_data1/oa_pdf/8c/c4/gku770.PMC4384000.pdf
We used official gene symbols and IDs from NCBI Gene (http://www.ncbi.nlm.nih.gov/gene ).,OADS,/arxiv_data1/oa_pdf/8c/c4/gku770.PMC4384000.pdf
"When combined with IDs from NCBI HomoloGene ( http://www.ncbi.nlm.nih.gov/homologene ), the official symbols and IDs allowed us to create CIShomology data for Homo sapiens ,Rattus norvegicus , Danio rerio, Drosophila melanogaster ,a n dSaccharomyces cerevisiae .",Non-OADS,/arxiv_data1/oa_pdf/8c/c4/gku770.PMC4384000.pdf
The use of official symbols also allowed us to associate records with genes present in the Cancer Gene Census (CGC) ( http://www.sanger.ac.uk/research/projects/ cancergenome/census.html ) and the COSMIC database (http://cancer.sanger.ac.uk/cancergenome/projects/census/ ) maintained by the Wellcome Trust Sanger Institute.,Non-OADS,/arxiv_data1/oa_pdf/8c/c4/gku770.PMC4384000.pdf
WEBSITE Search page We designed a Search page ( http://ccgd-starrlab.oit.umn.,Non-OADS,/arxiv_data1/oa_pdf/8c/c4/gku770.PMC4384000.pdf
"This includes the orthologous gene in Homo sapiens ,Rattus norvegicus, Drosophila melanogaster ,Danio rerio andSac- charomycescerevisiae genomes.Thepagecontainsotherin- formation such as CIS coordinates, study, cancer type, rel- ativerankandpredictedeffect.Inaddition,thepageshows the total number of studies finding the gene as a CIS andnotes whether the gene appears in the Sanger COSMIC databaseortheSangerCGClist.Thepagehashyperlinksto NCBI Gene, NCBI HomoloGene, NCBI PubMed, SangerCOSMIC and GeneCards ( http://www.genecards.org/ ).",OADS,/arxiv_data1/oa_pdf/8c/c4/gku770.PMC4384000.pdf
"If the database record contains complete CIS information, the page also provides hyperlinks to genome browsers at UCSC(http://genome.ucsc.edu/ )andEnsembl( http://www.",OADS,/arxiv_data1/oa_pdf/8c/c4/gku770.PMC4384000.pdf
AVAILABILITY The CCGD is accessible at http://ccgd-starrlab.oit.umn.,Non-OADS,/arxiv_data1/oa_pdf/8c/c4/gku770.PMC4384000.pdf
VirusMentha can be freely browsed at http://virusmentha.uniroma2.it/ and its complete data set is available for download.,OADS,/arxiv_data1/oa_pdf/11/1c/gku830.PMC4384001.pdf
"By exploiting a similarautomaticprocedurewecreatedVirusMentha,are- source that builds on the work started in VirusMINT by offering the curated data from our group combined withthe data captured from the other IMEx ( 9)p a r t n e r s .E v - ery week, VirusMentha integrates the virus–host interac- tionscuratedbytheIMExdatabasesremovingredundancy.Differently from other valuable resources, VirusMentha is not exclusively focused on specific organisms or viruses, such as HCVpro ( http://cbrc.kaust.edu.sa/hcvpro/ )(10)o r HIV host-interaction map ( http://www.ncbi.nlm.nih.gov/ projects/RefSeq/HIVInteractions/ )(11).",OADS,/arxiv_data1/oa_pdf/11/1c/gku830.PMC4384001.pdf
"To meet the data-driven research requirements, we improved the prediction pipeline and updated Ani-malTFDB to version 2.0 ( http://bioinfo.life.hust.edu.cn/ AnimalTFDB/ ).",OADS,/arxiv_data1/oa_pdf/59/97/gku887.PMC4384004.pdf
The pathway annotations were extracted from BioCarta (http://www.biocarta.com/ )andKEGGdatabases.Putative functional domains were searched by PfamScan ( ftp://ftp.,OADS,/arxiv_data1/oa_pdf/59/97/gku887.PMC4384004.pdf
"RichinformationforgeneexpressionisprovidedinAni- malTFDB2.0.Wedownloadedthehumangeneexpressiondata of cancers, tissues and cell lines from TCGA ( https: //tcga-data.nci.nih.gov/tcga/findArchives.htm )andEBIEx- pression Atlas ( http://www.ebi.ac.uk/gxa/download.html ).",OADS,/arxiv_data1/oa_pdf/59/97/gku887.PMC4384004.pdf
"In this regard, we set up a TF predic-tion server ( http://bioinfo.life.hust.edu.cn/AnimalTFDB/ prediction.shtml ) in AnimalTFDB 2.0 (Figure 1B).",OADS,/arxiv_data1/oa_pdf/59/97/gku887.PMC4384004.pdf
"BLASTsearch To help users find homologous gene and explore func- tions of poorly studied TFs, we provided a BLAST tool(http://bioinfo.life.hust.edu.cn/AnimalTFDB/blast.shtml ) tosearchagainstTFsinourdatabasewithproteinorDNA sequences(Figure 1C).Theproteinsequencesofallspecies or one specific species could be selected as the BLAST database.SUMMARY AND FUTURE PERSPECTIVES We have updated our AnimalTFDB to version 2.0, which provides TF, transcription co-factor and CRF repertoiresin 65 species across 11 lineages.",OADS,/arxiv_data1/oa_pdf/59/97/gku887.PMC4384004.pdf
"D300–D305 NucleicAcidsResearch,2015,Vol.43,Databaseissue Publishedonline27September2014 doi:10.1093/nar/gku888 NrichD database: sequence databases enriched with computationally designed protein-like sequences aid in remote homology detection Richa Mudgal1, Sankaran Sandhya2,G a y a t r iK u m a r3, Ramanathan Sowdhamini4, Nagasuma R. Chandra2and Narayanaswamy Srinivasan3,* 1IISc Mathematics Initiative, Indian Institute of Science, Bangalore 560 012, Karnataka, India,2Department of Biochemistry, Indian Institute of Science, Bangalore 560 012, Karnataka, India,3Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560 012, Karnataka, India and4National Centre for Biological Sciences, Gandhi Krishi Vignan Kendra Campus, Bellary road, Bangalore 560 065, Karnataka, India Received August 03, 2014; Revised September 11, 2014; Accepted September 15, 2014 ABSTRACT NrichD ( http://proline.biochem.iisc.ernet.in/NRICHD/ ) is a database of computationally designed protein- like sequences, augmented into natural sequencedatabases that can perform hops in protein se- quence space to assist in the detection of remote relationships.",OADS,/arxiv_data1/oa_pdf/90/b5/gku888.PMC4384005.pdf
"Raghava * Bioinformatics Centre, CSIR-Institute of Microbial Technology, Chandigarh 160036, Punjab, India Received August 05, 2014; Revised September 15, 2014; Accepted September 16, 2014 ABSTRACT CancerPPD ( http://crdd.osdd.net/raghava/ cancerppd/ ) is a repository of experimentally veriﬁed anticancer peptides (ACPs) and anticancer proteins.",OADS,/arxiv_data1/oa_pdf/41/f1/gku892.PMC4384006.pdf
AVAILABILITY CancerPPD is freely available at http://crdd.osdd.net/ raghava/cancerppd/ .,OADS,/arxiv_data1/oa_pdf/41/f1/gku892.PMC4384006.pdf
The mobile version of this database canbeaccessedat http://crdd.osdd.net/raghava/cancerppd/ mobile/cancerppd/ .,OADS,/arxiv_data1/oa_pdf/41/f1/gku892.PMC4384006.pdf
"D1152–D1157 NucleicAcidsResearch,2015,Vol.43,Databaseissue Publishedonline11November2014 doi:10.1093/nar/gku893 The Addgene repository: an international nonproﬁt plasmid and data resource Joanne Kamens* Addgene, Cambridge, MA 02139, USA Received August 01, 2014; Revised September 12, 2014; Accepted September 16, 2014 ABSTRACT The Addgene Repository ( http://www.addgene.org ) was founded to accelerate research and discov-ery by improving access to useful, high-quality re- search materials and information.",OADS,/arxiv_data1/oa_pdf/e1/f5/gku893.PMC4384007.pdf
"(2014) The10MostDistributedPlasmidTechnologiesin Addgene’sFirst10Years .http://blog.addgene.org/top-10-the-most- distributed-plasmid-technologies-in-addgenes-first-10-years (15 August2014,datelastaccessed).",OADS,/arxiv_data1/oa_pdf/e1/f5/gku893.PMC4384007.pdf
"http://blog.f1000research.com/2014/03/28/top- 25-plasmids-of-all-time-addgene-statistics-reveal-research-trends/(15August2014,datelastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/e1/f5/gku893.PMC4384007.pdf
"Here we develop MethBank ( http://dnamethylome.org ), a database of DNA methylome programming that inte-grates the genome-wide single-base nucleotide methylomesofgametesandearlyembryoscoveringmultiplediversede- velopmental stages and spanning different model organ- isms.",OADS,/arxiv_data1/oa_pdf/5f/13/gku920.PMC4384011.pdf
"IMPLEMENTATION MethBank has been implemented using MySQL ( http: //www.mysql.org ; a free and popular relational database management system), JSP (JavaServer Pages; a technology facilitatingrapiddevelopmentofdynamicwebpagesbased on the Java programming language) and Apache Tomcat (http://tomcat.apache.org ; an open source web server for",OADS,/arxiv_data1/oa_pdf/5f/13/gku920.PMC4384011.pdf
MethBank is freely avail-able athttp://dnamethylome.org .,OADS,/arxiv_data1/oa_pdf/5f/13/gku920.PMC4384011.pdf
"For each species, there are nine different developmental stages involving two gametes andseven embryos (for details see http://dnamethylome.org/ about).",Non-OADS,/arxiv_data1/oa_pdf/5f/13/gku920.PMC4384011.pdf
"Thecurrentlyavailablegeneticdatabasesforepilepsyare: GenEpi ( http://epilepsy.hardwicklab.org/ ), CarpeDB ( http: //www.carpedb.ua.edu/ ), epiGAD ( 12), The Lafora Gene MutationDatabase( 13)andMeGene( http://www.epigene.",OADS,/arxiv_data1/oa_pdf/7e/05/gku943.PMC4384015.pdf
"Initially, we retrospec- tivelysearchedthePubMeddatabase( http://www.ncbi.nih.",Non-OADS,/arxiv_data1/oa_pdf/7e/05/gku943.PMC4384015.pdf
"gov/pubmed ) with the following query terms: ‘epilepsy [Title /Abstract] OR specific phenotype such as West syn- drome [Title /Abstract] AND gene [Title /Abstract] OR ge- netic [Title /Abstract] AND mutation [Title /Abstract] OR variant[Title /Abstract]ORvariation[Title /Abstract]’.Ad- ditionally, EpilepsyGene also includes genetic variants se-lected with discretion from existing databases, including MITOMAP ( 14), The Lafora Gene Mutation Database (13), epiGAD ( 12), GenEpi ( http://epilepsy.hardwicklab.",OADS,/arxiv_data1/oa_pdf/7e/05/gku943.PMC4384015.pdf
org/) and MeGene( http://www.epigene.org/mutation/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/05/gku943.PMC4384015.pdf
"Firstly, gene an- notation file ‘Homo sapiens.gene info.gz’ was downloaded from NCBI ( http://www.ncbi.nlm.nih.gov/ ) to obtain ba- sicinformationofallepilepticgenes.Secondly,WebGestalt (21)wasusedtoenrichGO( 20)terms,WIKIpathways( 22), KEGG pathways ( 23) and Pathway Commons ( 24) associ- atedwiththegenes.Thirdly,brainexpressionlevelsofeach gene spanning 12 periods and 16 brain regions were ob- t a i n e df r o mR N A - s e q( 22) to present the expression pat- tern of the gene.",OADS,/arxiv_data1/oa_pdf/7e/05/gku943.PMC4384015.pdf
The human braindatafromdifferentperiodsinlifewereacquiredfromBrainSpan by RNA-seq ( http://www.brainspan.org/ )(22).,OADS,/arxiv_data1/oa_pdf/7e/05/gku943.PMC4384015.pdf
"D536–D541 NucleicAcidsResearch,2015,Vol.43,Databaseissue Publishedonline16October2014 doi:10.1093/nar/gku968 P2CS: updates of the prokaryotic two-component systems database Philippe Ortet1,2,3, David E. Whitworth4, Catherine Santaella1,2,3, Wafa Achouak1,2,3and Mohamed Barakat1,2,3,* 1CEA, IBEB, Lab Ecol Microb Rhizosphere & Environ Extrem, Saint-Paul-lez-Durance F-13108, France,2CNRS, UMR 7265 Biol Veget & Microbiol Environ, Saint-Paul-lez-Durance F-13108, France,3Aix Marseille Universit ´e, BVME UMR7265, Marseille F-13284, France and4Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Ceredigion, SY23 3DD, UK Received September 12, 2014; Revised October 1, 2014; Accepted October 02, 2014 ABSTRACT The P2CS database ( http://www.p2cs.org/ )i sac o m - prehensive resource for the analysis of ProkaryoticTwo-Component Systems (TCSs).",Non-OADS,/arxiv_data1/oa_pdf/79/a5/gku968.PMC4384028.pdf
The latest version of P2CS contains 164 651 TCS proteins from 2758 prokaryotic genomes and can beaccessed at http://www.p2cs.org/ .,OADS,/arxiv_data1/oa_pdf/79/a5/gku968.PMC4384028.pdf
"Here, we present the TTS Mapping and Integration (TTSMI; http://ttsmi.bii.a-star.edu.sg ) database, which provides a catalog of unique TTS locations in the human genome and tools for an-alyzing the co-localization of TTSs with genomic regulatory sequences and signals that were identi- ﬁed using next-generation sequencing techniquesand/or predicted by computational models.",OADS,/arxiv_data1/oa_pdf/2f/df/gku970.PMC4384029.pdf
Several genome annotation tracks from the UCSC (http://genome.ucsc.edu ) genome browser ( 20) were cho- sen and retrieved for integration with the TTS infor- mation.,OADS,/arxiv_data1/oa_pdf/2f/df/gku970.PMC4384029.pdf
"scripting language and the JavaScript language along with jQuery, jQuery Slider ( http://egorkhmelev.github.io/jslider ) and DataTables ( https://datatables.net ).",OADS,/arxiv_data1/oa_pdf/2f/df/gku970.PMC4384029.pdf
"Here, we report a new database, ImmuCo ( http://immuco.bjmu.edu.cn ), which is a cell-speciﬁc database that contains infor-mation about gene co-expression in immune cells, identifying co-expression and correlation between any two genes.",OADS,/arxiv_data1/oa_pdf/df/94/gku980.PMC4384033.pdf
MATERIALS AND METHODS Data set Microarray data set were downloaded from the Gene Ex- pression Omnibus (GEO) database ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/df/94/gku980.PMC4384033.pdf
"Gene IDs in (B) and (C) provide external links to the corresponding entries in the NCBI gene database (http://www.ncbi.nlm.nih.gov/gene ).Toidentifyco-expressionrelationshipsamongmultiplegenes,CSVformatfileresultscanbeintegrated.TheImmuCo databasecanbeaccessedatits homepage: http://immuco.bjmu.edu.cn .",OADS,/arxiv_data1/oa_pdf/df/94/gku980.PMC4384033.pdf
"Tosatto* Department of Biomedical Sciences, University of Padua, 35131 Padova, Italy Received August 15, 2014; Revised October 2, 2014; Accepted October 03, 2014 ABSTRACT MobiDB ( http://mobidb.bio.unipd.it/ ) is a database of intrinsically disordered and mobile proteins.",OADS,/arxiv_data1/oa_pdf/e1/f7/gku982.PMC4384034.pdf
"NucleicAcidsResearch,2015,Vol.43,Databaseissue D319 sentation.TheAngular.jsframeworkandBootstraplibrary providetheoveralllook-and-feel.Additionalinformationis added to entries by querying the Uniprot, PDB and Pfam webservices.MobiDBoffersusersbothgraphicalwebinter-faceaccessandexposesitsresourcesthroughRESTfulweb services, using the Restify library for Node.js from URL: http://mobidb.bio.unipd.it/ .",OADS,/arxiv_data1/oa_pdf/e1/f7/gku982.PMC4384034.pdf
The MTB ( http://tumor.informatics.jax.org )d a t a b a s ei s afreelyavailablecommunityinformaticsresourcedesigned to support the effective use of the laboratory mouse as a modelsystemforinvestigatingthegeneticandgenomicba-sis of human cancer.,Non-OADS,/arxiv_data1/oa_pdf/27/e7/gku987.PMC4384039.pdf
"For all of the gene, allele, mutation andstraindatainMTB,curatorsenforcethenomenclature standardssetbytheInternationalCommitteeonStandard-ized Nomenclature for Mice ( http://www.informatics.jax.",Non-OADS,/arxiv_data1/oa_pdf/27/e7/gku987.PMC4384039.pdf
"annotations in a simple GFF-formatted file (General Fea- ture Format; http://www.sanger.ac.uk/resources/software/ gff/) so they can be displayed in relationship to published QTLregions.Byhighlightingasubregionofachromosomeof interest, users are directed to another workspace where theycanfilterthegenesinaregionaccordingtothebiolog- ical (phenotype and function) annotations of those genes.For example, a researcher could identify a region of the genomewheremultiplelungcancerQTLhavebeenmapped and then filter the genes in that region to find those previ-ouslyassociatedwithlungphenotypes,biologicalprocesses or molecular functions.",OADS,/arxiv_data1/oa_pdf/27/e7/gku987.PMC4384039.pdf
"USER SUPPORT The MTB Database can be accessed at the MTB Home Page (http://tumor.informatics.jax.org ), which is part of theMGIgroupwebpages( http://www.informatics.jax.org ).",OADS,/arxiv_data1/oa_pdf/27/e7/gku987.PMC4384039.pdf
"Announcements about new MTB features are released via theMTBwebsiteaswellastheMGIFaceBookpage.User support for MTB is available in the form of online docu-mentation,email, faxand phone: Web:http://www.informatics.jax.org/mgihome/support/ support.shtml Email: mgi-help@jax.org Tel: +1 207.288.6445Fax: +1 207.288.6830 FaceBook: https://www.facebook.com/mgi.informatics DATA USE AND RESOURCE CITATION MTB data and software are provided freely to the scien- tific community for promoting education and research ac- tivities.Anyreproductionoruseforcommercialpurposeisprohibited without the prior express written permission of The Jackson Laboratory.",OADS,/arxiv_data1/oa_pdf/27/e7/gku987.PMC4384039.pdf
"lncRNAdb, available at http://lncrnadb.org ,p r o - vides users with a comprehensive, manually curated reference database of 287 eukaryotic lncRNAs thathave been described independently in the scientiﬁc literature.",OADS,/arxiv_data1/oa_pdf/56/e5/gku988.PMC4384040.pdf
Seventy-six of the 110 lncRNA entries onHUGOcitelncRNAdb( http://www.genenames.org/rna/ LNCRNA ).,OADS,/arxiv_data1/oa_pdf/56/e5/gku988.PMC4384040.pdf
http://lncrnadb.org/rest/hotair ) or specific con- tent(e.g.,Non-OADS,/arxiv_data1/oa_pdf/56/e5/gku988.PMC4384040.pdf
http://lncrnadb.org/rest/hotair/sequence )foranin- dividual lncRNA.,OADS,/arxiv_data1/oa_pdf/56/e5/gku988.PMC4384040.pdf
"Finally, the users can retrieve specificinformation for all entries, such as associated interacting components http://lncrnadb.org/rest/all/association .",OADS,/arxiv_data1/oa_pdf/56/e5/gku988.PMC4384040.pdf
"Newentries can be posted on the submission page with sup- portinginformationthroughaCAPTCHA-protectedform (SupplementaryFigureS2).Alluser-submitteddataispro- cessed by an expert human curator before incorporation intothedatabase.AdetaileddescriptionoftheprocessandacceptancecriteriaforlncRNAdbcontributionsisavailable athttp://lncrnadb.org/contribution .AsthepaceoflncRNA functionalcharacterizationcontinuestoincrease,weantic-ipateuser-submitteddatawillbecomemorecrucialinkeep- ing lncRNAdb up to date.",OADS,/arxiv_data1/oa_pdf/56/e5/gku988.PMC4384040.pdf
"TGF-β also upregulates  miR-21 expression in renal tissue, and thus promotes renal  fibrosis [ 14].Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> Received 23 October 2014 | Accepted 27 March 2015 | Published 30 March 2015© 2015 Molecular Vision 324MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid- associated ophthalmopathy Tong Bo-ding, Xiao Man-Yi, Zeng Jie-Xi, Xiong Wei Department of Ophthalmology and Eye Research Center, Hunan, China Purpose:  This study aimed to determine the role of miR-21 in orbital fibroblasts obtained from donors with thyroid-as - sociated ophthalmopathy (TAO) and to elucidate the regulation of fibrosis by miR-21 in the pathological process of TAO.",Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
"Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> © 2015 Molecular Vision  325MiRNA precursor molecules (miRNA mimics) are  small, chemically modified double-stranded RNA molecules  designed to mimic endogenous mature miRNAs, which enable  miRNA functional analysis by the upregulation of miRNA  activity.",Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
"Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> © 2015 Molecular Vision  326Genechem Co., Ltd.",Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> © 2015 Molecular Vision  327 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
"Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> © 2015 Molecular Vision  328mimic transfection aggregated the growth of orbital fibro - blasts (p<0.05, Figure 2B).",Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
"Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> © 2015 Molecular Vision  329MiR-21 activates TGF-β/Smad signaling by promoting Smad3  phosphorylation:  To determine whether miR-21 plays a role  in TGF-β/Smad signaling, we analyzed the phosphorylation  levels of Smad3 in miR-21 upregulated and downregulated  orbital fibroblasts.",Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> © 2015 Molecular Vision  330upregulated miR-21 levels in TAO orbital fibroblasts.,Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> © 2015 Molecular Vision  331 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> © 2015 Molecular Vision  332 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> © 2015 Molecular Vision  333TGF-β1 induced miR-21 expression in orbital fibroblasts in  a time- and dose-dependent manner.,Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
Molecular Vision  2015; 21:324-334 <http://www.molvis.org/molvis/v 21/324> © 2015 Molecular Vision  334glioblastoma cell T98G.,Non-OADS,/arxiv_data1/oa_pdf/01/5c/mv-v21-324.PMC4384173.pdf
"The human XRCC1  gene (Gene ID 37414;  OMIM 21171001  and 21174504 ) is 33 kb long and located on  chromosome 19q13.2–13.3, consists of 17 exons, and encodes  a 2.2 kb transcript, which corresponds to a putative protein Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> Received 29 April 2014 | Accepted 27 March 2015 | Published 30 March 2015© 2015 Molecular Vision 335XRCC1  and XPD  genetic polymorphisms and susceptibility to age- related cataract: A meta-analysis Xin-Xin Chi,1 You-Yu Liu,2 Su-Ning Shi,1 Zhuang Cong,1 Yu-Qing Liang,3 Hui-Jun Zhang1 1College nursing, Liaoning Medical University, Jinzhou, P .R.",Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
"Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  336of 633 amino acids [ 16,17].",Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  3372.3 kb [ 31].,Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  338Table  1.,Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  339languages other than English or Chinese; and (3) studies on  polymorphisms other than the selected two.,Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
"Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  340also investigated with the use of funnel plots and Egger’s  linear regression test [ 40].RESULTS Characteristics of the included studies:  Initially, our highly  sensitive search strategy identified 23 articles.",OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  341the titles and abstracts of all articles and excluded seven.,Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
"Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  342CI=1.12–1.40, p<0.001; dominant model: OR=1.34, 95%  CI=1.16–1.54, p<0.001; Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
"Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  343cortical: OR=26.14, 95% CI=10.42–65.58, p<0.001; nuclear:  OR=8.17, 95% CI=2.05–32.49, p=0.003; posterior subcap - sular: OR=7.58, 95% CI=1.08–53.35, p=0.042; Figure 4).",Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  344prone to bias whereas our analyses focused on the Asian  populations.,Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  34519.,Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
Molecular Vision  2015; 21:335-346 <http://www.molvis.org/molvis/v 21/335> © 2015 Molecular Vision  34646.,Non-OADS,/arxiv_data1/oa_pdf/c6/83/mv-v21-335.PMC4384174.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/ec/TOORTHJ-9-45.PMC4384222.pdf
[3] http://www.njrcentre.org.uk/njrcentre/Portals/0/Documents/England/R eports/10th_annual_report/NJR%2010th%20Annual%20Report%202013%20B.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/4e/TOORTHJ-9-68.PMC4384223.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/4e/TOORTHJ-9-68.PMC4384223.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/99/TOORTHJ-9-84.PMC4384224.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/46/TOORTHJ-9-73.PMC4384225.pdf
"Pub- lic Health , 2009 , 6, 798-843. http://www.pubmedcentral.nih.gov/ ar- ticlerender.fcgi?tool=pubmed&pubmedid=19440416  [21] Chaouachi, K. Is medical concern about hookah environmental  tobacco smoke hazards warranted ?",Non-OADS,/arxiv_data1/oa_pdf/61/34/TOMCJ-9-1.PMC4384226.pdf
"http://www.ash.org.uk/ media- room/press-releases/shisha-200-times-worse-than-a-cigarette- say- middle-east-experts  [24] Chaouachi, K. A Critique of the WHO's TobReg “Advisory Note”  entitled: “Waterpipe Tob acco Smoking: Health Effects, Research  Needs and Recommended Actions by Regulators.",Non-OADS,/arxiv_data1/oa_pdf/61/34/TOMCJ-9-1.PMC4384226.pdf
", 2006 , 5, 1-17. http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/61/34/TOMCJ-9-1.PMC4384226.pdf
http://www.thenational.ae/uae/health/shisha-the-middle-easts- favourite-toxin#full  [32] CDC.,Non-OADS,/arxiv_data1/oa_pdf/61/34/TOMCJ-9-1.PMC4384226.pdf
http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/61/34/TOMCJ-9-1.PMC4384226.pdf
"Accessed Jan. 2010. http://www.14wctoh.org/abstract/  abs_detail.asp?AbstractID=434  [42] Chaouachi, K.; Sajid, K.M.",OADS,/arxiv_data1/oa_pdf/61/34/TOMCJ-9-1.PMC4384226.pdf
"http://m.gulfnews.com/news/uae/general/shisha-smoking-  is-more-addictive-than-cocaine-expert-says-1.1247504  [51] Molimard, R. The myth of nicotine addiction.",Non-OADS,/arxiv_data1/oa_pdf/61/34/TOMCJ-9-1.PMC4384226.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/f6/TOORTHJ-9-78.PMC4384227.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/48/TOORTHJ-9-57.PMC4384228.pdf
"Available at  http://www.tobaccoatlas.org/uploads/Im ages/PDFs/Tobacco_Atlas_2ndPrint.pdf  (accessed June 1, 2014).",Non-OADS,/arxiv_data1/oa_pdf/de/79/pharmpract-13-486.PMC4384264.pdf
"Available at  http://nigerianstat.gov.ng/pages/download/157  (accessed June 1, 2014).",Non-OADS,/arxiv_data1/oa_pdf/de/79/pharmpract-13-486.PMC4384264.pdf
"Available at  http://www.cdc.gov/tobacco/bas ic_information/secondhand_smoke/  (accessed June 1, 2014).",Non-OADS,/arxiv_data1/oa_pdf/de/79/pharmpract-13-486.PMC4384264.pdf
"Available at http://www.iom.edu/~/media/Files/Report% 20Files/2009/Secondhand-Smoke-Exposure-and- Cardiovascular-Effects-Making-Sense-of-the-Evidenc e/Secondhand%20Smoke%20%20Report%20Brief%203.pdf   (accessed June 1, 2014).",Non-OADS,/arxiv_data1/oa_pdf/de/79/pharmpract-13-486.PMC4384264.pdf
"Available at  http://www.idrc.ca/EN/Resources/Publications/openebooks/510-6/index.html#page_29  (accessed June 1, 2014).",Non-OADS,/arxiv_data1/oa_pdf/de/79/pharmpract-13-486.PMC4384264.pdf
"Available at  http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf  (Accessed March 30, 2012).",Non-OADS,/arxiv_data1/oa_pdf/e4/b2/pharmpract-13-512.PMC4384265.pdf
"http://img.thebody.com/pinf/2010/pip50.pdf#page=7   (Accessed June 21, 2013).",Non-OADS,/arxiv_data1/oa_pdf/e4/b2/pharmpract-13-512.PMC4384265.pdf
"Gr eenwood Village, CO: Truven Health Analytics, 2013.  http://www.thomsonhc.com/.",Non-OADS,/arxiv_data1/oa_pdf/e4/b2/pharmpract-13-512.PMC4384265.pdf
"Available at http://nccc.ucsf.edu/clinician- consultation/hiv-aids-management/  (Accessed November 21, 2014).",Non-OADS,/arxiv_data1/oa_pdf/e4/b2/pharmpract-13-512.PMC4384265.pdf
Available at: http://www.jointcommission.org/assets/1/6/AHC_NPSG_Chapter_2014.pdf  (Accessed 2014 Feb  22).,OADS,/arxiv_data1/oa_pdf/72/4f/pharmpract-13-518.PMC4384267.pdf
"Available at: http://www.cdc.gov/drugresistanc e/threat-report-2013/pdf/ar-threats- 2013-508.pdf  (Accessed August 25, 2014).",OADS,/arxiv_data1/oa_pdf/c3/b2/pharmpract-13-523.PMC4384268.pdf
Available at:  http://rebracim.webnode.com.br/membros-rebracim/  (Accessed 1 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/52/06/pharmpract-13-524.PMC4384269.pdf
Available at: http://www.scielo.br/scielo.php?pi d=S0034-71672004000600007&script=sci_arttext  (Accessed 1 March  2014).,Non-OADS,/arxiv_data1/oa_pdf/52/06/pharmpract-13-524.PMC4384269.pdf
Available at: http://www.nccmerp.org/aboutMedErrors.html  (Accessed 1 April 2014).,OADS,/arxiv_data1/oa_pdf/52/06/pharmpract-13-524.PMC4384269.pdf
Available at: http://bvsms.saude.gov.br/bvs/saudel egis/anvisa/2013/rdc0036_25_07_2013.html   (Accessed 1 April 2014).,OADS,/arxiv_data1/oa_pdf/52/06/pharmpract-13-524.PMC4384269.pdf
Available at:  http://bvsms.saude.gov.br/bvs/saudelegis/gm/2013/prt2647_04_11_2013.html  (Accessed 1 April 2014].,Non-OADS,/arxiv_data1/oa_pdf/52/06/pharmpract-13-524.PMC4384269.pdf
Available at: http://www.nccmerp.org/medErrorCatIndex.html  (Accessed 1 November 2011).,OADS,/arxiv_data1/oa_pdf/52/06/pharmpract-13-524.PMC4384269.pdf
Available at:  http://www.ismp.org/Tools/institutionalhighAlert.asp  (Acessed 1 October 2012).,Non-OADS,/arxiv_data1/oa_pdf/52/06/pharmpract-13-524.PMC4384269.pdf
Available at:  http://www.anvisa.gov.br/hotsite/segur ancadopaciente/documentos/julho/Prot ocolo%20Identifica%C3%A7%C3%A3o% 20do%20Paciente.pdf  (Acessed 1 June 2014).,OADS,/arxiv_data1/oa_pdf/52/06/pharmpract-13-524.PMC4384269.pdf
Available at:  http://www.ascp.com/public/pr/guidelines/medication  (Acessed 1 June 2006).,Non-OADS,/arxiv_data1/oa_pdf/52/06/pharmpract-13-524.PMC4384269.pdf
Available at: http://5cpa.com.au/programs/phar macy-practice-incentives/  (Accessed 31 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/37/1a/pharmpract-13-529.PMC4384270.pdf
"Global Stra tegy for Asthma Management and Prevention, Available at  http://www.ginasthma.org  (Accessed: 31 October 2014).",Non-OADS,/arxiv_data1/oa_pdf/37/1a/pharmpract-13-529.PMC4384270.pdf
Available at: http://www.asthmahandbook.org.au  (Accessed: 31 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/37/1a/pharmpract-13-529.PMC4384270.pdf
[updated 26 September 2012]; Available from:  http://www.health.gov.au/internet/main/publishing.nsf/Content/chronic  (Accessed 31 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/37/1a/pharmpract-13-529.PMC4384270.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/33/TOORTHJ-9-26.PMC4384273.pdf
"232pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.4.232 Annals of Surgical Treatment and ResearchCASE REPORT Experience of direct percutaneous sac injection in type II  endoleak using cone beam computed tomography Yoong-Seok Park, Young Soo Do1, Hong Suk Park1, Kwang Bo Park1, Dong-Ik Kim Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine,  Seoul, 1Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea  INTRODUCTION Type II endoleak is the most common complication after  endovascular aneurysm repair (EVAR) which could lead to a  possible risk of aneurysmal sac enlargement and rupture [1].",Non-OADS,/arxiv_data1/oa_pdf/f4/bd/astr-88-232.PMC4384280.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cone beam CT, usually used in dental area, could easily obtain 3-dimensional images using cone beam shaped ionized  radiation.",Non-OADS,/arxiv_data1/oa_pdf/f4/bd/astr-88-232.PMC4384280.pdf
" Annals of Surgical Treatment and Research 215pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.4.215 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The effect of long Roux-en-Y gastrojejunostomy in gastric  cancer patients with type 2 diabetes and body mass index < 35 kg/m 2: preliminary results Ji Won Kim, Kwang Yong Kim, Seung Chul Lee, Dae Hyun Yang, Byung Chun Kim Department of Surgery, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea INTRODUCTION Type 2 diabetes mellitus (T2DM) is a global health problem  and a progressive chronic disease that can present life- threatening complications.",Non-OADS,/arxiv_data1/oa_pdf/bc/4d/astr-88-215.PMC4384281.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/4d/astr-88-215.PMC4384281.pdf
"222pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.4.222 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE De novo  malignancy after liver transplantation:   a single-center experience of 14 cases Peng Ji Gao, Jie Gao, Zhao Li, Zhi Ping Hu, Ji Ye Zhu Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China P < 1 (기호띄우기 ) μ α (symbol) vs. (이탤릭 ) – – < INTRODUCTION Since the first liver transplantation (LT) was performed in  1963, there has been much progress in immunosuppressive  therapy, surgical technique and perioperative treatment [1,2].",Non-OADS,/arxiv_data1/oa_pdf/0f/7e/astr-88-222.PMC4384282.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/7e/astr-88-222.PMC4384282.pdf
" Annals of Surgical Treatment and Research 193pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.4.193 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The benefits of preincision ropivacaine infiltration for  reducing postoperative pain after robotic bilateral  axillo-breast approach thyroidectomy: a prospective, randomized, double-blind, placebo-controlled study Kyung Ho Kang, Byung Seup Kim1, Hyun Kang2 Department of Surgery, Chung-Ang University College of Medicine, Seoul, 1Depratment of Surgery, Onuri Hospital, Incheon,  2Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul, Korea INTRODUCTION Differentiated thyroid carcinoma has been the most com­ mon carcinoma among female patients in South Korea since  2004, and the incidence has increased every year [1].",Non-OADS,/arxiv_data1/oa_pdf/77/ee/astr-88-193.PMC4384283.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/ee/astr-88-193.PMC4384283.pdf
"METHODS Patients The study protocol was approved by the Institutional Review  Board of the Chung ­Ang University College of Medicine and  registered with the Clinical Research Information Service (KCT0000555,  http://cris.nih.go.kr ).",Non-OADS,/arxiv_data1/oa_pdf/77/ee/astr-88-193.PMC4384283.pdf
" Annals of Surgical Treatment and Research 229pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.4.229 Annals of Surgical Treatment and ResearchCASE REPORT Double common bile duct with an ectopic drainage into  the stomach Jeong-Ik Park, Sang-Hoon Oh1 Department of Surgery, Inje University Haeundae Paik Hostpital, Inje University College of Medicine, Busan, 1Department of  Surgery, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea INTRODUCTION The anomalies of the biliary system are various and frequent,  however, double common bile duct (DCBD) is an extremely  rare congenital anomaly [1].",Non-OADS,/arxiv_data1/oa_pdf/93/58/astr-88-229.PMC4384284.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/58/astr-88-229.PMC4384284.pdf
"200pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.4.200 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Ki-67 and p53 expression as a predictive marker for early  postoperative recurrence in pancreatic head cancer Hohyun Kim, Chan Yong Park, Jae Hyuk Lee1, Jung Chul Kim2, Chol-Kyoon Cho2, Hee Jun Kim2 Department of Trauma Surgery, Pusan National University Hospital, Busan, Departments of 1Pathology and 2Surgery, Chonnam  National University Medical School, Gwangju, Korea INTRODUCTION Pancreatic ductal adenocarcinoma is the fifth leading  cause of cancer deaths in Europe and the United Stated,  with an estimated 5-year overall survival of less than 5% [1,2].",Non-OADS,/arxiv_data1/oa_pdf/4f/f2/astr-88-200.PMC4384285.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/f2/astr-88-200.PMC4384285.pdf
" Annals of Surgical Treatment and Research 187pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.4.187 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The neutrophil to lymphocyte ratio can discriminate  anaplastic thyroid cancer against poorly or well differentiated cancer Jin-Seong Cho, Min-Ho Park, Young-Jae Ryu, Jung-Han Yoon Department of Surgery, Chonnam National University College of Medicine, Gwangju, Korea INTRODUCTION The World Health Organization (WHO) Classification of  Tumors in 2004 defined poorly differentiated thyroid cancer  (PDTC) as “follicular-cell neoplasms that show limited evidence of structural follicular cell differentiation and occupy both morphologically and behaviorally an intermediate position between well differentiated thyroid cancer (WDTC) and anaplastic thyroid cancer (ATC)” [1-4].",Non-OADS,/arxiv_data1/oa_pdf/30/86/astr-88-187.PMC4384286.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/86/astr-88-187.PMC4384286.pdf
" Annals of Surgical Treatment and Research 181pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.4.181 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Feasibility of implementing a surgical student internship  program in South Korea HyeRin Roh, Ku Sang Kim1, Kee Hwan Kim2, In Seok Choi3, Kyu Eun Lee4, Hyun-Young Kim4, Nam-Joon Yi4, Sun- Whe Kim4, Min Gyu Kim5 Department of Medical Education, Inje University College of Medicine, Busan, 1Department of Surgery, Ajou University School of  Medicine, Suwon, 2Department of Surgery, The Catholic University of Korea College of Medicine, Seoul, 3Department of Surgery,  Konyang University College of Medicine, Daejeon, 4Department of Surgery, Seoul National University College of Medicine, Seoul,  5Department of Surgery, Hanyang University College of Medicine, Seoul, Korea INTRODUCTION Student internship (SI) is a component of the clinical edu­ cation program for fourth ­y ear students offered by most me­ dical schools in the United States [1].",Non-OADS,/arxiv_data1/oa_pdf/4b/04/astr-88-181.PMC4384287.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/04/astr-88-181.PMC4384287.pdf
Available from: http://connect.im.org/ p/cm/ld/fid=373.,Non-OADS,/arxiv_data1/oa_pdf/4b/04/astr-88-181.PMC4384287.pdf
Available from: http://connect.im.org/p/ cm/ld/fid=666.,OADS,/arxiv_data1/oa_pdf/4b/04/astr-88-181.PMC4384287.pdf
"208pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.4.208 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Follow-up results of acute portal and splenic vein  thrombosis with or without anticoagulation therapy after hepatobiliary and pancreatic surgery Chan Woo Cho, Yang Jin Park, Young-Wook Kim, Sung Ho Choi, Jin Seok Heo, Dong Wook Choi, Dong-Ik Kim Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea INTRODUCTION Abdominal intervention such as hepatobiliary and pancreatic  (HBP) surgery is known to be a risk factor associated with acute  portal and splenic vein thrombosis (APSVT).",Non-OADS,/arxiv_data1/oa_pdf/69/c2/astr-88-208.PMC4384288.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/c2/astr-88-208.PMC4384288.pdf
"236pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.4.236 Annals of Surgical Treatment and ResearchTECHNICAL ADVANCE Transanal gauze packing to manage massive presacral  bleeding secondary to prescral abscess caused by rectal anastomotic leakage: a novel approach Byung-Eun Yoo, Dong-Won Lee, Seung-Won Lee, Jung-Myun Kwak, Jin Kim, Seon-Hahn Kim Colorectal Division, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea INTRODUCTION Anastomotic leakage is a main cause of morbidity and mor­ tality following rectal resection [1].",Non-OADS,/arxiv_data1/oa_pdf/65/6f/astr-88-236.PMC4384289.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/6f/astr-88-236.PMC4384289.pdf
"Key Words: Acute lung injury, Diagnosis, Etiology, Prevention and control, Prognosis, Transfusion reaction.Transfusion-related acute lung  injury; clinical perspectives Jeongmin  Kim1,2 and Sungwon Na1,2 1Department of Anesthesiology and Pain Medicine, 2Anesthesia and Pain Research Institute, Yonsei University  College of Medicine, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/45/kjae-68-101.PMC4384395.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2015 Online access in http://ekja.orgpISSN 2005-6419 ·eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Sungwon Na, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Y onsei University College of Medicine, 50 Y onsei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel: 82-2-2228-2420, Fax: 82-2-312-7185E-mail: nswksj@yuhs.ac Received: December 30, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ff/45/kjae-68-101.PMC4384395.pdf
Korean J Anesthesiol 2015 April 68(2): 101-105  http://dx.doi.org/10.4097/kjae.2015.68.2.101,Non-OADS,/arxiv_data1/oa_pdf/ff/45/kjae-68-101.PMC4384395.pdf
102 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/ff/45/kjae-68-101.PMC4384395.pdf
103 Online access in http://ekja.orgKOrEAN J ANESTHESIOL Kim and Na  threshold model assumes that TRALI can occur when the sec- ond hit is so strong that an initial priming event is not needed.,OADS,/arxiv_data1/oa_pdf/ff/45/kjae-68-101.PMC4384395.pdf
104 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/ff/45/kjae-68-101.PMC4384395.pdf
105 Online access in http://ekja.orgKOrEAN J ANESTHESIOL Kim and Na  24.,Non-OADS,/arxiv_data1/oa_pdf/ff/45/kjae-68-101.PMC4384395.pdf
"Key Words: Checklist, Methods, Randomized controlled trial, Statistics.Statistical and methodological  considerations for reporting RCTs  in medical literature Sangseok Lee1 and Hyun Kang2 1Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, 2Chung-Ang University College of Medicine, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2015 Online access in http://ekja.orgpISSN 2005-6419 ·eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Hyun Kang, M.D., Ph.D., M.P .H.",Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
"Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, 102, Heukseok-ro, Dongjak-gu, Seoul 156-755, KoreaTel: 82-2-6299-2571, 2579, 2586, Fax: 82-2-6299-2585E-mail: roman00@naver.comORCID: http://orcid.org/0000-0003-2844-5880  Received: November 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
Korean J Anesthesiol 2015 April 68(2): 106-115  http://dx.doi.org/10.4097/kjae.2015.68.2.106,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
107 Online access in http://ekja.orgKOrEAN J ANESTHESIOL Lee and Kang to the research process or the method.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
The study to assess the kinds and degrees of biases contained  in the studies published on PubMed (http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
1)http://www.thelancet.com/protocol-reviews 2)http://www.thelancet.com/protocol-reviews 3)http://ekja.org/index.php?body=instruction 4)http://www.nature.com/authors/policies/checklist.pdf 5)http://www.bmj.com/content/312/7022/43.2Guidelines provide practical information designed to help  authors and reviewers report or review research methods and results by advising on the statistical and methodological ele - ments that must be included in the research papers.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
108 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
109 Online access in http://ekja.orgKOrEAN J ANESTHESIOL Lee and Kang 2-1.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
110 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
111 Online access in http://ekja.orgKOrEAN J ANESTHESIOL Lee and Kang member that sample size calculations and power analyses based  on primary endpoints may not be applied to secondary end-points.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
112 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
113 Online access in http://ekja.orgKOrEAN J ANESTHESIOL Lee and Kang The CONSORT Check List and other references have already  emphasized the importance of describing the blindness used in  research6) [27-29].,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
"If the measurement of the results is conducted at multiple  6)http://www.consort-statement.orgtime points, researchers must designate the most meaningful time point, or clarify whether they want to observe the differ - ences in specific time point or the overall differences.",Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
114 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
"ORCID Sangseok Lee, http://orcid.org/0000-0001-7023-3668 References 1.",Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
PLoS Med 2014; 11: e1001666.7)http://www.consort-statement.org,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
115 Online access in http://ekja.orgKOrEAN J ANESTHESIOL Lee and Kang 7.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/kjae-68-106.PMC4384396.pdf
"Key Words: Intubation, Laryngoscopy, Position.Comparison of the rate of  successful endotracheal intubation  between the “sniffing” and  “ramped” positions in patients with an expected difficult intubation   – a prospective randomized study- Ju-Hwan Lee, Hoe-Chang Jung, Ji-Hoon Shim, and Cheol Lee Department of Anesthesiology and Pain Medicine, Wonkwang University School of Medicine, Iksan, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/ad/kjae-68-116.PMC4384397.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2015 Online access in http://ekja.orgpISSN 2005-6419 ·eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Cheol Lee, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Wonkwang University School of Medicine, 895, Muwang-ro, Iksan 570-711, KoreaTel: 82-63-859-1564, Fax: 82-63-857-5472E-mail: ironyii@ wku.ac.kr Received: September 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/db/ad/kjae-68-116.PMC4384397.pdf
Korean J Anesthesiol 2015 April 68(2): 116-121  http://dx.doi.org/10.4097/kjae.2015.68.2.116,Non-OADS,/arxiv_data1/oa_pdf/db/ad/kjae-68-116.PMC4384397.pdf
117 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Lee et al.,OADS,/arxiv_data1/oa_pdf/db/ad/kjae-68-116.PMC4384397.pdf
118 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/db/ad/kjae-68-116.PMC4384397.pdf
119 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Lee et al.,OADS,/arxiv_data1/oa_pdf/db/ad/kjae-68-116.PMC4384397.pdf
120 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/db/ad/kjae-68-116.PMC4384397.pdf
121 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Lee et al.,OADS,/arxiv_data1/oa_pdf/db/ad/kjae-68-116.PMC4384397.pdf
"Key Words: Cerebral oximetry, Cerebral oxygenation, Indocyanine green, Near-infrared spectroscopy, Pulse oximetry.Effects of intravenously  administered indocyanine green  on near-infrared cerebral oximetry  and pulse oximetry readings Ho Y oung Baek, Hyun-jung Lee, Joung Min Kim, Soo-young Cho,   Seongtae Jeong, and Kyung Y eon Y oo  Department of Anesthesiology and Pain Medicine, Chonnam National University Hospital, Gwangju, Korea  CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/60/kjae-68-122.PMC4384398.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2015 Online access in http://ekja.orgpISSN 2005-6419 ·eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Kyung Y eon Y oo, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Chonnam National University Hospital, 42, Jebong-ro, Dong-gu, Gwangju 501-190, KoreaTel: 82-62-220-6893, Fax: 82-62-232-6294E-mail: kyyoo@jnu.ac.kr Received: August 26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/81/60/kjae-68-122.PMC4384398.pdf
Korean J Anesthesiol 2015 April 68(2): 122-127  http://dx.doi.org/10.4097/kjae.2015.68.2.122,Non-OADS,/arxiv_data1/oa_pdf/81/60/kjae-68-122.PMC4384398.pdf
123 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Baek et al.,OADS,/arxiv_data1/oa_pdf/81/60/kjae-68-122.PMC4384398.pdf
124 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/81/60/kjae-68-122.PMC4384398.pdf
125 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Baek et al.,OADS,/arxiv_data1/oa_pdf/81/60/kjae-68-122.PMC4384398.pdf
126 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/81/60/kjae-68-122.PMC4384398.pdf
127 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Baek et al.,OADS,/arxiv_data1/oa_pdf/81/60/kjae-68-122.PMC4384398.pdf
"Key Words: Fluid, Nomogram, Pharmacokinetics.The predictive performance of  infusion strategy nomogram based  on a fluid kinetic model Byung Moon Choi1, Myung Hwan Karm1, Kyeo Woon Jung1,   Y oung Goo Y eo2, and Kyu Taek Choi1 1Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine,  2The College of Engineering Hanyang University, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2015 Online access in http://ekja.orgpISSN 2005-6419 ·eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Kyu Taek Choi, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, KoreaTel: 82-2-3010-3857, Fax: 82-2-3010-6790E-mail: qtek@amc.seoul.kr Received: March 31, 2014.",Non-OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
Korean J Anesthesiol 2015 April 68(2): 128-135  http://dx.doi.org/10.4097/kjae.2015.68.2.128,Non-OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
129 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Choi et al.,OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
130 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
131 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Choi et al.,OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
132 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
"Statistical analysis  Population estimates of these performance measures was  calculated by a pooled data approach (fit4NM 3.5.1, Eun-Kyung Lee and Gyu-Jeong Noh, http://www.fit4nm.org/download, last accessed: Oct 17, 2011) [8,9].",OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
133 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Choi et al.,OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
134 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
135 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Choi et al.,OADS,/arxiv_data1/oa_pdf/34/0a/kjae-68-128.PMC4384399.pdf
"Key Words: Cisatracurium, Etomidate, Intratracheal intubation, Neuromuscular blockade, Propofol.Comparison of etomidate and  propofol on intubating conditions  and the onset time associated with  cisatracurium administration Y oung-Kwon Ko, Y oon-Hee Kim, Sang-Il Park, Woo Suk Chung, Chan Noh,  and Jung-Un Lee Department of Anesthesiology and Pain Medicine, Chungnam National University College of Medicine, Daejeon Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/26/kjae-68-136.PMC4384400.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2015 Online access in http://ekja.orgpISSN 2005-6419 ·eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Y oon-Hee Kim, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Chungnam National University College of Medicine, 282, Munhwa-ro, Jung-gu, Daejeon 301-721, KoreaTel: 82-42-280-7841, Fax: 82-42-280-7968E-mail: yhkim0404@cnu.ac.kr Received: September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6e/26/kjae-68-136.PMC4384400.pdf
Korean J Anesthesiol 2015 April 68(2): 136-140  http://dx.doi.org/10.4097/kjae.2015.68.2.136,Non-OADS,/arxiv_data1/oa_pdf/6e/26/kjae-68-136.PMC4384400.pdf
137 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Ko et al.,OADS,/arxiv_data1/oa_pdf/6e/26/kjae-68-136.PMC4384400.pdf
138 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/6e/26/kjae-68-136.PMC4384400.pdf
139 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Ko et al.,OADS,/arxiv_data1/oa_pdf/6e/26/kjae-68-136.PMC4384400.pdf
140 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/6e/26/kjae-68-136.PMC4384400.pdf
"Key Words: Bispectral index monitor, General anesthesia, Interventional radiology, Sevoflurane.The optimal anesthetic depth for  interventional neuroradiology:  comparisons between light  anesthesia and deep anesthesia Y oo Sun Jung1, Y e-Reum Han1, Eun-Su Choi2, Byung-Gun Kim2,   Hee-Pyoung Park1, Jung-Won Hwang2, and Y oung-Tae Jeon2 Department of Anesthesiology and Pain Medicine, 1Seoul National University Hospital, Seoul, 2Seoul National  University Bundang Hospital, Seongnam, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/a5/kjae-68-148.PMC4384402.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2015 Online access in http://ekja.orgpISSN 2005-6419 ·eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Y oung-Tae Jeon, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, 82, 173 beon-gil, Gumi-ro, Bundang-gu, Seongnam 463-707, Korea Tel: 82-31-787-7499, Fax: 82-31-787-4063E-mail: ytjeon@snubh.org Received: June 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/a5/kjae-68-148.PMC4384402.pdf
Korean J Anesthesiol 2015 April 68(2): 148-152  http://dx.doi.org/10.4097/kjae.2015.68.2.148,Non-OADS,/arxiv_data1/oa_pdf/3e/a5/kjae-68-148.PMC4384402.pdf
149 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Jung et al.,OADS,/arxiv_data1/oa_pdf/3e/a5/kjae-68-148.PMC4384402.pdf
150 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/3e/a5/kjae-68-148.PMC4384402.pdf
151 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Jung et al.,OADS,/arxiv_data1/oa_pdf/3e/a5/kjae-68-148.PMC4384402.pdf
152 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/3e/a5/kjae-68-148.PMC4384402.pdf
"Key Words: Fentanyl, Oxycodone, Patient-controlled analgesia, Postoperative pain.Comparison of oxycodone  and fentanyl for postoperative  patient-controlled analgesia after  laparoscopic gynecological surgery Joong-Ho Park, Chiu Lee, Y oungmin Shin, Ji-Hyun An, Jong-Seouk Ban,  and Ji-Hyang Lee Department of Anesthesiology and Pain Medicine, Daegu Fatima Hospital, Daegu, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/dd/kjae-68-153.PMC4384403.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2015 Online access in http://ekja.orgpISSN 2005-6419 ·eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Ji-Hyun An, M.D.",Non-OADS,/arxiv_data1/oa_pdf/b5/dd/kjae-68-153.PMC4384403.pdf
Korean J Anesthesiol 2015 April 68(2): 153-158  http://dx.doi.org/10.4097/kjae.2015.68.2.153,Non-OADS,/arxiv_data1/oa_pdf/b5/dd/kjae-68-153.PMC4384403.pdf
154 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/b5/dd/kjae-68-153.PMC4384403.pdf
155 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Park et al.,OADS,/arxiv_data1/oa_pdf/b5/dd/kjae-68-153.PMC4384403.pdf
156 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/b5/dd/kjae-68-153.PMC4384403.pdf
157 Online access in http://ekja.orgKOrEAN J ANESTHESIOL  Park et al.,OADS,/arxiv_data1/oa_pdf/b5/dd/kjae-68-153.PMC4384403.pdf
158 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/b5/dd/kjae-68-153.PMC4384403.pdf
"Key Words: Cytokine, Neuropathic pain, RNA interference.The time-course and RNA  interference of TNF-α, IL-6, and  IL-1β expression on neuropathic  pain induced by L5 spinal nerve transection in rats Byung Moon Choi1, Soo Han Lee2, Sang Mee An1, Do Y ang Park2,   Gwan Woo Lee3, and Gyu-Jeong Noh1,2 Departments of 1Anesthesiology and Pain Medicine, 2Clinical Pharmacology and Therapeutics, Asan Medical  Center, University of Ulsan College of Medicine, Seoul, 3Department of Anesthesiology and Pain Medicine, Dankook  University College of Medicine, Cheonan, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/13/kjae-68-159.PMC4384404.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2015 Online access in http://ekja.orgpISSN 2005-6419 ·eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Gyu-Jeong Noh, M.D., Ph.D.",Non-OADS,/arxiv_data1/oa_pdf/57/13/kjae-68-159.PMC4384404.pdf
